*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 280 GLU A 109 GLU~? 22.30 C2 PG4 C1130 A 283 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 288 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 4.25 95.66 42.75 4.18 93.57 42.69 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 9.66 95.18 46.95 8.19 90.97 44.00 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 13.49 92.75 43.16 12.39 91.15 42.33 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 A 232 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 280 GLU A 110 GLU~? 14.79 C2 PG4 C1130 A 283 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 288 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 4.25 95.66 42.75 4.18 93.57 42.69 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 9.66 95.18 46.95 8.19 90.97 44.00 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 13.49 92.75 43.16 12.39 91.15 42.33 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 A 232 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 280 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 283 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 4.25 95.66 42.75 4.18 93.57 42.69 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 9.66 95.18 46.95 8.19 90.97 44.00 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 13.49 92.75 43.16 12.39 91.15 42.33 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 4 4 # 4 A 232 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 280 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 283 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 4.25 95.66 42.75 4.18 93.57 42.69 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 9.66 95.18 46.95 8.19 90.97 44.00 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 13.49 92.75 43.16 12.39 91.15 42.33 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 5 4 # 5 A 232 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 280 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 283 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 288 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 4.25 95.66 42.75 4.18 93.57 42.69 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 9.66 95.18 46.95 8.19 90.97 44.00 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 13.49 92.75 43.16 12.39 91.15 42.33 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 6 4 # 6 A 232 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 280 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 283 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 288 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 4.25 95.66 42.75 4.18 93.57 42.69 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 9.66 95.18 46.95 8.19 90.97 44.00 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 13.49 92.75 43.16 12.39 91.15 42.33 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 7 4 # 7 A 232 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 280 GLU B 110 GLU~? 14.17 C17 P6G D1130 A 283 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 288 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 4.25 95.66 42.75 4.18 93.57 42.69 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 9.66 95.18 46.95 8.19 90.97 44.00 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 13.49 92.75 43.16 12.39 91.15 42.33 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 8 4 # 8 A 232 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 280 GLU B 120 GLU~? 31.89 C11 P6G D1130 A 283 LYS B 124 LYS~? 35.64 C18 P6G D1130 A 288 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 4.25 95.66 42.75 4.18 93.57 42.69 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 9.66 95.18 46.95 8.19 90.97 44.00 47.44 13.89 -26.91 47.07 18.95 -24.67 coo 13.49 92.75 43.16 12.39 91.15 42.33 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 9 4 # 9 A 232 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 280 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 283 LYS B 124 LYS~? 35.64 C18 P6G D1130 A 288 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 4.25 95.66 42.75 4.18 93.57 42.69 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 9.66 95.18 46.95 8.19 90.97 44.00 47.44 13.89 -26.91 47.07 18.95 -24.67 coo 13.49 92.75 43.16 12.39 91.15 42.33 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 10 4 # 10 A 232 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 280 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 283 LYS A 125 LYS~? 18.08 O1 P6G D1130 A 288 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 4.25 95.66 42.75 4.18 93.57 42.69 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 9.66 95.18 46.95 8.19 90.97 44.00 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 13.49 92.75 43.16 12.39 91.15 42.33 8.90 2.49 -40.53 8.63 4.21 -39.28 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 11 4 # 11 A 232 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 280 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 283 LYS A 125 LYS~? 18.08 O1 P6G D1130 A 288 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 4.25 95.66 42.75 4.18 93.57 42.69 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 9.66 95.18 46.95 8.19 90.97 44.00 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 13.49 92.75 43.16 12.39 91.15 42.33 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 12 4 # 12 A 232 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 280 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 283 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 4.25 95.66 42.75 4.18 93.57 42.69 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 9.66 95.18 46.95 8.19 90.97 44.00 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 13.49 92.75 43.16 12.39 91.15 42.33 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 13 4 # 13 A 232 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 280 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 283 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 288 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 5.76 85.47 37.35 6.76 85.56 39.24 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 4.25 95.66 42.75 4.18 93.57 42.69 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 9.66 95.18 46.95 8.19 90.97 44.00 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 13.49 92.75 43.16 12.39 91.15 42.33 30.54 14.87 -46.06 28.97 16.29 -46.38 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 13 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 280 GLU A 109 GLU~? 22.30 C2 PG4 C1130 B 283 LYS A 113 LYS~? 24.04 C2 PG4 C1130 B 288 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 B 232 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 280 GLU A 110 GLU~? 14.79 C2 PG4 C1130 B 283 LYS A 113 LYS~? 24.04 C2 PG4 C1130 B 288 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 B 232 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 280 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 283 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 4.39 5.46 -30.92 3.12 7.08 -30.47 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 9.54 9.95 -32.52 4.98 7.78 -34.65 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 4 4 # 4 B 232 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 280 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 283 LYS D 113 LYS~? 21.47 O1 P6G D1130 B 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 4.39 5.46 -30.92 3.12 7.08 -30.47 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 10.74 10.01 -28.88 5.91 8.82 -26.43 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 5 4 # 5 B 232 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 280 GLU D 110 GLU~? 16.67 O1 P6G D1130 B 283 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 288 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 12.41 4.04 -29.37 12.28 4.39 -27.28 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 9.54 9.95 -32.52 4.98 7.78 -34.65 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 6 4 # 6 B 232 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 280 GLU B 109 GLU~? 22.36 C17 P6G D1130 B 283 LYS B 113 LYS~? 24.16 C17 P6G D1130 B 288 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 32.72 14.03 -52.77 34.27 12.68 -52.28 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 38.03 21.53 -47.60 38.82 23.44 -47.86 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 39.51 19.43 -40.28 40.84 23.44 -43.47 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 7 4 # 7 B 232 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 280 GLU B 110 GLU~? 14.17 C17 P6G D1130 B 283 LYS B 113 LYS~? 24.16 C17 P6G D1130 B 288 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 32.72 14.03 -52.77 34.27 12.68 -52.28 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 32.90 20.43 -41.22 30.91 19.85 -41.11 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 39.51 19.43 -40.28 40.84 23.44 -43.47 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 8 4 # 8 B 232 GLU D 55 GLU~? 14.43 O7 P6G D1130 B 280 GLU D 69 GLU~? 15.99 C6 P6G D1130 B 283 LYS A 125 LYS~? 18.08 O1 P6G D1130 B 288 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 5.29 7.89 -51.10 4.11 8.75 -49.57 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 8.90 2.49 -40.53 8.63 4.21 -39.28 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 9 4 # 9 B 232 GLU D 55 GLU~? 14.43 O7 P6G D1130 B 280 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 283 LYS A 125 LYS~? 18.08 O1 P6G D1130 B 288 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 5.29 7.89 -51.10 4.11 8.75 -49.57 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 8.90 2.49 -40.53 8.63 4.21 -39.28 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 10 4 # 10 B 232 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 280 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 283 LYS D 113 LYS~? 21.47 O1 P6G D1130 B 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 8.90 2.49 -40.53 8.63 4.21 -39.28 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 4.39 5.46 -30.92 3.12 7.08 -30.47 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 10.74 10.01 -28.88 5.91 8.82 -26.43 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 11 4 # 11 B 232 GLU D 94 GLU~? 9.44 O19 P6G D1130 B 280 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 283 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 288 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo -0.96 61.87 2.24 -2.27 63.48 2.70 24.07 21.72 -40.89 25.61 20.78 -41.98 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 22.48 10.01 -42.20 22.42 10.27 -44.26 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 30.54 14.87 -46.06 28.97 16.29 -46.38 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 11 hits 1aq0_c01 naa= 4 ULMN 4 1bzy_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 133 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 134 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 137 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 13.34 89.40 45.53 11.81 89.79 44.14 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 9.14 89.42 48.04 8.93 88.63 46.06 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 11.51 80.72 44.41 10.38 78.98 44.80 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 13.35 79.17 49.96 8.00 78.73 47.28 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1bzy_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 A 133 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 134 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 137 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 13.34 89.40 45.53 11.81 89.79 44.14 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 9.14 89.42 48.04 8.93 88.63 46.06 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 11.51 80.72 44.41 10.38 78.98 44.80 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 13.35 79.17 49.96 8.00 78.73 47.28 23.08 11.99 -34.73 21.14 6.51 -33.38 1bzy_c00 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c00 naa= 4 ULMN 4 1bzy_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 B 133 GLU A 82 GLU~? 16.13 C6 PG4 C1130 B 134 ASP A 85 ASP~? 19.32 C6 PG4 C1130 B 137 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -0.78 112.03 42.85 0.95 111.50 41.80 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 2.83 112.32 46.21 3.45 112.93 44.27 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 1.33 120.54 41.38 2.37 122.32 41.83 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -1.54 122.74 46.23 4.22 122.84 44.60 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1bzy_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 B 133 GLU B 82 GLU~? 13.30 C2 P6G D1130 B 134 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 137 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -0.78 112.03 42.85 0.95 111.50 41.80 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 2.83 112.32 46.21 3.45 112.93 44.27 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 1.33 120.54 41.38 2.37 122.32 41.83 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -1.54 122.74 46.23 4.22 122.84 44.60 23.08 11.99 -34.73 21.14 6.51 -33.38 1bzy_c01 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c01 naa= 4 ULMN 4 1bzy_c02 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 133 GLU A 82 GLU~? 16.13 C6 PG4 C1130 C 134 ASP A 85 ASP~? 19.32 C6 PG4 C1130 C 137 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 0.15 90.11 85.87 1.29 91.36 87.12 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 4.00 91.31 83.02 4.55 90.96 85.06 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 5.10 82.97 88.07 6.79 81.71 87.85 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 4.16 80.06 82.93 9.22 82.34 85.00 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1bzy_c02 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 C 133 GLU B 82 GLU~? 13.30 C2 P6G D1130 C 134 ASP B 85 ASP~? 16.97 O1 P6G D1130 C 137 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 0.15 90.11 85.87 1.29 91.36 87.12 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 4.00 91.31 83.02 4.55 90.96 85.06 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 5.10 82.97 88.07 6.79 81.71 87.85 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 4.16 80.06 82.93 9.22 82.34 85.00 23.08 11.99 -34.73 21.14 6.51 -33.38 1bzy_c02 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c02 naa= 4 ULMN 4 1bzy_c03 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 D 133 GLU A 82 GLU~? 16.13 C6 PG4 C1130 D 134 ASP A 85 ASP~? 19.32 C6 PG4 C1130 D 137 ASP C 85 ASP~? 10.22 C6 PG4 C1130 D 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 4.48 116.39 84.65 3.07 115.42 85.88 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 1.16 114.72 81.44 0.30 115.35 83.28 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 1.15 125.85 79.67 -4.25 124.18 81.47 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1bzy_c03 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 D 133 GLU B 82 GLU~? 13.30 C2 P6G D1130 D 134 ASP B 85 ASP~? 16.97 O1 P6G D1130 D 137 ASP D 85 ASP~? 10.24 C11 P6G D1130 D 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 4.48 116.39 84.65 3.07 115.42 85.88 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 1.16 114.72 81.44 0.30 115.35 83.28 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -0.72 123.60 84.94 -2.32 124.82 84.32 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 1.15 125.85 79.67 -4.25 124.18 81.47 23.08 11.99 -34.73 21.14 6.51 -33.38 1bzy_c03 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c03 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP C 107 ASP.? 16.10 C8 PG4 C1130 M 206 SER A 78 SER~? 11.56 C6 PG4 C1130 M 210 ARG A 77 ARG~? 12.69 C2 PG4 C1130 M 214 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 1 hits 1c17_c11 naa= 4 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 A 393 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 433 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 456 LYS A 124 LYS~? 16.08 O1 P6G D1130 A 458 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 8.61 51.76 73.74 9.78 51.49 70.80 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 14.59 54.44 69.55 14.31 53.05 67.99 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 1.72 46.30 68.29 5.79 48.68 67.64 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo 6.20 47.59 62.97 6.73 49.77 65.20 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1d8h_c00 source 1d8h MRNA TRIPHOSPHATASE CET1 : 1 hits 1d8h_c00 naa= 4 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 B 393 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 433 GLU D 110 GLU~? 16.67 O1 P6G D1130 B 456 LYS A 124 LYS~? 16.08 O1 P6G D1130 B 458 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -1.83 99.06 29.59 -0.10 96.84 28.90 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -1.96 91.25 27.47 0.16 91.64 27.05 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 7.52 102.36 32.33 4.96 99.05 30.60 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo 9.47 95.54 30.17 6.44 95.66 31.22 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 2 4 # 2 B 393 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 433 GLU D 110 GLU~? 16.67 O1 P6G D1130 B 456 LYS A 125 LYS~? 18.08 O1 P6G D1130 B 458 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -1.83 99.06 29.59 -0.10 96.84 28.90 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -1.96 91.25 27.47 0.16 91.64 27.05 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 7.52 102.36 32.33 4.96 99.05 30.60 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 9.47 95.54 30.17 6.44 95.66 31.22 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1d8h_c01 source 1d8h MRNA TRIPHOSPHATASE CET1 : 2 hits 1d8h_c01 naa= 4 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 C 393 ARG D 77 ARG~? 8.78 O1 P6G D1130 C 433 GLU D 110 GLU~? 16.67 O1 P6G D1130 C 456 LYS A 124 LYS~? 16.08 O1 P6G D1130 C 458 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 5.89 19.72 74.11 3.89 22.05 73.98 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 2.64 24.82 79.60 2.66 26.04 77.84 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 2.79 21.47 64.30 3.04 22.87 68.57 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo -0.70 27.77 67.44 -0.05 25.34 69.46 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 2 4 # 2 C 393 ARG D 77 ARG~? 8.78 O1 P6G D1130 C 433 GLU D 110 GLU~? 16.67 O1 P6G D1130 C 456 LYS A 125 LYS~? 18.08 O1 P6G D1130 C 458 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 5.89 19.72 74.11 3.89 22.05 73.98 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 2.64 24.82 79.60 2.66 26.04 77.84 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 2.79 21.47 64.30 3.04 22.87 68.57 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo -0.70 27.77 67.44 -0.05 25.34 69.46 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1d8h_c02 source 1d8h MRNA TRIPHOSPHATASE CET1 : 2 hits 1d8h_c02 naa= 4 ULMN 4 1dgs_c02 DNA LIGASE user 1 4 # 1 A 116 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 118 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 196 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 312 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 28.15 14.26 17.66 24.32 10.53 19.45 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.81 17.20 14.31 21.99 17.18 16.45 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 19.30 14.28 13.45 20.80 11.67 12.77 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 26.32 10.33 25.16 21.66 11.07 21.98 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 4 1dgs_c02 DNA LIGASE user 2 4 # 2 A 116 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 118 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 196 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 312 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 28.15 14.26 17.66 24.32 10.53 19.45 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.81 17.20 14.31 21.99 17.18 16.45 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 19.30 14.28 13.45 20.80 11.67 12.77 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 26.32 10.33 25.16 21.66 11.07 21.98 39.66 6.36 -42.06 38.78 0.18 -41.50 1dgs_c02 source 1dgs DNA LIGASE : 2 hits 1dgs_c02 naa= 4 ULMN 4 1fsg_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 A 146 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 147 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 150 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 178 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 25.15 35.36 -14.10 25.49 37.13 -15.26 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 24.20 39.15 -10.33 23.35 40.02 -12.02 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 14.98 32.15 -10.38 13.23 37.46 -12.31 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1fsg_c00 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 A 146 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 147 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 150 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 178 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 25.15 35.36 -14.10 25.49 37.13 -15.26 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 24.20 39.15 -10.33 23.35 40.02 -12.02 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 14.98 32.15 -10.38 13.23 37.46 -12.31 23.08 11.99 -34.73 21.14 6.51 -33.38 1fsg_c00 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1fsg_c00 naa= 4 ULMN 4 1fsg_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 4 # 1 C 146 GLU A 82 GLU~? 16.13 C6 PG4 C1130 C 147 ASP A 85 ASP~? 19.32 C6 PG4 C1130 C 150 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 178 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 21.13 43.45 27.66 22.75 42.66 28.81 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 23.59 40.44 23.80 23.75 39.21 25.49 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 15.48 36.57 28.52 14.54 34.69 28.40 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 12.35 37.47 23.73 15.50 32.82 25.71 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1fsg_c01 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 4 # 2 C 146 GLU B 82 GLU~? 13.30 C2 P6G D1130 C 147 ASP B 85 ASP~? 16.97 O1 P6G D1130 C 150 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 178 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 21.13 43.45 27.66 22.75 42.66 28.81 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 23.59 40.44 23.80 23.75 39.21 25.49 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 15.48 36.57 28.52 14.54 34.69 28.40 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 12.35 37.47 23.73 15.50 32.82 25.71 23.08 11.99 -34.73 21.14 6.51 -33.38 1fsg_c01 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1fsg_c01 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 279 GLU A 109 GLU~? 22.30 C2 PG4 C1130 A 282 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 288 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 A 231 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 279 GLU A 110 GLU~? 14.79 C2 PG4 C1130 A 282 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 288 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 4 # 3 A 231 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 282 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 54.40 -0.12 97.85 55.58 0.51 96.24 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 4 # 4 A 231 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 282 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 54.40 -0.12 97.85 55.58 0.51 96.24 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 5 4 # 5 A 231 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 279 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 282 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 288 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 54.40 -0.12 97.85 55.58 0.51 96.24 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 6 4 # 6 A 231 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 279 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 282 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 288 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 54.40 -0.12 97.85 55.58 0.51 96.24 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 7 4 # 7 A 231 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 279 GLU B 110 GLU~? 14.17 C17 P6G D1130 A 282 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 288 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 54.40 -0.12 97.85 55.58 0.51 96.24 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 8 4 # 8 A 231 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 279 GLU B 120 GLU~? 31.89 C11 P6G D1130 A 282 LYS B 124 LYS~? 35.64 C18 P6G D1130 A 288 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 47.44 13.89 -26.91 47.07 18.95 -24.67 coo 54.40 -0.12 97.85 55.58 0.51 96.24 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 9 4 # 9 A 231 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 279 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 282 LYS B 124 LYS~? 35.64 C18 P6G D1130 A 288 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 47.44 13.89 -26.91 47.07 18.95 -24.67 coo 54.40 -0.12 97.85 55.58 0.51 96.24 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 10 4 # 10 A 231 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 279 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 282 LYS A 125 LYS~? 18.08 O1 P6G D1130 A 288 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 54.40 -0.12 97.85 55.58 0.51 96.24 8.90 2.49 -40.53 8.63 4.21 -39.28 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 11 4 # 11 A 231 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 279 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 282 LYS A 125 LYS~? 18.08 O1 P6G D1130 A 288 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 54.40 -0.12 97.85 55.58 0.51 96.24 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 12 4 # 12 A 231 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 282 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 54.40 -0.12 97.85 55.58 0.51 96.24 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 13 4 # 13 A 231 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 279 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 282 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 288 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 56.45 0.46 86.18 56.87 -0.85 87.80 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 54.40 -0.12 97.85 55.58 0.51 96.24 30.54 14.87 -46.06 28.97 16.29 -46.38 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 13 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 279 GLU A 109 GLU~? 22.30 C2 PG4 C1130 B 282 LYS A 113 LYS~? 24.04 C2 PG4 C1130 B 288 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 B 231 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 279 GLU A 110 GLU~? 14.79 C2 PG4 C1130 B 282 LYS A 113 LYS~? 24.04 C2 PG4 C1130 B 288 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 4 # 3 B 231 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 282 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 4 # 4 B 231 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 282 LYS D 113 LYS~? 21.47 O1 P6G D1130 B 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 5 4 # 5 B 231 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 279 GLU D 110 GLU~? 16.67 O1 P6G D1130 B 282 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 288 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 6 4 # 6 B 231 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 279 GLU B 109 GLU~? 22.36 C17 P6G D1130 B 282 LYS B 113 LYS~? 24.16 C17 P6G D1130 B 288 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 7 4 # 7 B 231 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 279 GLU B 110 GLU~? 14.17 C17 P6G D1130 B 282 LYS B 113 LYS~? 24.16 C17 P6G D1130 B 288 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 8 4 # 8 B 231 GLU B 100 GLU~? 26.53 C3 P6G D1130 B 279 GLU B 120 GLU~? 31.89 C11 P6G D1130 B 282 LYS B 124 LYS~? 35.64 C18 P6G D1130 B 288 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 47.44 13.89 -26.91 47.07 18.95 -24.67 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 9 4 # 9 B 231 GLU B 100 GLU~? 26.53 C3 P6G D1130 B 279 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 282 LYS B 124 LYS~? 35.64 C18 P6G D1130 B 288 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 47.44 13.89 -26.91 47.07 18.95 -24.67 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 10 4 # 10 B 231 GLU D 55 GLU~? 14.43 O7 P6G D1130 B 279 GLU D 69 GLU~? 15.99 C6 P6G D1130 B 282 LYS A 125 LYS~? 18.08 O1 P6G D1130 B 288 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 8.90 2.49 -40.53 8.63 4.21 -39.28 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 11 4 # 11 B 231 GLU D 55 GLU~? 14.43 O7 P6G D1130 B 279 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 282 LYS A 125 LYS~? 18.08 O1 P6G D1130 B 288 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 12 4 # 12 B 231 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 282 LYS D 113 LYS~? 21.47 O1 P6G D1130 B 288 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 13 4 # 13 B 231 GLU D 94 GLU~? 9.44 O19 P6G D1130 B 279 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 282 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 288 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 30.54 14.87 -46.06 28.97 16.29 -46.38 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 13 hits 1ghs_c01 naa= 4 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 1 4 # 1 A 131 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 179 SER A 106 SER~? 15.55 C4 PG4 C1130 A 210 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 263 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 15.28 27.01 21.57 16.48 25.33 21.25 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 16.21 20.65 20.59 17.61 22.54 21.18 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 coo 18.09 17.00 14.23 20.70 20.73 18.57 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 17.39 20.36 11.09 19.81 23.46 16.09 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 2 4 # 2 A 131 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 179 SER A 106 SER~? 15.55 C4 PG4 C1130 A 210 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 263 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 15.28 27.01 21.57 16.48 25.33 21.25 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 16.21 20.65 20.59 17.61 22.54 21.18 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 coo 18.09 17.00 14.23 20.70 20.73 18.57 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 17.39 20.36 11.09 19.81 23.46 16.09 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 3 4 # 3 A 131 ASP B 107 ASP.? 21.14 C14 P6G D1130 A 179 SER B 106 SER~? 15.38 C14 P6G D1130 A 210 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 263 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 15.28 27.01 21.57 16.48 25.33 21.25 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 16.21 20.65 20.59 17.61 22.54 21.18 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 18.09 17.00 14.23 20.70 20.73 18.57 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 17.39 20.36 11.09 19.81 23.46 16.09 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 4 4 # 4 A 131 ASP B 107 ASP.? 21.14 C14 P6G D1130 A 179 SER B 106 SER~? 15.38 C14 P6G D1130 A 210 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 263 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 15.28 27.01 21.57 16.48 25.33 21.25 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 16.21 20.65 20.59 17.61 22.54 21.18 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 18.09 17.00 14.23 20.70 20.73 18.57 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 17.39 20.36 11.09 19.81 23.46 16.09 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 5 4 # 5 A 131 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 179 SER C 106 SER~? 13.31 O4 PG4 C1130 A 210 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 263 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 15.28 27.01 21.57 16.48 25.33 21.25 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 16.21 20.65 20.59 17.61 22.54 21.18 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 18.09 17.00 14.23 20.70 20.73 18.57 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 17.39 20.36 11.09 19.81 23.46 16.09 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 6 4 # 6 A 131 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 179 SER C 106 SER~? 13.31 O4 PG4 C1130 A 210 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 263 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 15.28 27.01 21.57 16.48 25.33 21.25 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 16.21 20.65 20.59 17.61 22.54 21.18 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 18.09 17.00 14.23 20.70 20.73 18.57 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 17.39 20.36 11.09 19.81 23.46 16.09 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 7 4 # 7 A 131 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 179 SER D 106 SER~? 11.54 O1 P6G D1130 A 210 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 263 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 15.28 27.01 21.57 16.48 25.33 21.25 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 16.21 20.65 20.59 17.61 22.54 21.18 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 18.09 17.00 14.23 20.70 20.73 18.57 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 17.39 20.36 11.09 19.81 23.46 16.09 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 8 4 # 8 A 131 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 179 SER D 106 SER~? 11.54 O1 P6G D1130 A 210 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 263 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 15.28 27.01 21.57 16.48 25.33 21.25 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 16.21 20.65 20.59 17.61 22.54 21.18 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 18.09 17.00 14.23 20.70 20.73 18.57 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 17.39 20.36 11.09 19.81 23.46 16.09 14.51 2.78 -43.17 17.25 -1.27 -44.64 1h7o_c00 source 1h7o 5-AMINOLAEVULINIC ACID DEHYDRATASE : 8 hits 1h7o_c00 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 55 GLU~? 16.41 O5 PG4 C1130 A 485 LYS A 59 LYS~? 19.76 O5 PG4 C1130 A 488 GLU A 61 GLU~? 21.55 O5 PG4 C1130 A 603 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 A 481 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 485 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 488 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 603 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 A 481 GLU B 55 GLU~? 15.05 C3 P6G D1130 A 485 LYS B 59 LYS~? 17.23 O4 P6G D1130 A 488 GLU B 61 GLU~? 21.58 O4 P6G D1130 A 603 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 33.77 1.13 -50.00 34.67 1.54 -48.13 coo -9.44 10.08 8.58 -11.94 6.98 8.10 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo -13.30 11.40 4.76 -13.95 9.40 5.16 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo -21.26 6.97 3.81 -20.43 4.23 9.21 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 4 # 4 A 481 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 485 LYS C 59 LYS~? 18.46 C8 PG4 C1130 A 488 GLU C 61 GLU~? 21.06 O5 PG4 C1130 A 603 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 4 # 5 A 481 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 485 LYS C 84 LYS~? 13.44 C6 PG4 C1130 A 488 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 603 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 4 # 6 A 481 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 485 LYS D 59 LYS~? 18.77 O7 P6G D1130 A 488 GLU D 61 GLU~? 21.02 C9 P6G D1130 A 603 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 5.29 7.89 -51.10 4.11 8.75 -49.57 coo -9.44 10.08 8.58 -11.94 6.98 8.10 3.27 6.90 -57.68 0.31 8.60 -52.41 coo -13.30 11.40 4.76 -13.95 9.40 5.16 7.67 8.26 -62.85 7.30 9.08 -64.79 coo -21.26 6.97 3.81 -20.43 4.23 9.21 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 7 4 # 7 A 481 GLU D 61 GLU~? 21.02 C9 P6G D1130 A 485 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 488 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 603 LYS D 32 LYS~? 27.03 C6 P6G D1130 coo -7.79 3.39 10.29 -9.01 4.74 9.32 7.67 8.26 -62.85 7.30 9.08 -64.79 coo -9.44 10.08 8.58 -11.94 6.98 8.10 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -13.30 11.40 4.76 -13.95 9.40 5.16 16.41 7.14 -67.21 16.99 7.91 -69.11 coo -21.26 6.97 3.81 -20.43 4.23 9.21 14.22 -2.15 -70.37 13.65 -7.80 -70.43 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 8 4 # 8 A 481 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 485 LYS A 125 LYS~? 18.08 O1 P6G D1130 A 488 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 603 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -7.79 3.39 10.29 -9.01 4.74 9.32 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo -9.44 10.08 8.58 -11.94 6.98 8.10 6.58 -3.76 -40.18 3.66 -7.32 -42.07 coo -13.30 11.40 4.76 -13.95 9.40 5.16 8.90 2.49 -40.53 8.63 4.21 -39.28 coo -21.26 6.97 3.81 -20.43 4.23 9.21 14.33 6.41 -44.26 15.86 10.02 -47.66 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 8 hits 1jxa_c01 naa= 4 ULMN 4 1m53_c04 ISOMALTULOSE SYNTHASE user 1 4 # 1 A 241 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 295 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 297 PHE C 87 PHE~? 15.40 C1 PG4 C1130 A 369 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 16.11 33.72 80.99 14.10 33.54 81.63 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 14.66 28.57 79.93 13.93 26.21 81.24 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 1m53_c04 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c04 naa= 4 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 481 GLU A 37 GLU~? 22.40 O5 PG4 C1130 485 LYS A 41 LYS~? 15.70 O5 PG4 C1130 488 GLU A 44 GLU~? 13.07 O5 PG4 C1130 603 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 24.49 18.95 6.71 25.16 18.17 4.85 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 21.77 13.74 4.55 26.03 15.07 4.05 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 22.93 13.34 0.22 24.67 14.21 1.12 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 481 GLU B 69 GLU~? 16.29 C14 P6G D1130 485 LYS B 72 LYS~? 17.42 C8 P6G D1130 488 GLU B 73 GLU~? 10.65 C14 P6G D1130 603 LYS B 113 LYS~? 24.16 C17 P6G D1130 coo 24.49 18.95 6.71 25.16 18.17 4.85 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 21.77 13.74 4.55 26.03 15.07 4.05 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.93 13.34 0.22 24.67 14.21 1.12 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 31.74 12.46 -4.74 33.15 13.34 0.17 39.51 19.43 -40.28 40.84 23.44 -43.47 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 481 GLU C 37 GLU~? 22.29 O5 PG4 C1130 485 LYS C 41 LYS~? 13.38 C3 PG4 C1130 488 GLU C 44 GLU~? 12.88 O5 PG4 C1130 603 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 24.49 18.95 6.71 25.16 18.17 4.85 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 21.77 13.74 4.55 26.03 15.07 4.05 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 22.93 13.34 0.22 24.67 14.21 1.12 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 4 # 4 481 GLU C 37 GLU~? 22.29 O5 PG4 C1130 485 LYS C 41 LYS~? 13.38 C3 PG4 C1130 488 GLU C 44 GLU~? 12.88 O5 PG4 C1130 603 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 24.49 18.95 6.71 25.16 18.17 4.85 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 21.77 13.74 4.55 26.03 15.07 4.05 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 22.93 13.34 0.22 24.67 14.21 1.12 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 4 # 5 481 GLU D 37 GLU~? 22.00 C9 P6G D1130 485 LYS D 41 LYS~? 14.07 C15 P6G D1130 488 GLU D 44 GLU~? 13.05 C9 P6G D1130 603 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 24.49 18.95 6.71 25.16 18.17 4.85 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 21.77 13.74 4.55 26.03 15.07 4.05 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 22.93 13.34 0.22 24.67 14.21 1.12 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 31.74 12.46 -4.74 33.15 13.34 0.17 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 4 # 6 481 GLU D 37 GLU~? 22.00 C9 P6G D1130 485 LYS D 41 LYS~? 14.07 C15 P6G D1130 488 GLU D 44 GLU~? 13.05 C9 P6G D1130 603 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 24.49 18.95 6.71 25.16 18.17 4.85 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 21.77 13.74 4.55 26.03 15.07 4.05 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 22.93 13.34 0.22 24.67 14.21 1.12 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 31.74 12.46 -4.74 33.15 13.34 0.17 31.06 5.90 -60.97 28.02 9.66 -62.79 1moq_c00 source 1moq GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1moq_c00 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 A 302 SER A 116 SER~? 25.66 C6 PG4 C1130 A 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 85.01 60.31 56.44 83.15 64.89 56.44 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 71.86 54.60 60.61 70.38 53.71 61.84 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 68.68 62.06 66.08 69.52 59.75 65.97 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 66.34 67.16 63.84 67.47 65.57 63.06 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 A 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 A 302 SER B 106 SER~? 15.38 C14 P6G D1130 A 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 85.01 60.31 56.44 83.15 64.89 56.44 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 71.86 54.60 60.61 70.38 53.71 61.84 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 68.68 62.06 66.08 69.52 59.75 65.97 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 66.34 67.16 63.84 67.47 65.57 63.06 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 A 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 A 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 A 302 SER B 106 SER~? 15.38 C14 P6G D1130 A 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 85.01 60.31 56.44 83.15 64.89 56.44 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 71.86 54.60 60.61 70.38 53.71 61.84 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 68.68 62.06 66.08 69.52 59.75 65.97 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 66.34 67.16 63.84 67.47 65.57 63.06 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c00 naa= 4 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 B 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 B 302 SER A 116 SER~? 25.66 C6 PG4 C1130 B 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 54.45 47.08 36.74 56.53 48.29 32.40 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 67.17 40.71 41.61 68.49 39.13 42.13 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 70.41 37.34 33.01 69.41 36.86 35.23 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 73.06 40.82 28.87 71.88 41.23 30.58 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 B 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 B 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 B 302 SER B 106 SER~? 15.38 C14 P6G D1130 B 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 54.45 47.08 36.74 56.53 48.29 32.40 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 67.17 40.71 41.61 68.49 39.13 42.13 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 70.41 37.34 33.01 69.41 36.86 35.23 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 73.06 40.82 28.87 71.88 41.23 30.58 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 B 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 B 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 B 302 SER B 106 SER~? 15.38 C14 P6G D1130 B 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 54.45 47.08 36.74 56.53 48.29 32.40 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 67.17 40.71 41.61 68.49 39.13 42.13 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 70.41 37.34 33.01 69.41 36.86 35.23 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 73.06 40.82 28.87 71.88 41.23 30.58 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c01 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c01 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 C 302 SER A 116 SER~? 25.66 C6 PG4 C1130 C 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 83.30 16.28 88.61 85.25 11.75 88.79 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 79.88 15.02 74.11 80.06 15.36 72.02 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 87.46 9.36 71.39 86.33 11.53 71.37 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 87.65 3.44 72.32 86.49 4.99 73.13 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 C 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 C 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 C 302 SER B 106 SER~? 15.38 C14 P6G D1130 C 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 83.30 16.28 88.61 85.25 11.75 88.79 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 79.88 15.02 74.11 80.06 15.36 72.02 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 87.46 9.36 71.39 86.33 11.53 71.37 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 87.65 3.44 72.32 86.49 4.99 73.13 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 C 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 C 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 C 302 SER B 106 SER~? 15.38 C14 P6G D1130 C 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 83.30 16.28 88.61 85.25 11.75 88.79 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 79.88 15.02 74.11 80.06 15.36 72.02 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 87.46 9.36 71.39 86.33 11.53 71.37 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 87.65 3.44 72.32 86.49 4.99 73.13 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 D 302 SER A 116 SER~? 25.66 C6 PG4 C1130 D 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 51.91 3.68 69.52 49.61 2.30 73.71 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 55.94 16.93 75.09 55.86 19.04 75.37 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 48.09 18.43 80.84 49.40 18.94 78.77 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 47.32 15.81 86.19 48.62 15.41 84.58 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 D 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 D 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 D 302 SER B 106 SER~? 15.38 C14 P6G D1130 D 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 51.91 3.68 69.52 49.61 2.30 73.71 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 55.94 16.93 75.09 55.86 19.04 75.37 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 48.09 18.43 80.84 49.40 18.94 78.77 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 47.32 15.81 86.19 48.62 15.41 84.58 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 D 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 D 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 D 302 SER B 106 SER~? 15.38 C14 P6G D1130 D 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 51.91 3.68 69.52 49.61 2.30 73.71 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 55.94 16.93 75.09 55.86 19.04 75.37 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 48.09 18.43 80.84 49.40 18.94 78.77 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 47.32 15.81 86.19 48.62 15.41 84.58 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 E 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 E 302 SER A 116 SER~? 25.66 C6 PG4 C1130 E 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 52.46 147.49 107.94 50.14 148.75 103.77 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 57.01 134.41 102.36 57.01 132.29 102.10 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 49.26 132.62 96.59 50.54 132.08 98.67 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 48.52 135.25 91.24 49.73 135.67 92.87 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 E 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 E 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 E 302 SER B 106 SER~? 15.38 C14 P6G D1130 E 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 52.46 147.49 107.94 50.14 148.75 103.77 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 57.01 134.41 102.36 57.01 132.29 102.10 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 49.26 132.62 96.59 50.54 132.08 98.67 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 48.52 135.25 91.24 49.73 135.67 92.87 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 E 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 E 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 E 302 SER B 106 SER~? 15.38 C14 P6G D1130 E 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 52.46 147.49 107.94 50.14 148.75 103.77 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 57.01 134.41 102.36 57.01 132.29 102.10 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 49.26 132.62 96.59 50.54 132.08 98.67 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 48.52 135.25 91.24 49.73 135.67 92.87 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 F 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 F 302 SER A 116 SER~? 25.66 C6 PG4 C1130 F 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 84.18 136.24 88.80 85.96 140.90 88.66 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 80.72 137.29 103.27 80.90 136.95 105.39 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 87.99 143.28 106.06 86.95 141.03 106.01 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 87.94 149.19 105.12 86.87 147.57 104.33 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 F 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 F 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 F 302 SER B 106 SER~? 15.38 C14 P6G D1130 F 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 84.18 136.24 88.80 85.96 140.90 88.66 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 80.72 137.29 103.27 80.90 136.95 105.39 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 87.99 143.28 106.06 86.95 141.03 106.01 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 87.94 149.19 105.12 86.87 147.57 104.33 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 F 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 F 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 F 302 SER B 106 SER~? 15.38 C14 P6G D1130 F 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 84.18 136.24 88.80 85.96 140.90 88.66 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 80.72 137.29 103.27 80.90 136.95 105.39 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 87.99 143.28 106.06 86.95 141.03 106.01 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 87.94 149.19 105.12 86.87 147.57 104.33 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 G 268 GLU A 109 GLU~? 22.30 C2 PG4 C1130 G 302 SER A 116 SER~? 25.66 C6 PG4 C1130 G 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 56.79 103.91 140.42 58.85 102.76 144.77 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 69.06 110.82 135.59 70.39 112.47 135.16 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 72.18 114.35 144.24 71.25 114.81 141.99 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 75.14 110.89 148.28 73.91 110.46 146.63 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 G 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 G 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 G 302 SER A 116 SER~? 25.66 C6 PG4 C1130 G 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 56.79 103.91 140.42 58.85 102.76 144.77 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 69.06 110.82 135.59 70.39 112.47 135.16 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 72.18 114.35 144.24 71.25 114.81 141.99 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 75.14 110.89 148.28 73.91 110.46 146.63 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 G 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 G 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 G 302 SER B 106 SER~? 15.38 C14 P6G D1130 G 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 56.79 103.91 140.42 58.85 102.76 144.77 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 69.06 110.82 135.59 70.39 112.47 135.16 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 72.18 114.35 144.24 71.25 114.81 141.99 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 75.14 110.89 148.28 73.91 110.46 146.63 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 4 4 # 4 G 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 G 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 G 302 SER B 106 SER~? 15.38 C14 P6G D1130 G 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 56.79 103.91 140.42 58.85 102.76 144.77 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 69.06 110.82 135.59 70.39 112.47 135.16 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 72.18 114.35 144.24 71.25 114.81 141.99 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 75.14 110.89 148.28 73.91 110.46 146.63 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 4 hits 1o04_c06 naa= 4 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 H 192 LYS A 72 LYS~? 16.44 O5 PG4 C1130 H 268 GLU A 110 GLU~? 14.79 C2 PG4 C1130 H 302 SER A 116 SER~? 25.66 C6 PG4 C1130 H 399 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 87.99 92.28 120.76 86.42 87.51 120.70 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 74.53 97.35 116.61 73.03 98.14 115.35 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 71.83 89.76 111.02 72.57 92.08 111.26 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 69.74 84.60 113.28 70.77 86.22 114.09 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 H 192 LYS B 84 LYS~? 19.45 C18 P6G D1130 H 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 H 302 SER B 106 SER~? 15.38 C14 P6G D1130 H 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 87.99 92.28 120.76 86.42 87.51 120.70 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 74.53 97.35 116.61 73.03 98.14 115.35 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 71.83 89.76 111.02 72.57 92.08 111.26 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 69.74 84.60 113.28 70.77 86.22 114.09 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 3 4 # 3 H 192 LYS D 84 LYS~? 10.25 O1 P6G D1130 H 268 GLU B 110 GLU~? 14.17 C17 P6G D1130 H 302 SER B 106 SER~? 15.38 C14 P6G D1130 H 399 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 87.99 92.28 120.76 86.42 87.51 120.70 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 74.53 97.35 116.61 73.03 98.14 115.35 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 71.83 89.76 111.02 72.57 92.08 111.26 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 69.74 84.60 113.28 70.77 86.22 114.09 32.72 14.03 -52.77 34.27 12.68 -52.28 1o04_c07 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 3 hits 1o04_c07 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER A 106 SER~? 15.55 C4 PG4 C1130 A 159 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 184 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 189 GLU A 73 GLU~? 13.39 C4 PG4 C1130 coo 53.09 24.63 27.00 51.51 25.19 25.28 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 coo 52.64 14.17 18.05 51.99 14.09 16.04 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 45.78 18.05 21.49 44.51 17.88 18.72 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 49.07 22.26 28.01 48.95 23.27 26.11 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER D 78 SER~? -2.57 O10 P6G D1130s A 159 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 184 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 189 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 53.09 24.63 27.00 51.51 25.19 25.28 18.64 6.84 -41.57 17.91 7.53 -43.73 coo 52.64 14.17 18.05 51.99 14.09 16.04 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 45.78 18.05 21.49 44.51 17.88 18.72 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 49.07 22.26 28.01 48.95 23.27 26.11 22.48 10.01 -42.20 22.42 10.27 -44.26 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 2 hits 1og1_c00 naa= 4 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 1 4 # 1 A 36 LYS B 125 LYS~? 33.21 C11 P6G D1130 A 108 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 211 ARG B 123 ARG~? 30.75 C11 P6G D1130 A 319 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo 26.40 -0.07 5.65 25.70 1.89 10.82 46.03 11.05 -24.83 42.26 13.39 -21.60 coo 13.95 1.15 16.48 15.65 1.17 15.18 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 30.30 5.19 11.85 28.49 2.83 12.64 48.86 12.42 -33.59 48.71 12.69 -36.66 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 2 4 # 2 A 36 LYS C 84 LYS~? 13.44 C6 PG4 C1130 A 108 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 211 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 319 GLU A 52 GLU~? 14.14 O5 PG4 C1130 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo 13.95 1.15 16.48 15.65 1.17 15.18 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 30.30 5.19 11.85 28.49 2.83 12.64 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -7.58 5.14 -19.74 -8.46 3.38 -20.54 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 3 4 # 3 A 36 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 108 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 211 ARG C 77 ARG~? 11.94 C8 PG4 C1130 A 319 GLU C 52 GLU~? 9.38 O2 PG4 C1130 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 13.95 1.15 16.48 15.65 1.17 15.18 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 30.30 5.19 11.85 28.49 2.83 12.64 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 4 4 # 4 A 36 LYS C 125 LYS~? 21.37 C1 PG4 C1130 A 108 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 211 ARG C 123 ARG~? 15.20 O1 PG4 C1130 A 319 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo 26.40 -0.07 5.65 25.70 1.89 10.82 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 coo 13.95 1.15 16.48 15.65 1.17 15.18 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 30.30 5.19 11.85 28.49 2.83 12.64 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 5 4 # 5 A 36 LYS D 84 LYS~? 10.25 O1 P6G D1130 A 108 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 211 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 319 GLU B 52 GLU~? 14.42 C2 P6G D1130 coo 26.40 -0.07 5.65 25.70 1.89 10.82 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 13.95 1.15 16.48 15.65 1.17 15.18 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 30.30 5.19 11.85 28.49 2.83 12.64 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 32.10 -2.10 -44.27 32.78 -3.62 -42.92 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 6 4 # 6 A 36 LYS D 125 LYS~? 20.88 C18 P6G D1130 A 108 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 211 ARG D 123 ARG~? 17.23 O19 P6G D1130 A 319 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 26.40 -0.07 5.65 25.70 1.89 10.82 22.36 24.47 -28.29 24.66 21.32 -25.50 coo 13.95 1.15 16.48 15.65 1.17 15.18 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 30.30 5.19 11.85 28.49 2.83 12.64 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 22.48 10.01 -42.20 22.42 10.27 -44.26 1p4n_c00 source 1p4n UDP-MURNAC-PENTAPEPTIDE : 6 hits 1p4n_c00 naa= 4 ULMN 4 3csm_c00 CHORISMATE MUTASE user 1 4 # 1 A 16 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 157 ARG A 123 ARG~? 19.27 O1 P6G D1130 A 168 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 246 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 37.85 22.13 39.07 35.08 21.72 40.26 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 42.53 17.43 30.59 39.80 18.74 31.20 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 36.10 13.35 45.30 34.36 14.97 39.48 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 36.95 11.32 36.89 36.00 13.20 36.97 12.41 4.04 -29.37 12.28 4.39 -27.28 3csm_c00 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c00 naa= 4 ULMN 4 3csm_c01 CHORISMATE MUTASE user 1 4 # 1 B 16 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 157 ARG A 123 ARG~? 19.27 O1 P6G D1130 B 168 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 246 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 12.41 4.04 -29.37 12.28 4.39 -27.28 3csm_c01 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c01 naa= 4 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 1 4 # 1 A 283 GLU A 61 GLU~? 21.55 O5 PG4 C1130 C 12 THR A 39 THR~? 15.12 O5 PG4 C1130 C 25 TYR A 57 TYR~? 16.39 O5 PG4 C1130 C 89 THR A 34 THR~? 24.96 O5 PG4 C1130 coo 60.56 18.92 0.90 61.14 20.52 2.16 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 55.95 25.18 2.21 55.69 23.16 3.11 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 59.81 26.53 8.25 58.00 25.30 8.32 -14.30 4.75 4.28 -13.10 5.81 5.73 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 2 4 # 2 A 283 GLU B 61 GLU~? 21.58 O4 P6G D1130 C 12 THR B 39 THR~? 16.03 C8 P6G D1130 C 25 TYR B 57 TYR~? 16.24 O4 P6G D1130 C 89 THR B 34 THR~? 25.20 C6 P6G D1130 coo 60.56 18.92 0.90 61.14 20.52 2.16 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 55.95 25.18 2.21 55.69 23.16 3.11 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 55.67 19.31 -0.41 56.70 20.51 1.90 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 59.81 26.53 8.25 58.00 25.30 8.32 24.45 -3.48 -67.89 25.98 -4.62 -68.95 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 3 4 # 3 A 283 GLU C 61 GLU~? 21.06 O5 PG4 C1130 C 12 THR C 39 THR~? 14.51 O5 PG4 C1130 C 25 TYR C 57 TYR~? 15.97 O5 PG4 C1130 C 89 THR C 34 THR~? 24.00 O5 PG4 C1130 coo 60.56 18.92 0.90 61.14 20.52 2.16 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 55.95 25.18 2.21 55.69 23.16 3.11 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 59.81 26.53 8.25 58.00 25.30 8.32 -25.16 -1.64 5.50 -26.64 -2.67 6.71 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 4 4 # 4 A 283 GLU D 61 GLU~? 21.02 C9 P6G D1130 C 12 THR D 39 THR~? 15.06 C6 P6G D1130 C 25 TYR D 57 TYR~? 15.84 C9 P6G D1130 C 89 THR D 34 THR~? 24.52 C6 P6G D1130 coo 60.56 18.92 0.90 61.14 20.52 2.16 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 55.95 25.18 2.21 55.69 23.16 3.11 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 55.67 19.31 -0.41 56.70 20.51 1.90 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 59.81 26.53 8.25 58.00 25.30 8.32 13.70 3.26 -69.58 12.20 4.34 -70.72 3eca_c04 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c04 naa= 4 ULMN 4 3eca_c05 ASPARAGINASE TYPE II user 1 4 # 1 B 283 GLU A 61 GLU~? 21.55 O5 PG4 C1130 D 12 THR A 39 THR~? 15.12 O5 PG4 C1130 D 25 TYR A 57 TYR~? 16.39 O5 PG4 C1130 D 89 THR A 34 THR~? 24.96 O5 PG4 C1130 coo 30.23 27.31 19.48 30.08 25.34 19.98 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 32.19 21.46 15.06 33.45 23.05 16.00 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 31.17 27.34 14.84 32.70 26.15 16.86 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 35.78 18.11 20.94 36.76 19.54 19.61 -14.30 4.75 4.28 -13.10 5.81 5.73 ULMN 4 3eca_c05 ASPARAGINASE TYPE II user 2 4 # 2 B 283 GLU B 61 GLU~? 21.58 O4 P6G D1130 D 12 THR B 39 THR~? 16.03 C8 P6G D1130 D 25 TYR B 57 TYR~? 16.24 O4 P6G D1130 D 89 THR B 34 THR~? 25.20 C6 P6G D1130 coo 30.23 27.31 19.48 30.08 25.34 19.98 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 32.19 21.46 15.06 33.45 23.05 16.00 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 31.17 27.34 14.84 32.70 26.15 16.86 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 35.78 18.11 20.94 36.76 19.54 19.61 24.45 -3.48 -67.89 25.98 -4.62 -68.95 3eca_c05 source 3eca ASPARAGINASE TYPE II : 2 hits 3eca_c05 naa= 4 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 1 4 # 1 A 12 THR A 39 THR~? 15.12 O5 PG4 C1130 A 25 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 89 THR A 34 THR~? 24.96 O5 PG4 C1130 C 283 GLU A 61 GLU~? 21.55 O5 PG4 C1130 coo 76.53 15.20 38.92 75.75 17.07 38.27 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 78.55 20.90 39.91 77.09 20.09 37.68 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 72.66 13.38 32.85 71.79 14.81 34.24 -14.30 4.75 4.28 -13.10 5.81 5.73 coo 79.85 20.73 35.44 79.36 18.97 34.45 -8.37 6.43 -4.11 -7.95 7.95 -2.68 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 2 4 # 2 A 12 THR B 39 THR~? 16.03 C8 P6G D1130 A 25 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 89 THR B 34 THR~? 25.20 C6 P6G D1130 C 283 GLU B 61 GLU~? 21.58 O4 P6G D1130 coo 76.53 15.20 38.92 75.75 17.07 38.27 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 78.55 20.90 39.91 77.09 20.09 37.68 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 72.66 13.38 32.85 71.79 14.81 34.24 24.45 -3.48 -67.89 25.98 -4.62 -68.95 coo 79.85 20.73 35.44 79.36 18.97 34.45 30.88 -4.52 -59.91 31.08 -6.09 -61.35 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 3 4 # 3 A 12 THR C 39 THR~? 14.51 O5 PG4 C1130 A 25 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 89 THR C 34 THR~? 24.00 O5 PG4 C1130 C 283 GLU C 61 GLU~? 21.06 O5 PG4 C1130 coo 76.53 15.20 38.92 75.75 17.07 38.27 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 78.55 20.90 39.91 77.09 20.09 37.68 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 72.66 13.38 32.85 71.79 14.81 34.24 -25.16 -1.64 5.50 -26.64 -2.67 6.71 coo 79.85 20.73 35.44 79.36 18.97 34.45 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 4 4 # 4 A 12 THR D 39 THR~? 15.06 C6 P6G D1130 A 25 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 89 THR D 34 THR~? 24.52 C6 P6G D1130 C 283 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo 76.53 15.20 38.92 75.75 17.07 38.27 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 78.55 20.90 39.91 77.09 20.09 37.68 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 72.66 13.38 32.85 71.79 14.81 34.24 13.70 3.26 -69.58 12.20 4.34 -70.72 coo 79.85 20.73 35.44 79.36 18.97 34.45 7.67 8.26 -62.85 7.30 9.08 -64.79 3eca_c06 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c06 naa= 4 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 1 4 # 1 B 12 THR A 39 THR~? 15.12 O5 PG4 C1130 B 25 TYR A 57 TYR~? 16.39 O5 PG4 C1130 B 89 THR A 34 THR~? 24.96 O5 PG4 C1130 D 283 GLU A 61 GLU~? 21.55 O5 PG4 C1130 coo 53.77 21.59 52.52 53.72 19.81 51.24 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 52.81 15.60 53.32 51.72 16.94 51.12 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 50.67 24.88 46.55 52.16 23.30 46.40 -14.30 4.75 4.28 -13.10 5.81 5.73 coo 48.21 16.39 52.49 47.84 18.39 51.92 -8.37 6.43 -4.11 -7.95 7.95 -2.68 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 2 4 # 2 B 12 THR B 39 THR~? 16.03 C8 P6G D1130 B 25 TYR B 57 TYR~? 16.24 O4 P6G D1130 B 89 THR B 34 THR~? 25.20 C6 P6G D1130 D 283 GLU B 61 GLU~? 21.58 O4 P6G D1130 coo 53.77 21.59 52.52 53.72 19.81 51.24 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 52.81 15.60 53.32 51.72 16.94 51.12 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 50.67 24.88 46.55 52.16 23.30 46.40 24.45 -3.48 -67.89 25.98 -4.62 -68.95 coo 48.21 16.39 52.49 47.84 18.39 51.92 30.88 -4.52 -59.91 31.08 -6.09 -61.35 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 3 4 # 3 B 12 THR C 39 THR~? 14.51 O5 PG4 C1130 B 25 TYR C 57 TYR~? 15.97 O5 PG4 C1130 B 89 THR C 34 THR~? 24.00 O5 PG4 C1130 D 283 GLU C 61 GLU~? 21.06 O5 PG4 C1130 coo 53.77 21.59 52.52 53.72 19.81 51.24 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 52.81 15.60 53.32 51.72 16.94 51.12 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 50.67 24.88 46.55 52.16 23.30 46.40 -25.16 -1.64 5.50 -26.64 -2.67 6.71 coo 48.21 16.39 52.49 47.84 18.39 51.92 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 ULMN 4 3eca_c07 ASPARAGINASE TYPE II user 4 4 # 4 B 12 THR D 39 THR~? 15.06 C6 P6G D1130 B 25 TYR D 57 TYR~? 15.84 C9 P6G D1130 B 89 THR D 34 THR~? 24.52 C6 P6G D1130 D 283 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo 53.77 21.59 52.52 53.72 19.81 51.24 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 52.81 15.60 53.32 51.72 16.94 51.12 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 50.67 24.88 46.55 52.16 23.30 46.40 13.70 3.26 -69.58 12.20 4.34 -70.72 coo 48.21 16.39 52.49 47.84 18.39 51.92 7.67 8.26 -62.85 7.30 9.08 -64.79 3eca_c07 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c07 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 190 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 222 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 7.17 16.59 41.26 8.01 19.20 40.73 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 13.38 20.00 35.06 11.43 22.49 39.53 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 9.76 26.58 38.10 11.63 25.78 38.76 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 190 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 222 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 7.17 16.59 41.26 8.01 19.20 40.73 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 13.38 20.00 35.06 11.43 22.49 39.53 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 9.76 26.58 38.10 11.63 25.78 38.76 26.47 11.48 -38.21 26.51 9.40 -38.05 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 2 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 222 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 1.51 16.60 24.17 0.82 19.23 24.79 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 222 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 coo -4.61 20.12 30.34 -2.74 22.65 25.95 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -1.04 26.60 27.37 -2.94 25.93 26.69 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 1.51 16.60 24.17 0.82 19.23 24.79 29.55 2.80 -46.55 31.14 4.40 -48.22 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 2 hits 1a05_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 44 GLU~? 13.07 O5 PG4 C1130 A 60 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 175 TYR A 43 TYR~? 9.79 O5 PG4 C1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 56.42 28.06 12.93 55.01 27.92 14.50 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 45.02 22.04 15.38 46.16 24.00 13.76 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 60 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 175 TYR B 43 TYR~? 10.38 C8 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 56.42 28.06 12.93 55.01 27.92 14.50 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 45.02 22.04 15.38 46.16 24.00 13.76 21.94 3.80 -56.34 23.03 6.24 -57.25 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 60 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 175 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 56.42 28.06 12.93 55.01 27.92 14.50 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 45.02 22.04 15.38 46.16 24.00 13.76 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 60 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 175 TYR C 43 TYR~? 9.68 O5 PG4 C1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 56.42 28.06 12.93 55.01 27.92 14.50 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 45.02 22.04 15.38 46.16 24.00 13.76 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 60 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 175 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 56.42 28.06 12.93 55.01 27.92 14.50 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 45.02 22.04 15.38 46.16 24.00 13.76 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU D 44 GLU~? 13.05 C9 P6G D1130 A 60 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 175 TYR D 43 TYR~? 10.27 C6 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 56.42 28.06 12.93 55.01 27.92 14.50 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 45.02 22.04 15.38 46.16 24.00 13.76 17.02 2.86 -56.49 16.12 0.22 -56.60 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 60 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 175 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 56.42 28.06 12.93 55.01 27.92 14.50 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 45.02 22.04 15.38 46.16 24.00 13.76 9.62 8.34 -47.74 8.38 5.93 -48.44 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 60 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 175 TYR A 92 TYR~? 17.76 O1 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 56.42 28.06 12.93 55.01 27.92 14.50 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 45.02 22.04 15.38 46.16 24.00 13.76 2.30 -1.46 -39.04 1.18 -2.64 -41.31 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 9 3 # 9 A 49 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 60 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 175 TYR A 92 TYR~? 17.76 O1 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 56.42 28.06 12.93 55.01 27.92 14.50 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 45.02 22.04 15.38 46.16 24.00 13.76 2.30 -1.46 -39.04 1.18 -2.64 -41.31 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 10 3 # 10 A 49 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 60 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 175 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 46.10 28.27 19.27 45.48 26.99 20.84 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 56.42 28.06 12.93 55.01 27.92 14.50 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 45.02 22.04 15.38 46.16 24.00 13.76 24.24 21.35 -31.93 26.12 20.12 -30.25 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 10 hits 1a50_c03 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN D 108 ASN~? 12.52 O1 P6G D1130 63 ARG D 77 ARG~? 8.78 O1 P6G D1130 255 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 42.10 13.02 11.14 41.85 11.12 10.23 8.90 3.92 -35.18 9.80 2.60 -33.76 coo 44.36 11.24 3.39 41.81 12.78 4.00 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 38.40 3.83 10.26 40.02 6.30 9.25 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 1 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 50 ASP~? 13.04 O5 PG4 C1130 187 GLU A 55 GLU~? 16.41 O5 PG4 C1130 229 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 50 ASP~? 13.04 O5 PG4 C1130 187 GLU C 82 GLU~? -3.24 C6 PG4 C1130s 229 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 107 ASP.? 20.53 C4 PG4 C1130 187 GLU A 110 GLU~? 14.79 C2 PG4 C1130 229 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo -47.40 44.36 48.48 -50.80 49.18 46.20 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP A 129 ASP.? 5.22 O1 P6G D1130 187 GLU D 73 GLU~? 10.67 O1 P6G D1130 229 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo -45.08 48.37 46.81 -46.53 49.74 45.96 8.90 2.49 -40.53 8.63 4.21 -39.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP B 50 ASP~? 8.75 C2 P6G D1130 187 GLU B 55 GLU~? 15.05 C3 P6G D1130 229 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -45.08 48.37 46.81 -46.53 49.74 45.96 33.77 1.13 -50.00 34.67 1.54 -48.13 coo -47.40 44.36 48.48 -50.80 49.18 46.20 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B 107 ASP.? 21.14 C14 P6G D1130 187 GLU B 110 GLU~? 14.17 C17 P6G D1130 229 LYS B 113 LYS~? 24.16 C17 P6G D1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 37.26 15.33 -51.32 39.19 15.47 -52.18 coo -45.08 48.37 46.81 -46.53 49.74 45.96 32.90 20.43 -41.22 30.91 19.85 -41.11 coo -47.40 44.36 48.48 -50.80 49.18 46.20 39.51 19.43 -40.28 40.84 23.44 -43.47 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP C 50 ASP~? 5.21 O2 PG4 C1130 187 GLU C 55 GLU~? 14.48 C8 PG4 C1130 229 LYS C 59 LYS~? 18.46 C8 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP C 85 ASP~? 10.22 C6 PG4 C1130 187 GLU A 73 GLU~? 13.39 C4 PG4 C1130 229 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP C 85 ASP~? 10.22 C6 PG4 C1130 187 GLU A 110 GLU~? 14.79 C2 PG4 C1130 229 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo -47.40 44.36 48.48 -50.80 49.18 46.20 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP C 107 ASP.? 16.10 C8 PG4 C1130 187 GLU C 110 GLU~? 19.54 O4 PG4 C1130 229 LYS C 113 LYS~? 22.50 C5 PG4 C1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -28.66 1.59 -33.06 -27.87 1.89 -35.00 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP D 85 ASP~? 10.24 C11 P6G D1130 187 GLU B 73 GLU~? 10.65 C14 P6G D1130 229 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -45.08 48.37 46.81 -46.53 49.74 45.96 30.54 14.87 -46.06 28.97 16.29 -46.38 coo -47.40 44.36 48.48 -50.80 49.18 46.20 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP D 107 ASP.? 14.84 O1 P6G D1130 187 GLU D 110 GLU~? 16.67 O1 P6G D1130 229 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo -52.57 56.60 47.75 -51.52 54.87 46.95 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -45.08 48.37 46.81 -46.53 49.74 45.96 12.41 4.04 -29.37 12.28 4.39 -27.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 10.74 10.01 -28.88 5.91 8.82 -26.43 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 12 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP C 85 ASP~? 10.22 C6 PG4 C1130 214 ASP A 129 ASP.? 5.22 O1 P6G D1130 289 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 26.86 59.76 46.36 25.42 58.23 45.92 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 85 ASP~? 19.32 C6 PG4 C1130 204 GLU A 82 GLU~? 16.13 C6 PG4 C1130 289 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 4.34 62.44 32.05 4.22 64.48 32.53 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 85 ASP~? 19.32 C6 PG4 C1130 204 GLU C 88 GLU~? 16.97 C5 PG4 C1130 289 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 4.34 62.44 32.05 4.22 64.48 32.53 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 85 ASP~? 16.97 O1 P6G D1130 204 GLU B 82 GLU~? 13.30 C2 P6G D1130 289 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 4.34 62.44 32.05 4.22 64.48 32.53 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 85 ASP~? 16.97 O1 P6G D1130 204 GLU D 88 GLU~? 17.52 C12 P6G D1130 289 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 85 ASP~? 10.22 C6 PG4 C1130 204 GLU A 82 GLU~? 16.13 C6 PG4 C1130 289 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 4.34 62.44 32.05 4.22 64.48 32.53 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP C 85 ASP~? 10.22 C6 PG4 C1130 204 GLU C 88 GLU~? 16.97 C5 PG4 C1130 289 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 4.34 62.44 32.05 4.22 64.48 32.53 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP D 85 ASP~? 10.24 C11 P6G D1130 204 GLU B 82 GLU~? 13.30 C2 P6G D1130 289 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 4.34 62.44 32.05 4.22 64.48 32.53 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP D 85 ASP~? 10.24 C11 P6G D1130 204 GLU D 88 GLU~? 17.52 C12 P6G D1130 289 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.47 6.05 -29.78 29.50 6.72 -30.15 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 8 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 85 ASP~? 19.32 C6 PG4 C1130 227 GLU A 52 GLU~? 14.14 O5 PG4 C1130 289 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 3.96 55.76 41.24 4.83 57.69 41.17 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 85 ASP~? 19.32 C6 PG4 C1130 227 GLU A 100 GLU~? 21.70 O1 P6G D1130 289 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 3.96 55.76 41.24 4.83 57.69 41.17 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 85 ASP~? 19.32 C6 PG4 C1130 227 GLU A 121 GLU~? 21.00 O1 P6G D1130 289 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 3.96 55.76 41.24 4.83 57.69 41.17 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 85 ASP~? 16.97 O1 P6G D1130 227 GLU B 52 GLU~? 14.42 C2 P6G D1130 289 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 3.96 55.76 41.24 4.83 57.69 41.17 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 85 ASP~? 16.97 O1 P6G D1130 227 GLU B 100 GLU~? 26.53 C3 P6G D1130 289 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP C 85 ASP~? 10.22 C6 PG4 C1130 227 GLU A 52 GLU~? 14.14 O5 PG4 C1130 289 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 3.96 55.76 41.24 4.83 57.69 41.17 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 85 ASP~? 10.22 C6 PG4 C1130 227 GLU C 121 GLU~? 20.36 C1 PG4 C1130 289 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 3.96 55.76 41.24 4.83 57.69 41.17 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP D 85 ASP~? 10.24 C11 P6G D1130 227 GLU B 52 GLU~? 14.42 C2 P6G D1130 289 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 3.96 55.76 41.24 4.83 57.69 41.17 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP D 85 ASP~? 10.24 C11 P6G D1130 227 GLU D 121 GLU~? 20.22 C18 P6G D1130 289 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 3.96 55.76 41.24 4.83 57.69 41.17 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 31.47 6.05 -29.78 29.50 6.72 -30.15 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 9 hits 1amy_c06 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 342 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 531 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 1 hits 1asy_c00 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 265 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 265 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 A 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 265 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 39.74 52.86 65.74 41.15 55.14 66.52 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo 30.70 47.50 67.53 29.83 49.47 67.39 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 19.99 54.53 64.11 20.55 58.78 68.33 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 A 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 265 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo 30.70 47.50 67.53 29.83 49.47 67.39 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 19.99 54.53 64.11 20.55 58.78 68.33 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 265 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 19.99 54.53 64.11 20.55 58.78 68.33 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 19.99 54.53 64.11 20.55 58.78 68.33 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 265 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 19.99 54.53 64.11 20.55 58.78 68.33 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 265 LYS C 59 LYS~? 18.46 C8 PG4 C1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 30.70 47.50 67.53 29.83 49.47 67.39 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 265 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 30.70 47.50 67.53 29.83 49.47 67.39 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 19.99 54.53 64.11 20.55 58.78 68.33 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 223 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 19.99 54.53 64.11 20.55 58.78 68.33 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE D 48 PHE~? -7.47 C9 P6G D1130s A 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 265 LYS D 59 LYS~? 18.77 O7 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 30.70 47.50 67.53 29.83 49.47 67.39 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 19.99 54.53 64.11 20.55 58.78 68.33 3.27 6.90 -57.68 0.31 8.60 -52.41 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 265 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 30.70 47.50 67.53 29.83 49.47 67.39 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 19.99 54.53 64.11 20.55 58.78 68.33 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 223 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 30.70 47.50 67.53 29.83 49.47 67.39 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 19.99 54.53 64.11 20.55 58.78 68.33 31.42 9.18 -48.71 35.31 8.95 -53.15 1ax4_c04 source 1ax4 TRYPTOPHANASE : 14 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 B 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 265 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 B 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 B 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 265 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 B 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 265 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 7.48 54.94 99.62 7.67 52.27 100.42 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo 10.43 61.66 91.81 9.80 60.04 90.61 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 5.43 58.06 80.08 8.57 53.00 79.37 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 B 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 265 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo 10.43 61.66 91.81 9.80 60.04 90.61 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 5.43 58.06 80.08 8.57 53.00 79.37 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 265 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 5.43 58.06 80.08 8.57 53.00 79.37 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 5.43 58.06 80.08 8.57 53.00 79.37 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 265 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 5.43 58.06 80.08 8.57 53.00 79.37 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE C 48 PHE~? 7.58 C4 PG4 C1130 B 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 265 LYS C 59 LYS~? 18.46 C8 PG4 C1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 10.43 61.66 91.81 9.80 60.04 90.61 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE C 98 PHE~? -3.85 C1 PG4 C1130s B 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 265 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 10.43 61.66 91.81 9.80 60.04 90.61 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 5.43 58.06 80.08 8.57 53.00 79.37 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE C 99 PHE~? 10.28 C1 PG4 C1130 B 223 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 5.43 58.06 80.08 8.57 53.00 79.37 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE D 48 PHE~? -7.47 C9 P6G D1130s B 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 265 LYS D 59 LYS~? 18.77 O7 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 10.43 61.66 91.81 9.80 60.04 90.61 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 5.43 58.06 80.08 8.57 53.00 79.37 3.27 6.90 -57.68 0.31 8.60 -52.41 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 265 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 10.43 61.66 91.81 9.80 60.04 90.61 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 5.43 58.06 80.08 8.57 53.00 79.37 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE D 99 PHE~? 10.07 C18 P6G D1130 B 223 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 10.43 61.66 91.81 9.80 60.04 90.61 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 5.43 58.06 80.08 8.57 53.00 79.37 31.42 9.18 -48.71 35.31 8.95 -53.15 1ax4_c05 source 1ax4 TRYPTOPHANASE : 14 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 C 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 265 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 C 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 C 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 265 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 C 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 265 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo -9.52 75.74 33.62 -8.85 73.74 33.93 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -4.44 67.20 42.32 -7.50 62.41 40.49 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 C 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 265 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo -9.52 75.74 33.62 -8.85 73.74 33.93 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -4.44 67.20 42.32 -7.50 62.41 40.49 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 C 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 265 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo -9.52 75.74 33.62 -8.85 73.74 33.93 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -4.44 67.20 42.32 -7.50 62.41 40.49 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 265 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -4.44 67.20 42.32 -7.50 62.41 40.49 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -4.44 67.20 42.32 -7.50 62.41 40.49 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 265 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -4.44 67.20 42.32 -7.50 62.41 40.49 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE C 48 PHE~? 7.58 C4 PG4 C1130 C 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 265 LYS C 59 LYS~? 18.46 C8 PG4 C1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE C 98 PHE~? -3.85 C1 PG4 C1130s C 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 265 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE C 99 PHE~? 10.28 C1 PG4 C1130 C 223 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE D 48 PHE~? -7.47 C9 P6G D1130s C 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 265 LYS D 59 LYS~? 18.77 O7 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 21.21 11.49 -53.11 23.48 9.91 -53.52 coo -9.52 75.74 33.62 -8.85 73.74 33.93 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -4.44 67.20 42.32 -7.50 62.41 40.49 3.27 6.90 -57.68 0.31 8.60 -52.41 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE D 98 PHE~? -3.66 C18 P6G D1130s C 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 265 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 19.42 15.07 -40.90 21.07 15.22 -43.15 coo -9.52 75.74 33.62 -8.85 73.74 33.93 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -4.44 67.20 42.32 -7.50 62.41 40.49 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE D 99 PHE~? 10.07 C18 P6G D1130 C 223 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.40 15.07 -34.81 19.85 13.95 -34.07 coo -9.52 75.74 33.62 -8.85 73.74 33.93 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -4.44 67.20 42.32 -7.50 62.41 40.49 31.42 9.18 -48.71 35.31 8.95 -53.15 1ax4_c06 source 1ax4 TRYPTOPHANASE : 15 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 D 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 D 265 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 D 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 D 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 48 PHE~? 8.83 O5 PG4 C1130 D 223 ASP A 50 ASP~? 13.04 O5 PG4 C1130 D 265 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 D 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 265 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo -29.46 51.67 48.51 -28.63 53.31 49.56 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -18.87 56.53 54.79 -19.47 62.22 53.03 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 D 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 265 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo -29.46 51.67 48.51 -28.63 53.31 49.56 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -18.87 56.53 54.79 -19.47 62.22 53.03 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE A 87 PHE~? 21.78 O1 P6G D1130 D 223 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 265 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo -29.46 51.67 48.51 -28.63 53.31 49.56 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -18.87 56.53 54.79 -19.47 62.22 53.03 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 D 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 265 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -18.87 56.53 54.79 -19.47 62.22 53.03 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 D 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -18.87 56.53 54.79 -19.47 62.22 53.03 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 48 PHE~? 8.11 O4 P6G D1130 D 223 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 265 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -18.87 56.53 54.79 -19.47 62.22 53.03 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE C 48 PHE~? 7.58 C4 PG4 C1130 D 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 265 LYS C 59 LYS~? 18.46 C8 PG4 C1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE C 98 PHE~? -3.85 C1 PG4 C1130s D 223 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 265 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE C 99 PHE~? 10.28 C1 PG4 C1130 D 223 ASP C 85 ASP~? 10.22 C6 PG4 C1130 D 265 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE D 48 PHE~? -7.47 C9 P6G D1130s D 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 265 LYS D 59 LYS~? 18.77 O7 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 21.21 11.49 -53.11 23.48 9.91 -53.52 coo -29.46 51.67 48.51 -28.63 53.31 49.56 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -18.87 56.53 54.79 -19.47 62.22 53.03 3.27 6.90 -57.68 0.31 8.60 -52.41 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE D 98 PHE~? -3.66 C18 P6G D1130s D 223 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 265 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 19.42 15.07 -40.90 21.07 15.22 -43.15 coo -29.46 51.67 48.51 -28.63 53.31 49.56 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -18.87 56.53 54.79 -19.47 62.22 53.03 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE D 99 PHE~? 10.07 C18 P6G D1130 D 223 ASP D 85 ASP~? 10.24 C11 P6G D1130 D 265 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.40 15.07 -34.81 19.85 13.95 -34.07 coo -29.46 51.67 48.51 -28.63 53.31 49.56 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -18.87 56.53 54.79 -19.47 62.22 53.03 31.42 9.18 -48.71 35.31 8.95 -53.15 1ax4_c07 source 1ax4 TRYPTOPHANASE : 15 hits 1ax4_c07 naa= 3 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 A 71 GLU A 88 GLU~? 23.13 C5 PG4 C1130 A 161 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 192 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 1.71 48.67 0.56 0.18 47.85 1.75 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 coo -2.78 50.68 10.78 -4.68 50.49 8.71 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 A 71 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 161 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 192 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 1.71 48.67 0.56 0.18 47.85 1.75 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo -2.78 50.68 10.78 -4.68 50.49 8.71 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo -0.10 43.44 8.03 -1.33 45.05 7.36 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 3 3 # 3 A 71 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 161 CYH C 122 CYH~? 12.47 C1 PG4 C1130 A 192 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 1.71 48.67 0.56 0.18 47.85 1.75 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 4 3 # 4 A 71 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 161 CYH D 122 CYH~? 12.34 C18 P6G D1130 A 192 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 1.71 48.67 0.56 0.18 47.85 1.75 27.48 12.16 -32.01 27.65 12.79 -30.00 coo -2.78 50.68 10.78 -4.68 50.49 8.71 19.52 21.12 -30.74 19.88 19.17 -32.70 coo -0.10 43.44 8.03 -1.33 45.05 7.36 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 5 3 # 5 A 71 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 161 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 192 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 1.71 48.67 0.56 0.18 47.85 1.75 4.39 5.46 -30.92 3.12 7.08 -30.47 coo -2.78 50.68 10.78 -4.68 50.49 8.71 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -2.12 2.70 -37.07 -3.24 4.07 -38.22 1b02_c02 source 1b02 THYMIDYLATE SYNTHASE : 5 hits 1b02_c02 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 182 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 286 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 26.03 44.66 108.90 25.67 42.61 108.82 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 18.06 44.02 105.38 18.08 45.37 107.03 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 25.47 38.28 112.06 27.26 39.30 111.54 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 182 GLU A 69 GLU~? 16.61 C4 PG4 C1130 A 286 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 26.03 44.66 108.90 25.67 42.61 108.82 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 18.06 44.02 105.38 18.08 45.37 107.03 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 coo 25.47 38.28 112.06 27.26 39.30 111.54 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 182 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 286 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 26.03 44.66 108.90 25.67 42.61 108.82 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 18.06 44.02 105.38 18.08 45.37 107.03 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 25.47 38.28 112.06 27.26 39.30 111.54 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 182 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 286 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 26.03 44.66 108.90 25.67 42.61 108.82 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 18.06 44.02 105.38 18.08 45.37 107.03 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 25.47 38.28 112.06 27.26 39.30 111.54 8.90 3.92 -35.18 9.80 2.60 -33.76 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 4 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 182 GLU B 73 GLU~? 10.65 C14 P6G D1130 B 286 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 13.82 69.26 132.27 11.87 70.14 132.51 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 8.74 63.05 136.42 9.87 62.19 134.79 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 8.26 72.60 129.22 10.14 73.45 129.80 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 182 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 286 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 13.82 69.26 132.27 11.87 70.14 132.51 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 8.74 63.05 136.42 9.87 62.19 134.79 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 8.26 72.60 129.22 10.14 73.45 129.80 8.90 3.92 -35.18 9.80 2.60 -33.76 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 148 CYH A 122 CYH~? 19.70 O1 P6G D1130 B 179 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 30.30 0.93 3.58 31.01 1.18 0.88 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 4.55 4.63 -38.29 4.19 5.10 -40.34 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 1 hits 1b5d_c05 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 230 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 9.23 21.44 106.88 10.18 19.34 105.31 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 2.97 11.64 107.87 6.59 15.13 107.03 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 230 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 9.23 21.44 106.88 10.18 19.34 105.31 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 2.97 11.64 107.87 6.59 15.13 107.03 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 230 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 9.23 21.44 106.88 10.18 19.34 105.31 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 2.97 11.64 107.87 6.59 15.13 107.03 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR A 92 TYR~? 17.76 O1 P6G D1130 A 230 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 273 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 9.23 21.44 106.88 10.18 19.34 105.31 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 1.45 22.80 104.16 2.58 21.02 104.01 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 2.97 11.64 107.87 6.59 15.13 107.03 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 230 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 273 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 9.23 21.44 106.88 10.18 19.34 105.31 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 1.45 22.80 104.16 2.58 21.02 104.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 2.97 11.64 107.87 6.59 15.13 107.03 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 230 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 273 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 9.23 21.44 106.88 10.18 19.34 105.31 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 1.45 22.80 104.16 2.58 21.02 104.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 2.97 11.64 107.87 6.59 15.13 107.03 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 230 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 273 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 9.23 21.44 106.88 10.18 19.34 105.31 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 1.45 22.80 104.16 2.58 21.02 104.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 2.97 11.64 107.87 6.59 15.13 107.03 14.51 2.78 -43.17 17.25 -1.27 -44.64 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 7 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 46 TYR~? 5.44 O5 PG4 C1130 B 230 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 273 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 11.81 13.41 73.03 10.00 13.03 75.12 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 11.10 2.31 76.60 10.24 7.24 75.62 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 46 TYR~? 5.44 O5 PG4 C1130 B 230 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 273 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 11.81 13.41 73.03 10.00 13.03 75.12 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 11.10 2.31 76.60 10.24 7.24 75.62 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR A 46 TYR~? 5.44 O5 PG4 C1130 B 230 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 273 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 11.81 13.41 73.03 10.00 13.03 75.12 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 11.10 2.31 76.60 10.24 7.24 75.62 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR A 92 TYR~? 17.76 O1 P6G D1130 B 230 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 273 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 11.81 13.41 73.03 10.00 13.03 75.12 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 19.17 11.01 76.14 17.26 10.42 76.77 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 11.10 2.31 76.60 10.24 7.24 75.62 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR B 46 TYR~? 5.77 O4 P6G D1130 B 230 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 273 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 11.81 13.41 73.03 10.00 13.03 75.12 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 19.17 11.01 76.14 17.26 10.42 76.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 11.10 2.31 76.60 10.24 7.24 75.62 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR B 46 TYR~? 5.77 O4 P6G D1130 B 230 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 273 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 11.81 13.41 73.03 10.00 13.03 75.12 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 19.17 11.01 76.14 17.26 10.42 76.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 11.10 2.31 76.60 10.24 7.24 75.62 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR B 46 TYR~? 5.77 O4 P6G D1130 B 230 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 273 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 11.81 13.41 73.03 10.00 13.03 75.12 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 19.17 11.01 76.14 17.26 10.42 76.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 11.10 2.31 76.60 10.24 7.24 75.62 14.51 2.78 -43.17 17.25 -1.27 -44.64 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 7 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 159 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 188 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 159 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 188 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 159 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 188 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 159 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 188 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 98 PHE~? 19.95 C6 PG4 C1130 A 159 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 188 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 22.55 41.65 15.60 18.92 37.20 14.63 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE A 99 PHE~? 22.28 C6 PG4 C1130 A 159 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 188 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo 20.97 28.40 16.26 20.19 30.15 15.34 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 22.55 41.65 15.60 18.92 37.20 14.63 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 159 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 188 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 20.97 28.40 16.26 20.19 30.15 15.34 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 159 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 188 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 159 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 188 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 159 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 188 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 98 PHE~? 17.75 C3 P6G D1130 A 159 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 188 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 36.48 4.26 -36.04 35.13 1.81 -35.88 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 22.55 41.65 15.60 18.92 37.20 14.63 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 159 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 188 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 20.97 28.40 16.26 20.19 30.15 15.34 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 22.55 41.65 15.60 18.92 37.20 14.63 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 159 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 188 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 20.97 28.40 16.26 20.19 30.15 15.34 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE C 54 PHE~? 9.47 C8 PG4 C1130 A 159 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 188 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 20.97 28.40 16.26 20.19 30.15 15.34 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 159 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 188 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 13.91 34.58 14.67 12.95 36.00 12.47 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 159 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 188 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE D 48 PHE~? -7.47 C9 P6G D1130s A 159 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 188 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 20.97 28.40 16.26 20.19 30.15 15.34 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE D 54 PHE~? 9.38 C6 P6G D1130 A 159 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 188 LYS D 59 LYS~? 18.77 O7 P6G D1130 coo 13.91 34.58 14.67 12.95 36.00 12.47 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 20.97 28.40 16.26 20.19 30.15 15.34 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 3.27 6.90 -57.68 0.31 8.60 -52.41 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE D 54 PHE~? 9.38 C6 P6G D1130 A 159 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 188 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 13.91 34.58 14.67 12.95 36.00 12.47 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 20.97 28.40 16.26 20.19 30.15 15.34 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 22.55 41.65 15.60 18.92 37.20 14.63 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 159 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 188 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 13.91 34.58 14.67 12.95 36.00 12.47 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 159 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 188 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 13.91 34.58 14.67 12.95 36.00 12.47 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 20.97 28.40 16.26 20.19 30.15 15.34 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 14.33 6.41 -44.26 15.86 10.02 -47.66 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 21 hits 1b9h_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 85 ASP~? 19.32 C6 PG4 C1130 435 GLU A 82 GLU~? 16.13 C6 PG4 C1130 510 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 88.62 69.90 41.16 89.05 70.67 43.04 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 89.52 76.11 40.17 89.01 75.16 41.97 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 84.89 77.60 46.67 85.63 75.79 46.03 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP B 85 ASP~? 16.97 O1 P6G D1130 435 GLU B 82 GLU~? 13.30 C2 P6G D1130 510 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 88.62 69.90 41.16 89.05 70.67 43.04 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 89.52 76.11 40.17 89.01 75.16 41.97 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 84.89 77.60 46.67 85.63 75.79 46.03 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP B 85 ASP~? 16.97 O1 P6G D1130 435 GLU D 88 GLU~? 17.52 C12 P6G D1130 510 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 88.62 69.90 41.16 89.05 70.67 43.04 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 84.89 77.60 46.67 85.63 75.79 46.03 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP C 85 ASP~? 10.22 C6 PG4 C1130 435 GLU A 82 GLU~? 16.13 C6 PG4 C1130 510 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 88.62 69.90 41.16 89.05 70.67 43.04 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 89.52 76.11 40.17 89.01 75.16 41.97 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 84.89 77.60 46.67 85.63 75.79 46.03 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP C 85 ASP~? 10.22 C6 PG4 C1130 435 GLU C 88 GLU~? 16.97 C5 PG4 C1130 510 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 88.62 69.90 41.16 89.05 70.67 43.04 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 89.52 76.11 40.17 89.01 75.16 41.97 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 84.89 77.60 46.67 85.63 75.79 46.03 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP D 85 ASP~? 10.24 C11 P6G D1130 435 GLU D 88 GLU~? 17.52 C12 P6G D1130 510 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 88.62 69.90 41.16 89.05 70.67 43.04 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 84.89 77.60 46.67 85.63 75.79 46.03 31.47 6.05 -29.78 29.50 6.72 -30.15 1bf2_c00 source 1bf2 ISOAMYLASE : 6 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 66 GLU.? 16.09 O5 PG4 C1130 A 503 TYR A 43 TYR~? 9.79 O5 PG4 C1130 A 537 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 15.91 140.69 8.32 15.71 143.39 9.13 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 16.65 144.44 13.24 18.34 145.22 12.33 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 503 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 537 GLU A 121 GLU~? 21.00 O1 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 15.91 140.69 8.32 15.71 143.39 9.13 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 16.65 144.44 13.24 18.34 145.22 12.33 2.80 -10.41 -36.92 3.82 -11.51 -38.44 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU B 88 GLU~? 21.68 O1 P6G D1130 A 503 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 537 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 15.91 140.69 8.32 15.71 143.39 9.13 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 16.65 144.44 13.24 18.34 145.22 12.33 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU B 120 GLU~? 31.89 C11 P6G D1130 A 503 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 537 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 15.91 140.69 8.32 15.71 143.39 9.13 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 16.65 144.44 13.24 18.34 145.22 12.33 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU C 66 GLU.? 17.32 O5 PG4 C1130 A 503 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 537 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 -27.54 8.06 -6.82 -28.96 9.42 -7.64 coo 15.91 140.69 8.32 15.71 143.39 9.13 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 16.65 144.44 13.24 18.34 145.22 12.33 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 503 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 537 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 15.91 140.69 8.32 15.71 143.39 9.13 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 16.65 144.44 13.24 18.34 145.22 12.33 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU C 120 GLU~? 18.24 C1 PG4 C1130 A 503 TYR C 118 TYR~? 14.79 C5 PG4 C1130 A 537 GLU C 121 GLU~? 20.36 C1 PG4 C1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 coo 15.91 140.69 8.32 15.71 143.39 9.13 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo 16.65 144.44 13.24 18.34 145.22 12.33 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 8 3 # 8 A 461 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 503 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 537 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 15.91 140.69 8.32 15.71 143.39 9.13 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 16.65 144.44 13.24 18.34 145.22 12.33 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 9 3 # 9 A 461 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 503 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 537 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 15.91 140.69 8.32 15.71 143.39 9.13 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 16.65 144.44 13.24 18.34 145.22 12.33 7.67 8.26 -62.85 7.30 9.08 -64.79 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 10 3 # 10 A 461 GLU D 66 GLU.? 17.04 C6 P6G D1130 A 503 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 537 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 15.91 140.69 8.32 15.71 143.39 9.13 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 16.65 144.44 13.24 18.34 145.22 12.33 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 11 3 # 11 A 461 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 503 TYR A 92 TYR~? 17.76 O1 P6G D1130 A 537 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 24.06 146.21 11.09 22.89 146.18 9.36 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 15.91 140.69 8.32 15.71 143.39 9.13 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 16.65 144.44 13.24 18.34 145.22 12.33 8.90 2.49 -40.53 8.63 4.21 -39.28 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 11 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 66 GLU.? 16.09 O5 PG4 C1130 A 504 TYR A 43 TYR~? 9.79 O5 PG4 C1130 A 540 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 80.85 81.34 94.77 81.70 80.16 92.41 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 79.94 80.46 88.84 81.11 81.36 87.27 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 504 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 540 GLU A 121 GLU~? 21.00 O1 P6G D1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 80.85 81.34 94.77 81.70 80.16 92.41 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 79.94 80.46 88.84 81.11 81.36 87.27 2.80 -10.41 -36.92 3.82 -11.51 -38.44 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU B 66 GLU.? 14.53 C15 P6G D1130 A 504 TYR B 43 TYR~? 10.38 C8 P6G D1130 A 540 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 80.85 81.34 94.77 81.70 80.16 92.41 21.94 3.80 -56.34 23.03 6.24 -57.25 coo 79.94 80.46 88.84 81.11 81.36 87.27 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU B 66 GLU.? 14.53 C15 P6G D1130 A 504 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 540 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 80.85 81.34 94.77 81.70 80.16 92.41 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 79.94 80.46 88.84 81.11 81.36 87.27 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU B 120 GLU~? 31.89 C11 P6G D1130 A 504 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 540 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 80.85 81.34 94.77 81.70 80.16 92.41 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 79.94 80.46 88.84 81.11 81.36 87.27 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 6 3 # 6 A 451 GLU C 66 GLU.? 17.32 O5 PG4 C1130 A 504 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 540 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 -27.54 8.06 -6.82 -28.96 9.42 -7.64 coo 80.85 81.34 94.77 81.70 80.16 92.41 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 79.94 80.46 88.84 81.11 81.36 87.27 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 7 3 # 7 A 451 GLU C 120 GLU~? 18.24 C1 PG4 C1130 A 504 TYR C 118 TYR~? 14.79 C5 PG4 C1130 A 540 GLU C 121 GLU~? 20.36 C1 PG4 C1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 coo 80.85 81.34 94.77 81.70 80.16 92.41 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo 79.94 80.46 88.84 81.11 81.36 87.27 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 8 3 # 8 A 451 GLU D 66 GLU.? 17.04 C6 P6G D1130 A 504 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 540 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 80.85 81.34 94.77 81.70 80.16 92.41 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 79.94 80.46 88.84 81.11 81.36 87.27 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 9 3 # 9 A 451 GLU D 120 GLU~? 20.19 C18 P6G D1130 A 504 TYR D 118 TYR~? 14.64 C18 P6G D1130 A 540 GLU D 121 GLU~? 20.22 C18 P6G D1130 coo 81.34 87.29 87.22 82.36 86.09 88.61 14.39 19.77 -25.34 13.72 21.78 -25.43 coo 80.85 81.34 94.77 81.70 80.16 92.41 19.04 13.52 -30.73 20.87 11.60 -29.89 coo 79.94 80.46 88.84 81.11 81.36 87.27 19.28 17.06 -26.24 19.68 17.98 -24.36 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 9 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU C 120 GLU~? 18.24 C1 PG4 C1130 B 504 TYR C 118 TYR~? 14.79 C5 PG4 C1130 B 540 GLU C 121 GLU~? 20.36 C1 PG4 C1130 coo 86.52 35.28 112.74 87.08 36.38 110.99 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 coo 84.93 40.21 105.31 85.72 41.45 107.72 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo 83.38 41.19 112.55 85.47 40.59 112.72 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU D 66 GLU.? 17.04 C6 P6G D1130 B 504 TYR D 43 TYR~? 10.27 C6 P6G D1130 B 540 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 86.52 35.28 112.74 87.08 36.38 110.99 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 84.93 40.21 105.31 85.72 41.45 107.72 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU D 88 GLU~? 17.52 C12 P6G D1130 B 504 TYR B 118 TYR~? 21.87 C11 P6G D1130 B 540 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo 86.52 35.28 112.74 87.08 36.38 110.99 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 84.93 40.21 105.31 85.72 41.45 107.72 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 83.38 41.19 112.55 85.47 40.59 112.72 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU D 120 GLU~? 20.19 C18 P6G D1130 B 504 TYR D 118 TYR~? 14.64 C18 P6G D1130 B 540 GLU D 121 GLU~? 20.22 C18 P6G D1130 coo 86.52 35.28 112.74 87.08 36.38 110.99 14.39 19.77 -25.34 13.72 21.78 -25.43 coo 84.93 40.21 105.31 85.72 41.45 107.72 19.04 13.52 -30.73 20.87 11.60 -29.89 coo 83.38 41.19 112.55 85.47 40.59 112.72 19.28 17.06 -26.24 19.68 17.98 -24.36 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 451 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 540 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 79.04 80.20 80.81 79.58 81.40 83.63 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 81.34 87.29 87.22 82.36 86.09 88.61 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 79.94 80.46 88.84 81.11 81.36 87.27 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 451 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 540 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 79.04 80.20 80.81 79.58 81.40 83.63 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 81.34 87.29 87.22 82.36 86.09 88.61 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 79.94 80.46 88.84 81.11 81.36 87.27 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 451 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 540 GLU D 88 GLU~? 17.52 C12 P6G D1130 coo 79.04 80.20 80.81 79.58 81.40 83.63 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 79.94 80.46 88.84 81.11 81.36 87.27 27.48 12.16 -32.01 27.65 12.79 -30.00 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 451 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 540 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 79.04 80.20 80.81 79.58 81.40 83.63 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 81.34 87.29 87.22 82.36 86.09 88.61 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 79.94 80.46 88.84 81.11 81.36 87.27 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG D 123 ARG~? 17.23 O19 P6G D1130 A 451 GLU D 121 GLU~? 20.22 C18 P6G D1130 A 540 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 79.04 80.20 80.81 79.58 81.40 83.63 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 81.34 87.29 87.22 82.36 86.09 88.61 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 79.94 80.46 88.84 81.11 81.36 87.27 14.39 19.77 -25.34 13.72 21.78 -25.43 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 5 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 77 ARG~? 12.69 C2 PG4 C1130 B 451 GLU A 82 GLU~? 16.13 C6 PG4 C1130 B 540 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 82.21 41.07 119.14 83.95 40.66 116.59 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 86.52 35.28 112.74 87.08 36.38 110.99 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 83.38 41.19 112.55 85.47 40.59 112.72 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 123 ARG~? 19.27 O1 P6G D1130 B 451 GLU A 121 GLU~? 21.00 O1 P6G D1130 B 540 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 82.21 41.07 119.14 83.95 40.66 116.59 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 86.52 35.28 112.74 87.08 36.38 110.99 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 123 ARG~? 30.75 C11 P6G D1130 B 451 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 540 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 82.21 41.07 119.14 83.95 40.66 116.59 48.86 12.42 -33.59 48.71 12.69 -36.66 coo 86.52 35.28 112.74 87.08 36.38 110.99 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 83.38 41.19 112.55 85.47 40.59 112.72 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG C 123 ARG~? 15.20 O1 PG4 C1130 B 451 GLU C 121 GLU~? 20.36 C1 PG4 C1130 B 540 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 82.21 41.07 119.14 83.95 40.66 116.59 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 86.52 35.28 112.74 87.08 36.38 110.99 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 83.38 41.19 112.55 85.47 40.59 112.72 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG D 123 ARG~? 17.23 O19 P6G D1130 B 451 GLU D 121 GLU~? 20.22 C18 P6G D1130 B 540 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 82.21 41.07 119.14 83.95 40.66 116.59 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 86.52 35.28 112.74 87.08 36.38 110.99 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 83.38 41.19 112.55 85.47 40.59 112.72 14.39 19.77 -25.34 13.72 21.78 -25.43 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 5 hits 1bhg_c05 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 123 ARG~? 19.27 O1 P6G D1130 A 128 GLU A 121 GLU~? 21.00 O1 P6G D1130 A 225 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 38.56 19.11 14.83 37.12 21.00 16.76 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 36.48 24.43 22.02 36.86 26.34 21.13 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 40.16 23.71 17.01 38.52 24.96 17.40 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 128 GLU B 110 GLU~? 14.17 C17 P6G D1130 A 225 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 38.56 19.11 14.83 37.12 21.00 16.76 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 36.48 24.43 22.02 36.86 26.34 21.13 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 40.16 23.71 17.01 38.52 24.96 17.40 30.54 14.87 -46.06 28.97 16.29 -46.38 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 123 ARG~? 30.75 C11 P6G D1130 A 128 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 225 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 38.56 19.11 14.83 37.12 21.00 16.76 48.86 12.42 -33.59 48.71 12.69 -36.66 coo 36.48 24.43 22.02 36.86 26.34 21.13 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 40.16 23.71 17.01 38.52 24.96 17.40 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG C 123 ARG~? 15.20 O1 PG4 C1130 A 128 GLU C 121 GLU~? 20.36 C1 PG4 C1130 A 225 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 38.56 19.11 14.83 37.12 21.00 16.76 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 36.48 24.43 22.02 36.86 26.34 21.13 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 40.16 23.71 17.01 38.52 24.96 17.40 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG D 123 ARG~? 17.23 O19 P6G D1130 A 128 GLU D 121 GLU~? 20.22 C18 P6G D1130 A 225 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 38.56 19.11 14.83 37.12 21.00 16.76 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 36.48 24.43 22.02 36.86 26.34 21.13 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 40.16 23.71 17.01 38.52 24.96 17.40 14.39 19.77 -25.34 13.72 21.78 -25.43 1bqc_c01 source 1bqc BETA-MANNANASE : 5 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 99 PHE~? 22.28 C6 PG4 C1130 A 205 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 236 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 99 PHE~? 22.28 C6 PG4 C1130 A 205 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 236 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 99 PHE~? 22.28 C6 PG4 C1130 A 205 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 236 LYS A 124 LYS~? 16.08 O1 P6G D1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 8.72 -6.45 -38.52 11.43 -11.38 -40.04 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 205 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 236 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 205 ASP B 107 ASP.? 21.14 C14 P6G D1130 A 236 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 205 ASP B 107 ASP.? 21.14 C14 P6G D1130 A 236 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 205 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 236 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE C 54 PHE~? 9.47 C8 PG4 C1130 A 205 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 236 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 205 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 236 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 205 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 236 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 205 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 236 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE D 48 PHE~? -7.47 C9 P6G D1130s A 205 ASP B 107 ASP.? 21.14 C14 P6G D1130 A 236 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 4.14 2.10 36.34 6.69 3.08 36.92 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE D 54 PHE~? 9.38 C6 P6G D1130 A 205 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 236 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.04 15.06 -40.68 14.50 17.55 -45.86 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 205 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 236 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 205 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 236 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 205 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 236 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 4.14 2.10 36.34 6.69 3.08 36.92 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 14.33 6.41 -44.26 15.86 10.02 -47.66 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 16 hits 1bs0_c01 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 354 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 421 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 31.05 49.37 64.51 31.97 51.11 63.85 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 29.07 50.42 58.36 29.02 52.18 59.49 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 30.82 59.76 58.47 31.12 59.02 60.40 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 354 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 421 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 31.05 49.37 64.51 31.97 51.11 63.85 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 29.07 50.42 58.36 29.02 52.18 59.49 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 30.82 59.76 58.47 31.12 59.02 60.40 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 354 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 421 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 31.05 49.37 64.51 31.97 51.11 63.85 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 30.82 59.76 58.47 31.12 59.02 60.40 31.47 6.05 -29.78 29.50 6.72 -30.15 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 85 ASP~? 19.32 C6 PG4 C1130 B 354 GLU A 82 GLU~? 16.13 C6 PG4 C1130 B 421 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 25.90 8.19 53.87 25.36 6.97 52.29 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 27.87 10.66 47.95 27.82 8.60 48.27 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 26.02 1.87 43.38 25.90 1.97 45.49 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 354 GLU B 82 GLU~? 13.30 C2 P6G D1130 B 421 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 25.90 8.19 53.87 25.36 6.97 52.29 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 27.87 10.66 47.95 27.82 8.60 48.27 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 26.02 1.87 43.38 25.90 1.97 45.49 26.47 11.48 -38.21 26.51 9.40 -38.05 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c09 naa= 3 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 1 3 # 1 183 GLU A 109 GLU~? 22.30 C2 PG4 C1130 324 ASN A 108 ASN~? 14.80 C2 PG4 C1130 397 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 43.16 34.25 82.88 42.98 32.71 84.39 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 42.23 29.47 82.87 40.46 30.21 83.67 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 2 3 # 2 183 GLU A 110 GLU~? 14.79 C2 PG4 C1130 324 ASN A 108 ASN~? 14.80 C2 PG4 C1130 397 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 43.16 34.25 82.88 42.98 32.71 84.39 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 42.23 29.47 82.87 40.46 30.21 83.67 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 3 3 # 3 183 GLU B 69 GLU~? 16.29 C14 P6G D1130 324 ASN B 108 ASN~? 14.77 C17 P6G D1130 397 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 43.16 34.25 82.88 42.98 32.71 84.39 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 42.23 29.47 82.87 40.46 30.21 83.67 30.54 14.87 -46.06 28.97 16.29 -46.38 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 4 3 # 4 183 GLU B 73 GLU~? 10.65 C14 P6G D1130 324 ASN B 108 ASN~? 14.77 C17 P6G D1130 397 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 43.16 34.25 82.88 42.98 32.71 84.39 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 42.23 29.47 82.87 40.46 30.21 83.67 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 5 3 # 5 183 GLU B 73 GLU~? 10.65 C14 P6G D1130 324 ASN B 108 ASN~? 14.77 C17 P6G D1130 397 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 43.16 34.25 82.88 42.98 32.71 84.39 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 42.23 29.47 82.87 40.46 30.21 83.67 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 6 3 # 6 183 GLU B 109 GLU~? 22.36 C17 P6G D1130 324 ASN B 108 ASN~? 14.77 C17 P6G D1130 397 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 43.16 34.25 82.88 42.98 32.71 84.39 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 42.23 29.47 82.87 40.46 30.21 83.67 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 7 3 # 7 183 GLU B 110 GLU~? 14.17 C17 P6G D1130 324 ASN B 108 ASN~? 14.77 C17 P6G D1130 397 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 43.16 34.25 82.88 42.98 32.71 84.39 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 42.23 29.47 82.87 40.46 30.21 83.67 30.54 14.87 -46.06 28.97 16.29 -46.38 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 8 3 # 8 183 GLU B 110 GLU~? 14.17 C17 P6G D1130 324 ASN B 108 ASN~? 14.77 C17 P6G D1130 397 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 43.16 34.25 82.88 42.98 32.71 84.39 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 42.23 29.47 82.87 40.46 30.21 83.67 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 9 3 # 9 183 GLU C 109 GLU~? 22.49 C8 PG4 C1130 324 ASN C 108 ASN~? 16.59 C8 PG4 C1130 397 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 43.16 34.25 82.88 42.98 32.71 84.39 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 42.23 29.47 82.87 40.46 30.21 83.67 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 10 3 # 10 183 GLU C 110 GLU~? 19.54 O4 PG4 C1130 324 ASN C 108 ASN~? 16.59 C8 PG4 C1130 397 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 -28.66 1.59 -33.06 -27.87 1.89 -35.00 coo 43.16 34.25 82.88 42.98 32.71 84.39 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 42.23 29.47 82.87 40.46 30.21 83.67 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 11 3 # 11 183 GLU D 109 GLU~? 20.19 O1 P6G D1130 324 ASN D 108 ASN~? 12.52 O1 P6G D1130 397 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 43.16 34.25 82.88 42.98 32.71 84.39 8.90 3.92 -35.18 9.80 2.60 -33.76 coo 42.23 29.47 82.87 40.46 30.21 83.67 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 12 3 # 12 183 GLU D 110 GLU~? 16.67 O1 P6G D1130 324 ASN D 108 ASN~? 12.52 O1 P6G D1130 397 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 39.31 34.78 85.95 38.51 34.50 84.04 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 43.16 34.25 82.88 42.98 32.71 84.39 8.90 3.92 -35.18 9.80 2.60 -33.76 coo 42.23 29.47 82.87 40.46 30.21 83.67 4.39 5.46 -30.92 3.12 7.08 -30.47 1cbg_c00 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 12 hits 1cbg_c00 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 85 ASP~? 19.32 C6 PG4 C1130 264 GLU A 52 GLU~? 14.14 O5 PG4 C1130 328 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 59.69 92.71 39.85 58.53 92.03 41.47 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 50 ASP~? 8.75 C2 P6G D1130 264 GLU D 66 GLU.? 17.04 C6 P6G D1130 328 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 45.39 90.72 40.63 45.07 89.14 41.90 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP C 85 ASP~? 10.22 C6 PG4 C1130 264 GLU A 121 GLU~? 21.00 O1 P6G D1130 328 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 59.69 92.71 39.85 58.53 92.03 41.47 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 45.39 90.72 40.63 45.07 89.14 41.90 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP D 85 ASP~? 10.24 C11 P6G D1130 264 GLU B 100 GLU~? 26.53 C3 P6G D1130 328 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 59.69 92.71 39.85 58.53 92.03 41.47 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP D 85 ASP~? 10.24 C11 P6G D1130 264 GLU B 121 GLU~? 26.56 C11 P6G D1130 328 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 59.69 92.71 39.85 58.53 92.03 41.47 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.47 6.05 -29.78 29.50 6.72 -30.15 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 5 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 85 ASP~? 19.32 C6 PG4 C1130 257 GLU A 82 GLU~? 16.13 C6 PG4 C1130 328 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 48.97 85.16 40.39 47.18 86.25 40.47 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 85 ASP~? 19.32 C6 PG4 C1130 257 GLU C 88 GLU~? 16.97 C5 PG4 C1130 328 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 48.97 85.16 40.39 47.18 86.25 40.47 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 85 ASP~? 16.97 O1 P6G D1130 257 GLU B 82 GLU~? 13.30 C2 P6G D1130 328 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 48.97 85.16 40.39 47.18 86.25 40.47 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 85 ASP~? 16.97 O1 P6G D1130 257 GLU D 88 GLU~? 17.52 C12 P6G D1130 328 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP C 85 ASP~? 10.22 C6 PG4 C1130 257 GLU A 82 GLU~? 16.13 C6 PG4 C1130 328 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 48.97 85.16 40.39 47.18 86.25 40.47 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 45.39 90.72 40.63 45.07 89.14 41.90 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP C 85 ASP~? 10.22 C6 PG4 C1130 257 GLU C 88 GLU~? 16.97 C5 PG4 C1130 328 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 48.97 85.16 40.39 47.18 86.25 40.47 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP D 85 ASP~? 10.24 C11 P6G D1130 257 GLU B 82 GLU~? 13.30 C2 P6G D1130 328 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 48.97 85.16 40.39 47.18 86.25 40.47 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP D 85 ASP~? 10.24 C11 P6G D1130 257 GLU D 88 GLU~? 17.52 C12 P6G D1130 328 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 45.62 80.42 43.69 45.65 82.01 45.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 48.97 85.16 40.39 47.18 86.25 40.47 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 31.47 6.05 -29.78 29.50 6.72 -30.15 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 8 hits 1cdg_c04 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 83 GLY~? 20.43 C6 PG4 C1130 A 228 SER A 78 SER~? 11.56 C6 PG4 C1130 A 549 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 83 GLY~? 19.46 C3 P6G D1130 A 228 SER B 78 SER~? 10.35 C3 P6G D1130 A 549 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 35.61 7.43 -33.25 34.89 7.70 -32.90 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 26.47 11.48 -38.21 26.51 9.40 -38.05 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 83 GLY~? 20.43 C6 PG4 C1130 B1228 SER A 78 SER~? 11.56 C6 PG4 C1130 B1549 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 126.34 72.75 125.66 125.95 73.27 126.11 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 131.65 74.68 129.41 130.31 72.73 128.82 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 134.72 69.43 130.42 133.03 70.65 130.08 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 83 GLY~? 19.46 C3 P6G D1130 B1228 SER B 78 SER~? 10.35 C3 P6G D1130 B1549 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 126.34 72.75 125.66 125.95 73.27 126.11 35.61 7.43 -33.25 34.89 7.70 -32.90 coo 131.65 74.68 129.41 130.31 72.73 128.82 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 134.72 69.43 130.42 133.03 70.65 130.08 26.47 11.48 -38.21 26.51 9.40 -38.05 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 89 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 120 SER A 78 SER~? 11.56 C6 PG4 C1130 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 89 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 120 SER B 78 SER~? 10.35 C3 P6G D1130 coo -24.35 9.53 67.64 -25.07 11.29 68.60 30.54 14.87 -46.06 28.97 16.29 -46.38 coo -31.18 6.91 75.60 -32.39 8.51 74.91 22.48 10.01 -42.20 22.42 10.27 -44.26 coo -34.73 8.57 68.21 -33.63 9.08 70.28 29.57 8.47 -39.24 28.68 6.25 -39.24 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 89 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 120 SER B 116 SER~? 25.27 C11 P6G D1130 coo -24.35 9.53 67.64 -25.07 11.29 68.60 44.37 7.71 -38.80 45.94 6.33 -38.72 coo -31.18 6.91 75.60 -32.39 8.51 74.91 40.84 14.63 -29.45 39.08 15.39 -28.50 coo -34.73 8.57 68.21 -33.63 9.08 70.28 42.44 16.01 -37.83 43.08 16.69 -40.10 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 89 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 120 SER B 106 SER~? 15.38 C14 P6G D1130 coo -24.35 9.53 67.64 -25.07 11.29 68.60 38.03 21.53 -47.60 38.82 23.44 -47.86 coo -31.18 6.91 75.60 -32.39 8.51 74.91 30.54 14.87 -46.06 28.97 16.29 -46.38 coo -34.73 8.57 68.21 -33.63 9.08 70.28 36.13 12.10 -48.03 34.30 13.65 -47.56 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 89 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 120 SER B 116 SER~? 25.27 C11 P6G D1130 coo -24.35 9.53 67.64 -25.07 11.29 68.60 40.84 14.63 -29.45 39.08 15.39 -28.50 coo -31.18 6.91 75.60 -32.39 8.51 74.91 44.37 7.71 -38.80 45.94 6.33 -38.72 coo -34.73 8.57 68.21 -33.63 9.08 70.28 42.44 16.01 -37.83 43.08 16.69 -40.10 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU C 100 GLU~? 11.21 O1 PG4 C1130 A 89 GLU C 120 GLU~? 18.24 C1 PG4 C1130 A 120 SER C 116 SER~? 17.33 C1 PG4 C1130 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 1cns_c00 source 1cns CHITINASE : 6 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 55 GLU~? 16.41 O5 PG4 C1130 B 89 GLU A 69 GLU~? 16.61 C4 PG4 C1130 B 120 SER A 106 SER~? 15.55 C4 PG4 C1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 89 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 120 SER A 78 SER~? 11.56 C6 PG4 C1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 109 GLU~? 22.30 C2 PG4 C1130 B 89 GLU A 69 GLU~? 16.61 C4 PG4 C1130 B 120 SER A 106 SER~? 15.55 C4 PG4 C1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU A 110 GLU~? 14.79 C2 PG4 C1130 B 89 GLU C 88 GLU~? 16.97 C5 PG4 C1130 B 120 SER A 78 SER~? 11.56 C6 PG4 C1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 73 GLU~? 10.65 C14 P6G D1130 B 89 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 120 SER B 78 SER~? 10.35 C3 P6G D1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 29.57 8.47 -39.24 28.68 6.25 -39.24 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU B 110 GLU~? 14.17 C17 P6G D1130 B 89 GLU D 88 GLU~? 17.52 C12 P6G D1130 B 120 SER B 78 SER~? 10.35 C3 P6G D1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 32.90 20.43 -41.22 30.91 19.85 -41.11 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 29.57 8.47 -39.24 28.68 6.25 -39.24 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU D 100 GLU~? 11.53 O19 P6G D1130 B 89 GLU D 120 GLU~? 20.19 C18 P6G D1130 B 120 SER D 116 SER~? 16.17 C18 P6G D1130 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 11.11 19.18 -38.13 10.21 19.66 -36.27 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 14.39 19.77 -25.34 13.72 21.78 -25.43 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 11.98 14.89 -30.11 9.63 14.31 -30.33 1cns_c01 source 1cns CHITINASE : 7 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 92 TYR~? 17.76 O1 P6G D1130 A 173 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 48 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 24.35 4.55 25.11 25.94 3.23 25.53 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 123 ARG~? 19.27 O1 P6G D1130 C 101 TYR A 92 TYR~? 17.76 O1 P6G D1130 C 173 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 32.27 5.62 48.15 31.93 6.48 51.06 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 29.64 3.64 57.39 31.22 5.14 55.65 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 4.55 4.63 -38.29 4.19 5.10 -40.34 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 123 ARG~? 19.27 O1 P6G D1130 D 101 TYR A 92 TYR~? 17.76 O1 P6G D1130 D 173 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 69.08 8.58 32.60 69.70 10.81 30.58 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 71.77 11.86 24.26 70.23 12.22 26.56 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 71.60 6.14 19.25 70.26 6.87 20.69 4.55 4.63 -38.29 4.19 5.10 -40.34 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 92 TYR~? 17.76 O1 P6G D1130 B 173 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 48 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 90 ALA.? 19.83 O1 P6G D1130 A 74 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 75 GLY A 93 GLY~? 17.18 O1 P6G D1130 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo 1.20 66.40 122.20 2.03 64.53 121.46 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 4.68 65.84 125.52 4.11 65.60 126.05 3.56 2.15 -34.44 2.78 1.87 -34.42 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 90 ALA.? 29.32 O1 P6G D1130 A 74 ASN B 91 ASN~? 25.69 C2 P6G D1130 A 75 GLY B 93 GLY~? 27.46 C3 P6G D1130 coo -1.80 62.71 122.76 -1.88 63.70 123.92 39.13 5.51 -23.62 39.54 5.36 -22.16 coo 1.20 66.40 122.20 2.03 64.53 121.46 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 4.68 65.84 125.52 4.11 65.60 126.05 43.99 3.50 -30.67 43.17 3.69 -30.58 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA C 90 ALA.? 17.94 C1 PG4 C1130 A 74 ASN C 91 ASN~? 14.02 C1 PG4 C1130 A 75 GLY C 93 GLY~? 11.76 O1 PG4 C1130 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo 1.20 66.40 122.20 2.03 64.53 121.46 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo 4.68 65.84 125.52 4.11 65.60 126.05 -18.29 -19.21 -30.01 -17.99 -18.45 -29.78 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA D 90 ALA.? 17.47 C18 P6G D1130 A 74 ASN D 91 ASN~? 13.51 O19 P6G D1130 A 75 GLY D 93 GLY~? 11.29 O19 P6G D1130 coo -1.80 62.71 122.76 -1.88 63.70 123.92 28.43 19.70 -33.25 29.64 20.34 -32.58 coo 1.20 66.40 122.20 2.03 64.53 121.46 26.57 20.44 -37.63 28.54 20.81 -38.21 coo 4.68 65.84 125.52 4.11 65.60 126.05 21.50 23.72 -36.70 21.81 22.93 -36.81 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 90 ALA.? 19.83 O1 P6G D1130 B 74 ASN A 91 ASN~? 22.38 O1 P6G D1130 B 75 GLY A 93 GLY~? 17.18 O1 P6G D1130 coo 39.21 14.97 27.55 40.19 16.01 27.08 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo 43.06 12.94 25.74 42.26 11.81 27.44 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 46.38 13.54 29.18 46.14 14.29 29.26 3.56 2.15 -34.44 2.78 1.87 -34.42 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 90 ALA.? 29.32 O1 P6G D1130 B 74 ASN B 91 ASN~? 25.69 C2 P6G D1130 B 75 GLY B 93 GLY~? 27.46 C3 P6G D1130 coo 39.21 14.97 27.55 40.19 16.01 27.08 39.13 5.51 -23.62 39.54 5.36 -22.16 coo 43.06 12.94 25.74 42.26 11.81 27.44 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 46.38 13.54 29.18 46.14 14.29 29.26 43.99 3.50 -30.67 43.17 3.69 -30.58 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA C 90 ALA.? 17.94 C1 PG4 C1130 B 74 ASN C 91 ASN~? 14.02 C1 PG4 C1130 B 75 GLY C 93 GLY~? 11.76 O1 PG4 C1130 coo 39.21 14.97 27.55 40.19 16.01 27.08 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo 43.06 12.94 25.74 42.26 11.81 27.44 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo 46.38 13.54 29.18 46.14 14.29 29.26 -18.29 -19.21 -30.01 -17.99 -18.45 -29.78 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA D 90 ALA.? 17.47 C18 P6G D1130 B 74 ASN D 91 ASN~? 13.51 O19 P6G D1130 B 75 GLY D 93 GLY~? 11.29 O19 P6G D1130 coo 39.21 14.97 27.55 40.19 16.01 27.08 28.43 19.70 -33.25 29.64 20.34 -32.58 coo 43.06 12.94 25.74 42.26 11.81 27.44 26.57 20.44 -37.63 28.54 20.81 -38.21 coo 46.38 13.54 29.18 46.14 14.29 29.26 21.50 23.72 -36.70 21.81 22.93 -36.81 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 5 3 # 5 B 1 ALA D 95 ALA~? 9.46 C18 P6G D1130 B 74 ASN D 91 ASN~? 13.51 O19 P6G D1130 B 75 GLY D 93 GLY~? 11.29 O19 P6G D1130 coo 39.21 14.97 27.55 40.19 16.01 27.08 20.99 18.21 -37.32 21.64 17.75 -36.04 coo 43.06 12.94 25.74 42.26 11.81 27.44 26.57 20.44 -37.63 28.54 20.81 -38.21 coo 46.38 13.54 29.18 46.14 14.29 29.26 21.50 23.72 -36.70 21.81 22.93 -36.81 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 5 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 90 ALA.? 19.83 O1 P6G D1130 C 74 ASN A 91 ASN~? 22.38 O1 P6G D1130 C 75 GLY A 93 GLY~? 17.18 O1 P6G D1130 coo 16.14 15.08 36.63 15.28 14.65 37.81 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo 11.60 16.13 36.70 12.80 17.74 35.96 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 10.99 19.23 40.32 11.50 18.77 40.74 3.56 2.15 -34.44 2.78 1.87 -34.42 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 90 ALA.? 29.32 O1 P6G D1130 C 74 ASN B 91 ASN~? 25.69 C2 P6G D1130 C 75 GLY B 93 GLY~? 27.46 C3 P6G D1130 coo 16.14 15.08 36.63 15.28 14.65 37.81 39.13 5.51 -23.62 39.54 5.36 -22.16 coo 11.60 16.13 36.70 12.80 17.74 35.96 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 10.99 19.23 40.32 11.50 18.77 40.74 43.99 3.50 -30.67 43.17 3.69 -30.58 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA C 90 ALA.? 17.94 C1 PG4 C1130 C 74 ASN C 91 ASN~? 14.02 C1 PG4 C1130 C 75 GLY C 93 GLY~? 11.76 O1 PG4 C1130 coo 16.14 15.08 36.63 15.28 14.65 37.81 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo 11.60 16.13 36.70 12.80 17.74 35.96 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo 10.99 19.23 40.32 11.50 18.77 40.74 -18.29 -19.21 -30.01 -17.99 -18.45 -29.78 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA D 90 ALA.? 17.47 C18 P6G D1130 C 74 ASN D 91 ASN~? 13.51 O19 P6G D1130 C 75 GLY D 93 GLY~? 11.29 O19 P6G D1130 coo 16.14 15.08 36.63 15.28 14.65 37.81 28.43 19.70 -33.25 29.64 20.34 -32.58 coo 11.60 16.13 36.70 12.80 17.74 35.96 26.57 20.44 -37.63 28.54 20.81 -38.21 coo 10.99 19.23 40.32 11.50 18.77 40.74 21.50 23.72 -36.70 21.81 22.93 -36.81 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 90 ALA.? 19.83 O1 P6G D1130 D 74 ASN A 91 ASN~? 22.38 O1 P6G D1130 D 75 GLY A 93 GLY~? 17.18 O1 P6G D1130 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo -17.65 36.37 119.00 -16.85 36.22 119.00 3.56 2.15 -34.44 2.78 1.87 -34.42 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 90 ALA.? 29.32 O1 P6G D1130 D 74 ASN B 91 ASN~? 25.69 C2 P6G D1130 D 75 GLY B 93 GLY~? 27.46 C3 P6G D1130 coo -13.31 41.90 116.45 -13.05 40.39 116.25 39.13 5.51 -23.62 39.54 5.36 -22.16 coo -16.85 39.36 115.26 -17.55 40.58 116.90 38.86 2.42 -27.25 38.09 1.11 -25.75 coo -17.65 36.37 119.00 -16.85 36.22 119.00 43.99 3.50 -30.67 43.17 3.69 -30.58 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA C 90 ALA.? 17.94 C1 PG4 C1130 D 74 ASN C 91 ASN~? 14.02 C1 PG4 C1130 D 75 GLY C 93 GLY~? 11.76 O1 PG4 C1130 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -18.29 -19.21 -30.01 -17.99 -18.45 -29.78 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA D 90 ALA.? 17.47 C18 P6G D1130 D 74 ASN D 91 ASN~? 13.51 O19 P6G D1130 D 75 GLY D 93 GLY~? 11.29 O19 P6G D1130 coo -13.31 41.90 116.45 -13.05 40.39 116.25 28.43 19.70 -33.25 29.64 20.34 -32.58 coo -16.85 39.36 115.26 -17.55 40.58 116.90 26.57 20.44 -37.63 28.54 20.81 -38.21 coo -17.65 36.37 119.00 -16.85 36.22 119.00 21.50 23.72 -36.70 21.81 22.93 -36.81 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 5 3 # 5 D 1 ALA D 95 ALA~? 9.46 C18 P6G D1130 D 74 ASN D 91 ASN~? 13.51 O19 P6G D1130 D 75 GLY D 93 GLY~? 11.29 O19 P6G D1130 coo -13.31 41.90 116.45 -13.05 40.39 116.25 20.99 18.21 -37.32 21.64 17.75 -36.04 coo -16.85 39.36 115.26 -17.55 40.58 116.90 26.57 20.44 -37.63 28.54 20.81 -38.21 coo -17.65 36.37 119.00 -16.85 36.22 119.00 21.50 23.72 -36.70 21.81 22.93 -36.81 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 5 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 50 ASP~? 13.04 O5 PG4 C1130 315 GLU A 52 GLU~? 14.14 O5 PG4 C1130 390 TYR A 57 TYR~? 16.39 O5 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 32.04 94.22 18.23 30.57 94.75 16.88 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 21.10 94.74 18.36 23.09 96.71 18.59 -10.74 6.03 -7.67 -11.80 6.36 -5.11 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 85 ASP~? 19.32 C6 PG4 C1130 315 GLU A 82 GLU~? 16.13 C6 PG4 C1130 390 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 32.04 94.22 18.23 30.57 94.75 16.88 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 21.10 94.74 18.36 23.09 96.71 18.59 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP A 85 ASP~? 19.32 C6 PG4 C1130 315 GLU A 88 GLU~? 23.13 C5 PG4 C1130 390 TYR A 92 TYR~? 17.76 O1 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 32.04 94.22 18.23 30.57 94.75 16.88 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 coo 21.10 94.74 18.36 23.09 96.71 18.59 2.30 -1.46 -39.04 1.18 -2.64 -41.31 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP B 50 ASP~? 8.75 C2 P6G D1130 315 GLU B 52 GLU~? 14.42 C2 P6G D1130 390 TYR B 57 TYR~? 16.24 O4 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 32.04 94.22 18.23 30.57 94.75 16.88 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 21.10 94.74 18.36 23.09 96.71 18.59 28.47 -3.97 -56.19 27.34 -4.39 -58.70 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP B 85 ASP~? 16.97 O1 P6G D1130 315 GLU B 82 GLU~? 13.30 C2 P6G D1130 390 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 32.04 94.22 18.23 30.57 94.75 16.88 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 21.10 94.74 18.36 23.09 96.71 18.59 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP B 85 ASP~? 16.97 O1 P6G D1130 315 GLU B 88 GLU~? 21.68 O1 P6G D1130 390 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 32.04 94.22 18.23 30.57 94.75 16.88 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 21.10 94.74 18.36 23.09 96.71 18.59 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP B 85 ASP~? 16.97 O1 P6G D1130 315 GLU B 88 GLU~? 21.68 O1 P6G D1130 390 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 32.04 94.22 18.23 30.57 94.75 16.88 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 21.10 94.74 18.36 23.09 96.71 18.59 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP C 50 ASP~? 5.21 O2 PG4 C1130 315 GLU C 52 GLU~? 9.38 O2 PG4 C1130 390 TYR C 57 TYR~? 15.97 O5 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 32.04 94.22 18.23 30.57 94.75 16.88 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 21.10 94.74 18.36 23.09 96.71 18.59 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 9 3 # 9 313 ASP C 85 ASP~? 10.22 C6 PG4 C1130 315 GLU C 82 GLU~? -3.24 C6 PG4 C1130s 390 TYR A 51 TYR~? 11.49 O5 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 32.04 94.22 18.23 30.57 94.75 16.88 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 21.10 94.74 18.36 23.09 96.71 18.59 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 10 3 # 10 313 ASP C 85 ASP~? 10.22 C6 PG4 C1130 315 GLU C 82 GLU~? -3.24 C6 PG4 C1130s 390 TYR C 118 TYR~? 14.79 C5 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 32.04 94.22 18.23 30.57 94.75 16.88 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 21.10 94.74 18.36 23.09 96.71 18.59 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 11 3 # 11 313 ASP C 85 ASP~? 10.22 C6 PG4 C1130 315 GLU C 88 GLU~? 16.97 C5 PG4 C1130 390 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 32.04 94.22 18.23 30.57 94.75 16.88 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 21.10 94.74 18.36 23.09 96.71 18.59 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 12 3 # 12 313 ASP C 85 ASP~? 10.22 C6 PG4 C1130 315 GLU C 88 GLU~? 16.97 C5 PG4 C1130 390 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 32.04 94.22 18.23 30.57 94.75 16.88 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 21.10 94.74 18.36 23.09 96.71 18.59 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 13 3 # 13 313 ASP C 107 ASP.? 16.10 C8 PG4 C1130 315 GLU C 73 GLU~? 12.72 C8 PG4 C1130 390 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 32.04 94.22 18.23 30.57 94.75 16.88 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 21.10 94.74 18.36 23.09 96.71 18.59 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 14 3 # 14 313 ASP D 50 ASP~? 5.15 O16 P6G D1130 315 GLU D 52 GLU~? 9.77 O16 P6G D1130 390 TYR D 57 TYR~? 15.84 C9 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 32.04 94.22 18.23 30.57 94.75 16.88 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 21.10 94.74 18.36 23.09 96.71 18.59 9.96 9.67 -59.45 11.06 8.95 -61.91 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 15 3 # 15 313 ASP D 85 ASP~? 10.24 C11 P6G D1130 315 GLU D 82 GLU~? -3.29 C11 P6G D1130s 390 TYR B 51 TYR~? 10.58 C3 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 32.04 94.22 18.23 30.57 94.75 16.88 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 21.10 94.74 18.36 23.09 96.71 18.59 29.55 2.80 -46.55 31.14 4.40 -48.22 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 16 3 # 16 313 ASP D 85 ASP~? 10.24 C11 P6G D1130 315 GLU D 82 GLU~? -3.29 C11 P6G D1130s 390 TYR D 118 TYR~? 14.64 C18 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 32.04 94.22 18.23 30.57 94.75 16.88 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 21.10 94.74 18.36 23.09 96.71 18.59 19.04 13.52 -30.73 20.87 11.60 -29.89 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 17 3 # 17 313 ASP D 85 ASP~? 10.24 C11 P6G D1130 315 GLU D 88 GLU~? 17.52 C12 P6G D1130 390 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 32.04 94.22 18.23 30.57 94.75 16.88 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 21.10 94.74 18.36 23.09 96.71 18.59 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 18 3 # 18 313 ASP D 85 ASP~? 10.24 C11 P6G D1130 315 GLU D 88 GLU~? 17.52 C12 P6G D1130 390 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 32.04 94.22 18.23 30.57 94.75 16.88 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 21.10 94.74 18.36 23.09 96.71 18.59 24.24 21.35 -31.93 26.12 20.12 -30.25 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 19 3 # 19 313 ASP D 107 ASP.? 14.84 O1 P6G D1130 315 GLU D 73 GLU~? 10.67 O1 P6G D1130 390 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 32.46 99.13 19.34 30.94 100.38 20.07 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 32.04 94.22 18.23 30.57 94.75 16.88 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 21.10 94.74 18.36 23.09 96.71 18.59 9.62 8.34 -47.74 8.38 5.93 -48.44 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 19 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 340 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 395 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 340 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 395 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 30.92 4.89 -35.74 29.30 4.17 -34.66 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 340 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 395 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 340 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 395 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 27.48 12.16 -32.01 27.65 12.79 -30.00 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 31.47 6.05 -29.78 29.50 6.72 -30.15 1cwy_c00 source 1cwy AMYLOMALTASE : 4 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 56 ILE A 47 ILE~? 5.06 O5 PG4 C1130 A 82 TYR A 46 TYR~? 5.44 O5 PG4 C1130 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -20.77 1.18 -13.37 -21.79 0.38 -12.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 56 ILE A 80 ILE~? 17.21 C6 PG4 C1130 A 82 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -5.76 -7.89 -28.13 -5.24 -9.26 -28.11 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 56 ILE B 47 ILE~? 5.05 C6 P6G D1130 A 82 TYR B 46 TYR~? 5.77 O4 P6G D1130 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 18.55 1.15 -50.41 17.56 1.81 -51.09 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 23.81 3.51 -50.06 24.23 5.64 -48.28 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 56 ILE B 80 ILE~? 16.96 C11 P6G D1130 A 82 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 33.87 11.87 -37.32 34.37 13.17 -37.67 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 56 ILE C 47 ILE~? -4.76 O5 PG4 C1130s A 82 TYR C 46 TYR~? -4.42 C8 PG4 C1130s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -19.33 -5.33 -12.66 -18.36 -4.41 -12.36 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 56 ILE C 80 ILE~? 9.85 C5 PG4 C1130 A 82 TYR C 118 TYR~? 14.79 C5 PG4 C1130 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -22.60 -4.86 -27.98 -23.50 -4.40 -28.98 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 56 ILE D 47 ILE~? -4.89 C8 P6G D1130s A 82 TYR D 46 TYR~? -4.28 C6 P6G D1130s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 19.86 7.69 -51.78 20.81 6.75 -52.00 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 14.78 5.72 -50.79 14.70 4.54 -48.27 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 56 ILE D 80 ILE~? 9.47 O1 P6G D1130 A 82 TYR D 118 TYR~? 14.64 C18 P6G D1130 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 17.31 8.62 -36.21 16.78 9.31 -35.04 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 19.04 13.52 -30.73 20.87 11.60 -29.89 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 8 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 56 ILE A 47 ILE~? 5.06 O5 PG4 C1130 B 82 TYR A 46 TYR~? 5.44 O5 PG4 C1130 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -20.77 1.18 -13.37 -21.79 0.38 -12.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 85 ASP~? 19.32 C6 PG4 C1130 B 56 ILE A 80 ILE~? 17.21 C6 PG4 C1130 B 82 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -5.76 -7.89 -28.13 -5.24 -9.26 -28.11 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 56 ILE B 47 ILE~? 5.05 C6 P6G D1130 B 82 TYR B 46 TYR~? 5.77 O4 P6G D1130 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 18.55 1.15 -50.41 17.56 1.81 -51.09 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 23.81 3.51 -50.06 24.23 5.64 -48.28 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 56 ILE B 80 ILE~? 16.96 C11 P6G D1130 B 82 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 33.87 11.87 -37.32 34.37 13.17 -37.67 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 56 ILE C 47 ILE~? -4.76 O5 PG4 C1130s B 82 TYR C 46 TYR~? -4.42 C8 PG4 C1130s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -19.33 -5.33 -12.66 -18.36 -4.41 -12.36 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 56 ILE C 80 ILE~? 9.85 C5 PG4 C1130 B 82 TYR C 118 TYR~? 14.79 C5 PG4 C1130 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -22.60 -4.86 -27.98 -23.50 -4.40 -28.98 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 56 ILE D 47 ILE~? -4.89 C8 P6G D1130s B 82 TYR D 46 TYR~? -4.28 C6 P6G D1130s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 19.86 7.69 -51.78 20.81 6.75 -52.00 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 14.78 5.72 -50.79 14.70 4.54 -48.27 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 56 ILE D 80 ILE~? 9.47 O1 P6G D1130 B 82 TYR D 118 TYR~? 14.64 C18 P6G D1130 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 17.31 8.62 -36.21 16.78 9.31 -35.04 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 19.04 13.52 -30.73 20.87 11.60 -29.89 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 8 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 243 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 272 LYS C 113 LYS~? 22.50 C5 PG4 C1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 243 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 272 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 243 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 272 LYS C 112 LYS~? 18.47 C1 PG4 C1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 243 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 272 LYS C 113 LYS~? 22.50 C5 PG4 C1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 243 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 272 LYS C 112 LYS~? 18.47 C1 PG4 C1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 14.13 45.79 13.40 14.25 49.41 18.30 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 243 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 272 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo 16.93 55.67 9.65 17.16 54.23 11.19 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 14.13 45.79 13.40 14.25 49.41 18.30 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 243 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 272 LYS D 112 LYS~? 16.61 O1 P6G D1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 16.93 55.67 9.65 17.16 54.23 11.19 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 9.54 9.95 -32.52 4.98 7.78 -34.65 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 243 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 272 LYS A 124 LYS~? 16.08 O1 P6G D1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 14.13 45.79 13.40 14.25 49.41 18.30 8.72 -6.45 -38.52 11.43 -11.38 -40.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 243 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 272 LYS A 124 LYS~? 16.08 O1 P6G D1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 8.72 -6.45 -38.52 11.43 -11.38 -40.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 243 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 272 LYS D 112 LYS~? 16.61 O1 P6G D1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 16.93 55.67 9.65 17.16 54.23 11.19 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 14.13 45.79 13.40 14.25 49.41 18.30 9.54 9.95 -32.52 4.98 7.78 -34.65 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 243 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 272 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 2.03 68.31 21.46 0.66 68.36 23.90 24.24 21.35 -31.93 26.12 20.12 -30.25 coo 16.93 55.67 9.65 17.16 54.23 11.19 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 14.13 45.79 13.40 14.25 49.41 18.30 9.63 4.64 -45.08 4.33 7.57 -43.39 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 11 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 177 GLU A 44 GLU~? 13.07 O5 PG4 C1130 A 201 LEU A 40 LEU~? 14.12 O5 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -19.01 2.30 -3.28 -21.00 1.45 -3.09 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 64 LYS.? 18.05 O5 PG4 C1130 A 177 GLU A 61 GLU~? 21.55 O5 PG4 C1130 A 201 LEU A 63 LEU.? 17.30 O5 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -8.80 0.30 -4.09 -10.26 1.63 -3.22 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 177 GLU A 69 GLU~? 16.61 C4 PG4 C1130 A 201 LEU A 70 LEU~? 8.30 C4 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -12.26 -10.94 -14.01 -13.58 -12.04 -15.37 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 84 LYS~? 19.93 C5 PG4 C1130 A 177 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 201 LEU A 86 LEU~? 23.09 C6 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -3.85 0.15 -34.51 -4.48 1.96 -33.39 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS A 101 LYS~? 17.94 O5 PG4 C1130 A 177 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 201 LEU A 105 LEU~? 16.72 C6 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -2.71 -5.13 -19.00 -4.17 -3.75 -18.09 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS A 101 LYS~? 17.94 O5 PG4 C1130 A 177 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 201 LEU A 79 LEU~? 16.24 C6 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 177 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 201 LEU A 103 LEU~? 23.56 C6 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 2.20 -7.99 -23.80 3.77 -9.56 -23.73 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS A 124 LYS~? 16.08 O1 P6G D1130 A 177 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 201 LEU A 126 LEU~? 13.09 O1 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 8.17 -0.63 -37.01 6.46 0.51 -36.38 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS B 32 LYS~? 26.29 C8 P6G D1130 A 177 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 201 LEU D 33 LEU~? 24.56 C6 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 17.19 1.44 -71.70 18.51 3.04 -71.02 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 177 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 201 LEU B 40 LEU~? 14.67 C6 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 20.03 -0.73 -60.50 18.12 0.25 -60.86 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 A 145 LYS B 64 LYS.? 18.19 C9 P6G D1130 A 177 GLU B 61 GLU~? 21.58 O4 P6G D1130 A 201 LEU B 63 LEU.? 18.00 C8 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 31.06 5.90 -60.97 28.02 9.66 -62.79 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 30.19 1.62 -60.10 28.89 0.05 -60.91 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 A 145 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 177 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 201 LEU B 70 LEU~? 8.20 C14 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 26.74 13.39 -51.11 25.48 14.62 -49.80 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 A 145 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 177 GLU B 94 GLU~? 22.51 C2 P6G D1130 A 201 LEU B 86 LEU~? 21.10 C2 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 36.40 4.60 -30.00 35.97 2.83 -31.17 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 A 145 LYS B 101 LYS~? 19.06 C3 P6G D1130 A 177 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 201 LEU B 79 LEU~? 15.03 C3 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 34.24 7.10 -39.73 34.51 5.30 -40.93 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 15 3 # 15 A 145 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 177 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 201 LEU B 103 LEU~? 23.43 C11 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 41.52 11.84 -42.16 43.44 12.66 -42.88 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 16 3 # 16 A 145 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 177 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 201 LEU C 40 LEU~? 13.85 O5 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -20.35 -3.23 -2.13 -18.56 -3.80 -3.25 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 17 3 # 17 A 145 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 177 GLU C 61 GLU~? 21.06 O5 PG4 C1130 A 201 LEU C 63 LEU.? 16.71 O5 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -30.88 -1.64 -3.09 -28.87 -1.48 -2.33 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 18 3 # 18 A 145 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 177 GLU C 52 GLU~? 9.38 O2 PG4 C1130 A 201 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 19 3 # 19 A 145 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 177 GLU C 69 GLU~? 15.05 O5 PG4 C1130 A 201 LEU C 70 LEU~? 11.62 O5 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -32.98 6.49 -14.53 -31.30 7.57 -15.23 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -28.06 4.92 -17.12 -27.96 7.10 -17.24 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 20 3 # 20 A 145 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 177 GLU C 69 GLU~? 15.05 O5 PG4 C1130 A 201 LEU C 70 LEU~? 11.62 O5 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -32.98 6.49 -14.53 -31.30 7.57 -15.23 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -28.06 4.92 -17.12 -27.96 7.10 -17.24 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 21 3 # 21 A 145 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 177 GLU C 52 GLU~? 9.38 O2 PG4 C1130 A 201 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 22 3 # 22 A 145 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 177 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 201 LEU C 79 LEU~? -4.57 C5 PG4 C1130s coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 23 3 # 23 A 145 LYS C 84 LYS~? 13.44 C6 PG4 C1130 A 177 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 201 LEU C 86 LEU~? 9.11 C1 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 24 3 # 24 A 145 LYS C 101 LYS~? -2.55 O1 PG4 C1130s A 177 GLU C 52 GLU~? 9.38 O2 PG4 C1130 A 201 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 25 3 # 25 A 145 LYS C 101 LYS~? -2.55 O1 PG4 C1130s A 177 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 201 LEU C 79 LEU~? -4.57 C5 PG4 C1130s coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 26 3 # 26 A 145 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 177 GLU C 100 GLU~? 11.21 O1 PG4 C1130 A 201 LEU C 103 LEU~? 13.07 C1 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 27 3 # 27 A 145 LYS C 113 LYS~? 22.50 C5 PG4 C1130 A 177 GLU C 100 GLU~? 11.21 O1 PG4 C1130 A 201 LEU C 103 LEU~? 13.07 C1 PG4 C1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 28 3 # 28 A 145 LYS D 32 LYS~? 27.03 C6 P6G D1130 A 177 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 201 LEU D 33 LEU~? 24.56 C6 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 17.19 1.44 -71.70 18.51 3.04 -71.02 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 29 3 # 29 A 145 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 177 GLU D 44 GLU~? 13.05 C9 P6G D1130 A 201 LEU D 40 LEU~? 15.03 C8 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 18.53 5.09 -62.01 20.58 4.43 -62.09 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 30 3 # 30 A 145 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 177 GLU D 61 GLU~? 21.02 C9 P6G D1130 A 201 LEU D 63 LEU.? 16.70 C6 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 8.42 2.69 -60.22 9.99 3.13 -61.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 31 3 # 31 A 145 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 177 GLU D 52 GLU~? 9.77 O16 P6G D1130 A 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 32 3 # 32 A 145 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 177 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 201 LEU D 70 LEU~? 9.48 O1 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 11.83 -2.12 -46.05 12.13 -4.20 -45.51 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 33 3 # 33 A 145 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 177 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 201 LEU D 70 LEU~? 9.48 O1 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 11.83 -2.12 -46.05 12.13 -4.20 -45.51 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 34 3 # 34 A 145 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 177 GLU D 52 GLU~? 9.77 O16 P6G D1130 A 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 35 3 # 35 A 145 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 177 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 201 LEU D 79 LEU~? -4.46 C12 P6G D1130s coo 46.63 -7.12 50.78 48.41 -11.39 47.79 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 15.99 10.92 -40.88 15.13 11.96 -42.64 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 36 3 # 36 A 145 LYS D 84 LYS~? 10.25 O1 P6G D1130 A 177 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 201 LEU D 86 LEU~? 8.72 C18 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 24.52 16.51 -38.13 24.47 16.89 -40.23 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 37 3 # 37 A 145 LYS D 101 LYS~? -3.05 O19 P6G D1130s A 177 GLU D 52 GLU~? 9.77 O16 P6G D1130 A 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 38 3 # 38 A 145 LYS D 101 LYS~? -3.05 O19 P6G D1130s A 177 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 39 3 # 39 A 145 LYS D 101 LYS~? -3.05 O19 P6G D1130s A 177 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 201 LEU D 79 LEU~? -4.46 C12 P6G D1130s coo 46.63 -7.12 50.78 48.41 -11.39 47.79 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 15.99 10.92 -40.88 15.13 11.96 -42.64 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 40 3 # 40 A 145 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 177 GLU D 100 GLU~? 11.53 O19 P6G D1130 A 201 LEU D 103 LEU~? 12.85 C18 P6G D1130 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 11.11 19.18 -38.13 10.21 19.66 -36.27 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.97 14.18 -35.42 8.61 14.71 -33.79 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 40 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 177 GLU A 44 GLU~? 13.07 O5 PG4 C1130 B 201 LEU A 40 LEU~? 14.12 O5 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 27.00 6.35 51.01 26.30 4.53 50.18 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -19.01 2.30 -3.28 -21.00 1.45 -3.09 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 64 LYS.? 18.05 O5 PG4 C1130 B 177 GLU A 61 GLU~? 21.55 O5 PG4 C1130 B 201 LEU A 63 LEU.? 17.30 O5 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo 27.00 6.35 51.01 26.30 4.53 50.18 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -8.80 0.30 -4.09 -10.26 1.63 -3.22 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 177 GLU A 69 GLU~? 16.61 C4 PG4 C1130 B 201 LEU A 70 LEU~? 8.30 C4 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 27.00 6.35 51.01 26.30 4.53 50.18 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -12.26 -10.94 -14.01 -13.58 -12.04 -15.37 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 177 GLU A 82 GLU~? 16.13 C6 PG4 C1130 B 201 LEU A 79 LEU~? 16.24 C6 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 27.00 6.35 51.01 26.30 4.53 50.18 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS A 84 LYS~? 19.93 C5 PG4 C1130 B 177 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 201 LEU A 86 LEU~? 23.09 C6 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 27.00 6.35 51.01 26.30 4.53 50.18 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -3.85 0.15 -34.51 -4.48 1.96 -33.39 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS A 101 LYS~? 17.94 O5 PG4 C1130 B 177 GLU A 82 GLU~? 16.13 C6 PG4 C1130 B 201 LEU A 79 LEU~? 16.24 C6 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo 27.00 6.35 51.01 26.30 4.53 50.18 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS A 112 LYS~? 23.21 C4 PG4 C1130 B 177 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 201 LEU A 103 LEU~? 23.56 C6 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 27.00 6.35 51.01 26.30 4.53 50.18 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 23.74 1.68 49.50 22.87 -0.24 49.97 2.20 -7.99 -23.80 3.77 -9.56 -23.73 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS A 124 LYS~? 16.08 O1 P6G D1130 B 177 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 201 LEU A 126 LEU~? 13.09 O1 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo 27.00 6.35 51.01 26.30 4.53 50.18 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 23.74 1.68 49.50 22.87 -0.24 49.97 8.17 -0.63 -37.01 6.46 0.51 -36.38 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS B 32 LYS~? 26.29 C8 P6G D1130 B 177 GLU D 37 GLU~? 22.00 C9 P6G D1130 B 201 LEU D 33 LEU~? 24.56 C6 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 27.00 6.35 51.01 26.30 4.53 50.18 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 23.74 1.68 49.50 22.87 -0.24 49.97 17.19 1.44 -71.70 18.51 3.04 -71.02 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 B 145 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 177 GLU B 44 GLU~? 13.14 C6 P6G D1130 B 201 LEU B 40 LEU~? 14.67 C6 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 27.00 6.35 51.01 26.30 4.53 50.18 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 23.74 1.68 49.50 22.87 -0.24 49.97 20.03 -0.73 -60.50 18.12 0.25 -60.86 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 B 145 LYS B 64 LYS.? 18.19 C9 P6G D1130 B 177 GLU B 61 GLU~? 21.58 O4 P6G D1130 B 201 LEU B 63 LEU.? 18.00 C8 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 31.06 5.90 -60.97 28.02 9.66 -62.79 coo 27.00 6.35 51.01 26.30 4.53 50.18 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 23.74 1.68 49.50 22.87 -0.24 49.97 30.19 1.62 -60.10 28.89 0.05 -60.91 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 B 145 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 177 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 201 LEU B 70 LEU~? 8.20 C14 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 23.74 1.68 49.50 22.87 -0.24 49.97 26.74 13.39 -51.11 25.48 14.62 -49.80 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 B 145 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 177 GLU B 82 GLU~? 13.30 C2 P6G D1130 B 201 LEU B 79 LEU~? 15.03 C3 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 27.00 6.35 51.01 26.30 4.53 50.18 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 23.74 1.68 49.50 22.87 -0.24 49.97 34.24 7.10 -39.73 34.51 5.30 -40.93 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 B 145 LYS B 84 LYS~? 19.45 C18 P6G D1130 B 177 GLU B 94 GLU~? 22.51 C2 P6G D1130 B 201 LEU B 86 LEU~? 21.10 C2 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 27.00 6.35 51.01 26.30 4.53 50.18 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 23.74 1.68 49.50 22.87 -0.24 49.97 36.40 4.60 -30.00 35.97 2.83 -31.17 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 15 3 # 15 B 145 LYS B 101 LYS~? 19.06 C3 P6G D1130 B 177 GLU B 82 GLU~? 13.30 C2 P6G D1130 B 201 LEU B 79 LEU~? 15.03 C3 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 27.00 6.35 51.01 26.30 4.53 50.18 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 23.74 1.68 49.50 22.87 -0.24 49.97 34.24 7.10 -39.73 34.51 5.30 -40.93 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 16 3 # 16 B 145 LYS B 112 LYS~? 22.45 C14 P6G D1130 B 177 GLU B 100 GLU~? 26.53 C3 P6G D1130 B 201 LEU B 103 LEU~? 23.43 C11 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 27.00 6.35 51.01 26.30 4.53 50.18 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 23.74 1.68 49.50 22.87 -0.24 49.97 41.52 11.84 -42.16 43.44 12.66 -42.88 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 17 3 # 17 B 145 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 177 GLU C 44 GLU~? 12.88 O5 PG4 C1130 B 201 LEU C 40 LEU~? 13.85 O5 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 27.00 6.35 51.01 26.30 4.53 50.18 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -20.35 -3.23 -2.13 -18.56 -3.80 -3.25 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 18 3 # 18 B 145 LYS C 64 LYS.? 19.97 O5 PG4 C1130 B 177 GLU C 61 GLU~? 21.06 O5 PG4 C1130 B 201 LEU C 63 LEU.? 16.71 O5 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo 27.00 6.35 51.01 26.30 4.53 50.18 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -30.88 -1.64 -3.09 -28.87 -1.48 -2.33 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 19 3 # 19 B 145 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 177 GLU C 52 GLU~? 9.38 O2 PG4 C1130 B 201 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.00 6.35 51.01 26.30 4.53 50.18 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 20 3 # 20 B 145 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 177 GLU C 69 GLU~? 15.05 O5 PG4 C1130 B 201 LEU C 70 LEU~? 11.62 O5 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.00 6.35 51.01 26.30 4.53 50.18 -32.98 6.49 -14.53 -31.30 7.57 -15.23 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -28.06 4.92 -17.12 -27.96 7.10 -17.24 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 21 3 # 21 B 145 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 177 GLU C 69 GLU~? 15.05 O5 PG4 C1130 B 201 LEU C 70 LEU~? 11.62 O5 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 27.00 6.35 51.01 26.30 4.53 50.18 -32.98 6.49 -14.53 -31.30 7.57 -15.23 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -28.06 4.92 -17.12 -27.96 7.10 -17.24 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 22 3 # 22 B 145 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 177 GLU C 52 GLU~? 9.38 O2 PG4 C1130 B 201 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 23 3 # 23 B 145 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 177 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 201 LEU C 79 LEU~? -4.57 C5 PG4 C1130s coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 24 3 # 24 B 145 LYS C 84 LYS~? 13.44 C6 PG4 C1130 B 177 GLU C 94 GLU~? 10.36 O1 PG4 C1130 B 201 LEU C 86 LEU~? 9.11 C1 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo 27.00 6.35 51.01 26.30 4.53 50.18 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 25 3 # 25 B 145 LYS C 101 LYS~? -2.55 O1 PG4 C1130s B 177 GLU C 52 GLU~? 9.38 O2 PG4 C1130 B 201 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo 27.00 6.35 51.01 26.30 4.53 50.18 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 26 3 # 26 B 145 LYS C 101 LYS~? -2.55 O1 PG4 C1130s B 177 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 201 LEU C 79 LEU~? -4.57 C5 PG4 C1130s coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo 27.00 6.35 51.01 26.30 4.53 50.18 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 27 3 # 27 B 145 LYS C 112 LYS~? 18.47 C1 PG4 C1130 B 177 GLU C 100 GLU~? 11.21 O1 PG4 C1130 B 201 LEU C 103 LEU~? 13.07 C1 PG4 C1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 27.00 6.35 51.01 26.30 4.53 50.18 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 28 3 # 28 B 145 LYS D 32 LYS~? 27.03 C6 P6G D1130 B 177 GLU D 37 GLU~? 22.00 C9 P6G D1130 B 201 LEU D 33 LEU~? 24.56 C6 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 27.00 6.35 51.01 26.30 4.53 50.18 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 23.74 1.68 49.50 22.87 -0.24 49.97 17.19 1.44 -71.70 18.51 3.04 -71.02 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 29 3 # 29 B 145 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 177 GLU D 44 GLU~? 13.05 C9 P6G D1130 B 201 LEU D 40 LEU~? 15.03 C8 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 27.00 6.35 51.01 26.30 4.53 50.18 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 23.74 1.68 49.50 22.87 -0.24 49.97 18.53 5.09 -62.01 20.58 4.43 -62.09 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 30 3 # 30 B 145 LYS D 64 LYS.? 21.53 C6 P6G D1130 B 177 GLU D 61 GLU~? 21.02 C9 P6G D1130 B 201 LEU D 63 LEU.? 16.70 C6 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 23.74 1.68 49.50 22.87 -0.24 49.97 8.42 2.69 -60.22 9.99 3.13 -61.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 31 3 # 31 B 145 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 177 GLU D 52 GLU~? 9.77 O16 P6G D1130 B 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 23.74 1.68 49.50 22.87 -0.24 49.97 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 32 3 # 32 B 145 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 177 GLU D 69 GLU~? 15.99 C6 P6G D1130 B 201 LEU D 70 LEU~? 9.48 O1 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.00 6.35 51.01 26.30 4.53 50.18 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 23.74 1.68 49.50 22.87 -0.24 49.97 11.83 -2.12 -46.05 12.13 -4.20 -45.51 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 33 3 # 33 B 145 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 177 GLU D 69 GLU~? 15.99 C6 P6G D1130 B 201 LEU D 70 LEU~? 9.48 O1 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 27.00 6.35 51.01 26.30 4.53 50.18 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 23.74 1.68 49.50 22.87 -0.24 49.97 11.83 -2.12 -46.05 12.13 -4.20 -45.51 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 34 3 # 34 B 145 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 177 GLU D 52 GLU~? 9.77 O16 P6G D1130 B 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 23.74 1.68 49.50 22.87 -0.24 49.97 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 35 3 # 35 B 145 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 177 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 201 LEU D 79 LEU~? -4.46 C12 P6G D1130s coo 25.29 -4.12 49.41 22.68 -2.48 54.25 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 27.00 6.35 51.01 26.30 4.53 50.18 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 15.99 10.92 -40.88 15.13 11.96 -42.64 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 36 3 # 36 B 145 LYS D 84 LYS~? 10.25 O1 P6G D1130 B 177 GLU D 94 GLU~? 9.44 O19 P6G D1130 B 201 LEU D 86 LEU~? 8.72 C18 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 27.00 6.35 51.01 26.30 4.53 50.18 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 23.74 1.68 49.50 22.87 -0.24 49.97 24.52 16.51 -38.13 24.47 16.89 -40.23 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 37 3 # 37 B 145 LYS D 101 LYS~? -3.05 O19 P6G D1130s B 177 GLU D 52 GLU~? 9.77 O16 P6G D1130 B 201 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 27.00 6.35 51.01 26.30 4.53 50.18 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 23.74 1.68 49.50 22.87 -0.24 49.97 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 38 3 # 38 B 145 LYS D 101 LYS~? -3.05 O19 P6G D1130s B 177 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 201 LEU D 79 LEU~? -4.46 C12 P6G D1130s coo 25.29 -4.12 49.41 22.68 -2.48 54.25 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 27.00 6.35 51.01 26.30 4.53 50.18 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 15.99 10.92 -40.88 15.13 11.96 -42.64 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 39 3 # 39 B 145 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 177 GLU D 100 GLU~? 11.53 O19 P6G D1130 B 201 LEU D 103 LEU~? 12.85 C18 P6G D1130 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 27.00 6.35 51.01 26.30 4.53 50.18 11.11 19.18 -38.13 10.21 19.66 -36.27 coo 23.74 1.68 49.50 22.87 -0.24 49.97 9.97 14.18 -35.42 8.61 14.71 -33.79 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 39 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR C 89 THR~? 14.94 C2 PG4 C1130 A 156 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 160 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 10.50 56.87 17.73 11.24 57.93 19.43 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 11.64 63.07 23.95 11.76 62.47 21.20 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 5.78 61.30 21.65 8.04 62.89 17.54 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR D 89 THR~? 14.44 C17 P6G D1130 A 156 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 160 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 10.50 56.87 17.73 11.24 57.93 19.43 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 11.64 63.07 23.95 11.76 62.47 21.20 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 5.78 61.30 21.65 8.04 62.89 17.54 34.20 9.92 -30.73 30.97 14.90 -30.33 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 55 GLU~? 16.41 O5 PG4 C1130 A 226 THR C 39 THR~? 14.51 O5 PG4 C1130 A 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 7.24 97.46 49.60 8.11 95.69 48.80 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 10.53 97.56 43.71 9.33 93.71 47.17 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 55 GLU~? 15.05 C3 P6G D1130 A 226 THR D 39 THR~? 15.06 C6 P6G D1130 A 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 7.24 97.46 49.60 8.11 95.69 48.80 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 226 THR A 39 THR~? 15.12 O5 PG4 C1130 A 229 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 7.24 97.46 49.60 8.11 95.69 48.80 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 10.53 97.56 43.71 9.33 93.71 47.17 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 226 THR C 39 THR~? 14.51 O5 PG4 C1130 A 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 7.24 97.46 49.60 8.11 95.69 48.80 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 10.53 97.56 43.71 9.33 93.71 47.17 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU D 52 GLU~? 9.77 O16 P6G D1130 A 226 THR A 89 THR.? 25.53 O1 P6G D1130 A 229 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 7.24 97.46 49.60 8.11 95.69 48.80 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo 10.53 97.56 43.71 9.33 93.71 47.17 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 226 THR B 39 THR~? 16.03 C8 P6G D1130 A 229 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 7.24 97.46 49.60 8.11 95.69 48.80 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 226 THR D 39 THR~? 15.06 C6 P6G D1130 A 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 7.24 97.46 49.60 8.11 95.69 48.80 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 226 THR C 89 THR~? 14.94 C2 PG4 C1130 A 229 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 9.66 102.78 70.07 9.79 101.18 71.42 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 7.24 97.46 49.60 8.11 95.69 48.80 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 55 GLU~? 16.41 O5 PG4 C1130 B 226 THR C 39 THR~? 14.51 O5 PG4 C1130 B 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 20.74 95.78 68.68 19.29 96.84 69.83 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 22.32 101.61 71.64 17.89 98.63 71.55 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU B 55 GLU~? 15.05 C3 P6G D1130 B 226 THR D 39 THR~? 15.06 C6 P6G D1130 B 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 20.74 95.78 68.68 19.29 96.84 69.83 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU C 55 GLU~? 14.48 C8 PG4 C1130 B 226 THR A 39 THR~? 15.12 O5 PG4 C1130 B 229 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 20.74 95.78 68.68 19.29 96.84 69.83 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 22.32 101.61 71.64 17.89 98.63 71.55 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 226 THR C 39 THR~? 14.51 O5 PG4 C1130 B 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 20.74 95.78 68.68 19.29 96.84 69.83 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 22.32 101.61 71.64 17.89 98.63 71.55 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU D 52 GLU~? 9.77 O16 P6G D1130 B 226 THR A 89 THR.? 25.53 O1 P6G D1130 B 229 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 20.74 95.78 68.68 19.29 96.84 69.83 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo 22.32 101.61 71.64 17.89 98.63 71.55 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU D 55 GLU~? 14.43 O7 P6G D1130 B 226 THR B 39 THR~? 16.03 C8 P6G D1130 B 229 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 20.74 95.78 68.68 19.29 96.84 69.83 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 226 THR D 39 THR~? 15.06 C6 P6G D1130 B 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 20.74 95.78 68.68 19.29 96.84 69.83 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 226 THR C 89 THR~? 14.94 C2 PG4 C1130 B 229 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 15.90 87.61 49.61 13.92 86.96 49.36 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 20.74 95.78 68.68 19.29 96.84 69.83 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 55 GLU~? 16.41 O5 PG4 C1130 C 226 THR C 39 THR~? 14.51 O5 PG4 C1130 C 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 22.16 45.88 73.63 23.23 47.70 73.25 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 28.90 45.91 73.55 25.22 49.72 72.97 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU B 55 GLU~? 15.05 C3 P6G D1130 C 226 THR D 39 THR~? 15.06 C6 P6G D1130 C 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 22.16 45.88 73.63 23.23 47.70 73.25 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU C 55 GLU~? 14.48 C8 PG4 C1130 C 226 THR A 39 THR~? 15.12 O5 PG4 C1130 C 229 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 22.16 45.88 73.63 23.23 47.70 73.25 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 28.90 45.91 73.55 25.22 49.72 72.97 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU C 82 GLU~? -3.24 C6 PG4 C1130s C 226 THR C 39 THR~? 14.51 O5 PG4 C1130 C 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 22.16 45.88 73.63 23.23 47.70 73.25 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 28.90 45.91 73.55 25.22 49.72 72.97 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU D 52 GLU~? 9.77 O16 P6G D1130 C 226 THR A 89 THR.? 25.53 O1 P6G D1130 C 229 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 22.16 45.88 73.63 23.23 47.70 73.25 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo 28.90 45.91 73.55 25.22 49.72 72.97 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU D 55 GLU~? 14.43 O7 P6G D1130 C 226 THR B 39 THR~? 16.03 C8 P6G D1130 C 229 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 22.16 45.88 73.63 23.23 47.70 73.25 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU D 82 GLU~? -3.29 C11 P6G D1130s C 226 THR D 39 THR~? 15.06 C6 P6G D1130 C 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 22.16 45.88 73.63 23.23 47.70 73.25 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 226 THR C 89 THR~? 14.94 C2 PG4 C1130 C 229 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 5.43 40.40 61.63 4.27 41.99 60.90 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 22.16 45.88 73.63 23.23 47.70 73.25 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 55 GLU~? 16.41 O5 PG4 C1130 D 226 THR C 39 THR~? 14.51 O5 PG4 C1130 D 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 11.79 47.62 52.67 10.10 46.51 53.39 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 10.05 41.79 49.80 7.94 44.71 53.76 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU B 55 GLU~? 15.05 C3 P6G D1130 D 226 THR D 39 THR~? 15.06 C6 P6G D1130 D 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 11.79 47.62 52.67 10.10 46.51 53.39 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU C 55 GLU~? 14.48 C8 PG4 C1130 D 226 THR A 39 THR~? 15.12 O5 PG4 C1130 D 229 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 11.79 47.62 52.67 10.10 46.51 53.39 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 10.05 41.79 49.80 7.94 44.71 53.76 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU C 82 GLU~? -3.24 C6 PG4 C1130s D 226 THR C 39 THR~? 14.51 O5 PG4 C1130 D 229 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 11.79 47.62 52.67 10.10 46.51 53.39 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 10.05 41.79 49.80 7.94 44.71 53.76 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU D 52 GLU~? 9.77 O16 P6G D1130 D 226 THR A 89 THR.? 25.53 O1 P6G D1130 D 229 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 11.79 47.62 52.67 10.10 46.51 53.39 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo 10.05 41.79 49.80 7.94 44.71 53.76 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU D 55 GLU~? 14.43 O7 P6G D1130 D 226 THR B 39 THR~? 16.03 C8 P6G D1130 D 229 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 11.79 47.62 52.67 10.10 46.51 53.39 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU D 82 GLU~? -3.29 C11 P6G D1130s D 226 THR D 39 THR~? 15.06 C6 P6G D1130 D 229 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 11.79 47.62 52.67 10.10 46.51 53.39 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU D 109 GLU~? 20.19 O1 P6G D1130 D 226 THR C 89 THR~? 14.94 C2 PG4 C1130 D 229 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 26.07 55.89 66.14 25.33 56.50 68.01 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 11.79 47.62 52.67 10.10 46.51 53.39 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 8 hits 1dfo_c07 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 118 TYR~? 23.63 C5 PG4 C1130 150 LYS A 84 LYS~? 19.93 C5 PG4 C1130 186 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 27.04 52.42 22.30 26.88 49.99 27.00 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 36.98 50.30 37.29 35.85 50.29 35.50 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 118 TYR~? 23.63 C5 PG4 C1130 150 LYS A 84 LYS~? 19.93 C5 PG4 C1130 186 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 27.04 52.42 22.30 26.88 49.99 27.00 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 36.98 50.30 37.29 35.85 50.29 35.50 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 150 LYS B 84 LYS~? 19.45 C18 P6G D1130 186 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 27.04 52.42 22.30 26.88 49.99 27.00 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 36.98 50.30 37.29 35.85 50.29 35.50 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 150 LYS B 84 LYS~? 19.45 C18 P6G D1130 186 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 27.04 52.42 22.30 26.88 49.99 27.00 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 36.98 50.30 37.29 35.85 50.29 35.50 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s 150 LYS C 74 LYS~? 8.83 O5 PG4 C1130 186 ASN C 56 ASN~? 14.82 O2 PG4 C1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 27.04 52.42 22.30 26.88 49.99 27.00 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 36.98 50.30 37.29 35.85 50.29 35.50 -33.22 -10.82 -9.01 -34.40 -11.65 -10.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR C 118 TYR~? 14.79 C5 PG4 C1130 150 LYS C 84 LYS~? 13.44 C6 PG4 C1130 186 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo 27.04 52.42 22.30 26.88 49.99 27.00 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo 36.98 50.30 37.29 35.85 50.29 35.50 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR C 118 TYR~? 14.79 C5 PG4 C1130 150 LYS C 84 LYS~? 13.44 C6 PG4 C1130 186 ASN C 108 ASN~? 16.59 C8 PG4 C1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo 27.04 52.42 22.30 26.88 49.99 27.00 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo 36.98 50.30 37.29 35.85 50.29 35.50 -31.84 0.42 -27.78 -31.41 2.13 -28.96 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s 150 LYS D 74 LYS~? -4.32 C2 P6G D1130s 186 ASN D 56 ASN~? 14.55 O16 P6G D1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 27.04 52.42 22.30 26.88 49.99 27.00 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 36.98 50.30 37.29 35.85 50.29 35.50 5.59 12.59 -55.26 4.79 13.42 -53.45 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR D 118 TYR~? 14.64 C18 P6G D1130 150 LYS D 84 LYS~? 10.25 O1 P6G D1130 186 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 19.04 13.52 -30.73 20.87 11.60 -29.89 coo 27.04 52.42 22.30 26.88 49.99 27.00 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR D 118 TYR~? 14.64 C18 P6G D1130 150 LYS D 84 LYS~? 10.25 O1 P6G D1130 186 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 32.88 50.55 24.33 31.89 51.78 26.65 19.04 13.52 -30.73 20.87 11.60 -29.89 coo 27.04 52.42 22.30 26.88 49.99 27.00 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 8.90 3.92 -35.18 9.80 2.60 -33.76 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 10 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 183 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 19.43 18.53 42.32 17.66 18.80 40.15 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 21.92 15.80 36.19 17.64 19.44 36.35 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 15.46 19.03 31.40 15.01 18.25 33.31 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 183 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 19.43 18.53 42.32 17.66 18.80 40.15 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 21.92 15.80 36.19 17.64 19.44 36.35 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 15.46 19.03 31.40 15.01 18.25 33.31 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 183 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 19.43 18.53 42.32 17.66 18.80 40.15 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 21.92 15.80 36.19 17.64 19.44 36.35 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 15.46 19.03 31.40 15.01 18.25 33.31 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 183 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 19.43 18.53 42.32 17.66 18.80 40.15 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 21.92 15.80 36.19 17.64 19.44 36.35 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 15.46 19.03 31.40 15.01 18.25 33.31 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 183 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 278 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 19.43 18.53 42.32 17.66 18.80 40.15 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 21.92 15.80 36.19 17.64 19.44 36.35 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 15.46 19.03 31.40 15.01 18.25 33.31 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 183 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 278 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 19.43 18.53 42.32 17.66 18.80 40.15 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 21.92 15.80 36.19 17.64 19.44 36.35 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 15.46 19.03 31.40 15.01 18.25 33.31 16.73 -3.96 -41.52 17.31 -2.00 -40.88 1do8_c00 source 1do8 MALIC ENZYME : 6 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 183 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 58.62 15.99 58.34 60.98 14.60 58.93 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 60.11 10.60 53.63 62.59 10.74 58.67 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 66.50 7.32 58.45 66.26 9.42 58.23 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 183 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 58.62 15.99 58.34 60.98 14.60 58.93 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 60.11 10.60 53.63 62.59 10.74 58.67 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 66.50 7.32 58.45 66.26 9.42 58.23 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 183 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 58.62 15.99 58.34 60.98 14.60 58.93 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 60.11 10.60 53.63 62.59 10.74 58.67 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 66.50 7.32 58.45 66.26 9.42 58.23 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 183 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 58.62 15.99 58.34 60.98 14.60 58.93 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 60.11 10.60 53.63 62.59 10.74 58.67 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 66.50 7.32 58.45 66.26 9.42 58.23 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR D 46 TYR~? -4.28 C6 P6G D1130s B 183 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 278 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 58.62 15.99 58.34 60.98 14.60 58.93 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 60.11 10.60 53.63 62.59 10.74 58.67 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 66.50 7.32 58.45 66.26 9.42 58.23 16.73 -3.96 -41.52 17.31 -2.00 -40.88 1do8_c01 source 1do8 MALIC ENZYME : 5 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 183 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 183 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 183 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 183 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR C 46 TYR~? -4.42 C8 PG4 C1130s C 183 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 278 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR D 46 TYR~? -4.28 C6 P6G D1130s C 183 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 278 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 16.73 -3.96 -41.52 17.31 -2.00 -40.88 1do8_c02 source 1do8 MALIC ENZYME : 6 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 183 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 183 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 278 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 183 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 183 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 278 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR D 46 TYR~? -4.28 C6 P6G D1130s D 183 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 278 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 16.73 -3.96 -41.52 17.31 -2.00 -40.88 1do8_c03 source 1do8 MALIC ENZYME : 5 hits 1do8_c03 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 67 GLY~? 11.58 C4 PG4 C1130 B 144 GLU A 66 GLU.? 16.09 O5 PG4 C1130 B 164 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 88.87 114.43 152.30 88.45 115.15 152.32 -12.53 -9.29 -9.44 -11.99 -8.76 -9.16 coo 85.20 111.99 152.05 86.60 110.89 150.91 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 88.14 113.46 145.73 86.79 113.92 147.30 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 B 144 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 164 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 88.87 114.43 152.30 88.45 115.15 152.32 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 85.20 111.99 152.05 86.60 110.89 150.91 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 88.14 113.46 145.73 86.79 113.92 147.30 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 B 144 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 164 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 88.87 114.43 152.30 88.45 115.15 152.32 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 85.20 111.99 152.05 86.60 110.89 150.91 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 88.14 113.46 145.73 86.79 113.92 147.30 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY B 67 GLY~? 11.72 C14 P6G D1130 B 144 GLU B 66 GLU.? 14.53 C15 P6G D1130 B 164 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 88.87 114.43 152.30 88.45 115.15 152.32 26.53 11.48 -55.55 27.03 10.89 -55.78 coo 85.20 111.99 152.05 86.60 110.89 150.91 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 88.14 113.46 145.73 86.79 113.92 147.30 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY D 67 GLY~? 11.48 C5 P6G D1130 B 144 GLU D 66 GLU.? 17.04 C6 P6G D1130 B 164 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 88.87 114.43 152.30 88.45 115.15 152.32 11.46 -3.78 -50.70 10.94 -3.36 -51.20 coo 85.20 111.99 152.05 86.60 110.89 150.91 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 88.14 113.46 145.73 86.79 113.92 147.30 18.51 -2.46 -55.26 18.22 -3.73 -56.94 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 5 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 67 GLY~? 11.58 C4 PG4 C1130 C 144 GLU A 66 GLU.? 16.09 O5 PG4 C1130 C 164 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 56.28 104.55 135.84 56.09 105.34 136.05 -12.53 -9.29 -9.44 -11.99 -8.76 -9.16 coo 58.46 103.90 139.48 57.57 102.00 139.16 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 51.71 102.03 140.09 53.02 103.62 140.54 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 C 144 GLU A 94 GLU~? 22.82 O1 P6G D1130 C 164 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 56.28 104.55 135.84 56.09 105.34 136.05 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 58.46 103.90 139.48 57.57 102.00 139.16 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 51.71 102.03 140.09 53.02 103.62 140.54 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 C 144 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 164 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 56.28 104.55 135.84 56.09 105.34 136.05 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 58.46 103.90 139.48 57.57 102.00 139.16 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 51.71 102.03 140.09 53.02 103.62 140.54 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY B 67 GLY~? 11.72 C14 P6G D1130 C 144 GLU B 66 GLU.? 14.53 C15 P6G D1130 C 164 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 56.28 104.55 135.84 56.09 105.34 136.05 26.53 11.48 -55.55 27.03 10.89 -55.78 coo 58.46 103.90 139.48 57.57 102.00 139.16 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 51.71 102.03 140.09 53.02 103.62 140.54 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY D 67 GLY~? 11.48 C5 P6G D1130 C 144 GLU D 66 GLU.? 17.04 C6 P6G D1130 C 164 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 56.28 104.55 135.84 56.09 105.34 136.05 11.46 -3.78 -50.70 10.94 -3.36 -51.20 coo 58.46 103.90 139.48 57.57 102.00 139.16 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 51.71 102.03 140.09 53.02 103.62 140.54 18.51 -2.46 -55.26 18.22 -3.73 -56.94 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 5 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 67 GLY~? 11.58 C4 PG4 C1130 D 144 GLU A 66 GLU.? 16.09 O5 PG4 C1130 D 164 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 86.19 80.64 132.77 86.38 79.85 132.93 -12.53 -9.29 -9.44 -11.99 -8.76 -9.16 coo 84.75 81.24 136.88 85.62 83.14 136.43 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 91.47 83.05 136.24 90.35 81.38 136.84 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 D 144 GLU A 94 GLU~? 22.82 O1 P6G D1130 D 164 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 86.19 80.64 132.77 86.38 79.85 132.93 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 84.75 81.24 136.88 85.62 83.14 136.43 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 91.47 83.05 136.24 90.35 81.38 136.84 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 D 144 GLU D 109 GLU~? 20.19 O1 P6G D1130 D 164 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 86.19 80.64 132.77 86.38 79.85 132.93 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 84.75 81.24 136.88 85.62 83.14 136.43 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 91.47 83.05 136.24 90.35 81.38 136.84 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY B 67 GLY~? 11.72 C14 P6G D1130 D 144 GLU B 66 GLU.? 14.53 C15 P6G D1130 D 164 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 86.19 80.64 132.77 86.38 79.85 132.93 26.53 11.48 -55.55 27.03 10.89 -55.78 coo 84.75 81.24 136.88 85.62 83.14 136.43 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 91.47 83.05 136.24 90.35 81.38 136.84 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY D 67 GLY~? 11.48 C5 P6G D1130 D 144 GLU D 66 GLU.? 17.04 C6 P6G D1130 D 164 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 86.19 80.64 132.77 86.38 79.85 132.93 11.46 -3.78 -50.70 10.94 -3.36 -51.20 coo 84.75 81.24 136.88 85.62 83.14 136.43 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 91.47 83.05 136.24 90.35 81.38 136.84 18.51 -2.46 -55.26 18.22 -3.73 -56.94 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 5 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 67 GLY~? 11.58 C4 PG4 C1130 E 144 GLU A 66 GLU.? 16.09 O5 PG4 C1130 E 164 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 90.07 81.07 170.50 90.23 80.26 170.38 -12.53 -9.29 -9.44 -11.99 -8.76 -9.16 coo 87.05 81.30 167.53 86.38 82.74 168.94 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 84.40 80.02 173.80 85.08 79.06 172.03 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 E 144 GLU D 109 GLU~? 20.19 O1 P6G D1130 E 164 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 90.07 81.07 170.50 90.23 80.26 170.38 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 87.05 81.30 167.53 86.38 82.74 168.94 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 84.40 80.02 173.80 85.08 79.06 172.03 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 67 GLY~? 11.72 C14 P6G D1130 E 144 GLU B 66 GLU.? 14.53 C15 P6G D1130 E 164 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 90.07 81.07 170.50 90.23 80.26 170.38 26.53 11.48 -55.55 27.03 10.89 -55.78 coo 87.05 81.30 167.53 86.38 82.74 168.94 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 84.40 80.02 173.80 85.08 79.06 172.03 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY D 67 GLY~? 11.48 C5 P6G D1130 E 144 GLU D 66 GLU.? 17.04 C6 P6G D1130 E 164 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 90.07 81.07 170.50 90.23 80.26 170.38 11.46 -3.78 -50.70 10.94 -3.36 -51.20 coo 87.05 81.30 167.53 86.38 82.74 168.94 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 84.40 80.02 173.80 85.08 79.06 172.03 18.51 -2.46 -55.26 18.22 -3.73 -56.94 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 67 GLY~? 11.58 C4 PG4 C1130 F 144 GLU A 66 GLU.? 16.09 O5 PG4 C1130 F 164 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 57.12 70.68 155.10 57.52 69.95 155.02 -12.53 -9.29 -9.44 -11.99 -8.76 -9.16 coo 60.62 73.13 154.21 59.05 74.26 153.35 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 56.75 71.71 148.46 58.44 71.01 149.54 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 F 144 GLU A 94 GLU~? 22.82 O1 P6G D1130 F 164 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 57.12 70.68 155.10 57.52 69.95 155.02 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 60.62 73.13 154.21 59.05 74.26 153.35 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 56.75 71.71 148.46 58.44 71.01 149.54 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY A 93 GLY~? 17.18 O1 P6G D1130 F 144 GLU D 109 GLU~? 20.19 O1 P6G D1130 F 164 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 57.12 70.68 155.10 57.52 69.95 155.02 3.56 2.15 -34.44 2.78 1.87 -34.42 coo 60.62 73.13 154.21 59.05 74.26 153.35 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 56.75 71.71 148.46 58.44 71.01 149.54 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY B 67 GLY~? 11.72 C14 P6G D1130 F 144 GLU B 66 GLU.? 14.53 C15 P6G D1130 F 164 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 57.12 70.68 155.10 57.52 69.95 155.02 26.53 11.48 -55.55 27.03 10.89 -55.78 coo 60.62 73.13 154.21 59.05 74.26 153.35 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 56.75 71.71 148.46 58.44 71.01 149.54 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY D 67 GLY~? 11.48 C5 P6G D1130 F 144 GLU D 66 GLU.? 17.04 C6 P6G D1130 F 164 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 57.12 70.68 155.10 57.52 69.95 155.02 11.46 -3.78 -50.70 10.94 -3.36 -51.20 coo 60.62 73.13 154.21 59.05 74.26 153.35 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 56.75 71.71 148.46 58.44 71.01 149.54 18.51 -2.46 -55.26 18.22 -3.73 -56.94 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 5 hits 1dub_c17 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 32 LYS~? 25.27 O5 PG4 C1130 A 215 LYS A 64 LYS.? 18.05 O5 PG4 C1130 A 277 LYS A 59 LYS~? 19.76 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 13.06 30.79 51.73 11.40 35.76 53.48 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo 13.04 31.88 60.72 10.57 35.34 57.49 -3.94 3.00 -8.37 -1.40 0.97 -13.12 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 215 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 277 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 13.04 31.88 60.72 10.57 35.34 57.49 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 215 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 277 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 13.06 30.79 51.73 11.40 35.76 53.48 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 13.04 31.88 60.72 10.57 35.34 57.49 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 59 LYS~? 19.76 O5 PG4 C1130 A 215 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 277 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 13.06 30.79 51.73 11.40 35.76 53.48 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 215 LYS A 64 LYS.? 18.05 O5 PG4 C1130 A 277 LYS A 38 LYS~? 22.91 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 13.06 30.79 51.73 11.40 35.76 53.48 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo 13.04 31.88 60.72 10.57 35.34 57.49 -13.68 4.03 -1.81 -8.47 6.66 0.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 215 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 277 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 0.50 24.09 51.68 1.51 29.34 52.35 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 13.06 30.79 51.73 11.40 35.76 53.48 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 13.04 31.88 60.72 10.57 35.34 57.49 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 215 LYS A 59 LYS~? 19.76 O5 PG4 C1130 A 277 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 13.04 31.88 60.72 10.57 35.34 57.49 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 215 LYS A 101 LYS~? 17.94 O5 PG4 C1130 A 277 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 13.06 30.79 51.73 11.40 35.76 53.48 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo 13.04 31.88 60.72 10.57 35.34 57.49 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 32 LYS~? 26.29 C8 P6G D1130 A 215 LYS B 64 LYS.? 18.19 C9 P6G D1130 A 277 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 13.06 30.79 51.73 11.40 35.76 53.48 31.06 5.90 -60.97 28.02 9.66 -62.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 215 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 277 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 13.04 31.88 60.72 10.57 35.34 57.49 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 215 LYS B 32 LYS~? 26.29 C8 P6G D1130 A 277 LYS D 32 LYS~? 27.03 C6 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 13.04 31.88 60.72 10.57 35.34 57.49 14.22 -2.15 -70.37 13.65 -7.80 -70.43 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 215 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 277 LYS D 32 LYS~? 27.03 C6 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 13.04 31.88 60.72 10.57 35.34 57.49 14.22 -2.15 -70.37 13.65 -7.80 -70.43 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 215 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 277 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 13.04 31.88 60.72 10.57 35.34 57.49 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS B 59 LYS~? 17.23 O4 P6G D1130 A 215 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 277 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 13.06 30.79 51.73 11.40 35.76 53.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 13.04 31.88 60.72 10.57 35.34 57.49 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS B 59 LYS~? 17.23 O4 P6G D1130 A 215 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 277 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 13.06 30.79 51.73 11.40 35.76 53.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 215 LYS B 64 LYS.? 18.19 C9 P6G D1130 A 277 LYS B 38 LYS~? 23.39 O4 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 31.06 5.90 -60.97 28.02 9.66 -62.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 25.30 -2.41 -62.07 30.29 -5.23 -64.65 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 215 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 277 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 0.50 24.09 51.68 1.51 29.34 52.35 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 13.06 30.79 51.73 11.40 35.76 53.48 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 13.04 31.88 60.72 10.57 35.34 57.49 12.04 15.06 -40.68 14.50 17.55 -45.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 215 LYS B 59 LYS~? 17.23 O4 P6G D1130 A 277 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 13.04 31.88 60.72 10.57 35.34 57.49 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 215 LYS B 101 LYS~? 19.06 C3 P6G D1130 A 277 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 13.04 31.88 60.72 10.57 35.34 57.49 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 215 LYS B 101 LYS~? 19.06 C3 P6G D1130 A 277 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 13.06 30.79 51.73 11.40 35.76 53.48 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 13.04 31.88 60.72 10.57 35.34 57.49 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 A 131 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 215 LYS B 101 LYS~? 19.06 C3 P6G D1130 A 277 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 13.06 30.79 51.73 11.40 35.76 53.48 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 13.04 31.88 60.72 10.57 35.34 57.49 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 A 131 LYS C 32 LYS~? 27.65 O5 PG4 C1130 A 215 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 277 LYS C 59 LYS~? 18.46 C8 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 13.06 30.79 51.73 11.40 35.76 53.48 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo 13.04 31.88 60.72 10.57 35.34 57.49 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 A 131 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 215 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 277 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 13.06 30.79 51.73 11.40 35.76 53.48 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 A 131 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 215 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 277 LYS A 32 LYS~? 25.27 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 13.06 30.79 51.73 11.40 35.76 53.48 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 -14.45 0.07 7.16 -16.37 -4.18 8.40 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 A 131 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 215 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 277 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 13.06 30.79 51.73 11.40 35.76 53.48 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 26 3 # 26 A 131 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 215 LYS C 32 LYS~? 27.65 O5 PG4 C1130 A 277 LYS A 32 LYS~? 25.27 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 13.06 30.79 51.73 11.40 35.76 53.48 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 13.04 31.88 60.72 10.57 35.34 57.49 -14.45 0.07 7.16 -16.37 -4.18 8.40 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 27 3 # 27 A 131 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 215 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 277 LYS C 38 LYS~? 22.42 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 13.06 30.79 51.73 11.40 35.76 53.48 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 28 3 # 28 A 131 LYS C 84 LYS~? 13.44 C6 PG4 C1130 A 215 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 277 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 coo 13.06 30.79 51.73 11.40 35.76 53.48 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 29 3 # 29 A 131 LYS C 113 LYS~? 22.50 C5 PG4 C1130 A 215 LYS C 101 LYS~? -2.55 O1 PG4 C1130s A 277 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 0.50 24.09 51.68 1.51 29.34 52.35 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 coo 13.06 30.79 51.73 11.40 35.76 53.48 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 30 3 # 30 A 131 LYS D 32 LYS~? 27.03 C6 P6G D1130 A 215 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 277 LYS D 59 LYS~? 18.77 O7 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 13.06 30.79 51.73 11.40 35.76 53.48 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo 13.04 31.88 60.72 10.57 35.34 57.49 3.27 6.90 -57.68 0.31 8.60 -52.41 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 31 3 # 31 A 131 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 215 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 277 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 13.06 30.79 51.73 11.40 35.76 53.48 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 32 3 # 32 A 131 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 215 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 277 LYS B 32 LYS~? 26.29 C8 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 13.06 30.79 51.73 11.40 35.76 53.48 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 24.48 1.33 -71.20 20.78 5.38 -73.37 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 33 3 # 33 A 131 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 215 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 277 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 13.06 30.79 51.73 11.40 35.76 53.48 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 34 3 # 34 A 131 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 215 LYS D 32 LYS~? 27.03 C6 P6G D1130 A 277 LYS B 32 LYS~? 26.29 C8 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 13.06 30.79 51.73 11.40 35.76 53.48 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 13.04 31.88 60.72 10.57 35.34 57.49 24.48 1.33 -71.20 20.78 5.38 -73.37 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 35 3 # 35 A 131 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 215 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 277 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo 13.06 30.79 51.73 11.40 35.76 53.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 13.04 31.88 60.72 10.57 35.34 57.49 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 36 3 # 36 A 131 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 215 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 277 LYS D 38 LYS~? 22.21 C6 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 13.06 30.79 51.73 11.40 35.76 53.48 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo 13.04 31.88 60.72 10.57 35.34 57.49 13.18 5.53 -63.93 7.70 4.95 -66.54 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 37 3 # 37 A 131 LYS D 84 LYS~? 10.25 O1 P6G D1130 A 215 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 277 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 23.08 11.99 -34.73 21.14 6.51 -33.38 coo 13.06 30.79 51.73 11.40 35.76 53.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 38 3 # 38 A 131 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 215 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 277 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 13.04 31.88 60.72 10.57 35.34 57.49 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 39 3 # 39 A 131 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 215 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 277 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 0.50 24.09 51.68 1.51 29.34 52.35 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 13.04 31.88 60.72 10.57 35.34 57.49 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 40 3 # 40 A 131 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 215 LYS D 101 LYS~? -3.05 O19 P6G D1130s A 277 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 0.50 24.09 51.68 1.51 29.34 52.35 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 13.06 30.79 51.73 11.40 35.76 53.48 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 13.04 31.88 60.72 10.57 35.34 57.49 14.33 6.41 -44.26 15.86 10.02 -47.66 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 40 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 215 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 277 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 20.33 37.78 11.20 16.77 34.53 13.47 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 215 LYS A 32 LYS~? 25.27 O5 PG4 C1130 B 277 LYS C 32 LYS~? 27.65 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 17.88 38.77 19.81 16.38 34.23 17.24 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 20.33 37.78 11.20 16.77 34.53 13.47 -24.29 3.76 6.29 -22.32 9.47 8.21 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 215 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 277 LYS C 32 LYS~? 27.65 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 17.88 38.77 19.81 16.38 34.23 17.24 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 20.33 37.78 11.20 16.77 34.53 13.47 -24.29 3.76 6.29 -22.32 9.47 8.21 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 215 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 277 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 17.88 38.77 19.81 16.38 34.23 17.24 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 20.33 37.78 11.20 16.77 34.53 13.47 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS A 59 LYS~? 19.76 O5 PG4 C1130 B 215 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 277 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 17.88 38.77 19.81 16.38 34.23 17.24 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 215 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 277 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 6.78 45.91 16.15 7.82 40.81 15.84 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 17.88 38.77 19.81 16.38 34.23 17.24 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 20.33 37.78 11.20 16.77 34.53 13.47 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 215 LYS A 59 LYS~? 19.76 O5 PG4 C1130 B 277 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 20.33 37.78 11.20 16.77 34.53 13.47 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS A 113 LYS~? 24.04 C2 PG4 C1130 B 215 LYS A 101 LYS~? 17.94 O5 PG4 C1130 B 277 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 17.88 38.77 19.81 16.38 34.23 17.24 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo 20.33 37.78 11.20 16.77 34.53 13.47 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 215 LYS D 32 LYS~? 27.03 C6 P6G D1130 B 277 LYS D 38 LYS~? 22.21 C6 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 20.33 37.78 11.20 16.77 34.53 13.47 13.18 5.53 -63.93 7.70 4.95 -66.54 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 215 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 277 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 20.33 37.78 11.20 16.77 34.53 13.47 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 215 LYS B 32 LYS~? 26.29 C8 P6G D1130 B 277 LYS D 32 LYS~? 27.03 C6 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 20.33 37.78 11.20 16.77 34.53 13.47 14.22 -2.15 -70.37 13.65 -7.80 -70.43 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 215 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 277 LYS D 32 LYS~? 27.03 C6 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 20.33 37.78 11.20 16.77 34.53 13.47 14.22 -2.15 -70.37 13.65 -7.80 -70.43 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 215 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 277 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 20.33 37.78 11.20 16.77 34.53 13.47 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 B 131 LYS B 59 LYS~? 17.23 O4 P6G D1130 B 215 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 277 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 17.88 38.77 19.81 16.38 34.23 17.24 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 20.33 37.78 11.20 16.77 34.53 13.47 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 B 131 LYS B 59 LYS~? 17.23 O4 P6G D1130 B 215 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 277 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 17.88 38.77 19.81 16.38 34.23 17.24 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 B 131 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 215 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 277 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 6.78 45.91 16.15 7.82 40.81 15.84 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 17.88 38.77 19.81 16.38 34.23 17.24 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 20.33 37.78 11.20 16.77 34.53 13.47 12.04 15.06 -40.68 14.50 17.55 -45.86 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 B 131 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 215 LYS B 59 LYS~? 17.23 O4 P6G D1130 B 277 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 17.88 38.77 19.81 16.38 34.23 17.24 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 20.33 37.78 11.20 16.77 34.53 13.47 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 B 131 LYS B 84 LYS~? 19.45 C18 P6G D1130 B 215 LYS B 101 LYS~? 19.06 C3 P6G D1130 B 277 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 17.88 38.77 19.81 16.38 34.23 17.24 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 20.33 37.78 11.20 16.77 34.53 13.47 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 B 131 LYS B 113 LYS~? 24.16 C17 P6G D1130 B 215 LYS B 101 LYS~? 19.06 C3 P6G D1130 B 277 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 17.88 38.77 19.81 16.38 34.23 17.24 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 20.33 37.78 11.20 16.77 34.53 13.47 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 B 131 LYS B 113 LYS~? 24.16 C17 P6G D1130 B 215 LYS B 101 LYS~? 19.06 C3 P6G D1130 B 277 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 17.88 38.77 19.81 16.38 34.23 17.24 39.66 6.36 -42.06 38.78 0.18 -41.50 coo 20.33 37.78 11.20 16.77 34.53 13.47 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 B 131 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 215 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 277 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 17.88 38.77 19.81 16.38 34.23 17.24 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 B 131 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 215 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 277 LYS A 32 LYS~? 25.27 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 17.88 38.77 19.81 16.38 34.23 17.24 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 -14.45 0.07 7.16 -16.37 -4.18 8.40 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 B 131 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 215 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 277 LYS A 64 LYS.? 18.05 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 17.88 38.77 19.81 16.38 34.23 17.24 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 B 131 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 215 LYS C 32 LYS~? 27.65 O5 PG4 C1130 B 277 LYS A 32 LYS~? 25.27 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 17.88 38.77 19.81 16.38 34.23 17.24 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 20.33 37.78 11.20 16.77 34.53 13.47 -14.45 0.07 7.16 -16.37 -4.18 8.40 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 B 131 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 215 LYS C 59 LYS~? 18.46 C8 PG4 C1130 B 277 LYS C 64 LYS.? 19.97 O5 PG4 C1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 17.88 38.77 19.81 16.38 34.23 17.24 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo 20.33 37.78 11.20 16.77 34.53 13.47 -31.89 2.68 -4.52 -34.59 7.10 -6.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 26 3 # 26 B 131 LYS C 113 LYS~? 22.50 C5 PG4 C1130 B 215 LYS C 101 LYS~? -2.55 O1 PG4 C1130s B 277 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 6.78 45.91 16.15 7.82 40.81 15.84 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 coo 17.88 38.77 19.81 16.38 34.23 17.24 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo 20.33 37.78 11.20 16.77 34.53 13.47 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 27 3 # 27 B 131 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 215 LYS B 32 LYS~? 26.29 C8 P6G D1130 B 277 LYS B 38 LYS~? 23.39 O4 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 17.88 38.77 19.81 16.38 34.23 17.24 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 20.33 37.78 11.20 16.77 34.53 13.47 25.30 -2.41 -62.07 30.29 -5.23 -64.65 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 28 3 # 28 B 131 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 215 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 277 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 29 3 # 29 B 131 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 215 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 277 LYS B 32 LYS~? 26.29 C8 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 24.48 1.33 -71.20 20.78 5.38 -73.37 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 30 3 # 30 B 131 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 215 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 277 LYS B 64 LYS.? 18.19 C9 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 17.88 38.77 19.81 16.38 34.23 17.24 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 31.06 5.90 -60.97 28.02 9.66 -62.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 31 3 # 31 B 131 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 215 LYS D 32 LYS~? 27.03 C6 P6G D1130 B 277 LYS B 32 LYS~? 26.29 C8 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 17.88 38.77 19.81 16.38 34.23 17.24 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 20.33 37.78 11.20 16.77 34.53 13.47 24.48 1.33 -71.20 20.78 5.38 -73.37 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 32 3 # 32 B 131 LYS D 64 LYS.? 21.53 C6 P6G D1130 B 215 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 277 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo 17.88 38.77 19.81 16.38 34.23 17.24 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 20.33 37.78 11.20 16.77 34.53 13.47 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 33 3 # 33 B 131 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 215 LYS D 59 LYS~? 18.77 O7 P6G D1130 B 277 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 17.88 38.77 19.81 16.38 34.23 17.24 3.27 6.90 -57.68 0.31 8.60 -52.41 coo 20.33 37.78 11.20 16.77 34.53 13.47 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 34 3 # 34 B 131 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 215 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 277 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 20.33 37.78 11.20 16.77 34.53 13.47 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 35 3 # 35 B 131 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 215 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 277 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 6.78 45.91 16.15 7.82 40.81 15.84 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 20.33 37.78 11.20 16.77 34.53 13.47 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 36 3 # 36 B 131 LYS D 113 LYS~? 21.47 O1 P6G D1130 B 215 LYS D 101 LYS~? -3.05 O19 P6G D1130s B 277 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 6.78 45.91 16.15 7.82 40.81 15.84 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 17.88 38.77 19.81 16.38 34.23 17.24 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 20.33 37.78 11.20 16.77 34.53 13.47 14.33 6.41 -44.26 15.86 10.02 -47.66 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 36 hits 1e19_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 76 ALA~? 14.67 C6 PG4 C1130 A 136 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 140 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo 59.38 10.02 17.51 59.95 9.89 20.21 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 59.52 3.69 18.67 62.31 6.19 22.58 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 76 ALA~? 14.67 C6 PG4 C1130 A 136 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 140 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo 59.38 10.02 17.51 59.95 9.89 20.21 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 59.52 3.69 18.67 62.31 6.19 22.58 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA A 95 ALA~? 21.68 O1 P6G D1130 A 136 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 140 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo 59.38 10.02 17.51 59.95 9.89 20.21 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 59.52 3.69 18.67 62.31 6.19 22.58 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA A 115 ALA~? 21.26 C6 PG4 C1130 A 136 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 140 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo 59.38 10.02 17.51 59.95 9.89 20.21 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 59.52 3.69 18.67 62.31 6.19 22.58 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 5 3 # 5 A 107 ALA B 76 ALA~? 14.74 C11 P6G D1130 A 136 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 140 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 33.17 9.74 -42.93 33.99 10.72 -43.77 coo 59.38 10.02 17.51 59.95 9.89 20.21 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 59.52 3.69 18.67 62.31 6.19 22.58 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 6 3 # 6 A 107 ALA B 95 ALA~? 23.69 C3 P6G D1130 A 136 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 140 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 39.47 6.03 -32.16 39.38 7.03 -31.00 coo 59.38 10.02 17.51 59.95 9.89 20.21 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 59.52 3.69 18.67 62.31 6.19 22.58 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 7 3 # 7 A 107 ALA B 127 ALA~? 37.42 C3 P6G D1130 A 136 TYR B 92 TYR~? 29.58 C3 P6G D1130 A 140 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 51.38 10.66 -25.48 51.36 12.18 -25.67 coo 59.38 10.02 17.51 59.95 9.89 20.21 42.63 7.31 -26.13 41.44 8.28 -23.79 coo 59.52 3.69 18.67 62.31 6.19 22.58 46.03 11.05 -24.83 42.26 13.39 -21.60 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 8 3 # 8 A 107 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 136 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 140 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 59.38 10.02 17.51 59.95 9.89 20.21 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 59.52 3.69 18.67 62.31 6.19 22.58 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 9 3 # 9 A 107 ALA C 95 ALA~? 9.85 C1 PG4 C1130 A 136 TYR C 118 TYR~? 14.79 C5 PG4 C1130 A 140 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo 59.38 10.02 17.51 59.95 9.89 20.21 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo 59.52 3.69 18.67 62.31 6.19 22.58 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 10 3 # 10 A 107 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 136 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 140 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 59.38 10.02 17.51 59.95 9.89 20.21 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 59.52 3.69 18.67 62.31 6.19 22.58 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 11 3 # 11 A 107 ALA D 95 ALA~? 9.46 C18 P6G D1130 A 136 TYR D 118 TYR~? 14.64 C18 P6G D1130 A 140 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 55.90 7.49 23.83 56.71 8.23 22.76 20.99 18.21 -37.32 21.64 17.75 -36.04 coo 59.38 10.02 17.51 59.95 9.89 20.21 19.04 13.52 -30.73 20.87 11.60 -29.89 coo 59.52 3.69 18.67 62.31 6.19 22.58 23.08 11.99 -34.73 21.14 6.51 -33.38 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 11 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 207 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 366 ASP A 107 ASP.? 20.53 C4 PG4 C1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 207 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 366 ASP B 107 ASP.? 21.14 C14 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 37.26 15.33 -51.32 39.19 15.47 -52.18 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 7 3 # 7 A 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 207 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 8 3 # 8 A 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 207 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 9 3 # 9 A 205 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 207 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 366 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 10 3 # 10 A 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 207 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 11 3 # 11 A 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 207 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 12 3 # 12 A 205 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 366 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 13 3 # 13 A 205 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 366 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 11.91 14.56 -48.67 12.89 16.26 -47.87 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 13 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 207 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 366 ASP A 107 ASP.? 20.53 C4 PG4 C1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 207 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 366 ASP B 107 ASP.? 21.14 C14 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -11.13 25.71 4.86 -10.82 24.43 3.24 37.26 15.33 -51.32 39.19 15.47 -52.18 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -11.13 25.71 4.86 -10.82 24.43 3.24 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -11.13 25.71 4.86 -10.82 24.43 3.24 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 7 3 # 7 B 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 207 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 8 3 # 8 B 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 207 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 9 3 # 9 B 205 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 207 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 366 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 10 3 # 10 B 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 207 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -11.13 25.71 4.86 -10.82 24.43 3.24 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 11 3 # 11 B 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 207 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -11.13 25.71 4.86 -10.82 24.43 3.24 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 12 3 # 12 B 205 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 366 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -11.13 25.71 4.86 -10.82 24.43 3.24 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 13 3 # 13 B 205 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 366 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -11.13 25.71 4.86 -10.82 24.43 3.24 11.91 14.56 -48.67 12.89 16.26 -47.87 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 13 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 207 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 366 ASP A 107 ASP.? 20.53 C4 PG4 C1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 207 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 366 ASP B 107 ASP.? 21.14 C14 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 37.26 15.33 -51.32 39.19 15.47 -52.18 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 7 3 # 7 C 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 207 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 8 3 # 8 C 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 207 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 9 3 # 9 C 205 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 207 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 366 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 10 3 # 10 C 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 207 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 11 3 # 11 C 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 207 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 12 3 # 12 C 205 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 366 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 13 3 # 13 C 205 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 366 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 11.91 14.56 -48.67 12.89 16.26 -47.87 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 13 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 207 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 366 ASP A 107 ASP.? 20.53 C4 PG4 C1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 207 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 366 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 207 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 366 ASP B 107 ASP.? 21.14 C14 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 37.26 15.33 -51.32 39.19 15.47 -52.18 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 207 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 366 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 7 3 # 7 D 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 207 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 8 3 # 8 D 205 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 207 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 366 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 9 3 # 9 D 205 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 207 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 366 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 10 3 # 10 D 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 207 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 11 3 # 11 D 205 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 207 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 366 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 12 3 # 12 D 205 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 366 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 13 3 # 13 D 205 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 207 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 366 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 11.91 14.56 -48.67 12.89 16.26 -47.87 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 13 hits 1ec9_c07 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 76 ALA~? 14.67 C6 PG4 C1130 A 257 ALA A 102 ALA~? 18.16 C6 PG4 C1130 A 328 ASP A 107 ASP.? 20.53 C4 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 102 ALA~? 18.16 C6 PG4 C1130 A 257 ALA A 76 ALA~? 14.67 C6 PG4 C1130 A 328 ASP A 107 ASP.? 20.53 C4 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 102 ALA~? 18.16 C6 PG4 C1130 A 257 ALA A 76 ALA~? 14.67 C6 PG4 C1130 A 328 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA B 102 ALA~? 17.96 C11 P6G D1130 A 257 ALA B 76 ALA~? 14.74 C11 P6G D1130 A 328 ASP B 107 ASP.? 21.14 C14 P6G D1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 37.30 9.41 -41.92 36.70 9.99 -40.66 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.17 9.74 -42.93 33.99 10.72 -43.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 37.26 15.33 -51.32 39.19 15.47 -52.18 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 102 ALA~? 17.96 C11 P6G D1130 A 257 ALA B 76 ALA~? 14.74 C11 P6G D1130 A 328 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 37.30 9.41 -41.92 36.70 9.99 -40.66 coo 43.22 26.73 5.37 41.81 27.09 5.79 33.17 9.74 -42.93 33.99 10.72 -43.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 257 ALA C 102 ALA~? 8.71 C5 PG4 C1130 A 328 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 38.17 34.10 6.67 37.72 32.06 6.84 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 257 ALA C 102 ALA~? 8.71 C5 PG4 C1130 A 328 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 38.17 34.10 6.67 37.72 32.06 6.84 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA C 102 ALA~? 8.71 C5 PG4 C1130 A 257 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 328 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 43.22 26.73 5.37 41.81 27.09 5.79 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA C 102 ALA~? 8.71 C5 PG4 C1130 A 257 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 328 ASP C 107 ASP.? 16.10 C8 PG4 C1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 43.22 26.73 5.37 41.81 27.09 5.79 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 257 ALA D 102 ALA~? 8.61 C12 P6G D1130 A 328 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 43.22 26.73 5.37 41.81 27.09 5.79 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.91 14.56 -48.67 12.89 16.26 -47.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 257 ALA D 102 ALA~? 8.61 C12 P6G D1130 A 328 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 43.22 26.73 5.37 41.81 27.09 5.79 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 4.55 4.63 -38.29 4.19 5.10 -40.34 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA D 102 ALA~? 8.61 C12 P6G D1130 A 257 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 328 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.91 14.56 -48.67 12.89 16.26 -47.87 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA D 102 ALA~? 8.61 C12 P6G D1130 A 257 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 328 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 39.84 24.12 8.44 38.50 24.23 9.11 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 4.55 4.63 -38.29 4.19 5.10 -40.34 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 13 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 78 SER~? 11.56 C6 PG4 C1130 A 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 34.67 35.79 48.83 33.57 37.88 49.47 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 29.60 38.99 53.89 30.10 37.88 51.36 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 32.73 32.94 54.42 29.29 32.83 50.35 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER A 78 SER~? 11.56 C6 PG4 C1130 A 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 34.67 35.79 48.83 33.57 37.88 49.47 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 29.60 38.99 53.89 30.10 37.88 51.36 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 32.73 32.94 54.42 29.29 32.83 50.35 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER B 78 SER~? 10.35 C3 P6G D1130 A 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 34.67 35.79 48.83 33.57 37.88 49.47 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 29.60 38.99 53.89 30.10 37.88 51.36 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 32.73 32.94 54.42 29.29 32.83 50.35 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 A 116 SER B 78 SER~? 10.35 C3 P6G D1130 A 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 34.67 35.79 48.83 33.57 37.88 49.47 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 29.60 38.99 53.89 30.10 37.88 51.36 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 32.73 32.94 54.42 29.29 32.83 50.35 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 A 116 SER C 106 SER~? 13.31 O4 PG4 C1130 A 140 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 144 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 34.67 35.79 48.83 33.57 37.88 49.47 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 29.60 38.99 53.89 30.10 37.88 51.36 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 32.73 32.94 54.42 29.29 32.83 50.35 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 A 116 SER D 106 SER~? 11.54 O1 P6G D1130 A 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 34.67 35.79 48.83 33.57 37.88 49.47 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 29.60 38.99 53.89 30.10 37.88 51.36 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 32.73 32.94 54.42 29.29 32.83 50.35 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 6 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 78 SER~? 11.56 C6 PG4 C1130 B 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 30.90 35.65 89.60 29.85 37.72 88.83 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 24.43 38.83 86.53 27.07 38.03 86.12 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 25.13 32.62 89.49 27.74 32.61 84.91 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER A 78 SER~? 11.56 C6 PG4 C1130 B 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 30.90 35.65 89.60 29.85 37.72 88.83 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 24.43 38.83 86.53 27.07 38.03 86.12 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 25.13 32.62 89.49 27.74 32.61 84.91 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER B 78 SER~? 10.35 C3 P6G D1130 B 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 30.90 35.65 89.60 29.85 37.72 88.83 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 24.43 38.83 86.53 27.07 38.03 86.12 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 25.13 32.62 89.49 27.74 32.61 84.91 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 B 116 SER B 78 SER~? 10.35 C3 P6G D1130 B 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 30.90 35.65 89.60 29.85 37.72 88.83 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 24.43 38.83 86.53 27.07 38.03 86.12 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 25.13 32.62 89.49 27.74 32.61 84.91 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 B 116 SER D 106 SER~? 11.54 O1 P6G D1130 B 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 30.90 35.65 89.60 29.85 37.72 88.83 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 24.43 38.83 86.53 27.07 38.03 86.12 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 25.13 32.62 89.49 27.74 32.61 84.91 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 78 SER~? 11.56 C6 PG4 C1130 C 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER A 78 SER~? 11.56 C6 PG4 C1130 C 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER B 78 SER~? 10.35 C3 P6G D1130 C 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -8.96 33.70 98.81 -8.96 35.77 97.56 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -8.28 37.01 91.79 -6.99 36.16 94.13 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -10.48 30.66 93.19 -5.27 31.07 94.32 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 C 116 SER B 78 SER~? 10.35 C3 P6G D1130 C 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo -8.96 33.70 98.81 -8.96 35.77 97.56 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -8.28 37.01 91.79 -6.99 36.16 94.13 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -10.48 30.66 93.19 -5.27 31.07 94.32 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 C 116 SER C 106 SER~? 13.31 O4 PG4 C1130 C 140 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 144 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -8.96 33.70 98.81 -8.96 35.77 97.56 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 C 116 SER D 106 SER~? 11.54 O1 P6G D1130 C 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -8.96 33.70 98.81 -8.96 35.77 97.56 8.27 7.70 -38.86 9.17 6.34 -37.11 coo -8.28 37.01 91.79 -6.99 36.16 94.13 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -10.48 30.66 93.19 -5.27 31.07 94.32 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 6 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 78 SER~? 11.56 C6 PG4 C1130 D 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER A 78 SER~? 11.56 C6 PG4 C1130 D 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER B 78 SER~? 10.35 C3 P6G D1130 D 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -29.80 31.30 63.54 -28.79 33.52 63.37 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -23.30 35.33 62.20 -25.10 34.24 64.06 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -24.76 28.82 60.31 -24.27 29.01 65.58 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 D 116 SER B 78 SER~? 10.35 C3 P6G D1130 D 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo -29.80 31.30 63.54 -28.79 33.52 63.37 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -23.30 35.33 62.20 -25.10 34.24 64.06 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -24.76 28.82 60.31 -24.27 29.01 65.58 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 D 116 SER D 106 SER~? 11.54 O1 P6G D1130 D 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -29.80 31.30 63.54 -28.79 33.52 63.37 8.27 7.70 -38.86 9.17 6.34 -37.11 coo -23.30 35.33 62.20 -25.10 34.24 64.06 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -24.76 28.82 60.31 -24.27 29.01 65.58 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 78 SER~? 11.56 C6 PG4 C1130 E 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 E 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER A 78 SER~? 11.56 C6 PG4 C1130 E 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 E 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER B 78 SER~? 10.35 C3 P6G D1130 E 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 E 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -3.01 32.72 32.71 -2.80 34.91 33.79 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 0.04 36.70 38.68 -2.21 35.46 37.50 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 1.93 30.52 36.31 -2.84 30.18 38.54 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 E 116 SER B 78 SER~? 10.35 C3 P6G D1130 E 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 E 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo -3.01 32.72 32.71 -2.80 34.91 33.79 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 0.04 36.70 38.68 -2.21 35.46 37.50 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 1.93 30.52 36.31 -2.84 30.18 38.54 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 E 116 SER D 106 SER~? 11.54 O1 P6G D1130 E 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 E 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -3.01 32.72 32.71 -2.80 34.91 33.79 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 0.04 36.70 38.68 -2.21 35.46 37.50 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 1.93 30.52 36.31 -2.84 30.18 38.54 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 78 SER~? 11.56 C6 PG4 C1130 F 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 F 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 55.30 92.46 56.72 55.15 90.39 55.38 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 54.49 89.31 49.65 53.35 90.16 52.06 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 56.78 95.62 51.15 51.59 95.31 52.37 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER A 78 SER~? 11.56 C6 PG4 C1130 F 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 F 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 55.30 92.46 56.72 55.15 90.39 55.38 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 54.49 89.31 49.65 53.35 90.16 52.06 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 56.78 95.62 51.15 51.59 95.31 52.37 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER B 78 SER~? 10.35 C3 P6G D1130 F 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 F 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 55.30 92.46 56.72 55.15 90.39 55.38 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 54.49 89.31 49.65 53.35 90.16 52.06 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 56.78 95.62 51.15 51.59 95.31 52.37 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 F 116 SER B 78 SER~? 10.35 C3 P6G D1130 F 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 F 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 55.30 92.46 56.72 55.15 90.39 55.38 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 54.49 89.31 49.65 53.35 90.16 52.06 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 56.78 95.62 51.15 51.59 95.31 52.37 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 F 116 SER C 106 SER~? 13.31 O4 PG4 C1130 F 140 TYR C 51 TYR~? 9.35 C8 PG4 C1130 F 144 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 55.30 92.46 56.72 55.15 90.39 55.38 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 54.49 89.31 49.65 53.35 90.16 52.06 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 56.78 95.62 51.15 51.59 95.31 52.37 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 F 116 SER D 106 SER~? 11.54 O1 P6G D1130 F 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 F 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 55.30 92.46 56.72 55.15 90.39 55.38 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 54.49 89.31 49.65 53.35 90.16 52.06 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 56.78 95.62 51.15 51.59 95.31 52.37 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 6 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 78 SER~? 11.56 C6 PG4 C1130 G 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 G 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 76.25 95.63 21.56 75.29 93.40 21.36 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 69.78 91.62 20.06 71.51 92.68 22.02 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 71.19 98.21 18.32 70.69 97.75 23.67 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER A 78 SER~? 11.56 C6 PG4 C1130 G 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 G 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 76.25 95.63 21.56 75.29 93.40 21.36 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 69.78 91.62 20.06 71.51 92.68 22.02 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 71.19 98.21 18.32 70.69 97.75 23.67 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER B 78 SER~? 10.35 C3 P6G D1130 G 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 G 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 76.25 95.63 21.56 75.29 93.40 21.36 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 69.78 91.62 20.06 71.51 92.68 22.02 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 71.19 98.21 18.32 70.69 97.75 23.67 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 G 116 SER B 78 SER~? 10.35 C3 P6G D1130 G 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 G 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 76.25 95.63 21.56 75.29 93.40 21.36 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 69.78 91.62 20.06 71.51 92.68 22.02 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 71.19 98.21 18.32 70.69 97.75 23.67 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 G 116 SER D 106 SER~? 11.54 O1 P6G D1130 G 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 G 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 76.25 95.63 21.56 75.29 93.40 21.36 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 69.78 91.62 20.06 71.51 92.68 22.02 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 71.19 98.21 18.32 70.69 97.75 23.67 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 78 SER~? 11.56 C6 PG4 C1130 H 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 H 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 15.45 90.62 47.70 16.55 88.57 46.97 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 21.92 87.58 44.67 19.30 88.41 44.23 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 21.26 93.70 47.67 18.47 93.68 43.08 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER A 78 SER~? 11.56 C6 PG4 C1130 H 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 H 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 15.45 90.62 47.70 16.55 88.57 46.97 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 21.92 87.58 44.67 19.30 88.41 44.23 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 21.26 93.70 47.67 18.47 93.68 43.08 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER B 78 SER~? 10.35 C3 P6G D1130 H 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 H 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 15.45 90.62 47.70 16.55 88.57 46.97 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 21.92 87.58 44.67 19.30 88.41 44.23 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 21.26 93.70 47.67 18.47 93.68 43.08 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 H 116 SER B 78 SER~? 10.35 C3 P6G D1130 H 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 H 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 15.45 90.62 47.70 16.55 88.57 46.97 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 21.92 87.58 44.67 19.30 88.41 44.23 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 21.26 93.70 47.67 18.47 93.68 43.08 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 H 116 SER C 106 SER~? 13.31 O4 PG4 C1130 H 140 TYR C 51 TYR~? 9.35 C8 PG4 C1130 H 144 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 15.45 90.62 47.70 16.55 88.57 46.97 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 21.92 87.58 44.67 19.30 88.41 44.23 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 21.26 93.70 47.67 18.47 93.68 43.08 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 H 116 SER D 106 SER~? 11.54 O1 P6G D1130 H 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 H 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 15.45 90.62 47.70 16.55 88.57 46.97 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 21.92 87.58 44.67 19.30 88.41 44.23 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 21.26 93.70 47.67 18.47 93.68 43.08 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 6 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 78 SER~? 11.56 C6 PG4 C1130 I 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 I 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 11.78 90.82 7.18 12.84 88.72 7.93 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 16.78 87.76 12.19 16.39 88.69 9.59 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 13.67 93.83 12.65 17.08 93.94 8.58 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER A 78 SER~? 11.56 C6 PG4 C1130 I 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 I 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 11.78 90.82 7.18 12.84 88.72 7.93 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 16.78 87.76 12.19 16.39 88.69 9.59 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 13.67 93.83 12.65 17.08 93.94 8.58 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER B 78 SER~? 10.35 C3 P6G D1130 I 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 I 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 11.78 90.82 7.18 12.84 88.72 7.93 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 16.78 87.76 12.19 16.39 88.69 9.59 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 13.67 93.83 12.65 17.08 93.94 8.58 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 I 116 SER B 78 SER~? 10.35 C3 P6G D1130 I 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 I 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 11.78 90.82 7.18 12.84 88.72 7.93 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 16.78 87.76 12.19 16.39 88.69 9.59 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 13.67 93.83 12.65 17.08 93.94 8.58 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 I 116 SER D 106 SER~? 11.54 O1 P6G D1130 I 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 I 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 11.78 90.82 7.18 12.84 88.72 7.93 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 16.78 87.76 12.19 16.39 88.69 9.59 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 13.67 93.83 12.65 17.08 93.94 8.58 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 78 SER~? 11.56 C6 PG4 C1130 J 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 J 144 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER A 78 SER~? 11.56 C6 PG4 C1130 J 140 TYR A 51 TYR~? 11.49 O5 PG4 C1130 J 144 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER B 78 SER~? 10.35 C3 P6G D1130 J 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 J 144 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 J 116 SER B 78 SER~? 10.35 C3 P6G D1130 J 140 TYR B 51 TYR~? 10.58 C3 P6G D1130 J 144 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 J 116 SER C 106 SER~? 13.31 O4 PG4 C1130 J 140 TYR C 51 TYR~? 9.35 C8 PG4 C1130 J 144 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 J 116 SER D 106 SER~? 11.54 O1 P6G D1130 J 140 TYR D 51 TYR~? 9.17 O7 P6G D1130 J 144 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 49.46 93.97 -9.19 49.31 91.82 -8.04 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 14.33 6.41 -44.26 15.86 10.02 -47.66 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 6 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 60 LYS~? 20.53 O5 PG4 C1130 A 193 GLU A 55 GLU~? 16.41 O5 PG4 C1130 A 217 VAL A 58 VAL~? 15.53 O5 PG4 C1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -3.82 6.30 -6.49 -4.25 8.23 -10.56 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -7.71 2.31 -7.89 -8.41 0.27 -8.41 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 101 LYS~? 17.94 O5 PG4 C1130 A 193 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 217 VAL A 97 VAL~? 22.17 O1 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 0.07 12.29 66.53 -0.24 11.95 64.38 1.95 0.30 -28.20 2.12 2.47 -27.80 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS A 101 LYS~? 17.94 O5 PG4 C1130 A 193 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 217 VAL A 97 VAL~? 22.17 O1 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.27 -2.68 -23.03 -3.47 1.45 -20.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 0.07 12.29 66.53 -0.24 11.95 64.38 1.95 0.30 -28.20 2.12 2.47 -27.80 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 60 LYS~? 18.39 O4 P6G D1130 A 193 GLU B 55 GLU~? 15.05 C3 P6G D1130 A 217 VAL B 58 VAL~? 15.70 O4 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 35.13 -4.39 -57.50 30.78 -7.61 -55.34 coo -5.33 11.71 69.72 -4.62 11.92 67.73 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 0.07 12.29 66.53 -0.24 11.95 64.38 31.45 -0.31 -56.26 30.80 1.73 -55.79 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS B 101 LYS~? 19.06 C3 P6G D1130 A 193 GLU B 94 GLU~? 22.51 C2 P6G D1130 A 217 VAL B 97 VAL~? 23.09 C3 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.66 6.36 -42.06 38.78 0.18 -41.50 coo -5.33 11.71 69.72 -4.62 11.92 67.73 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 0.07 12.29 66.53 -0.24 11.95 64.38 41.87 4.27 -36.65 42.08 2.06 -36.75 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS C 60 LYS~? 23.71 C3 PG4 C1130 A 193 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 217 VAL C 58 VAL~? 14.79 C8 PG4 C1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -35.53 -7.83 -3.33 -38.18 -11.20 -0.84 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -31.98 -4.58 -6.14 -31.26 -2.86 -7.29 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 193 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 217 VAL C 58 VAL~? 14.79 C8 PG4 C1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -31.98 -4.58 -6.14 -31.26 -2.86 -7.29 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 159 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 193 GLU C 61 GLU~? 21.06 O5 PG4 C1130 A 217 VAL C 58 VAL~? 14.79 C8 PG4 C1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -31.98 -4.58 -6.14 -31.26 -2.86 -7.29 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 159 LYS D 60 LYS~? 24.27 C15 P6G D1130 A 193 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 217 VAL D 58 VAL~? 14.75 C6 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 3.35 9.26 -60.71 0.52 11.83 -63.90 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 0.07 12.29 66.53 -0.24 11.95 64.38 7.08 6.20 -57.77 7.83 4.60 -56.44 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 159 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 193 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 217 VAL D 58 VAL~? 14.75 C6 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 0.07 12.29 66.53 -0.24 11.95 64.38 7.08 6.20 -57.77 7.83 4.60 -56.44 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 159 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 193 GLU D 61 GLU~? 21.02 C9 P6G D1130 A 217 VAL D 58 VAL~? 14.75 C6 P6G D1130 coo 2.10 10.68 61.44 -2.14 13.16 60.61 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 0.07 12.29 66.53 -0.24 11.95 64.38 7.08 6.20 -57.77 7.83 4.60 -56.44 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 11 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 34 THR~? 24.96 O5 PG4 C1130 A 159 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 193 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -14.30 4.75 4.28 -13.10 5.81 5.73 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 34 THR~? 24.96 O5 PG4 C1130 A 159 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 193 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -14.30 4.75 4.28 -13.10 5.81 5.73 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 39 THR~? 15.12 O5 PG4 C1130 A 159 LYS A 64 LYS.? 18.05 O5 PG4 C1130 A 193 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR A 39 THR~? 15.12 O5 PG4 C1130 A 159 LYS A 64 LYS.? 18.05 O5 PG4 C1130 A 193 GLU A 69 GLU~? 16.61 C4 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 34 THR~? 25.20 C6 P6G D1130 A 159 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 193 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 24.45 -3.48 -67.89 25.98 -4.62 -68.95 coo 2.10 10.68 61.44 -2.14 13.16 60.61 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 34 THR~? 25.20 C6 P6G D1130 A 159 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 193 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 24.45 -3.48 -67.89 25.98 -4.62 -68.95 coo 2.10 10.68 61.44 -2.14 13.16 60.61 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 39 THR~? 16.03 C8 P6G D1130 A 159 LYS B 64 LYS.? 18.19 C9 P6G D1130 A 193 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 2.10 10.68 61.44 -2.14 13.16 60.61 31.06 5.90 -60.97 28.02 9.66 -62.79 coo -5.33 11.71 69.72 -4.62 11.92 67.73 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 39 THR~? 16.03 C8 P6G D1130 A 159 LYS B 64 LYS.? 18.19 C9 P6G D1130 A 193 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 2.10 10.68 61.44 -2.14 13.16 60.61 31.06 5.90 -60.97 28.02 9.66 -62.79 coo -5.33 11.71 69.72 -4.62 11.92 67.73 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR B 89 THR~? 23.45 O1 P6G D1130 A 159 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 193 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 35.32 4.97 -23.65 34.17 3.75 -25.02 coo 2.10 10.68 61.44 -2.14 13.16 60.61 34.20 9.92 -30.73 30.97 14.90 -30.33 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR C 34 THR~? 24.00 O5 PG4 C1130 A 159 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 193 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -25.16 -1.64 5.50 -26.64 -2.67 6.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR C 34 THR~? 24.00 O5 PG4 C1130 A 159 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 193 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -25.16 -1.64 5.50 -26.64 -2.67 6.71 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR C 39 THR~? 14.51 O5 PG4 C1130 A 159 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 193 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR C 39 THR~? 14.51 O5 PG4 C1130 A 159 LYS C 64 LYS.? 19.97 O5 PG4 C1130 A 193 GLU C 69 GLU~? 15.05 O5 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -31.89 2.68 -4.52 -34.59 7.10 -6.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -32.98 6.49 -14.53 -31.30 7.57 -15.23 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR C 89 THR~? 14.94 C2 PG4 C1130 A 159 LYS A 84 LYS~? 19.93 C5 PG4 C1130 A 193 GLU A 121 GLU~? 21.00 O1 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo -5.33 11.71 69.72 -4.62 11.92 67.73 2.80 -10.41 -36.92 3.82 -11.51 -38.44 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 15 3 # 15 A 38 THR C 89 THR~? 14.94 C2 PG4 C1130 A 159 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 193 GLU A 73 GLU~? 13.39 C4 PG4 C1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 16 3 # 16 A 38 THR C 89 THR~? 14.94 C2 PG4 C1130 A 159 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 193 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 17 3 # 17 A 38 THR C 89 THR~? 14.94 C2 PG4 C1130 A 159 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 193 GLU A 121 GLU~? 21.00 O1 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 2.80 -10.41 -36.92 3.82 -11.51 -38.44 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 18 3 # 18 A 38 THR D 34 THR~? 24.52 C6 P6G D1130 A 159 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 193 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 13.70 3.26 -69.58 12.20 4.34 -70.72 coo 2.10 10.68 61.44 -2.14 13.16 60.61 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -5.33 11.71 69.72 -4.62 11.92 67.73 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 19 3 # 19 A 38 THR D 39 THR~? 15.06 C6 P6G D1130 A 159 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 193 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 2.10 10.68 61.44 -2.14 13.16 60.61 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 20 3 # 20 A 38 THR D 39 THR~? 15.06 C6 P6G D1130 A 159 LYS D 64 LYS.? 21.53 C6 P6G D1130 A 193 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 2.10 10.68 61.44 -2.14 13.16 60.61 7.23 -1.35 -58.56 7.04 -5.82 -62.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 21 3 # 21 A 38 THR D 89 THR~? 14.44 C17 P6G D1130 A 159 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 193 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 34.20 9.92 -30.73 30.97 14.90 -30.33 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 22 3 # 22 A 38 THR D 89 THR~? 14.44 C17 P6G D1130 A 159 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 193 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.07 16.52 -42.78 41.38 14.10 -46.96 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 23 3 # 23 A 38 THR D 89 THR~? 14.44 C17 P6G D1130 A 159 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 193 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.07 16.52 -42.78 41.38 14.10 -46.96 coo -5.33 11.71 69.72 -4.62 11.92 67.73 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 24 3 # 24 A 38 THR D 89 THR~? 14.44 C17 P6G D1130 A 159 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 193 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.51 19.43 -40.28 40.84 23.44 -43.47 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 25 3 # 25 A 38 THR D 89 THR~? 14.44 C17 P6G D1130 A 159 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 193 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.51 19.43 -40.28 40.84 23.44 -43.47 coo -5.33 11.71 69.72 -4.62 11.92 67.73 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 26 3 # 26 A 38 THR D 89 THR~? 14.44 C17 P6G D1130 A 159 LYS D 84 LYS~? 10.25 O1 P6G D1130 A 193 GLU D 121 GLU~? 20.22 C18 P6G D1130 coo -2.58 16.31 54.79 -4.02 14.93 55.64 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 23.08 11.99 -34.73 21.14 6.51 -33.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 19.28 17.06 -26.24 19.68 17.98 -24.36 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 26 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP B 85 ASP~? 16.97 O1 P6G D1130 260 GLU B 121 GLU~? 26.56 C11 P6G D1130 370 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP C 85 ASP~? 10.22 C6 PG4 C1130 260 GLU C 94 GLU~? 10.36 O1 PG4 C1130 370 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 107 ASP.? 16.10 C8 PG4 C1130 260 GLU C 55 GLU~? 14.48 C8 PG4 C1130 370 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP C 129 ASP.? 25.37 C1 PG4 C1130 260 GLU C 121 GLU~? 20.36 C1 PG4 C1130 370 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP D 85 ASP~? 10.24 C11 P6G D1130 260 GLU D 94 GLU~? 9.44 O19 P6G D1130 370 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 24.24 21.35 -31.93 26.12 20.12 -30.25 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP D 129 ASP.? 22.88 C18 P6G D1130 260 GLU D 121 GLU~? 20.22 C18 P6G D1130 370 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 23.03 25.83 -22.84 23.72 24.15 -23.95 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 24.24 21.35 -31.93 26.12 20.12 -30.25 1euu_c00 source 1euu SIALIDASE : 6 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 260 ARG C 77 ARG~? 11.94 C8 PG4 C1130 A 270 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 39.80 27.50 22.98 42.20 26.56 21.34 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 48.83 21.70 19.50 47.44 24.99 15.25 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 260 ARG A 123 ARG~? 19.27 O1 P6G D1130 A 270 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 39.80 27.50 22.98 42.20 26.56 21.34 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 48.83 21.70 19.50 47.44 24.99 15.25 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 260 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 270 LYS A 124 LYS~? 16.08 O1 P6G D1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 39.80 27.50 22.98 42.20 26.56 21.34 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 8.72 -6.45 -38.52 11.43 -11.38 -40.04 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 260 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 270 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 39.80 27.50 22.98 42.20 26.56 21.34 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 260 ARG D 35 ARG~? 21.81 C6 P6G D1130 A 270 LYS D 64 LYS.? 21.53 C6 P6G D1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 39.80 27.50 22.98 42.20 26.56 21.34 10.98 -2.55 -67.37 13.68 -3.80 -66.48 coo 48.83 21.70 19.50 47.44 24.99 15.25 7.23 -1.35 -58.56 7.04 -5.82 -62.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 260 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 270 LYS B 112 LYS~? 22.45 C14 P6G D1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 39.80 27.50 22.98 42.20 26.56 21.34 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 39.07 16.52 -42.78 41.38 14.10 -46.96 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 260 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 270 LYS B 113 LYS~? 24.16 C17 P6G D1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 39.80 27.50 22.98 42.20 26.56 21.34 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 39.51 19.43 -40.28 40.84 23.44 -43.47 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 260 ARG A 35 ARG~? 23.61 O5 PG4 C1130 A 270 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 39.80 27.50 22.98 42.20 26.56 21.34 -11.68 -1.74 4.09 -8.68 -2.48 3.95 coo 48.83 21.70 19.50 47.44 24.99 15.25 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU C 69 GLU~? 15.05 O5 PG4 C1130 A 260 ARG C 77 ARG~? 11.94 C8 PG4 C1130 A 270 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.98 6.49 -14.53 -31.30 7.57 -15.23 coo 39.80 27.50 22.98 42.20 26.56 21.34 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 48.83 21.70 19.50 47.44 24.99 15.25 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 260 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 270 LYS A 124 LYS~? 16.08 O1 P6G D1130 coo 50.99 29.43 12.86 52.11 29.45 14.65 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 8.72 -6.45 -38.52 11.43 -11.38 -40.04 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 10 hits 1euy_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 85 ASP~? 19.32 C6 PG4 C1130 C 117 GLU A 82 GLU~? 16.13 C6 PG4 C1130 C 131 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo 68.01 56.37 72.57 68.42 56.10 70.51 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 66.59 62.50 67.44 67.57 60.64 67.12 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 69.24 52.27 71.96 69.91 50.26 71.89 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 85 ASP~? 16.97 O1 P6G D1130 C 117 GLU B 94 GLU~? 22.51 C2 P6G D1130 C 131 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo 68.01 56.37 72.57 68.42 56.10 70.51 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 66.59 62.50 67.44 67.57 60.64 67.12 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 69.24 52.27 71.96 69.91 50.26 71.89 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP B 107 ASP.? 21.14 C14 P6G D1130 C 117 GLU B 109 GLU~? 22.36 C17 P6G D1130 C 131 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 68.01 56.37 72.57 68.42 56.10 70.51 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 66.59 62.50 67.44 67.57 60.64 67.12 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 69.24 52.27 71.96 69.91 50.26 71.89 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 117 GLU A 82 GLU~? 16.13 C6 PG4 C1130 C 131 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo 68.01 56.37 72.57 68.42 56.10 70.51 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 66.59 62.50 67.44 67.57 60.64 67.12 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 69.24 52.27 71.96 69.91 50.26 71.89 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP C 107 ASP.? 16.10 C8 PG4 C1130 C 117 GLU C 109 GLU~? 22.49 C8 PG4 C1130 C 131 GLU C 73 GLU~? 12.72 C8 PG4 C1130 coo 68.01 56.37 72.57 68.42 56.10 70.51 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 66.59 62.50 67.44 67.57 60.64 67.12 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 69.24 52.27 71.96 69.91 50.26 71.89 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 3 # 6 C 95 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 117 GLU B 73 GLU~? 10.65 C14 P6G D1130 C 131 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 68.01 56.37 72.57 68.42 56.10 70.51 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 66.59 62.50 67.44 67.57 60.64 67.12 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 69.24 52.27 71.96 69.91 50.26 71.89 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 7 3 # 7 C 95 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 117 GLU B 82 GLU~? 13.30 C2 P6G D1130 C 131 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 68.01 56.37 72.57 68.42 56.10 70.51 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 66.59 62.50 67.44 67.57 60.64 67.12 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 69.24 52.27 71.96 69.91 50.26 71.89 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 8 3 # 8 C 95 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 117 GLU D 88 GLU~? 17.52 C12 P6G D1130 C 131 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 68.01 56.37 72.57 68.42 56.10 70.51 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 66.59 62.50 67.44 67.57 60.64 67.12 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 69.24 52.27 71.96 69.91 50.26 71.89 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 9 3 # 9 C 95 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 117 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 131 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 68.01 56.37 72.57 68.42 56.10 70.51 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 66.59 62.50 67.44 67.57 60.64 67.12 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 69.24 52.27 71.96 69.91 50.26 71.89 8.90 2.49 -40.53 8.63 4.21 -39.28 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 9 hits 1f6d_c02 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 98 PHE~? 19.95 C6 PG4 C1130 A 210 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 244 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -1.20 42.34 17.67 3.19 45.13 19.06 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 98 PHE~? 19.95 C6 PG4 C1130 A 210 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 244 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 98 PHE~? 19.95 C6 PG4 C1130 A 210 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 244 LYS A 112 LYS~? 23.21 C4 PG4 C1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 210 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 244 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 10.51 37.86 19.71 9.07 39.38 20.04 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -1.20 42.34 17.67 3.19 45.13 19.06 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 210 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 244 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -1.20 42.34 17.67 3.19 45.13 19.06 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 210 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 244 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 10.51 37.86 19.71 9.07 39.38 20.04 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -1.20 42.34 17.67 3.19 45.13 19.06 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 210 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 244 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 10.51 37.86 19.71 9.07 39.38 20.04 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -1.20 42.34 17.67 3.19 45.13 19.06 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 210 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 244 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 9.23 46.77 25.11 11.48 48.39 24.76 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE D 48 PHE~? -7.47 C9 P6G D1130s A 210 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 244 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 9.23 46.77 25.11 11.48 48.39 24.76 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE D 87 PHE~? 15.25 C18 P6G D1130 A 210 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 244 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 210 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 244 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 9.23 46.77 25.11 11.48 48.39 24.76 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 210 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 244 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 9.23 46.77 25.11 11.48 48.39 24.76 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 210 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 244 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 9.23 46.77 25.11 11.48 48.39 24.76 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 10.51 37.86 19.71 9.07 39.38 20.04 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 14.33 6.41 -44.26 15.86 10.02 -47.66 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 13 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 98 PHE~? 19.95 C6 PG4 C1130 B 210 ASP A 85 ASP~? 19.32 C6 PG4 C1130 B 244 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -2.38 51.82 41.62 2.07 49.19 40.42 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 98 PHE~? 19.95 C6 PG4 C1130 B 210 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 244 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 98 PHE~? 19.95 C6 PG4 C1130 B 210 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 244 LYS A 112 LYS~? 23.21 C4 PG4 C1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 99 PHE~? 22.15 C3 P6G D1130 B 210 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 244 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 9.06 56.85 40.30 7.71 55.27 39.90 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -2.38 51.82 41.62 2.07 49.19 40.42 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE C 48 PHE~? 7.58 C4 PG4 C1130 B 210 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 244 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE C 98 PHE~? -3.85 C1 PG4 C1130s B 210 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 244 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 9.06 56.85 40.30 7.71 55.27 39.90 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -2.38 51.82 41.62 2.07 49.19 40.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE C 98 PHE~? -3.85 C1 PG4 C1130s B 210 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 244 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 9.06 56.85 40.30 7.71 55.27 39.90 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE C 99 PHE~? 10.28 C1 PG4 C1130 B 210 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 244 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 8.76 47.85 34.91 11.08 46.36 35.41 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE D 48 PHE~? -7.47 C9 P6G D1130s B 210 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 244 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 8.76 47.85 34.91 11.08 46.36 35.41 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE D 87 PHE~? 15.25 C18 P6G D1130 B 210 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 244 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 210 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 244 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 8.76 47.85 34.91 11.08 46.36 35.41 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 210 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 244 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 8.76 47.85 34.91 11.08 46.36 35.41 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE D 99 PHE~? 10.07 C18 P6G D1130 B 210 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 244 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 8.76 47.85 34.91 11.08 46.36 35.41 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 9.06 56.85 40.30 7.71 55.27 39.90 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 14.33 6.41 -44.26 15.86 10.02 -47.66 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 13 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 43 TYR~? 9.79 O5 PG4 C1130 A 142 LEU A 71 LEU~? 8.37 C7 PG4 C1130 A 165 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -11.87 -5.55 -14.19 -13.88 -5.33 -13.44 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 A 165 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 A 165 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 92 TYR~? 17.76 O1 P6G D1130 A 142 LEU A 86 LEU~? 23.09 C6 PG4 C1130 A 165 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 142 LEU A 96 LEU~? 18.30 O1 P6G D1130 A 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 142 LEU A 103 LEU~? 23.56 C6 PG4 C1130 A 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 142 LEU A 119 LEU~? 21.73 O1 P6G D1130 A 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR B 43 TYR~? 10.38 C8 P6G D1130 A 142 LEU B 71 LEU~? 8.21 C8 P6G D1130 A 165 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 21.94 3.80 -56.34 23.03 6.24 -57.25 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 27.39 8.09 -50.41 25.35 7.85 -51.19 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 A 165 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 A 165 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR B 92 TYR~? 29.58 C3 P6G D1130 A 142 LEU B 86 LEU~? 21.10 C2 P6G D1130 A 165 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 42.63 7.31 -26.13 41.44 8.28 -23.79 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 36.40 4.60 -30.00 35.97 2.83 -31.17 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 46.03 11.05 -24.83 42.26 13.39 -21.60 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 A 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 142 LEU B 96 LEU~? 27.30 C3 P6G D1130 A 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 44.10 6.64 -33.57 46.02 7.50 -33.98 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 A 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 142 LEU B 103 LEU~? 23.43 C11 P6G D1130 A 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 A 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 142 LEU B 119 LEU~? 26.05 C11 P6G D1130 A 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 A 137 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 142 LEU C 71 LEU~? 7.81 O5 PG4 C1130 A 165 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.82 0.05 -14.81 -26.48 0.89 -13.31 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 A 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 A 165 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 A 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 A 165 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 A 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 142 LEU C 86 LEU~? 9.11 C1 PG4 C1130 A 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 A 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 A 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 A 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 A 142 LEU C 96 LEU~? 10.59 O1 PG4 C1130 A 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -22.38 -16.85 -29.95 -24.08 -18.13 -30.36 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 A 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 A 142 LEU C 103 LEU~? 13.07 C1 PG4 C1130 A 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 A 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 A 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 A 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 A 137 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 142 LEU D 71 LEU~? 7.06 C6 P6G D1130 A 165 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 17.02 2.86 -56.49 16.12 0.22 -56.60 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 11.44 2.52 -48.70 12.78 1.60 -50.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 A 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 A 165 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 13.88 10.45 -55.46 13.15 11.98 -56.83 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 A 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 A 165 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 13.88 10.45 -55.46 13.15 11.98 -56.83 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 A 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 142 LEU D 86 LEU~? 8.72 C18 P6G D1130 A 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 24.52 16.51 -38.13 24.47 16.89 -40.23 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 A 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 A 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 28 3 # 28 A 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 A 142 LEU D 96 LEU~? 10.22 O19 P6G D1130 A 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 17.51 21.39 -36.10 15.86 22.74 -35.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 29 3 # 29 A 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 A 142 LEU D 103 LEU~? 12.85 C18 P6G D1130 A 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 9.97 14.18 -35.42 8.61 14.71 -33.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 30 3 # 30 A 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 A 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 A 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 23.08 11.99 -34.73 21.14 6.51 -33.38 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 30 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 43 TYR~? 9.79 O5 PG4 C1130 B 142 LEU A 71 LEU~? 8.37 C7 PG4 C1130 B 165 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -11.87 -5.55 -14.19 -13.88 -5.33 -13.44 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 B 165 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 B 165 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 92 TYR~? 17.76 O1 P6G D1130 B 142 LEU A 86 LEU~? 23.09 C6 PG4 C1130 B 165 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 B 142 LEU A 103 LEU~? 23.56 C6 PG4 C1130 B 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 B 142 LEU A 119 LEU~? 21.73 O1 P6G D1130 B 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR B 43 TYR~? 10.38 C8 P6G D1130 B 142 LEU B 71 LEU~? 8.21 C8 P6G D1130 B 165 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 21.94 3.80 -56.34 23.03 6.24 -57.25 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 27.39 8.09 -50.41 25.35 7.85 -51.19 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 B 165 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 B 165 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR B 92 TYR~? 29.58 C3 P6G D1130 B 142 LEU B 86 LEU~? 21.10 C2 P6G D1130 B 165 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 42.63 7.31 -26.13 41.44 8.28 -23.79 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 36.40 4.60 -30.00 35.97 2.83 -31.17 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 46.03 11.05 -24.83 42.26 13.39 -21.60 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 B 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 B 142 LEU B 103 LEU~? 23.43 C11 P6G D1130 B 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 41.52 11.84 -42.16 43.44 12.66 -42.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 B 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 B 142 LEU B 119 LEU~? 26.05 C11 P6G D1130 B 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 43.87 12.60 -35.81 43.71 11.06 -37.32 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 B 137 TYR C 43 TYR~? 9.68 O5 PG4 C1130 B 142 LEU C 71 LEU~? 7.81 O5 PG4 C1130 B 165 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.82 0.05 -14.81 -26.48 0.89 -13.31 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 B 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 B 165 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 B 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 B 165 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 B 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 B 142 LEU C 86 LEU~? 9.11 C1 PG4 C1130 B 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 B 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 B 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 B 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 B 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 B 142 LEU C 103 LEU~? 13.07 C1 PG4 C1130 B 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 B 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 B 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 B 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 B 137 TYR D 43 TYR~? 10.27 C6 P6G D1130 B 142 LEU D 71 LEU~? 7.06 C6 P6G D1130 B 165 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 17.02 2.86 -56.49 16.12 0.22 -56.60 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 11.44 2.52 -48.70 12.78 1.60 -50.15 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 B 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 B 165 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 13.88 10.45 -55.46 13.15 11.98 -56.83 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 B 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 B 165 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 13.88 10.45 -55.46 13.15 11.98 -56.83 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 B 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 B 142 LEU D 86 LEU~? 8.72 C18 P6G D1130 B 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 24.52 16.51 -38.13 24.47 16.89 -40.23 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 B 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 B 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 B 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 13.90 18.18 -31.81 13.32 18.29 -33.87 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 B 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 B 142 LEU D 96 LEU~? 10.22 O19 P6G D1130 B 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 17.51 21.39 -36.10 15.86 22.74 -35.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 B 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 B 142 LEU D 103 LEU~? 12.85 C18 P6G D1130 B 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 9.97 14.18 -35.42 8.61 14.71 -33.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 B 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 B 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 B 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 13.90 18.18 -31.81 13.32 18.29 -33.87 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 23.08 11.99 -34.73 21.14 6.51 -33.38 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 27 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 43 TYR~? 9.79 O5 PG4 C1130 C 142 LEU A 71 LEU~? 8.37 C7 PG4 C1130 C 165 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -11.87 -5.55 -14.19 -13.88 -5.33 -13.44 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 C 165 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 C 165 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 92 TYR~? 17.76 O1 P6G D1130 C 142 LEU A 86 LEU~? 23.09 C6 PG4 C1130 C 165 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 C 142 LEU A 103 LEU~? 23.56 C6 PG4 C1130 C 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 C 142 LEU A 119 LEU~? 21.73 O1 P6G D1130 C 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR B 43 TYR~? 10.38 C8 P6G D1130 C 142 LEU B 71 LEU~? 8.21 C8 P6G D1130 C 165 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 21.94 3.80 -56.34 23.03 6.24 -57.25 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 27.39 8.09 -50.41 25.35 7.85 -51.19 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 C 165 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 C 165 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR B 92 TYR~? 29.58 C3 P6G D1130 C 142 LEU B 86 LEU~? 21.10 C2 P6G D1130 C 165 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 42.63 7.31 -26.13 41.44 8.28 -23.79 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 36.40 4.60 -30.00 35.97 2.83 -31.17 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 46.03 11.05 -24.83 42.26 13.39 -21.60 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 C 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 C 142 LEU B 103 LEU~? 23.43 C11 P6G D1130 C 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 C 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 C 142 LEU B 119 LEU~? 26.05 C11 P6G D1130 C 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 C 137 TYR C 43 TYR~? 9.68 O5 PG4 C1130 C 142 LEU C 71 LEU~? 7.81 O5 PG4 C1130 C 165 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.82 0.05 -14.81 -26.48 0.89 -13.31 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 C 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 C 165 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 C 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 C 165 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 C 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 C 142 LEU C 86 LEU~? 9.11 C1 PG4 C1130 C 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 C 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 C 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 C 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 C 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 C 142 LEU C 103 LEU~? 13.07 C1 PG4 C1130 C 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 C 137 TYR D 43 TYR~? 10.27 C6 P6G D1130 C 142 LEU D 71 LEU~? 7.06 C6 P6G D1130 C 165 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 17.02 2.86 -56.49 16.12 0.22 -56.60 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 11.44 2.52 -48.70 12.78 1.60 -50.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 C 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 C 165 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 13.88 10.45 -55.46 13.15 11.98 -56.83 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 C 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 C 165 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 13.88 10.45 -55.46 13.15 11.98 -56.83 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 C 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 C 142 LEU D 86 LEU~? 8.72 C18 P6G D1130 C 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 24.52 16.51 -38.13 24.47 16.89 -40.23 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 C 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 C 142 LEU D 103 LEU~? 12.85 C18 P6G D1130 C 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 9.97 14.18 -35.42 8.61 14.71 -33.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 C 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 C 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 C 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 23.08 11.99 -34.73 21.14 6.51 -33.38 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 24 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 43 TYR~? 9.79 O5 PG4 C1130 D 142 LEU A 71 LEU~? 8.37 C7 PG4 C1130 D 165 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -11.87 -5.55 -14.19 -13.88 -5.33 -13.44 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 D 165 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 142 LEU A 45 LEU~? 11.97 O5 PG4 C1130 D 165 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -14.74 5.11 -11.61 -14.05 7.02 -10.96 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 92 TYR~? 17.76 O1 P6G D1130 D 142 LEU A 86 LEU~? 23.09 C6 PG4 C1130 D 165 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 D 142 LEU A 103 LEU~? 23.56 C6 PG4 C1130 D 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR A 118 TYR~? 23.63 C5 PG4 C1130 D 142 LEU A 119 LEU~? 21.73 O1 P6G D1130 D 165 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR B 43 TYR~? 10.38 C8 P6G D1130 D 142 LEU B 71 LEU~? 8.21 C8 P6G D1130 D 165 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 21.94 3.80 -56.34 23.03 6.24 -57.25 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 27.39 8.09 -50.41 25.35 7.85 -51.19 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 D 165 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 142 LEU B 45 LEU~? 11.29 O4 P6G D1130 D 165 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 24.70 -2.86 -52.16 25.38 -4.85 -52.81 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR B 92 TYR~? 29.58 C3 P6G D1130 D 142 LEU B 86 LEU~? 21.10 C2 P6G D1130 D 165 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 42.63 7.31 -26.13 41.44 8.28 -23.79 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 36.40 4.60 -30.00 35.97 2.83 -31.17 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 46.03 11.05 -24.83 42.26 13.39 -21.60 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 D 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 D 142 LEU B 103 LEU~? 23.43 C11 P6G D1130 D 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 D 137 TYR B 118 TYR~? 21.87 C11 P6G D1130 D 142 LEU B 119 LEU~? 26.05 C11 P6G D1130 D 165 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 D 137 TYR C 43 TYR~? 9.68 O5 PG4 C1130 D 142 LEU C 71 LEU~? 7.81 O5 PG4 C1130 D 165 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.82 0.05 -14.81 -26.48 0.89 -13.31 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 D 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 D 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 D 165 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 D 137 TYR C 51 TYR~? 9.35 C8 PG4 C1130 D 142 LEU C 45 LEU~? 10.23 C3 PG4 C1130 D 165 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 D 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 D 142 LEU C 86 LEU~? 9.11 C1 PG4 C1130 D 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 D 137 TYR C 92 TYR~? 16.40 C1 PG4 C1130 D 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 D 165 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 D 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 D 142 LEU C 103 LEU~? 13.07 C1 PG4 C1130 D 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 D 137 TYR C 118 TYR~? 14.79 C5 PG4 C1130 D 142 LEU C 119 LEU~? 12.55 C1 PG4 C1130 D 165 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 D 137 TYR D 43 TYR~? 10.27 C6 P6G D1130 D 142 LEU D 71 LEU~? 7.06 C6 P6G D1130 D 165 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 17.02 2.86 -56.49 16.12 0.22 -56.60 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 11.44 2.52 -48.70 12.78 1.60 -50.15 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 D 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 D 165 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 13.88 10.45 -55.46 13.15 11.98 -56.83 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 D 137 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 142 LEU D 45 LEU~? 10.26 C15 P6G D1130 D 165 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 13.88 10.45 -55.46 13.15 11.98 -56.83 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 D 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 D 142 LEU D 86 LEU~? 8.72 C18 P6G D1130 D 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 24.52 16.51 -38.13 24.47 16.89 -40.23 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 D 137 TYR D 92 TYR~? 16.07 C18 P6G D1130 D 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 D 165 LYS D 125 LYS~? 20.88 C18 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 22.36 24.47 -28.29 24.66 21.32 -25.50 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 D 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 D 142 LEU D 96 LEU~? 10.22 O19 P6G D1130 D 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 17.51 21.39 -36.10 15.86 22.74 -35.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 D 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 D 142 LEU D 103 LEU~? 12.85 C18 P6G D1130 D 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 9.97 14.18 -35.42 8.61 14.71 -33.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 D 137 TYR D 118 TYR~? 14.64 C18 P6G D1130 D 142 LEU D 119 LEU~? 12.39 C18 P6G D1130 D 165 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 19.04 13.52 -30.73 20.87 11.60 -29.89 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 23.08 11.99 -34.73 21.14 6.51 -33.38 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 27 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 123 ARG~? 19.27 O1 P6G D1130 A 136 GLU A 121 GLU~? 21.00 O1 P6G D1130 A 246 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 13.48 30.30 107.06 11.75 30.99 109.44 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 9.46 32.37 115.82 8.50 34.20 115.47 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 11.99 34.33 109.92 10.08 34.19 110.77 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 123 ARG~? 30.75 C11 P6G D1130 A 136 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 246 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 13.48 30.30 107.06 11.75 30.99 109.44 48.86 12.42 -33.59 48.71 12.69 -36.66 coo 9.46 32.37 115.82 8.50 34.20 115.47 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 11.99 34.33 109.92 10.08 34.19 110.77 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 123 ARG~? 15.20 O1 PG4 C1130 A 136 GLU C 121 GLU~? 20.36 C1 PG4 C1130 A 246 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 13.48 30.30 107.06 11.75 30.99 109.44 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 9.46 32.37 115.82 8.50 34.20 115.47 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 11.99 34.33 109.92 10.08 34.19 110.77 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG D 123 ARG~? 17.23 O19 P6G D1130 A 136 GLU D 121 GLU~? 20.22 C18 P6G D1130 A 246 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 13.48 30.30 107.06 11.75 30.99 109.44 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 9.46 32.37 115.82 8.50 34.20 115.47 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 11.99 34.33 109.92 10.08 34.19 110.77 14.39 19.77 -25.34 13.72 21.78 -25.43 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 4 hits 1fhl_c00 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER A 116 SER~? 25.66 C6 PG4 C1130 272 CYH A 122 CYH~? 19.70 O1 P6G D1130 312 GLU A 121 GLU~? 21.00 O1 P6G D1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 18.48 7.50 15.98 21.17 6.92 15.38 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 22.30 10.15 12.52 24.07 9.52 13.47 2.80 -10.41 -36.92 3.82 -11.51 -38.44 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 2 3 # 2 96 SER B 116 SER~? 25.27 C11 P6G D1130 272 CYH B 122 CYH~? 26.34 C3 P6G D1130 312 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 42.44 16.01 -37.83 43.08 16.69 -40.10 coo 18.48 7.50 15.98 21.17 6.92 15.38 44.04 10.92 -29.63 42.03 9.66 -31.09 coo 22.30 10.15 12.52 24.07 9.52 13.47 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 3 3 # 3 96 SER B 116 SER~? 25.27 C11 P6G D1130 272 CYH B 122 CYH~? 26.34 C3 P6G D1130 312 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 42.44 16.01 -37.83 43.08 16.69 -40.10 coo 18.48 7.50 15.98 21.17 6.92 15.38 44.04 10.92 -29.63 42.03 9.66 -31.09 coo 22.30 10.15 12.52 24.07 9.52 13.47 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 4 3 # 4 96 SER C 116 SER~? 17.33 C1 PG4 C1130 272 CYH C 122 CYH~? 12.47 C1 PG4 C1130 312 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo 18.48 7.50 15.98 21.17 6.92 15.38 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 22.30 10.15 12.52 24.07 9.52 13.47 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 5 3 # 5 96 SER C 116 SER~? 17.33 C1 PG4 C1130 272 CYH C 122 CYH~? 12.47 C1 PG4 C1130 312 GLU C 121 GLU~? 20.36 C1 PG4 C1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo 18.48 7.50 15.98 21.17 6.92 15.38 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 22.30 10.15 12.52 24.07 9.52 13.47 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 6 3 # 6 96 SER D 116 SER~? 16.17 C18 P6G D1130 272 CYH D 122 CYH~? 12.34 C18 P6G D1130 312 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 11.98 14.89 -30.11 9.63 14.31 -30.33 coo 18.48 7.50 15.98 21.17 6.92 15.38 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 22.30 10.15 12.52 24.07 9.52 13.47 14.39 19.77 -25.34 13.72 21.78 -25.43 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 7 3 # 7 96 SER D 116 SER~? 16.17 C18 P6G D1130 272 CYH D 122 CYH~? 12.34 C18 P6G D1130 312 GLU D 121 GLU~? 20.22 C18 P6G D1130 coo 27.57 5.78 14.13 25.30 6.31 13.99 11.98 14.89 -30.11 9.63 14.31 -30.33 coo 18.48 7.50 15.98 21.17 6.92 15.38 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 22.30 10.15 12.52 24.07 9.52 13.47 19.28 17.06 -26.24 19.68 17.98 -24.36 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 7 hits 1fnb_c00 naa= 3 ULMN 3 1fo6_c00 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 A 47 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 127 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 172 CYH B 122 CYH~? 26.34 C3 P6G D1130 coo 14.84 17.73 17.72 12.66 18.02 17.60 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 13.59 13.62 10.66 10.48 17.11 15.01 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 10.73 13.80 18.28 9.65 16.43 18.61 44.04 10.92 -29.63 42.03 9.66 -31.09 1fo6_c00 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c00 naa= 3 ULMN 3 1fo6_c01 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 B 47 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 127 LYS B 84 LYS~? 19.45 C18 P6G D1130 B 172 CYH B 122 CYH~? 26.34 C3 P6G D1130 coo -11.43 -15.11 20.71 -9.41 -15.34 21.12 40.84 14.63 -29.45 39.08 15.39 -28.50 coo -8.59 -13.62 12.98 -6.65 -15.32 18.82 34.20 9.92 -30.73 30.97 14.90 -30.33 coo -7.53 -11.08 20.68 -6.56 -13.38 22.13 44.04 10.92 -29.63 42.03 9.66 -31.09 1fo6_c01 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c01 naa= 3 ULMN 3 1fo6_c02 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 C 47 GLU B 121 GLU~? 26.56 C11 P6G D1130 C 127 LYS B 84 LYS~? 19.45 C18 P6G D1130 C 172 CYH B 122 CYH~? 26.34 C3 P6G D1130 coo -14.75 22.68 45.73 -12.65 22.97 45.86 40.84 14.63 -29.45 39.08 15.39 -28.50 coo -13.46 21.30 53.90 -10.36 22.98 48.58 34.20 9.92 -30.73 30.97 14.90 -30.33 coo -10.67 18.91 46.59 -9.50 21.20 45.39 44.04 10.92 -29.63 42.03 9.66 -31.09 1fo6_c02 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c02 naa= 3 ULMN 3 1fo6_c03 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 D 47 GLU B 121 GLU~? 26.56 C11 P6G D1130 D 127 LYS B 84 LYS~? 19.45 C18 P6G D1130 D 172 CYH B 122 CYH~? 26.34 C3 P6G D1130 coo 11.48 -9.38 54.24 9.40 -9.76 53.86 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 8.59 -5.45 60.90 6.67 -8.84 55.89 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 7.45 -5.79 52.90 6.67 -8.39 52.10 44.04 10.92 -29.63 42.03 9.66 -31.09 1fo6_c03 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c03 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 123 ARG~? 19.27 O1 P6G D1130 A 136 GLU A 121 GLU~? 21.00 O1 P6G D1130 A 246 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 13.94 29.84 106.80 11.67 30.40 108.79 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 9.52 31.97 115.23 8.45 33.74 114.72 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 11.92 33.82 109.35 10.10 33.50 110.39 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 123 ARG~? 30.75 C11 P6G D1130 A 136 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 246 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 13.94 29.84 106.80 11.67 30.40 108.79 48.86 12.42 -33.59 48.71 12.69 -36.66 coo 9.52 31.97 115.23 8.45 33.74 114.72 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 11.92 33.82 109.35 10.10 33.50 110.39 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 123 ARG~? 15.20 O1 PG4 C1130 A 136 GLU C 121 GLU~? 20.36 C1 PG4 C1130 A 246 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 13.94 29.84 106.80 11.67 30.40 108.79 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 9.52 31.97 115.23 8.45 33.74 114.72 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 11.92 33.82 109.35 10.10 33.50 110.39 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG D 123 ARG~? 17.23 O19 P6G D1130 A 136 GLU D 121 GLU~? 20.22 C18 P6G D1130 A 246 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 13.94 29.84 106.80 11.67 30.40 108.79 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 9.52 31.97 115.23 8.45 33.74 114.72 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 11.92 33.82 109.35 10.10 33.50 110.39 14.39 19.77 -25.34 13.72 21.78 -25.43 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 4 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 319 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 359 ARG A 77 ARG~? 12.69 C2 PG4 C1130 coo 14.41 12.40 16.42 12.92 13.74 15.71 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 12.25 13.04 23.85 11.56 15.02 23.93 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 10.89 14.95 28.28 12.39 12.53 29.31 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 319 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 359 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 14.41 12.40 16.42 12.92 13.74 15.71 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 12.25 13.04 23.85 11.56 15.02 23.93 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 10.89 14.95 28.28 12.39 12.53 29.31 28.29 14.60 -40.19 29.66 17.13 -41.31 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 2 hits 1fr8_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 88 GLU~? 23.13 C5 PG4 C1130 A 47 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 161 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 coo 29.81 8.06 73.13 30.21 10.11 72.95 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 37.29 15.56 67.90 37.37 13.79 70.08 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 47 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 161 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 29.81 8.06 73.13 30.21 10.11 72.95 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 37.29 15.56 67.90 37.37 13.79 70.08 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 47 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 161 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 29.81 8.06 73.13 30.21 10.11 72.95 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 37.29 15.56 67.90 37.37 13.79 70.08 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU C 52 GLU~? 9.38 O2 PG4 C1130 A 47 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 161 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 29.81 8.06 73.13 30.21 10.11 72.95 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 37.29 15.56 67.90 37.37 13.79 70.08 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 47 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 161 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 29.81 8.06 73.13 30.21 10.11 72.95 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 37.29 15.56 67.90 37.37 13.79 70.08 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU D 52 GLU~? 9.77 O16 P6G D1130 A 47 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 161 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 29.81 8.06 73.13 30.21 10.11 72.95 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 37.29 15.56 67.90 37.37 13.79 70.08 9.62 8.34 -47.74 8.38 5.93 -48.44 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 47 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 161 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 37.12 18.35 73.76 37.09 16.69 72.44 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 29.81 8.06 73.13 30.21 10.11 72.95 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 37.29 15.56 67.90 37.37 13.79 70.08 9.62 8.34 -47.74 8.38 5.93 -48.44 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 7 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 88 GLU~? 23.13 C5 PG4 C1130 B 47 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 161 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 coo 63.47 43.65 53.95 61.45 43.07 54.06 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 56.38 35.81 59.19 58.25 35.77 57.10 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 47 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 161 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 63.47 43.65 53.95 61.45 43.07 54.06 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 56.38 35.81 59.19 58.25 35.77 57.10 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 47 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 161 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 63.47 43.65 53.95 61.45 43.07 54.06 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 56.38 35.81 59.19 58.25 35.77 57.10 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU C 52 GLU~? 9.38 O2 PG4 C1130 B 47 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B 161 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 63.47 43.65 53.95 61.45 43.07 54.06 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 56.38 35.81 59.19 58.25 35.77 57.10 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU C 55 GLU~? 14.48 C8 PG4 C1130 B 47 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B 161 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 63.47 43.65 53.95 61.45 43.07 54.06 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 56.38 35.81 59.19 58.25 35.77 57.10 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU D 52 GLU~? 9.77 O16 P6G D1130 B 47 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 161 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 63.47 43.65 53.95 61.45 43.07 54.06 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 56.38 35.81 59.19 58.25 35.77 57.10 9.62 8.34 -47.74 8.38 5.93 -48.44 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU D 55 GLU~? 14.43 O7 P6G D1130 B 47 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 161 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 53.87 35.49 53.22 55.44 35.72 54.61 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 63.47 43.65 53.95 61.45 43.07 54.06 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 56.38 35.81 59.19 58.25 35.77 57.10 9.62 8.34 -47.74 8.38 5.93 -48.44 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 7 hits 1geq_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 298 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 329 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 12.42 6.10 23.27 9.95 1.57 20.16 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 329 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 12.42 6.10 23.27 9.95 1.57 20.16 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 329 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 12.42 6.10 23.27 9.95 1.57 20.16 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 329 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 12.42 6.10 23.27 9.95 1.57 20.16 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 329 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 2.59 0.29 25.55 4.65 0.18 25.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE C 54 PHE~? 9.47 C8 PG4 C1130 A 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 329 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 2.59 0.29 25.55 4.65 0.18 25.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE C 87 PHE~? 15.40 C1 PG4 C1130 A 298 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 329 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 12.42 6.10 23.27 9.95 1.57 20.16 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE D 54 PHE~? 9.38 C6 P6G D1130 A 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 2.59 0.29 25.55 4.65 0.18 25.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE D 87 PHE~? 15.25 C18 P6G D1130 A 298 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 329 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 2.59 0.29 25.55 4.65 0.18 25.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 12.42 6.10 23.27 9.95 1.57 20.16 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 2.59 0.29 25.55 4.65 0.18 25.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.42 6.10 23.27 9.95 1.57 20.16 14.51 2.78 -43.17 17.25 -1.27 -44.64 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 54 PHE~? 10.14 O5 PG4 C1130 B 298 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 329 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 329 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 329 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 329 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE C 48 PHE~? 7.58 C4 PG4 C1130 B 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 329 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE C 54 PHE~? 9.47 C8 PG4 C1130 B 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 329 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE C 87 PHE~? 15.40 C1 PG4 C1130 B 298 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 329 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE D 54 PHE~? 9.38 C6 P6G D1130 B 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE D 87 PHE~? 15.25 C18 P6G D1130 B 298 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 329 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 14.51 2.78 -43.17 17.25 -1.27 -44.64 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 54 PHE~? 10.14 O5 PG4 C1130 C 298 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 329 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 17.41 60.57 64.39 18.40 58.12 65.34 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 27.64 56.61 58.17 22.18 57.92 60.36 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 C 329 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 17.41 60.57 64.39 18.40 58.12 65.34 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.64 56.61 58.17 22.18 57.92 60.36 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 C 329 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 17.41 60.57 64.39 18.40 58.12 65.34 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.64 56.61 58.17 22.18 57.92 60.36 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 C 329 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 17.41 60.57 64.39 18.40 58.12 65.34 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.64 56.61 58.17 22.18 57.92 60.36 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE C 48 PHE~? 7.58 C4 PG4 C1130 C 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 329 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 17.41 60.57 64.39 18.40 58.12 65.34 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 24.10 66.43 63.33 24.18 64.30 63.40 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE C 54 PHE~? 9.47 C8 PG4 C1130 C 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 329 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 17.41 60.57 64.39 18.40 58.12 65.34 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 24.10 66.43 63.33 24.18 64.30 63.40 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE C 87 PHE~? 15.40 C1 PG4 C1130 C 298 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 329 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 17.41 60.57 64.39 18.40 58.12 65.34 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 27.64 56.61 58.17 22.18 57.92 60.36 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE D 54 PHE~? 9.38 C6 P6G D1130 C 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 17.41 60.57 64.39 18.40 58.12 65.34 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 24.10 66.43 63.33 24.18 64.30 63.40 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE D 87 PHE~? 15.25 C18 P6G D1130 C 298 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 329 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 17.41 60.57 64.39 18.40 58.12 65.34 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 24.10 66.43 63.33 24.18 64.30 63.40 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 27.64 56.61 58.17 22.18 57.92 60.36 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE D 98 PHE~? -3.66 C18 P6G D1130s C 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 17.41 60.57 64.39 18.40 58.12 65.34 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 24.10 66.43 63.33 24.18 64.30 63.40 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 27.64 56.61 58.17 22.18 57.92 60.36 14.51 2.78 -43.17 17.25 -1.27 -44.64 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 54 PHE~? 10.14 O5 PG4 C1130 D 298 ASP A 50 ASP~? 13.04 O5 PG4 C1130 D 329 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 35.44 53.35 83.81 35.65 54.53 81.28 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 36.89 44.91 74.55 37.33 48.94 79.01 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 D 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 D 329 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 35.44 53.35 83.81 35.65 54.53 81.28 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 36.89 44.91 74.55 37.33 48.94 79.01 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 D 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 D 329 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 35.44 53.35 83.81 35.65 54.53 81.28 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 36.89 44.91 74.55 37.33 48.94 79.01 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 48 PHE~? 8.11 O4 P6G D1130 D 298 ASP A 129 ASP.? 5.22 O1 P6G D1130 D 329 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 35.44 53.35 83.81 35.65 54.53 81.28 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 36.89 44.91 74.55 37.33 48.94 79.01 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE C 48 PHE~? 7.58 C4 PG4 C1130 D 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 329 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 35.44 53.35 83.81 35.65 54.53 81.28 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 29.72 46.46 83.60 30.79 47.36 81.99 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE C 54 PHE~? 9.47 C8 PG4 C1130 D 298 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 329 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 35.44 53.35 83.81 35.65 54.53 81.28 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 29.72 46.46 83.60 30.79 47.36 81.99 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE C 87 PHE~? 15.40 C1 PG4 C1130 D 298 ASP C 85 ASP~? 10.22 C6 PG4 C1130 D 329 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 35.44 53.35 83.81 35.65 54.53 81.28 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 36.89 44.91 74.55 37.33 48.94 79.01 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE D 54 PHE~? 9.38 C6 P6G D1130 D 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 35.44 53.35 83.81 35.65 54.53 81.28 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 29.72 46.46 83.60 30.79 47.36 81.99 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE D 87 PHE~? 15.25 C18 P6G D1130 D 298 ASP D 85 ASP~? 10.24 C11 P6G D1130 D 329 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 35.44 53.35 83.81 35.65 54.53 81.28 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 29.72 46.46 83.60 30.79 47.36 81.99 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 36.89 44.91 74.55 37.33 48.94 79.01 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE D 98 PHE~? -3.66 C18 P6G D1130s D 298 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 329 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 35.44 53.35 83.81 35.65 54.53 81.28 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 29.72 46.46 83.60 30.79 47.36 81.99 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 36.89 44.91 74.55 37.33 48.94 79.01 14.51 2.78 -43.17 17.25 -1.27 -44.64 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 10 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 78 SER~? 11.56 C6 PG4 C1130 A 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 168 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 32.37 52.40 49.35 31.32 53.88 47.74 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 29.69 55.04 42.83 31.98 53.56 43.49 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 26.96 50.99 47.03 31.03 48.83 44.33 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER A 78 SER~? 11.56 C6 PG4 C1130 A 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 168 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 32.37 52.40 49.35 31.32 53.88 47.74 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 29.69 55.04 42.83 31.98 53.56 43.49 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 26.96 50.99 47.03 31.03 48.83 44.33 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER B 78 SER~? 10.35 C3 P6G D1130 A 164 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 168 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 32.37 52.40 49.35 31.32 53.88 47.74 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 29.69 55.04 42.83 31.98 53.56 43.49 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 26.96 50.99 47.03 31.03 48.83 44.33 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 A 151 SER C 106 SER~? 13.31 O4 PG4 C1130 A 164 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 168 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 32.37 52.40 49.35 31.32 53.88 47.74 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 29.69 55.04 42.83 31.98 53.56 43.49 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 26.96 50.99 47.03 31.03 48.83 44.33 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 A 151 SER D 106 SER~? 11.54 O1 P6G D1130 A 164 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 168 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 32.37 52.40 49.35 31.32 53.88 47.74 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 29.69 55.04 42.83 31.98 53.56 43.49 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 26.96 50.99 47.03 31.03 48.83 44.33 9.63 4.64 -45.08 4.33 7.57 -43.39 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 5 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 78 SER~? 11.56 C6 PG4 C1130 B 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 168 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 13.08 50.93 56.67 13.12 48.99 55.27 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 11.52 46.03 51.32 10.06 47.90 52.76 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 15.72 50.86 51.22 10.77 52.35 51.39 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER A 78 SER~? 11.56 C6 PG4 C1130 B 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 168 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 13.08 50.93 56.67 13.12 48.99 55.27 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 11.52 46.03 51.32 10.06 47.90 52.76 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 15.72 50.86 51.22 10.77 52.35 51.39 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER B 78 SER~? 10.35 C3 P6G D1130 B 164 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 168 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 13.08 50.93 56.67 13.12 48.99 55.27 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 11.52 46.03 51.32 10.06 47.90 52.76 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 15.72 50.86 51.22 10.77 52.35 51.39 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 B 151 SER C 106 SER~? 13.31 O4 PG4 C1130 B 164 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 168 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 13.08 50.93 56.67 13.12 48.99 55.27 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 11.52 46.03 51.32 10.06 47.90 52.76 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 15.72 50.86 51.22 10.77 52.35 51.39 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 B 151 SER D 106 SER~? 11.54 O1 P6G D1130 B 164 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 168 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 13.08 50.93 56.67 13.12 48.99 55.27 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 11.52 46.03 51.32 10.06 47.90 52.76 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 15.72 50.86 51.22 10.77 52.35 51.39 9.63 4.64 -45.08 4.33 7.57 -43.39 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 5 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 78 SER~? 11.56 C6 PG4 C1130 C 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 168 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 11.22 34.38 82.32 11.07 36.29 83.78 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 8.83 39.27 87.38 7.60 37.43 85.69 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 12.98 34.46 88.14 8.11 32.96 87.14 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER A 78 SER~? 11.56 C6 PG4 C1130 C 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 168 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 11.22 34.38 82.32 11.07 36.29 83.78 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 8.83 39.27 87.38 7.60 37.43 85.69 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 12.98 34.46 88.14 8.11 32.96 87.14 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER B 78 SER~? 10.35 C3 P6G D1130 C 164 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 168 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 11.22 34.38 82.32 11.07 36.29 83.78 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 8.83 39.27 87.38 7.60 37.43 85.69 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 12.98 34.46 88.14 8.11 32.96 87.14 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 C 151 SER C 106 SER~? 13.31 O4 PG4 C1130 C 164 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 168 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 11.22 34.38 82.32 11.07 36.29 83.78 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 8.83 39.27 87.38 7.60 37.43 85.69 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 12.98 34.46 88.14 8.11 32.96 87.14 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 C 151 SER D 106 SER~? 11.54 O1 P6G D1130 C 164 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 168 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 11.22 34.38 82.32 11.07 36.29 83.78 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 8.83 39.27 87.38 7.60 37.43 85.69 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 12.98 34.46 88.14 8.11 32.96 87.14 9.63 4.64 -45.08 4.33 7.57 -43.39 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 5 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 78 SER~? 11.56 C6 PG4 C1130 D 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 168 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 29.15 32.90 92.57 27.86 31.44 94.02 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 25.49 30.28 98.59 27.88 31.73 98.26 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 23.46 34.31 94.02 27.08 36.46 97.29 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER A 78 SER~? 11.56 C6 PG4 C1130 D 164 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 168 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 29.15 32.90 92.57 27.86 31.44 94.02 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 25.49 30.28 98.59 27.88 31.73 98.26 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 23.46 34.31 94.02 27.08 36.46 97.29 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER B 78 SER~? 10.35 C3 P6G D1130 D 164 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 168 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 29.15 32.90 92.57 27.86 31.44 94.02 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 25.49 30.28 98.59 27.88 31.73 98.26 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 23.46 34.31 94.02 27.08 36.46 97.29 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 D 151 SER C 106 SER~? 13.31 O4 PG4 C1130 D 164 TYR C 51 TYR~? 9.35 C8 PG4 C1130 D 168 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 29.15 32.90 92.57 27.86 31.44 94.02 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 25.49 30.28 98.59 27.88 31.73 98.26 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 23.46 34.31 94.02 27.08 36.46 97.29 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 D 151 SER D 106 SER~? 11.54 O1 P6G D1130 D 164 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 168 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 29.15 32.90 92.57 27.86 31.44 94.02 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 25.49 30.28 98.59 27.88 31.73 98.26 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 23.46 34.31 94.02 27.08 36.46 97.29 9.63 4.64 -45.08 4.33 7.57 -43.39 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 5 hits 1gz6_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 327 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 339 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 85.81 57.99 116.01 86.03 55.86 115.89 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 82.23 40.35 159.87 85.09 40.67 161.01 28.29 14.60 -40.19 29.66 17.13 -41.31 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 327 GLU C 100 GLU~? 11.21 O1 PG4 C1130 A 339 ARG C 123 ARG~? 15.20 O1 PG4 C1130 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 327 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 339 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 82.23 40.35 159.87 85.09 40.67 161.01 28.29 14.60 -40.19 29.66 17.13 -41.31 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 327 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 339 ARG A 77 ARG~? 12.69 C2 PG4 C1130 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 4 hits 1hto_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 58 VAL~? 15.53 O5 PG4 C1130 A 200 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 226 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -7.71 2.31 -7.89 -8.41 0.27 -8.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 58 VAL~? 15.53 O5 PG4 C1130 A 200 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 226 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 19.13 38.05 1.41 19.72 38.80 -0.53 -7.71 2.31 -7.89 -8.41 0.27 -8.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 97 VAL~? 22.17 O1 P6G D1130 A 200 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 226 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.95 0.30 -28.20 2.12 2.47 -27.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 97 VAL~? 22.17 O1 P6G D1130 A 200 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 226 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 19.13 38.05 1.41 19.72 38.80 -0.53 1.95 0.30 -28.20 2.12 2.47 -27.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.04 15.06 -40.68 14.50 17.55 -45.86 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 58 VAL~? 15.70 O4 P6G D1130 A 200 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 226 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 19.13 38.05 1.41 19.72 38.80 -0.53 31.45 -0.31 -56.26 30.80 1.73 -55.79 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 97 VAL~? 23.09 C3 P6G D1130 A 200 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 226 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 19.13 38.05 1.41 19.72 38.80 -0.53 41.87 4.27 -36.65 42.08 2.06 -36.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL C 97 VAL~? 5.21 O1 PG4 C1130 A 200 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 226 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.28 -15.61 -25.73 -22.76 -16.83 -24.00 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 34.47 51.09 7.19 28.58 51.18 7.53 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL D 97 VAL~? -4.86 O19 P6G D1130s A 200 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 226 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 19.13 38.05 1.41 19.72 38.80 -0.53 16.42 19.33 -40.05 16.76 20.45 -41.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 31.42 9.18 -48.71 35.31 8.95 -53.15 1i29_c03 source 1i29 CSDB : 8 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 28 3 # 28 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 29 3 # 29 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 30 3 # 30 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 31 3 # 31 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 32 3 # 32 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 33 3 # 33 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 34 3 # 34 A 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 35 3 # 35 A 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 36 3 # 36 A 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 37 3 # 37 A 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 38 3 # 38 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 39 3 # 39 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 40 3 # 40 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 41 3 # 41 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 42 3 # 42 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 43 3 # 43 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 44 3 # 44 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 45 3 # 45 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 46 3 # 46 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 47 3 # 47 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 48 3 # 48 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 49 3 # 49 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 50 3 # 50 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 51 3 # 51 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 52 3 # 52 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 53 3 # 53 A 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 54 3 # 54 A 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 55 3 # 55 A 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 56 3 # 56 A 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 57 3 # 57 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 58 3 # 58 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 59 3 # 59 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 60 3 # 60 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 61 3 # 61 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 62 3 # 62 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 63 3 # 63 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 64 3 # 64 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 65 3 # 65 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 66 3 # 66 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 67 3 # 67 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 68 3 # 68 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 69 3 # 69 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 70 3 # 70 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 71 3 # 71 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 72 3 # 72 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 12.41 4.04 -29.37 12.28 4.39 -27.28 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 72 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 28 3 # 28 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU D 88 GLU~? 17.52 C12 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 27.48 12.16 -32.01 27.65 12.79 -30.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 29 3 # 29 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 30 3 # 30 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 31 3 # 31 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 32 3 # 32 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 33 3 # 33 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 34 3 # 34 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 35 3 # 35 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 36 3 # 36 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 37 3 # 37 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 38 3 # 38 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 39 3 # 39 B 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 40 3 # 40 B 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 41 3 # 41 B 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 42 3 # 42 B 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 43 3 # 43 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 44 3 # 44 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 45 3 # 45 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 46 3 # 46 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 47 3 # 47 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 48 3 # 48 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 49 3 # 49 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 50 3 # 50 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 51 3 # 51 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 52 3 # 52 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 53 3 # 53 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 54 3 # 54 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 55 3 # 55 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 56 3 # 56 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 57 3 # 57 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 58 3 # 58 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 59 3 # 59 B 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 60 3 # 60 B 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 61 3 # 61 B 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 62 3 # 62 B 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 63 3 # 63 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 64 3 # 64 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 65 3 # 65 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 66 3 # 66 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 67 3 # 67 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 68 3 # 68 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 69 3 # 69 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 70 3 # 70 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 71 3 # 71 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 72 3 # 72 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 73 3 # 73 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 74 3 # 74 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 75 3 # 75 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 76 3 # 76 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 77 3 # 77 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 78 3 # 78 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 79 3 # 79 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 80 3 # 80 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 81 3 # 81 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 82 3 # 82 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 12.41 4.04 -29.37 12.28 4.39 -27.28 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 82 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 85 ASP~? 19.32 C6 PG4 C1130 158 THR A 89 THR.? 25.53 O1 P6G D1130 317 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo -12.63 17.64 33.66 -10.65 17.90 34.40 4.55 4.63 -38.29 4.19 5.10 -40.34 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 1 hits 1inp_c02 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP D 107 ASP.? 14.84 O1 P6G D1130 A1134 ALA A 90 ALA.? 19.83 O1 P6G D1130 A1137 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo -27.05 34.58 17.12 -25.81 32.84 17.16 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -2.12 2.70 -37.07 -3.24 4.07 -38.22 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 1 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 204 GLU A 52 GLU~? 14.14 O5 PG4 C1130 A 279 TYR A 57 TYR~? 16.39 O5 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 7.79 1.83 27.81 9.08 3.25 26.92 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 8.22 7.77 18.64 7.58 8.47 21.28 -10.74 6.03 -7.67 -11.80 6.36 -5.11 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 204 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 279 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 7.79 1.83 27.81 9.08 3.25 26.92 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 8.22 7.77 18.64 7.58 8.47 21.28 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 204 GLU A 88 GLU~? 23.13 C5 PG4 C1130 A 279 TYR A 92 TYR~? 17.76 O1 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 7.79 1.83 27.81 9.08 3.25 26.92 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 coo 8.22 7.77 18.64 7.58 8.47 21.28 2.30 -1.46 -39.04 1.18 -2.64 -41.31 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 204 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 279 TYR B 57 TYR~? 16.24 O4 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 7.79 1.83 27.81 9.08 3.25 26.92 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 8.22 7.77 18.64 7.58 8.47 21.28 28.47 -3.97 -56.19 27.34 -4.39 -58.70 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 204 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 279 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 7.79 1.83 27.81 9.08 3.25 26.92 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 8.22 7.77 18.64 7.58 8.47 21.28 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 204 GLU B 88 GLU~? 21.68 O1 P6G D1130 A 279 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 7.79 1.83 27.81 9.08 3.25 26.92 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 8.22 7.77 18.64 7.58 8.47 21.28 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 7 3 # 7 A 202 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 204 GLU B 88 GLU~? 21.68 O1 P6G D1130 A 279 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 7.79 1.83 27.81 9.08 3.25 26.92 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 8.22 7.77 18.64 7.58 8.47 21.28 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 8 3 # 8 A 202 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 204 GLU C 52 GLU~? 9.38 O2 PG4 C1130 A 279 TYR C 57 TYR~? 15.97 O5 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 7.79 1.83 27.81 9.08 3.25 26.92 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 8.22 7.77 18.64 7.58 8.47 21.28 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 9 3 # 9 A 202 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 204 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 279 TYR A 51 TYR~? 11.49 O5 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 7.79 1.83 27.81 9.08 3.25 26.92 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 8.22 7.77 18.64 7.58 8.47 21.28 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 10 3 # 10 A 202 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 204 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 279 TYR C 118 TYR~? 14.79 C5 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 7.79 1.83 27.81 9.08 3.25 26.92 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 8.22 7.77 18.64 7.58 8.47 21.28 -21.30 -7.93 -33.87 -19.60 -5.89 -34.73 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 11 3 # 11 A 202 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 204 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 279 TYR A 118 TYR~? 23.63 C5 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 7.79 1.83 27.81 9.08 3.25 26.92 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 8.22 7.77 18.64 7.58 8.47 21.28 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 12 3 # 12 A 202 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 204 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 279 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 7.79 1.83 27.81 9.08 3.25 26.92 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 8.22 7.77 18.64 7.58 8.47 21.28 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 13 3 # 13 A 202 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 204 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 279 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 7.79 1.83 27.81 9.08 3.25 26.92 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 8.22 7.77 18.64 7.58 8.47 21.28 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 14 3 # 14 A 202 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 204 GLU D 52 GLU~? 9.77 O16 P6G D1130 A 279 TYR D 57 TYR~? 15.84 C9 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 7.79 1.83 27.81 9.08 3.25 26.92 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 8.22 7.77 18.64 7.58 8.47 21.28 9.96 9.67 -59.45 11.06 8.95 -61.91 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 15 3 # 15 A 202 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 204 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 279 TYR B 51 TYR~? 10.58 C3 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 7.79 1.83 27.81 9.08 3.25 26.92 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 8.22 7.77 18.64 7.58 8.47 21.28 29.55 2.80 -46.55 31.14 4.40 -48.22 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 16 3 # 16 A 202 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 204 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 279 TYR D 118 TYR~? 14.64 C18 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 7.79 1.83 27.81 9.08 3.25 26.92 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 8.22 7.77 18.64 7.58 8.47 21.28 19.04 13.52 -30.73 20.87 11.60 -29.89 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 17 3 # 17 A 202 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 204 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 279 TYR B 118 TYR~? 21.87 C11 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 7.79 1.83 27.81 9.08 3.25 26.92 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 8.22 7.77 18.64 7.58 8.47 21.28 37.69 14.21 -33.01 35.23 15.36 -32.38 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 18 3 # 18 A 202 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 204 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 279 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 7.79 1.83 27.81 9.08 3.25 26.92 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 8.22 7.77 18.64 7.58 8.47 21.28 24.24 21.35 -31.93 26.12 20.12 -30.25 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 19 3 # 19 A 202 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 204 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 279 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo 5.85 5.60 30.32 5.00 7.49 29.88 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 7.79 1.83 27.81 9.08 3.25 26.92 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 8.22 7.77 18.64 7.58 8.47 21.28 9.62 8.34 -47.74 8.38 5.93 -48.44 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 19 hits 1itx_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 A 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 A 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 A 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 A 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU A 44 GLU~? 13.07 O5 PG4 C1130 A 56 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU A 61 GLU~? 21.55 O5 PG4 C1130 A 56 LYS A 59 LYS~? 19.76 O5 PG4 C1130 A 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU A 66 GLU.? 16.09 O5 PG4 C1130 A 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 A 56 LYS B 32 LYS~? 26.29 C8 P6G D1130 A 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 38.45 -0.44 19.89 37.36 0.90 25.90 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 A 56 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 38.45 -0.44 19.89 37.36 0.90 25.90 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 A 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 A 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 38.45 -0.44 19.89 37.36 0.90 25.90 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 A 2 GLU B 61 GLU~? 21.58 O4 P6G D1130 A 56 LYS B 59 LYS~? 17.23 O4 P6G D1130 A 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 38.45 -0.44 19.89 37.36 0.90 25.90 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 A 2 GLU B 66 GLU.? 14.53 C15 P6G D1130 A 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 38.45 -0.44 19.89 37.36 0.90 25.90 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 A 2 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 56 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 258 ARG B 123 ARG~? 30.75 C11 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 38.45 -0.44 19.89 37.36 0.90 25.90 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 48.86 12.42 -33.59 48.71 12.69 -36.66 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 A 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 A 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 A 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 A 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 A 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 A 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 A 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 A 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 A 2 GLU C 61 GLU~? 21.06 O5 PG4 C1130 A 56 LYS C 59 LYS~? 18.46 C8 PG4 C1130 A 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 A 2 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 56 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 258 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 A 2 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 56 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 258 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 A 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 A 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 38.45 -0.44 19.89 37.36 0.90 25.90 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 A 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 A 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 38.45 -0.44 19.89 37.36 0.90 25.90 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 A 2 GLU D 61 GLU~? 21.02 C9 P6G D1130 A 56 LYS D 59 LYS~? 18.77 O7 P6G D1130 A 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 38.45 -0.44 19.89 37.36 0.90 25.90 3.27 6.90 -57.68 0.31 8.60 -52.41 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 A 2 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 56 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 258 ARG D 77 ARG~? 8.78 O1 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 38.45 -0.44 19.89 37.36 0.90 25.90 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 14.97 1.88 -38.30 12.52 1.24 -36.50 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 A 2 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 56 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 258 ARG D 77 ARG~? 8.78 O1 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 38.45 -0.44 19.89 37.36 0.90 25.90 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 14.97 1.88 -38.30 12.52 1.24 -36.50 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 23 3 # 23 A 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 38.45 -0.44 19.89 37.36 0.90 25.90 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 24 3 # 24 A 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 56 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 38.45 -0.44 19.89 37.36 0.90 25.90 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 25 3 # 25 A 2 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 42.33 1.56 26.99 42.38 2.91 28.66 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 38.45 -0.44 19.89 37.36 0.90 25.90 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 25 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 B 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 B 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 2.64 1.83 34.81 1.56 1.13 32.02 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 B 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 B 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 2.64 1.83 34.81 1.56 1.13 32.02 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU A 44 GLU~? 13.07 O5 PG4 C1130 B 56 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 2.64 1.83 34.81 1.56 1.13 32.02 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU A 61 GLU~? 21.55 O5 PG4 C1130 B 56 LYS A 59 LYS~? 19.76 O5 PG4 C1130 B 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 2.64 1.83 34.81 1.56 1.13 32.02 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU A 66 GLU.? 16.09 O5 PG4 C1130 B 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 2.64 1.83 34.81 1.56 1.13 32.02 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU A 121 GLU~? 21.00 O1 P6G D1130 B 56 LYS A 84 LYS~? 19.93 C5 PG4 C1130 B 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 B 56 LYS B 32 LYS~? 26.29 C8 P6G D1130 B 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 2.64 1.83 34.81 1.56 1.13 32.02 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 B 56 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 2.64 1.83 34.81 1.56 1.13 32.02 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 B 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 B 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 B 2 GLU B 61 GLU~? 21.58 O4 P6G D1130 B 56 LYS B 59 LYS~? 17.23 O4 P6G D1130 B 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 B 2 GLU B 66 GLU.? 14.53 C15 P6G D1130 B 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 B 2 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 56 LYS B 84 LYS~? 19.45 C18 P6G D1130 B 258 ARG B 123 ARG~? 30.75 C11 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 2.64 1.83 34.81 1.56 1.13 32.02 48.86 12.42 -33.59 48.71 12.69 -36.66 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 B 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 B 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 2.64 1.83 34.81 1.56 1.13 32.02 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 B 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 B 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 2.64 1.83 34.81 1.56 1.13 32.02 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 B 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 2.64 1.83 34.81 1.56 1.13 32.02 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 B 2 GLU C 61 GLU~? 21.06 O5 PG4 C1130 B 56 LYS C 59 LYS~? 18.46 C8 PG4 C1130 B 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo 2.64 1.83 34.81 1.56 1.13 32.02 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 B 2 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 56 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 258 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 2.64 1.83 34.81 1.56 1.13 32.02 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 B 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 B 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 B 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 B 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 B 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 2.64 1.83 34.81 1.56 1.13 32.02 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 B 2 GLU D 61 GLU~? 21.02 C9 P6G D1130 B 56 LYS D 59 LYS~? 18.77 O7 P6G D1130 B 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 3.27 6.90 -57.68 0.31 8.60 -52.41 coo 2.64 1.83 34.81 1.56 1.13 32.02 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 B 2 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 56 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 258 ARG D 77 ARG~? 8.78 O1 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 2.64 1.83 34.81 1.56 1.13 32.02 14.97 1.88 -38.30 12.52 1.24 -36.50 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 B 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 23 3 # 23 B 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 56 LYS D 113 LYS~? 21.47 O1 P6G D1130 B 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 24 3 # 24 B 2 GLU D 110 GLU~? 16.67 O1 P6G D1130 B 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 B 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 24 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 C 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 C 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 C 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 C 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU A 44 GLU~? 13.07 O5 PG4 C1130 C 56 LYS A 38 LYS~? 22.91 O5 PG4 C1130 C 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU A 61 GLU~? 21.55 O5 PG4 C1130 C 56 LYS A 59 LYS~? 19.76 O5 PG4 C1130 C 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU A 66 GLU.? 16.09 O5 PG4 C1130 C 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 C 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU A 121 GLU~? 21.00 O1 P6G D1130 C 56 LYS A 84 LYS~? 19.93 C5 PG4 C1130 C 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 C 56 LYS B 32 LYS~? 26.29 C8 P6G D1130 C 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 C 56 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 C 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 C 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 C 2 GLU B 61 GLU~? 21.58 O4 P6G D1130 C 56 LYS B 59 LYS~? 17.23 O4 P6G D1130 C 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 C 2 GLU B 66 GLU.? 14.53 C15 P6G D1130 C 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 C 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 C 2 GLU B 121 GLU~? 26.56 C11 P6G D1130 C 56 LYS B 84 LYS~? 19.45 C18 P6G D1130 C 258 ARG B 123 ARG~? 30.75 C11 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 48.86 12.42 -33.59 48.71 12.69 -36.66 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 C 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 C 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 C 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 C 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 C 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 C 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 C 2 GLU C 61 GLU~? 21.06 O5 PG4 C1130 C 56 LYS C 59 LYS~? 18.46 C8 PG4 C1130 C 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 C 2 GLU C 82 GLU~? -3.24 C6 PG4 C1130s C 56 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 258 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 C 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 C 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 C 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 C 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 C 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 C 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 C 2 GLU D 61 GLU~? 21.02 C9 P6G D1130 C 56 LYS D 59 LYS~? 18.77 O7 P6G D1130 C 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 3.27 6.90 -57.68 0.31 8.60 -52.41 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 C 2 GLU D 82 GLU~? -3.29 C11 P6G D1130s C 56 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 258 ARG D 77 ARG~? 8.78 O1 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 14.97 1.88 -38.30 12.52 1.24 -36.50 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 C 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 C 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 23 3 # 23 C 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 56 LYS D 113 LYS~? 21.47 O1 P6G D1130 C 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 24 3 # 24 C 2 GLU D 110 GLU~? 16.67 O1 P6G D1130 C 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 C 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 24 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 D 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 D 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 37 GLU~? 22.40 O5 PG4 C1130 D 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 D 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU A 44 GLU~? 13.07 O5 PG4 C1130 D 56 LYS A 38 LYS~? 22.91 O5 PG4 C1130 D 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU A 61 GLU~? 21.55 O5 PG4 C1130 D 56 LYS A 59 LYS~? 19.76 O5 PG4 C1130 D 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU A 66 GLU.? 16.09 O5 PG4 C1130 D 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 D 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU A 121 GLU~? 21.00 O1 P6G D1130 D 56 LYS A 84 LYS~? 19.93 C5 PG4 C1130 D 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 2.80 -10.41 -36.92 3.82 -11.51 -38.44 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 D 56 LYS B 32 LYS~? 26.29 C8 P6G D1130 D 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 D 56 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU B 37 GLU~? 22.87 C6 P6G D1130 D 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 D 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 D 2 GLU B 61 GLU~? 21.58 O4 P6G D1130 D 56 LYS B 59 LYS~? 17.23 O4 P6G D1130 D 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 D 2 GLU B 66 GLU.? 14.53 C15 P6G D1130 D 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 D 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 D 2 GLU B 121 GLU~? 26.56 C11 P6G D1130 D 56 LYS B 84 LYS~? 19.45 C18 P6G D1130 D 258 ARG B 123 ARG~? 30.75 C11 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 48.86 12.42 -33.59 48.71 12.69 -36.66 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 D 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 D 56 LYS A 32 LYS~? 25.27 O5 PG4 C1130 D 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -14.45 0.07 7.16 -16.37 -4.18 8.40 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 D 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 D 56 LYS C 32 LYS~? 27.65 O5 PG4 C1130 D 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 D 2 GLU C 37 GLU~? 22.29 O5 PG4 C1130 D 56 LYS C 41 LYS~? 13.38 C3 PG4 C1130 D 258 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 D 2 GLU C 61 GLU~? 21.06 O5 PG4 C1130 D 56 LYS C 59 LYS~? 18.46 C8 PG4 C1130 D 258 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 D 2 GLU C 82 GLU~? -3.24 C6 PG4 C1130s D 56 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 258 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 18 3 # 18 D 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 D 56 LYS D 32 LYS~? 27.03 C6 P6G D1130 D 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 19 3 # 19 D 2 GLU D 37 GLU~? 22.00 C9 P6G D1130 D 56 LYS D 41 LYS~? 14.07 C15 P6G D1130 D 258 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 20 3 # 20 D 2 GLU D 61 GLU~? 21.02 C9 P6G D1130 D 56 LYS D 59 LYS~? 18.77 O7 P6G D1130 D 258 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 7.67 8.26 -62.85 7.30 9.08 -64.79 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 3.27 6.90 -57.68 0.31 8.60 -52.41 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 10.98 -2.55 -67.37 13.68 -3.80 -66.48 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 21 3 # 21 D 2 GLU D 82 GLU~? -3.29 C11 P6G D1130s D 56 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 258 ARG D 77 ARG~? 8.78 O1 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 14.97 1.88 -38.30 12.52 1.24 -36.50 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 22 3 # 22 D 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 D 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 D 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 23 3 # 23 D 2 GLU D 109 GLU~? 20.19 O1 P6G D1130 D 56 LYS D 113 LYS~? 21.47 O1 P6G D1130 D 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 24 3 # 24 D 2 GLU D 110 GLU~? 16.67 O1 P6G D1130 D 56 LYS D 112 LYS~? 16.61 O1 P6G D1130 D 258 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 24 hits 1k82_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 19.46 3.44 61.93 23.95 1.12 60.13 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 19.46 3.44 61.93 23.95 1.12 60.13 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.46 3.44 61.93 23.95 1.12 60.13 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.46 3.44 61.93 23.95 1.12 60.13 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.46 3.44 61.93 23.95 1.12 60.13 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU D 88 GLU~? 17.52 C12 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 27.48 12.16 -32.01 27.65 12.79 -30.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU D 88 GLU~? 17.52 C12 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 27.48 12.16 -32.01 27.65 12.79 -30.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 38 3 # 38 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 39 3 # 39 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.46 3.44 61.93 23.95 1.12 60.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 40 3 # 40 A 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 19.46 3.44 61.93 23.95 1.12 60.13 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 41 3 # 41 A 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 19.46 3.44 61.93 23.95 1.12 60.13 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 42 3 # 42 A 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 43 3 # 43 A 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 44 3 # 44 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 45 3 # 45 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 46 3 # 46 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 47 3 # 47 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 48 3 # 48 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 49 3 # 49 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 50 3 # 50 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 51 3 # 51 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 52 3 # 52 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 53 3 # 53 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 54 3 # 54 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 55 3 # 55 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 56 3 # 56 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 57 3 # 57 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 58 3 # 58 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 59 3 # 59 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 60 3 # 60 A 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 61 3 # 61 A 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 19.46 3.44 61.93 23.95 1.12 60.13 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 62 3 # 62 A 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 63 3 # 63 A 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 64 3 # 64 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 65 3 # 65 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 66 3 # 66 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 67 3 # 67 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 68 3 # 68 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 69 3 # 69 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 70 3 # 70 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 71 3 # 71 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 72 3 # 72 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.46 3.44 61.93 23.95 1.12 60.13 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 73 3 # 73 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 74 3 # 74 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 75 3 # 75 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 76 3 # 76 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 77 3 # 77 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 78 3 # 78 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 79 3 # 79 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 80 3 # 80 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 81 3 # 81 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 24.97 5.82 58.78 26.79 1.97 55.46 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 12.41 4.04 -29.37 12.28 4.39 -27.28 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 81 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 10.43 2.88 20.75 5.72 0.41 23.95 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 10.43 2.88 20.75 5.72 0.41 23.95 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 10.43 2.88 20.75 5.72 0.41 23.95 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 10.43 2.88 20.75 5.72 0.41 23.95 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 10.43 2.88 20.75 5.72 0.41 23.95 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 10.43 2.88 20.75 5.72 0.41 23.95 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 B 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 38 3 # 38 B 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 39 3 # 39 B 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 40 3 # 40 B 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 41 3 # 41 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 42 3 # 42 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 43 3 # 43 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 44 3 # 44 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 45 3 # 45 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 46 3 # 46 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 47 3 # 47 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 48 3 # 48 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 49 3 # 49 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 50 3 # 50 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.43 2.88 20.75 5.72 0.41 23.95 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 51 3 # 51 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.43 2.88 20.75 5.72 0.41 23.95 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 52 3 # 52 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 10.43 2.88 20.75 5.72 0.41 23.95 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 53 3 # 53 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 54 3 # 54 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 55 3 # 55 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 56 3 # 56 B 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 57 3 # 57 B 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 10.43 2.88 20.75 5.72 0.41 23.95 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 58 3 # 58 B 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 59 3 # 59 B 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 60 3 # 60 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 61 3 # 61 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 62 3 # 62 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 63 3 # 63 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 64 3 # 64 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 65 3 # 65 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 66 3 # 66 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 67 3 # 67 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 68 3 # 68 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.43 2.88 20.75 5.72 0.41 23.95 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 69 3 # 69 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 70 3 # 70 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 71 3 # 71 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 72 3 # 72 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 73 3 # 73 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 74 3 # 74 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 75 3 # 75 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 76 3 # 76 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 4.84 5.09 23.75 3.30 1.39 27.48 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 12.41 4.04 -29.37 12.28 4.39 -27.28 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 76 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 C 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 C 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 12.06 27.10 15.56 13.23 27.02 13.80 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 C 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 C 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 12.29 34.52 28.11 16.84 32.47 25.43 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 C 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 C 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 12.29 34.52 28.11 16.84 32.47 25.43 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 12.06 27.10 15.56 13.23 27.02 13.80 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 C 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 12.06 27.10 15.56 13.23 27.02 13.80 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 C 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 C 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 12.06 27.10 15.56 13.23 27.02 13.80 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 C 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 C 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 12.29 34.52 28.11 16.84 32.47 25.43 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 C 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 C 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 12.29 34.52 28.11 16.84 32.47 25.43 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 C 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 C 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 C 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 12.29 34.52 28.11 16.84 32.47 25.43 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 C 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 C 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 C 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.06 27.10 15.56 13.23 27.02 13.80 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 C 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.06 27.10 15.56 13.23 27.02 13.80 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 C 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.06 27.10 15.56 13.23 27.02 13.80 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 C 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 C 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 C 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 C 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 C 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 C 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 C 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 C 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 C 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 12.29 34.52 28.11 16.84 32.47 25.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 C 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 C 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 C 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 12.29 34.52 28.11 16.84 32.47 25.43 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 12.06 27.10 15.56 13.23 27.02 13.80 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 C 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 C 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 C 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 12.29 34.52 28.11 16.84 32.47 25.43 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 12.06 27.10 15.56 13.23 27.02 13.80 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 38 3 # 38 C 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 C 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 C 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 12.06 27.10 15.56 13.23 27.02 13.80 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 39 3 # 39 C 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 C 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 C 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 12.06 27.10 15.56 13.23 27.02 13.80 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 40 3 # 40 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.06 27.10 15.56 13.23 27.02 13.80 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 41 3 # 41 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.06 27.10 15.56 13.23 27.02 13.80 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 42 3 # 42 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 43 3 # 43 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.06 27.10 15.56 13.23 27.02 13.80 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 44 3 # 44 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 45 3 # 45 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 46 3 # 46 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 47 3 # 47 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 48 3 # 48 C 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.29 34.52 28.11 16.84 32.47 25.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 49 3 # 49 C 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.29 34.52 28.11 16.84 32.47 25.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 50 3 # 50 C 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.29 34.52 28.11 16.84 32.47 25.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 51 3 # 51 C 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 12.29 34.52 28.11 16.84 32.47 25.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 52 3 # 52 C 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 53 3 # 53 C 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 54 3 # 54 C 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s C 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 12.06 27.10 15.56 13.23 27.02 13.80 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 55 3 # 55 C 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 C 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 C 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 12.06 27.10 15.56 13.23 27.02 13.80 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 56 3 # 56 C 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 C 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 C 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 12.29 34.52 28.11 16.84 32.47 25.43 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 57 3 # 57 C 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 C 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 C 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 12.06 27.10 15.56 13.23 27.02 13.80 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 58 3 # 58 C 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 C 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 C 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 12.29 34.52 28.11 16.84 32.47 25.43 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 59 3 # 59 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.06 27.10 15.56 13.23 27.02 13.80 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 60 3 # 60 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 61 3 # 61 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.06 27.10 15.56 13.23 27.02 13.80 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 62 3 # 62 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.06 27.10 15.56 13.23 27.02 13.80 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 63 3 # 63 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.06 27.10 15.56 13.23 27.02 13.80 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 64 3 # 64 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.06 27.10 15.56 13.23 27.02 13.80 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 65 3 # 65 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 66 3 # 66 C 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.29 34.52 28.11 16.84 32.47 25.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.06 27.10 15.56 13.23 27.02 13.80 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 67 3 # 67 C 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 68 3 # 68 C 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 69 3 # 69 C 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 70 3 # 70 C 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 71 3 # 71 C 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 72 3 # 72 C 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 73 3 # 73 C 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 74 3 # 74 C 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s C 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 17.59 37.25 25.80 19.64 34.15 21.60 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 12.29 34.52 28.11 16.84 32.47 25.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 12.06 27.10 15.56 13.23 27.02 13.80 12.41 4.04 -29.37 12.28 4.39 -27.28 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 74 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 D 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 D 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 D 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 D 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 D 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 D 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 D 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 D 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 D 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 D 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 D 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 D 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 D 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 D 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 D 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 D 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 D 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 D 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 D 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 D 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 D 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 D 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 D 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 D 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 D 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 D 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 D 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 D 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 D 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 D 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 D 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 D 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 D 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 D 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 D 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 D 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 38 3 # 38 D 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 D 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 D 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 39 3 # 39 D 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 D 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 D 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 40 3 # 40 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 41 3 # 41 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 42 3 # 42 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 43 3 # 43 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 44 3 # 44 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 45 3 # 45 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 46 3 # 46 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 47 3 # 47 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 48 3 # 48 D 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 49 3 # 49 D 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 50 3 # 50 D 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 51 3 # 51 D 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 52 3 # 52 D 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 53 3 # 53 D 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 54 3 # 54 D 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s D 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 55 3 # 55 D 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 D 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 D 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 56 3 # 56 D 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 D 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 D 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 57 3 # 57 D 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 D 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 D 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 58 3 # 58 D 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 D 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 D 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 59 3 # 59 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 60 3 # 60 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 61 3 # 61 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 62 3 # 62 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 63 3 # 63 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 64 3 # 64 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 65 3 # 65 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 66 3 # 66 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 67 3 # 67 D 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 68 3 # 68 D 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 69 3 # 69 D 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 70 3 # 70 D 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 71 3 # 71 D 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 72 3 # 72 D 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 73 3 # 73 D 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 74 3 # 74 D 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 75 3 # 75 D 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s D 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 12.41 4.04 -29.37 12.28 4.39 -27.28 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 75 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 129 ASP.? 5.22 O1 P6G D1130 262 LYS D 74 LYS~? -4.32 C2 P6G D1130s 336 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 61.88 50.78 12.96 63.84 50.60 13.71 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 63.59 44.40 18.32 63.20 49.74 17.95 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 72.60 57.42 15.86 71.61 56.68 18.70 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP C 85 ASP~? 10.22 C6 PG4 C1130 262 LYS A 74 LYS~? 4.39 C4 PG4 C1130 336 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo 61.88 50.78 12.96 63.84 50.60 13.71 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 63.59 44.40 18.32 63.20 49.74 17.95 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 72.60 57.42 15.86 71.61 56.68 18.70 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP C 85 ASP~? 10.22 C6 PG4 C1130 262 LYS A 75 LYS~? 13.44 O5 PG4 C1130 336 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo 61.88 50.78 12.96 63.84 50.60 13.71 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 63.59 44.40 18.32 63.20 49.74 17.95 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 72.60 57.42 15.86 71.61 56.68 18.70 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP D 107 ASP.? 14.84 O1 P6G D1130 262 LYS D 72 LYS~? 14.11 O7 P6G D1130 336 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 61.88 50.78 12.96 63.84 50.60 13.71 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 63.59 44.40 18.32 63.20 49.74 17.95 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 72.60 57.42 15.86 71.61 56.68 18.70 9.14 -6.20 -31.52 9.40 -6.54 -28.47 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP D 107 ASP.? 14.84 O1 P6G D1130 262 LYS D 112 LYS~? 16.61 O1 P6G D1130 336 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 61.88 50.78 12.96 63.84 50.60 13.71 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 63.59 44.40 18.32 63.20 49.74 17.95 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 72.60 57.42 15.86 71.61 56.68 18.70 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 5 hits 1lam_c00 naa= 3 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 1 3 # 1 198 CYH A 122 CYH~? 19.70 O1 P6G D1130 229 ASN D 108 ASN~? 12.52 O1 P6G D1130 232 SER D 106 SER~? 11.54 O1 P6G D1130 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 8.90 3.92 -35.18 9.80 2.60 -33.76 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 8.27 7.70 -38.86 9.17 6.34 -37.11 1lcb_c00 source 1lcb THYMIDYLATE SYNTHASE : 1 hits 1lcb_c00 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU A 88 GLU~? 23.13 C5 PG4 C1130 198 CYH A 122 CYH~? 19.70 O1 P6G D1130 229 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 60 GLU A 94 GLU~? 22.82 O1 P6G D1130 198 CYH A 122 CYH~? 19.70 O1 P6G D1130 229 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 3 3 # 3 60 GLU B 88 GLU~? 21.68 O1 P6G D1130 198 CYH B 122 CYH~? 26.34 C3 P6G D1130 229 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 44.04 10.92 -29.63 42.03 9.66 -31.09 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 4 3 # 4 60 GLU C 88 GLU~? 16.97 C5 PG4 C1130 198 CYH C 122 CYH~? 12.47 C1 PG4 C1130 229 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 5 3 # 5 60 GLU D 88 GLU~? 17.52 C12 P6G D1130 198 CYH D 122 CYH~? 12.34 C18 P6G D1130 229 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 6 3 # 6 60 GLU D 109 GLU~? 20.19 O1 P6G D1130 198 CYH A 122 CYH~? 19.70 O1 P6G D1130 229 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -2.12 2.70 -37.07 -3.24 4.07 -38.22 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 6 hits 1lcb_c02 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 81 ALA~? 14.49 C6 PG4 C1130 A 317 GLY A 83 GLY~? 20.43 C6 PG4 C1130 A 318 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 127 ALA.? 9.98 O1 P6G D1130 A 317 GLY A 128 GLY.? 6.90 O1 P6G D1130 A 318 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 12.96 -1.11 -42.18 13.03 -1.90 -41.92 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 81 ALA~? 14.45 C11 P6G D1130 A 317 GLY B 83 GLY~? 19.46 C3 P6G D1130 A 318 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 35.61 7.43 -33.25 34.89 7.70 -32.90 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA C 81 ALA~? 7.50 C6 PG4 C1130 A 317 GLY C 83 GLY~? 8.16 C1 PG4 C1130 A 318 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 127 ALA~? 21.60 O1 PG4 C1130 A 317 GLY C 128 GLY.? 23.20 O1 PG4 C1130 A 318 ASP C 129 ASP.? 25.37 C1 PG4 C1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -21.48 -22.98 -39.56 -22.74 -22.35 -40.13 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -18.12 -22.67 -41.34 -18.70 -22.15 -41.48 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA D 81 ALA~? 6.42 O1 P6G D1130 A 317 GLY D 83 GLY~? 7.98 C18 P6G D1130 A 318 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 21.39 8.12 -37.80 21.60 6.90 -38.67 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 21.02 13.56 -37.58 21.63 12.97 -37.48 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1lij_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA D 127 ALA~? 21.80 O19 P6G D1130 A 317 GLY D 128 GLY.? 23.24 O19 P6G D1130 A 318 ASP D 129 ASP.? 22.88 C18 P6G D1130 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 19.87 29.05 -27.32 18.84 28.51 -26.37 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 23.42 29.13 -25.94 22.84 28.44 -25.92 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 23.03 25.83 -22.84 23.72 24.15 -23.95 1lij_c01 source 1lij ADENOSINE KINASE : 7 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 81 ALA~? 14.49 C6 PG4 C1130 A 317 GLY A 83 GLY~? 20.43 C6 PG4 C1130 A 318 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 27.87 23.16 38.17 28.43 22.97 38.87 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 32.11 22.71 40.58 33.42 24.22 39.78 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 127 ALA.? 9.98 O1 P6G D1130 A 317 GLY A 128 GLY.? 6.90 O1 P6G D1130 A 318 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo 27.87 23.16 38.17 28.43 22.97 38.87 12.96 -1.11 -42.18 13.03 -1.90 -41.92 coo 32.11 22.71 40.58 33.42 24.22 39.78 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 81 ALA~? 14.45 C11 P6G D1130 A 317 GLY B 83 GLY~? 19.46 C3 P6G D1130 A 318 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 27.87 23.16 38.17 28.43 22.97 38.87 35.61 7.43 -33.25 34.89 7.70 -32.90 coo 32.11 22.71 40.58 33.42 24.22 39.78 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA C 81 ALA~? 7.50 C6 PG4 C1130 A 317 GLY C 83 GLY~? 8.16 C1 PG4 C1130 A 318 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo 27.87 23.16 38.17 28.43 22.97 38.87 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo 32.11 22.71 40.58 33.42 24.22 39.78 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA C 127 ALA~? 21.60 O1 PG4 C1130 A 317 GLY C 128 GLY.? 23.20 O1 PG4 C1130 A 318 ASP C 129 ASP.? 25.37 C1 PG4 C1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 -21.48 -22.98 -39.56 -22.74 -22.35 -40.13 coo 27.87 23.16 38.17 28.43 22.97 38.87 -18.12 -22.67 -41.34 -18.70 -22.15 -41.48 coo 32.11 22.71 40.58 33.42 24.22 39.78 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA D 81 ALA~? 6.42 O1 P6G D1130 A 317 GLY D 83 GLY~? 7.98 C18 P6G D1130 A 318 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 21.39 8.12 -37.80 21.60 6.90 -38.67 coo 27.87 23.16 38.17 28.43 22.97 38.87 21.02 13.56 -37.58 21.63 12.97 -37.48 coo 32.11 22.71 40.58 33.42 24.22 39.78 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1lio_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA D 127 ALA~? 21.80 O19 P6G D1130 A 317 GLY D 128 GLY.? 23.24 O19 P6G D1130 A 318 ASP D 129 ASP.? 22.88 C18 P6G D1130 coo 27.04 23.54 41.85 25.72 24.19 42.18 19.87 29.05 -27.32 18.84 28.51 -26.37 coo 27.87 23.16 38.17 28.43 22.97 38.87 23.42 29.13 -25.94 22.84 28.44 -25.92 coo 32.11 22.71 40.58 33.42 24.22 39.78 23.03 25.83 -22.84 23.72 24.15 -23.95 1lio_c01 source 1lio ADENOSINE KINASE : 7 hits 1lio_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 295 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 369 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 16.11 33.72 80.99 14.10 33.54 81.63 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 295 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 369 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 16.11 33.72 80.99 14.10 33.54 81.63 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 295 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 369 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 16.11 33.72 80.99 14.10 33.54 81.63 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 295 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 369 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 295 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 369 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 16.11 33.72 80.99 14.10 33.54 81.63 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 295 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 369 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 16.11 33.72 80.99 14.10 33.54 81.63 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 295 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 369 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.47 6.05 -29.78 29.50 6.72 -30.15 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 7 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 265 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 369 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 265 GLU D 66 GLU.? 17.04 C6 P6G D1130 A 369 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.50 -6.01 -56.32 9.81 -7.18 -55.76 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 265 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 369 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 265 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 369 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 265 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 369 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 265 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 369 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 265 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 369 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 265 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 369 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 265 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 369 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 31.47 6.05 -29.78 29.50 6.72 -30.15 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 9 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 279 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 369 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 16.54 46.37 63.94 14.77 45.79 62.95 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 279 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 369 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 16.54 46.37 63.94 14.77 45.79 62.95 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 279 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 369 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 279 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 369 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 279 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 369 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 279 GLU A 69 GLU~? 16.61 C4 PG4 C1130 A 369 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 16.54 46.37 63.94 14.77 45.79 62.95 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 6 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 123 ARG~? 19.27 O1 P6G D1130 229 SER A 116 SER~? 25.66 C6 PG4 C1130 325 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 2.54 15.84 18.57 3.24 17.85 16.30 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 10.17 13.48 15.92 9.61 15.76 15.27 3.16 -11.28 -28.49 3.95 -12.20 -26.36 coo 5.42 13.04 19.75 5.74 13.81 17.79 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 123 ARG~? 30.75 C11 P6G D1130 229 SER B 116 SER~? 25.27 C11 P6G D1130 325 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 2.54 15.84 18.57 3.24 17.85 16.30 48.86 12.42 -33.59 48.71 12.69 -36.66 coo 10.17 13.48 15.92 9.61 15.76 15.27 42.44 16.01 -37.83 43.08 16.69 -40.10 coo 5.42 13.04 19.75 5.74 13.81 17.79 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG C 123 ARG~? 15.20 O1 PG4 C1130 229 SER C 116 SER~? 17.33 C1 PG4 C1130 325 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 2.54 15.84 18.57 3.24 17.85 16.30 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 10.17 13.48 15.92 9.61 15.76 15.27 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo 5.42 13.04 19.75 5.74 13.81 17.79 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 3 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 38 LYS~? 22.91 O5 PG4 C1130 166 LYS A 41 LYS~? 15.70 O5 PG4 C1130 324 SER A 106 SER~? 15.55 C4 PG4 C1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 27.27 1.43 25.09 29.18 5.25 22.89 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 46.32 14.55 19.93 45.95 12.72 21.27 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 41 LYS~? 15.70 O5 PG4 C1130 166 LYS A 38 LYS~? 22.91 O5 PG4 C1130 324 SER A 78 SER~? 11.56 C6 PG4 C1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 27.27 1.43 25.09 29.18 5.25 22.89 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 46.32 14.55 19.93 45.95 12.72 21.27 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 41 LYS~? 15.70 O5 PG4 C1130 166 LYS A 38 LYS~? 22.91 O5 PG4 C1130 324 SER A 106 SER~? 15.55 C4 PG4 C1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 27.27 1.43 25.09 29.18 5.25 22.89 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 46.32 14.55 19.93 45.95 12.72 21.27 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 38 LYS~? 23.39 O4 P6G D1130 166 LYS B 41 LYS~? 19.06 O4 P6G D1130 324 SER B 106 SER~? 15.38 C14 P6G D1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 27.27 1.43 25.09 29.18 5.25 22.89 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 46.32 14.55 19.93 45.95 12.72 21.27 36.13 12.10 -48.03 34.30 13.65 -47.56 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS B 41 LYS~? 19.06 O4 P6G D1130 166 LYS B 38 LYS~? 23.39 O4 P6G D1130 324 SER B 78 SER~? 10.35 C3 P6G D1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 27.27 1.43 25.09 29.18 5.25 22.89 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 29.57 8.47 -39.24 28.68 6.25 -39.24 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS B 41 LYS~? 19.06 O4 P6G D1130 166 LYS B 38 LYS~? 23.39 O4 P6G D1130 324 SER B 106 SER~? 15.38 C14 P6G D1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 27.27 1.43 25.09 29.18 5.25 22.89 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 46.32 14.55 19.93 45.95 12.72 21.27 36.13 12.10 -48.03 34.30 13.65 -47.56 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS B 74 LYS~? 4.23 C14 P6G D1130 166 LYS B 72 LYS~? 17.42 C8 P6G D1130 324 SER D 106 SER~? 11.54 O1 P6G D1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 46.32 14.55 19.93 45.95 12.72 21.27 8.27 7.70 -38.86 9.17 6.34 -37.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 75 LYS~? 10.18 C3 P6G D1130 166 LYS B 72 LYS~? 17.42 C8 P6G D1130 324 SER D 106 SER~? 11.54 O1 P6G D1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 46.32 14.55 19.93 45.95 12.72 21.27 8.27 7.70 -38.86 9.17 6.34 -37.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS C 41 LYS~? 13.38 C3 PG4 C1130 166 LYS C 38 LYS~? 22.42 O5 PG4 C1130 324 SER C 106 SER~? 13.31 O4 PG4 C1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 27.27 1.43 25.09 29.18 5.25 22.89 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 46.32 14.55 19.93 45.95 12.72 21.27 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS D 41 LYS~? 14.07 C15 P6G D1130 166 LYS D 38 LYS~? 22.21 C6 P6G D1130 324 SER D 106 SER~? 11.54 O1 P6G D1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 27.27 1.43 25.09 29.18 5.25 22.89 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 46.32 14.55 19.93 45.95 12.72 21.27 8.27 7.70 -38.86 9.17 6.34 -37.11 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS D 72 LYS~? 14.11 O7 P6G D1130 166 LYS D 74 LYS~? -4.32 C2 P6G D1130s 324 SER A 116 SER~? 25.66 C6 PG4 C1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 27.27 1.43 25.09 29.18 5.25 22.89 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 46.32 14.55 19.93 45.95 12.72 21.27 3.16 -11.28 -28.49 3.95 -12.20 -26.36 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS D 74 LYS~? -4.32 C2 P6G D1130s 166 LYS D 72 LYS~? 14.11 O7 P6G D1130 324 SER A 116 SER~? 25.66 C6 PG4 C1130 coo 25.93 8.11 25.51 26.40 7.80 19.66 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 27.27 1.43 25.09 29.18 5.25 22.89 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 46.32 14.55 19.93 45.95 12.72 21.27 3.16 -11.28 -28.49 3.95 -12.20 -26.36 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 12 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY D 93 GLY~? 11.29 O19 P6G D1130 A 501 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 367 TYR D 57 TYR~? 15.84 C9 P6G D1130 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 21.50 23.72 -36.70 21.81 22.93 -36.81 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 9.96 9.67 -59.45 11.06 8.95 -61.91 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 1 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY D 93 GLY~? 11.29 O19 P6G D1130 D 501 ASP B 85 ASP~? 16.97 O1 P6G D1130 E 367 TYR D 57 TYR~? 15.84 C9 P6G D1130 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 21.50 23.72 -36.70 21.81 22.93 -36.81 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 9.96 9.67 -59.45 11.06 8.95 -61.91 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 1 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 55 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 84 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 11.09 42.89 24.44 11.32 42.06 22.49 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 4.60 40.33 20.42 7.25 39.50 20.05 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 9.71 44.83 15.47 10.13 41.43 19.93 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 55 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 84 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 11.09 42.89 24.44 11.32 42.06 22.49 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 4.60 40.33 20.42 7.25 39.50 20.05 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 9.71 44.83 15.47 10.13 41.43 19.93 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 55 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 84 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 11.09 42.89 24.44 11.32 42.06 22.49 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 4.60 40.33 20.42 7.25 39.50 20.05 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 9.71 44.83 15.47 10.13 41.43 19.93 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 55 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 84 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 11.09 42.89 24.44 11.32 42.06 22.49 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 4.60 40.33 20.42 7.25 39.50 20.05 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 9.71 44.83 15.47 10.13 41.43 19.93 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 55 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 84 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 11.09 42.89 24.44 11.32 42.06 22.49 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 4.60 40.33 20.42 7.25 39.50 20.05 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 9.71 44.83 15.47 10.13 41.43 19.93 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 55 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 84 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 11.09 42.89 24.44 11.32 42.06 22.49 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 9.71 44.83 15.47 10.13 41.43 19.93 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 55 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 84 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 11.09 42.89 24.44 11.32 42.06 22.49 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 9.71 44.83 15.47 10.13 41.43 19.93 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 55 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 84 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 11.09 42.89 24.44 11.32 42.06 22.49 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 4.60 40.33 20.42 7.25 39.50 20.05 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 9.71 44.83 15.47 10.13 41.43 19.93 12.04 15.06 -40.68 14.50 17.55 -45.86 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 8 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 169 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 327 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 24.31 10.25 23.71 29.02 12.05 20.75 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 21.86 20.40 18.59 22.12 18.33 18.33 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 169 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 327 GLU A 69 GLU~? 16.61 C4 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 24.31 10.25 23.71 29.02 12.05 20.75 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 21.86 20.40 18.59 22.12 18.33 18.33 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 169 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 327 GLU A 69 GLU~? 16.61 C4 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 24.31 10.25 23.71 29.02 12.05 20.75 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.86 20.40 18.59 22.12 18.33 18.33 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 169 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 327 GLU A 52 GLU~? 14.14 O5 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 24.31 10.25 23.71 29.02 12.05 20.75 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.86 20.40 18.59 22.12 18.33 18.33 -7.58 5.14 -19.74 -8.46 3.38 -20.54 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 169 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 327 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo 20.73 15.53 25.54 22.09 15.64 19.40 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 24.31 10.25 23.71 29.02 12.05 20.75 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.86 20.40 18.59 22.12 18.33 18.33 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 6 3 # 6 A 167 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 169 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 327 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 24.31 10.25 23.71 29.02 12.05 20.75 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 21.86 20.40 18.59 22.12 18.33 18.33 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 7 3 # 7 A 167 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 169 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 327 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 24.31 10.25 23.71 29.02 12.05 20.75 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.86 20.40 18.59 22.12 18.33 18.33 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 8 3 # 8 A 167 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 169 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 327 GLU B 52 GLU~? 14.42 C2 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 24.31 10.25 23.71 29.02 12.05 20.75 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.86 20.40 18.59 22.12 18.33 18.33 32.10 -2.10 -44.27 32.78 -3.62 -42.92 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 9 3 # 9 A 167 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 169 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 327 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 20.73 15.53 25.54 22.09 15.64 19.40 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 24.31 10.25 23.71 29.02 12.05 20.75 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.86 20.40 18.59 22.12 18.33 18.33 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 10 3 # 10 A 167 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 169 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 327 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 24.31 10.25 23.71 29.02 12.05 20.75 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 21.86 20.40 18.59 22.12 18.33 18.33 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 11 3 # 11 A 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 169 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 327 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 24.31 10.25 23.71 29.02 12.05 20.75 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 21.86 20.40 18.59 22.12 18.33 18.33 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 12 3 # 12 A 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 169 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 327 GLU C 69 GLU~? 15.05 O5 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 24.31 10.25 23.71 29.02 12.05 20.75 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 21.86 20.40 18.59 22.12 18.33 18.33 -32.98 6.49 -14.53 -31.30 7.57 -15.23 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 13 3 # 13 A 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 169 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 327 GLU C 52 GLU~? 9.38 O2 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 24.31 10.25 23.71 29.02 12.05 20.75 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.86 20.40 18.59 22.12 18.33 18.33 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 14 3 # 14 A 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 169 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 327 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 24.31 10.25 23.71 29.02 12.05 20.75 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.86 20.40 18.59 22.12 18.33 18.33 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 15 3 # 15 A 167 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 169 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 327 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 24.31 10.25 23.71 29.02 12.05 20.75 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 21.86 20.40 18.59 22.12 18.33 18.33 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 16 3 # 16 A 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 169 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 327 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 24.31 10.25 23.71 29.02 12.05 20.75 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.86 20.40 18.59 22.12 18.33 18.33 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 17 3 # 17 A 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 169 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 327 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 24.31 10.25 23.71 29.02 12.05 20.75 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.86 20.40 18.59 22.12 18.33 18.33 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 18 3 # 18 A 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 169 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 327 GLU D 52 GLU~? 9.77 O16 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 24.31 10.25 23.71 29.02 12.05 20.75 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.86 20.40 18.59 22.12 18.33 18.33 7.48 14.12 -48.51 7.76 13.12 -46.67 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 19 3 # 19 A 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 169 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 327 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 24.31 10.25 23.71 29.02 12.05 20.75 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.86 20.40 18.59 22.12 18.33 18.33 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 20 3 # 20 A 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 169 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 327 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 20.73 15.53 25.54 22.09 15.64 19.40 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 24.31 10.25 23.71 29.02 12.05 20.75 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.86 20.40 18.59 22.12 18.33 18.33 5.13 -2.81 -47.72 4.71 -3.46 -49.70 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 20 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 169 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 327 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 169 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 327 GLU A 69 GLU~? 16.61 C4 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 169 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 327 GLU A 69 GLU~? 16.61 C4 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -6.34 -10.93 -10.72 -6.36 -12.66 -9.49 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 169 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 327 GLU A 52 GLU~? 14.14 O5 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -7.58 5.14 -19.74 -8.46 3.38 -20.54 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 169 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 327 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 169 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 327 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 169 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 327 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 169 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 327 GLU B 52 GLU~? 14.42 C2 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 32.10 -2.10 -44.27 32.78 -3.62 -42.92 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 9 3 # 9 B 167 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 169 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 327 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 25.79 1.90 -25.69 27.00 2.59 -19.56 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 10 3 # 10 B 167 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 169 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 327 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 11 3 # 11 B 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 169 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 327 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 12 3 # 12 B 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 169 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 327 GLU C 69 GLU~? 15.05 O5 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -32.98 6.49 -14.53 -31.30 7.57 -15.23 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 13 3 # 13 B 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 169 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 327 GLU C 52 GLU~? 9.38 O2 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 14 3 # 14 B 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 169 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 327 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 15 3 # 15 B 167 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 169 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 327 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 16 3 # 16 B 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 169 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 327 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 17 3 # 17 B 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 169 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 327 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 18 3 # 18 B 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 169 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 327 GLU D 52 GLU~? 9.77 O16 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 7.48 14.12 -48.51 7.76 13.12 -46.67 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 19 3 # 19 B 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 169 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 327 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 20 3 # 20 B 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 169 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 327 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 5.13 -2.81 -47.72 4.71 -3.46 -49.70 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 20 hits 1muc_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 38 LYS~? 22.91 O5 PG4 C1130 631 LYS C 72 LYS~? 14.53 C8 PG4 C1130 708 LYS A 32 LYS~? 25.27 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.45 0.07 7.16 -16.37 -4.18 8.40 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 38 LYS~? 22.91 O5 PG4 C1130 631 LYS C 72 LYS~? 14.53 C8 PG4 C1130 708 LYS A 60 LYS~? 20.53 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 18.16 32.86 9.85 16.06 28.20 13.56 -3.82 6.30 -6.49 -4.25 8.23 -10.56 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 38 LYS~? 22.91 O5 PG4 C1130 631 LYS C 74 LYS~? 8.83 O5 PG4 C1130 708 LYS A 32 LYS~? 25.27 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.45 0.07 7.16 -16.37 -4.18 8.40 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS A 64 LYS.? 18.05 O5 PG4 C1130 631 LYS A 112 LYS~? 23.21 C4 PG4 C1130 708 LYS A 38 LYS~? 22.91 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 18.16 32.86 9.85 16.06 28.20 13.56 -13.68 4.03 -1.81 -8.47 6.66 0.55 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS A 72 LYS~? 16.44 O5 PG4 C1130 631 LYS C 72 LYS~? 14.53 C8 PG4 C1130 708 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 18.16 32.86 9.85 16.06 28.20 13.56 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS A 74 LYS~? 4.39 C4 PG4 C1130 631 LYS A 38 LYS~? 22.91 O5 PG4 C1130 708 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS A 74 LYS~? 4.39 C4 PG4 C1130 631 LYS A 60 LYS~? 20.53 O5 PG4 C1130 708 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -3.82 6.30 -6.49 -4.25 8.23 -10.56 coo 18.16 32.86 9.85 16.06 28.20 13.56 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS A 75 LYS~? 13.44 O5 PG4 C1130 631 LYS C 41 LYS~? 13.38 C3 PG4 C1130 708 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 18.16 32.86 9.85 16.06 28.20 13.56 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS A 75 LYS~? 13.44 O5 PG4 C1130 631 LYS C 72 LYS~? 14.53 C8 PG4 C1130 708 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 18.16 32.86 9.85 16.06 28.20 13.56 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS A 75 LYS~? 13.44 O5 PG4 C1130 631 LYS C 112 LYS~? 18.47 C1 PG4 C1130 708 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 18.16 32.86 9.85 16.06 28.20 13.56 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS B 38 LYS~? 23.39 O4 P6G D1130 631 LYS D 72 LYS~? 14.11 O7 P6G D1130 708 LYS B 32 LYS~? 26.29 C8 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 18.16 32.86 9.85 16.06 28.20 13.56 24.48 1.33 -71.20 20.78 5.38 -73.37 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS B 38 LYS~? 23.39 O4 P6G D1130 631 LYS D 72 LYS~? 14.11 O7 P6G D1130 708 LYS B 60 LYS~? 18.39 O4 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 18.16 32.86 9.85 16.06 28.20 13.56 35.13 -4.39 -57.50 30.78 -7.61 -55.34 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS B 38 LYS~? 23.39 O4 P6G D1130 631 LYS D 74 LYS~? -4.32 C2 P6G D1130s 708 LYS B 32 LYS~? 26.29 C8 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -11.99 27.40 17.14 -13.60 24.52 11.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 18.16 32.86 9.85 16.06 28.20 13.56 24.48 1.33 -71.20 20.78 5.38 -73.37 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS B 64 LYS.? 18.19 C9 P6G D1130 631 LYS B 112 LYS~? 22.45 C14 P6G D1130 708 LYS B 38 LYS~? 23.39 O4 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 31.06 5.90 -60.97 28.02 9.66 -62.79 coo -11.99 27.40 17.14 -13.60 24.52 11.71 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 18.16 32.86 9.85 16.06 28.20 13.56 25.30 -2.41 -62.07 30.29 -5.23 -64.65 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS B 72 LYS~? 17.42 C8 P6G D1130 631 LYS D 72 LYS~? 14.11 O7 P6G D1130 708 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -11.99 27.40 17.14 -13.60 24.52 11.71 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS B 74 LYS~? 4.23 C14 P6G D1130 631 LYS B 38 LYS~? 23.39 O4 P6G D1130 708 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS B 74 LYS~? 4.23 C14 P6G D1130 631 LYS B 60 LYS~? 18.39 O4 P6G D1130 708 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 35.13 -4.39 -57.50 30.78 -7.61 -55.34 coo 18.16 32.86 9.85 16.06 28.20 13.56 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS B 75 LYS~? 10.18 C3 P6G D1130 631 LYS D 41 LYS~? 14.07 C15 P6G D1130 708 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS B 75 LYS~? 10.18 C3 P6G D1130 631 LYS D 72 LYS~? 14.11 O7 P6G D1130 708 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 20 3 # 20 549 LYS B 75 LYS~? 10.18 C3 P6G D1130 631 LYS D 112 LYS~? 16.61 O1 P6G D1130 708 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 21 3 # 21 549 LYS C 38 LYS~? 22.42 O5 PG4 C1130 631 LYS A 72 LYS~? 16.44 O5 PG4 C1130 708 LYS C 32 LYS~? 27.65 O5 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 18.16 32.86 9.85 16.06 28.20 13.56 -24.29 3.76 6.29 -22.32 9.47 8.21 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 22 3 # 22 549 LYS C 38 LYS~? 22.42 O5 PG4 C1130 631 LYS A 72 LYS~? 16.44 O5 PG4 C1130 708 LYS C 60 LYS~? 23.71 C3 PG4 C1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 18.16 32.86 9.85 16.06 28.20 13.56 -35.53 -7.83 -3.33 -38.18 -11.20 -0.84 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 23 3 # 23 549 LYS C 72 LYS~? 14.53 C8 PG4 C1130 631 LYS A 38 LYS~? 22.91 O5 PG4 C1130 708 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 24 3 # 24 549 LYS C 75 LYS~? -2.86 O3 PG4 C1130s 631 LYS A 38 LYS~? 22.91 O5 PG4 C1130 708 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 8.61 33.06 11.15 10.12 29.19 8.82 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 25 3 # 25 549 LYS C 75 LYS~? -2.86 O3 PG4 C1130s 631 LYS A 64 LYS.? 18.05 O5 PG4 C1130 708 LYS C 101 LYS~? -2.55 O1 PG4 C1130s coo 8.61 33.06 11.15 10.12 29.19 8.82 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -7.96 -3.98 -3.34 -10.31 -8.95 -2.90 coo 18.16 32.86 9.85 16.06 28.20 13.56 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 26 3 # 26 549 LYS D 38 LYS~? 22.21 C6 P6G D1130 631 LYS B 72 LYS~? 17.42 C8 P6G D1130 708 LYS D 32 LYS~? 27.03 C6 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -11.99 27.40 17.14 -13.60 24.52 11.71 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 18.16 32.86 9.85 16.06 28.20 13.56 14.22 -2.15 -70.37 13.65 -7.80 -70.43 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 27 3 # 27 549 LYS D 38 LYS~? 22.21 C6 P6G D1130 631 LYS B 72 LYS~? 17.42 C8 P6G D1130 708 LYS D 60 LYS~? 24.27 C15 P6G D1130 coo 8.61 33.06 11.15 10.12 29.19 8.82 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -11.99 27.40 17.14 -13.60 24.52 11.71 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 18.16 32.86 9.85 16.06 28.20 13.56 3.35 9.26 -60.71 0.52 11.83 -63.90 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 28 3 # 28 549 LYS D 72 LYS~? 14.11 O7 P6G D1130 631 LYS B 38 LYS~? 23.39 O4 P6G D1130 708 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 8.61 33.06 11.15 10.12 29.19 8.82 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -11.99 27.40 17.14 -13.60 24.52 11.71 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 12.04 15.06 -40.68 14.50 17.55 -45.86 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 29 3 # 29 549 LYS D 75 LYS~? -3.20 O13 P6G D1130s 631 LYS B 38 LYS~? 23.39 O4 P6G D1130 708 LYS D 101 LYS~? -3.05 O19 P6G D1130s coo 8.61 33.06 11.15 10.12 29.19 8.82 14.33 6.41 -44.26 15.86 10.02 -47.66 coo -11.99 27.40 17.14 -13.60 24.52 11.71 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 12.04 15.06 -40.68 14.50 17.55 -45.86 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 29 hits 1nsf_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 903 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 972 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 61.58 117.15 13.99 62.31 115.51 15.12 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 60.18 107.64 21.53 58.13 110.55 17.14 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 903 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 972 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 61.58 117.15 13.99 62.31 115.51 15.12 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 60.18 107.64 21.53 58.13 110.55 17.14 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 903 GLU D 44 GLU~? 13.05 C9 P6G D1130 A 972 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 61.58 117.15 13.99 62.31 115.51 15.12 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 60.18 107.64 21.53 58.13 110.55 17.14 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 903 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 972 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 61.58 117.15 13.99 62.31 115.51 15.12 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 60.18 107.64 21.53 58.13 110.55 17.14 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 A 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 A 903 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 972 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 61.58 117.15 13.99 62.31 115.51 15.12 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 60.18 107.64 21.53 58.13 110.55 17.14 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 A 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 A 903 GLU A 52 GLU~? 14.14 O5 PG4 C1130 A 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 61.58 117.15 13.99 62.31 115.51 15.12 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 60.18 107.64 21.53 58.13 110.55 17.14 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 A 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 A 903 GLU A 55 GLU~? 16.41 O5 PG4 C1130 A 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 61.58 117.15 13.99 62.31 115.51 15.12 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 60.18 107.64 21.53 58.13 110.55 17.14 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 8 3 # 8 A 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 A 903 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 61.58 117.15 13.99 62.31 115.51 15.12 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 60.18 107.64 21.53 58.13 110.55 17.14 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 9 3 # 9 A 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 A 903 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 61.58 117.15 13.99 62.31 115.51 15.12 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 60.18 107.64 21.53 58.13 110.55 17.14 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 10 3 # 10 A 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 A 903 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 972 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 61.58 117.15 13.99 62.31 115.51 15.12 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 60.18 107.64 21.53 58.13 110.55 17.14 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 11 3 # 11 A 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 A 903 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 972 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 61.58 117.15 13.99 62.31 115.51 15.12 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 60.18 107.64 21.53 58.13 110.55 17.14 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 12 3 # 12 A 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 A 903 GLU B 55 GLU~? 15.05 C3 P6G D1130 A 972 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 61.58 117.15 13.99 62.31 115.51 15.12 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 60.18 107.64 21.53 58.13 110.55 17.14 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 13 3 # 13 A 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 A 903 GLU B 94 GLU~? 22.51 C2 P6G D1130 A 972 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 61.58 117.15 13.99 62.31 115.51 15.12 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 60.18 107.64 21.53 58.13 110.55 17.14 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 14 3 # 14 A 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 A 903 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 972 LYS B 124 LYS~? 35.64 C18 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 61.58 117.15 13.99 62.31 115.51 15.12 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 60.18 107.64 21.53 58.13 110.55 17.14 47.44 13.89 -26.91 47.07 18.95 -24.67 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 15 3 # 15 A 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 A 903 GLU B 120 GLU~? 31.89 C11 P6G D1130 A 972 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo 88.42 112.53 24.94 87.72 110.88 27.11 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 61.58 117.15 13.99 62.31 115.51 15.12 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 60.18 107.64 21.53 58.13 110.55 17.14 46.03 11.05 -24.83 42.26 13.39 -21.60 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 15 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 B 903 GLU B 52 GLU~? 14.42 C2 P6G D1130 B 972 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 4.13 40.53 14.21 5.06 38.89 15.19 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 4.08 30.40 21.12 1.62 33.28 16.83 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 B 903 GLU B 82 GLU~? 13.30 C2 P6G D1130 B 972 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 4.13 40.53 14.21 5.06 38.89 15.19 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 4.08 30.40 21.12 1.62 33.28 16.83 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 B 903 GLU D 44 GLU~? 13.05 C9 P6G D1130 B 972 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 4.13 40.53 14.21 5.06 38.89 15.19 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 4.08 30.40 21.12 1.62 33.28 16.83 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 B 903 GLU D 88 GLU~? 17.52 C12 P6G D1130 B 972 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 4.13 40.53 14.21 5.06 38.89 15.19 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 4.08 30.40 21.12 1.62 33.28 16.83 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 B 1 CYH A 122 CYH~? 19.70 O1 P6G D1130 B 903 GLU D 88 GLU~? 17.52 C12 P6G D1130 B 972 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 4.13 40.53 14.21 5.06 38.89 15.19 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 4.08 30.40 21.12 1.62 33.28 16.83 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 B 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 B 903 GLU A 52 GLU~? 14.14 O5 PG4 C1130 B 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 4.13 40.53 14.21 5.06 38.89 15.19 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 4.08 30.40 21.12 1.62 33.28 16.83 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 B 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 B 903 GLU A 55 GLU~? 16.41 O5 PG4 C1130 B 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 4.13 40.53 14.21 5.06 38.89 15.19 -5.51 1.40 -14.13 -4.52 0.89 -15.91 coo 4.08 30.40 21.12 1.62 33.28 16.83 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 8 3 # 8 B 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 B 903 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 4.13 40.53 14.21 5.06 38.89 15.19 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 4.08 30.40 21.12 1.62 33.28 16.83 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 9 3 # 9 B 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 B 903 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 972 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 4.13 40.53 14.21 5.06 38.89 15.19 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 4.08 30.40 21.12 1.62 33.28 16.83 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 10 3 # 10 B 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 B 903 GLU A 120 GLU~? 20.88 O1 P6G D1130 B 972 LYS A 101 LYS~? 17.94 O5 PG4 C1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 4.13 40.53 14.21 5.06 38.89 15.19 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 4.08 30.40 21.12 1.62 33.28 16.83 0.27 -2.68 -23.03 -3.47 1.45 -20.16 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 11 3 # 11 B 1 CYH C 122 CYH~? 12.47 C1 PG4 C1130 B 903 GLU A 120 GLU~? 20.88 O1 P6G D1130 B 972 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 4.13 40.53 14.21 5.06 38.89 15.19 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 4.08 30.40 21.12 1.62 33.28 16.83 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 12 3 # 12 B 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 B 903 GLU B 52 GLU~? 14.42 C2 P6G D1130 B 972 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 4.13 40.53 14.21 5.06 38.89 15.19 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 4.08 30.40 21.12 1.62 33.28 16.83 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 13 3 # 13 B 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 B 903 GLU B 55 GLU~? 15.05 C3 P6G D1130 B 972 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 4.13 40.53 14.21 5.06 38.89 15.19 33.77 1.13 -50.00 34.67 1.54 -48.13 coo 4.08 30.40 21.12 1.62 33.28 16.83 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 14 3 # 14 B 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 B 903 GLU B 94 GLU~? 22.51 C2 P6G D1130 B 972 LYS B 101 LYS~? 19.06 C3 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 4.13 40.53 14.21 5.06 38.89 15.19 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 4.08 30.40 21.12 1.62 33.28 16.83 39.66 6.36 -42.06 38.78 0.18 -41.50 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 15 3 # 15 B 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 B 903 GLU B 100 GLU~? 26.53 C3 P6G D1130 B 972 LYS B 124 LYS~? 35.64 C18 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 4.13 40.53 14.21 5.06 38.89 15.19 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 4.08 30.40 21.12 1.62 33.28 16.83 47.44 13.89 -26.91 47.07 18.95 -24.67 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 16 3 # 16 B 1 CYH D 122 CYH~? 12.34 C18 P6G D1130 B 903 GLU B 120 GLU~? 31.89 C11 P6G D1130 B 972 LYS B 125 LYS~? 33.21 C11 P6G D1130 coo 31.47 38.87 24.90 30.94 36.98 26.93 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 4.13 40.53 14.21 5.06 38.89 15.19 46.57 16.64 -34.21 48.52 15.81 -33.97 coo 4.08 30.40 21.12 1.62 33.28 16.83 46.03 11.05 -24.83 42.26 13.39 -21.60 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 16 hits 1ofd_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 1.87 119.38 16.45 1.41 122.11 16.84 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -2.59 124.07 12.67 -0.91 126.17 18.42 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -2.59 124.07 12.67 -0.91 126.17 18.42 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 1.87 119.38 16.45 1.41 122.11 16.84 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 1.87 119.38 16.45 1.41 122.11 16.84 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 1.87 119.38 16.45 1.41 122.11 16.84 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 1.87 119.38 16.45 1.41 122.11 16.84 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 1.87 119.38 16.45 1.41 122.11 16.84 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 1.87 119.38 16.45 1.41 122.11 16.84 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 A 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 1.87 119.38 16.45 1.41 122.11 16.84 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -2.59 124.07 12.67 -0.91 126.17 18.42 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 A 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -3.50 124.89 25.05 -2.25 124.77 23.26 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 1.87 119.38 16.45 1.41 122.11 16.84 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -2.59 124.07 12.67 -0.91 126.17 18.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 A 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 1.87 119.38 16.45 1.41 122.11 16.84 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -2.59 124.07 12.67 -0.91 126.17 18.42 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 A 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 1.87 119.38 16.45 1.41 122.11 16.84 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -2.59 124.07 12.67 -0.91 126.17 18.42 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 A 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -3.50 124.89 25.05 -2.25 124.77 23.26 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 1.87 119.38 16.45 1.41 122.11 16.84 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -2.59 124.07 12.67 -0.91 126.17 18.42 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 A 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -3.50 124.89 25.05 -2.25 124.77 23.26 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 1.87 119.38 16.45 1.41 122.11 16.84 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -2.59 124.07 12.67 -0.91 126.17 18.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 A 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -3.50 124.89 25.05 -2.25 124.77 23.26 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 1.87 119.38 16.45 1.41 122.11 16.84 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -2.59 124.07 12.67 -0.91 126.17 18.42 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 B 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 B 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -4.18 120.17 46.85 -4.02 115.31 51.00 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 B 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -4.18 120.17 46.85 -4.02 115.31 51.00 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s B 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s B 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 B 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 B 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s B 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 0.22 114.56 44.62 -0.76 115.18 47.18 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -4.18 120.17 46.85 -4.02 115.31 51.00 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 B 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s B 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -7.43 109.06 51.23 -5.84 110.54 50.86 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 0.22 114.56 44.62 -0.76 115.18 47.18 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -4.18 120.17 46.85 -4.02 115.31 51.00 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 B 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 B 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 0.22 114.56 44.62 -0.76 115.18 47.18 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -4.18 120.17 46.85 -4.02 115.31 51.00 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 B 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 0.22 114.56 44.62 -0.76 115.18 47.18 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -4.18 120.17 46.85 -4.02 115.31 51.00 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 B 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 B 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -7.43 109.06 51.23 -5.84 110.54 50.86 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 0.22 114.56 44.62 -0.76 115.18 47.18 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -4.18 120.17 46.85 -4.02 115.31 51.00 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 B 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -7.43 109.06 51.23 -5.84 110.54 50.86 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 0.22 114.56 44.62 -0.76 115.18 47.18 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -4.18 120.17 46.85 -4.02 115.31 51.00 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 B 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -7.43 109.06 51.23 -5.84 110.54 50.86 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 0.22 114.56 44.62 -0.76 115.18 47.18 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -4.18 120.17 46.85 -4.02 115.31 51.00 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 C 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 C 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -11.22 87.18 53.49 -10.94 81.64 50.31 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 C 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -11.22 87.18 53.49 -10.94 81.64 50.31 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s C 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s C 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 C 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 C 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 C 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 C 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 C 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s C 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -5.65 86.78 48.49 -7.16 84.72 49.65 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -11.22 87.18 53.49 -10.94 81.64 50.31 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 C 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s C 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -13.49 79.65 43.90 -12.13 80.29 45.45 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -5.65 86.78 48.49 -7.16 84.72 49.65 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -11.22 87.18 53.49 -10.94 81.64 50.31 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 C 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 C 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -5.65 86.78 48.49 -7.16 84.72 49.65 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -11.22 87.18 53.49 -10.94 81.64 50.31 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 C 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -5.65 86.78 48.49 -7.16 84.72 49.65 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -11.22 87.18 53.49 -10.94 81.64 50.31 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 C 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 C 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -13.49 79.65 43.90 -12.13 80.29 45.45 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -5.65 86.78 48.49 -7.16 84.72 49.65 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -11.22 87.18 53.49 -10.94 81.64 50.31 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 C 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -13.49 79.65 43.90 -12.13 80.29 45.45 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -5.65 86.78 48.49 -7.16 84.72 49.65 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -11.22 87.18 53.49 -10.94 81.64 50.31 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 C 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -13.49 79.65 43.90 -12.13 80.29 45.45 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -5.65 86.78 48.49 -7.16 84.72 49.65 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -11.22 87.18 53.49 -10.94 81.64 50.31 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 D 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 D 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 D 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -14.24 70.61 23.48 -12.55 71.73 17.42 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 D 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -14.24 70.61 23.48 -12.55 71.73 17.42 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s D 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s D 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 D 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 D 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 D 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 D 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 D 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 D 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 D 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 D 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s D 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -7.85 74.44 22.75 -9.22 72.86 20.89 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -14.24 70.61 23.48 -12.55 71.73 17.42 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 D 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s D 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -13.44 77.36 13.12 -12.53 75.97 14.48 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -7.85 74.44 22.75 -9.22 72.86 20.89 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -14.24 70.61 23.48 -12.55 71.73 17.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 D 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 D 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -7.85 74.44 22.75 -9.22 72.86 20.89 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -14.24 70.61 23.48 -12.55 71.73 17.42 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 D 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 D 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -7.85 74.44 22.75 -9.22 72.86 20.89 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -14.24 70.61 23.48 -12.55 71.73 17.42 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 D 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 D 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 D 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -13.44 77.36 13.12 -12.53 75.97 14.48 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -7.85 74.44 22.75 -9.22 72.86 20.89 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -14.24 70.61 23.48 -12.55 71.73 17.42 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 D 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -13.44 77.36 13.12 -12.53 75.97 14.48 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -7.85 74.44 22.75 -9.22 72.86 20.89 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -14.24 70.61 23.48 -12.55 71.73 17.42 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 D 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -13.44 77.36 13.12 -12.53 75.97 14.48 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -7.85 74.44 22.75 -9.22 72.86 20.89 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -14.24 70.61 23.48 -12.55 71.73 17.42 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 E 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 E 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 E 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 E 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 E 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 E 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 E 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s E 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 E 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s E 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 E 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 E 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 E 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 E 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 E 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 E 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 E 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 E 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 E 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 E 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s E 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -3.11 94.55 3.01 -3.83 95.92 0.66 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 E 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 E 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s E 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -7.12 105.25 1.43 -6.30 103.34 0.77 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -3.11 94.55 3.01 -3.83 95.92 0.66 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 E 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 E 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 E 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -3.11 94.55 3.01 -3.83 95.92 0.66 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 E 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 E 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 E 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -3.11 94.55 3.01 -3.83 95.92 0.66 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 E 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 E 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 E 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -7.12 105.25 1.43 -6.30 103.34 0.77 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -3.11 94.55 3.01 -3.83 95.92 0.66 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 E 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 E 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 E 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -7.12 105.25 1.43 -6.30 103.34 0.77 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -3.11 94.55 3.01 -3.83 95.92 0.66 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 E 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 E 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 E 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -7.12 105.25 1.43 -6.30 103.34 0.77 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -3.11 94.55 3.01 -3.83 95.92 0.66 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 F 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 F 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 F 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 F 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -44.10 135.86 19.99 -45.67 134.21 14.07 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 F 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 F 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -44.10 135.86 19.99 -45.67 134.21 14.07 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 F 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s F 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 F 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s F 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 F 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 F 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 F 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 F 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 F 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 F 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 F 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 F 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 F 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 F 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s F 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -50.43 131.90 19.60 -49.04 133.31 17.60 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -44.10 135.86 19.99 -45.67 134.21 14.07 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 F 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 F 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s F 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -44.75 128.15 10.28 -45.68 129.67 11.55 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -50.43 131.90 19.60 -49.04 133.31 17.60 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -44.10 135.86 19.99 -45.67 134.21 14.07 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 F 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 F 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 F 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -50.43 131.90 19.60 -49.04 133.31 17.60 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -44.10 135.86 19.99 -45.67 134.21 14.07 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 F 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 F 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 F 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -50.43 131.90 19.60 -49.04 133.31 17.60 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -44.10 135.86 19.99 -45.67 134.21 14.07 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 F 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 F 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 F 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -44.75 128.15 10.28 -45.68 129.67 11.55 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -50.43 131.90 19.60 -49.04 133.31 17.60 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -44.10 135.86 19.99 -45.67 134.21 14.07 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 F 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 F 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 F 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -44.75 128.15 10.28 -45.68 129.67 11.55 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -50.43 131.90 19.60 -49.04 133.31 17.60 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -44.10 135.86 19.99 -45.67 134.21 14.07 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 F 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 F 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 F 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -44.75 128.15 10.28 -45.68 129.67 11.55 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -50.43 131.90 19.60 -49.04 133.31 17.60 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -44.10 135.86 19.99 -45.67 134.21 14.07 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 G 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 G 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 G 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 G 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -47.30 122.24 51.49 -47.46 127.44 47.81 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 G 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 G 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -47.30 122.24 51.49 -47.46 127.44 47.81 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 G 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s G 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 G 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s G 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 G 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 G 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 G 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 G 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 G 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 G 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 G 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 G 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 G 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 G 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s G 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -52.83 122.13 46.42 -51.31 124.30 47.39 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -47.30 122.24 51.49 -47.46 127.44 47.81 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 G 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 G 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s G 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -44.97 128.78 41.20 -46.32 128.26 42.83 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -52.83 122.13 46.42 -51.31 124.30 47.39 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -47.30 122.24 51.49 -47.46 127.44 47.81 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 G 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 G 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 G 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -52.83 122.13 46.42 -51.31 124.30 47.39 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -47.30 122.24 51.49 -47.46 127.44 47.81 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 G 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 G 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 G 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -52.83 122.13 46.42 -51.31 124.30 47.39 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -47.30 122.24 51.49 -47.46 127.44 47.81 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 G 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 G 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 G 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -44.97 128.78 41.20 -46.32 128.26 42.83 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -52.83 122.13 46.42 -51.31 124.30 47.39 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -47.30 122.24 51.49 -47.46 127.44 47.81 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 G 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 G 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 G 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -44.97 128.78 41.20 -46.32 128.26 42.83 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -52.83 122.13 46.42 -51.31 124.30 47.39 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -47.30 122.24 51.49 -47.46 127.44 47.81 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 G 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 G 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 G 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -44.97 128.78 41.20 -46.32 128.26 42.83 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -52.83 122.13 46.42 -51.31 124.30 47.39 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -47.30 122.24 51.49 -47.46 127.44 47.81 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 H 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 H 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 H 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 H 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -54.32 88.79 48.13 -54.61 94.04 51.74 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 H 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 H 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -54.32 88.79 48.13 -54.61 94.04 51.74 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 H 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s H 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 H 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s H 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 H 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 H 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 H 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 H 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 H 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 H 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 H 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 H 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 H 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 H 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s H 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -58.70 94.17 45.32 -57.76 93.82 47.92 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -54.32 88.79 48.13 -54.61 94.04 51.74 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 H 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 H 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s H 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -51.11 100.30 51.41 -52.67 98.82 51.12 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -58.70 94.17 45.32 -57.76 93.82 47.92 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -54.32 88.79 48.13 -54.61 94.04 51.74 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 H 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 H 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 H 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -58.70 94.17 45.32 -57.76 93.82 47.92 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -54.32 88.79 48.13 -54.61 94.04 51.74 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 H 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 H 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 H 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -58.70 94.17 45.32 -57.76 93.82 47.92 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -54.32 88.79 48.13 -54.61 94.04 51.74 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 H 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 H 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 H 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -51.11 100.30 51.41 -52.67 98.82 51.12 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -58.70 94.17 45.32 -57.76 93.82 47.92 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -54.32 88.79 48.13 -54.61 94.04 51.74 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 H 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 H 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 H 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -51.11 100.30 51.41 -52.67 98.82 51.12 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -58.70 94.17 45.32 -57.76 93.82 47.92 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -54.32 88.79 48.13 -54.61 94.04 51.74 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 H 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 H 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 H 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -51.11 100.30 51.41 -52.67 98.82 51.12 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -58.70 94.17 45.32 -57.76 93.82 47.92 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -54.32 88.79 48.13 -54.61 94.04 51.74 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 I 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 I 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 I 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 I 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -55.38 81.61 14.50 -57.11 80.05 20.41 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 I 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 I 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -55.38 81.61 14.50 -57.11 80.05 20.41 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 I 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s I 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 I 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s I 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 I 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 I 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 I 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 I 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 I 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 I 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 I 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 I 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 I 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 I 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s I 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -59.92 86.62 17.74 -59.42 83.94 18.40 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -55.38 81.61 14.50 -57.11 80.05 20.41 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 I 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 I 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s I 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -54.65 81.97 26.87 -55.88 81.89 25.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -59.92 86.62 17.74 -59.42 83.94 18.40 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -55.38 81.61 14.50 -57.11 80.05 20.41 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 I 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 I 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 I 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -59.92 86.62 17.74 -59.42 83.94 18.40 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -55.38 81.61 14.50 -57.11 80.05 20.41 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 I 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 I 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 I 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -59.92 86.62 17.74 -59.42 83.94 18.40 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -55.38 81.61 14.50 -57.11 80.05 20.41 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 I 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 I 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 I 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -54.65 81.97 26.87 -55.88 81.89 25.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -59.92 86.62 17.74 -59.42 83.94 18.40 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -55.38 81.61 14.50 -57.11 80.05 20.41 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 I 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 I 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 I 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -54.65 81.97 26.87 -55.88 81.89 25.07 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -59.92 86.62 17.74 -59.42 83.94 18.40 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -55.38 81.61 14.50 -57.11 80.05 20.41 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 I 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 I 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 I 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -54.65 81.97 26.87 -55.88 81.89 25.07 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -59.92 86.62 17.74 -59.42 83.94 18.40 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -55.38 81.61 14.50 -57.11 80.05 20.41 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 50 ASP~? 13.04 O5 PG4 C1130 J 146 TYR A 57 TYR~? 16.39 O5 PG4 C1130 J 177 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 J 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 J 177 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 50 ASP~? 8.75 C2 P6G D1130 J 146 TYR B 57 TYR~? 16.24 O4 P6G D1130 J 177 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 J 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s J 177 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 J 146 TYR C 46 TYR~? -4.42 C8 PG4 C1130s J 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP C 50 ASP~? 5.21 O2 PG4 C1130 J 146 TYR C 57 TYR~? 15.97 O5 PG4 C1130 J 177 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP C 85 ASP~? 10.22 C6 PG4 C1130 J 146 TYR A 51 TYR~? 11.49 O5 PG4 C1130 J 177 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 J 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 J 177 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP C 107 ASP.? 16.10 C8 PG4 C1130 J 146 TYR C 51 TYR~? 9.35 C8 PG4 C1130 J 177 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 J 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 J 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s J 177 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 J 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 J 146 TYR D 46 TYR~? -4.28 C6 P6G D1130s J 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -50.64 99.08 1.52 -51.52 100.83 0.67 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 14.78 5.72 -50.79 14.70 4.54 -48.27 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 J 24 ASP D 50 ASP~? 5.15 O16 P6G D1130 J 146 TYR D 57 TYR~? 15.84 C9 P6G D1130 J 177 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 J 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 J 146 TYR B 51 TYR~? 10.58 C3 P6G D1130 J 177 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 29.55 2.80 -46.55 31.14 4.40 -48.22 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 J 24 ASP D 85 ASP~? 10.24 C11 P6G D1130 J 146 TYR B 118 TYR~? 21.87 C11 P6G D1130 J 177 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo -50.64 99.08 1.52 -51.52 100.83 0.67 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 37.69 14.21 -33.01 35.23 15.36 -32.38 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 J 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 J 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 J 177 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -50.64 99.08 1.52 -51.52 100.83 0.67 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 J 24 ASP D 107 ASP.? 14.84 O1 P6G D1130 J 146 TYR D 51 TYR~? 9.17 O7 P6G D1130 J 177 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -50.64 99.08 1.52 -51.52 100.83 0.67 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 14.33 6.41 -44.26 15.86 10.02 -47.66 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 96 GLU A 44 GLU~? 13.07 O5 PG4 C1130 A 132 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.82 3.20 24.36 27.99 4.86 24.98 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 29.99 0.62 22.18 30.38 6.69 20.81 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 96 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 132 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.82 3.20 24.36 27.99 4.86 24.98 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 96 GLU A 110 GLU~? 14.79 C2 PG4 C1130 A 132 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 26.82 3.20 24.36 27.99 4.86 24.98 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 29.99 0.62 22.18 30.38 6.69 20.81 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 96 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 132 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.82 3.20 24.36 27.99 4.86 24.98 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 29.99 0.62 22.18 30.38 6.69 20.81 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 96 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 132 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.82 3.20 24.36 27.99 4.86 24.98 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 29.99 0.62 22.18 30.38 6.69 20.81 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 96 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 132 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 26.82 3.20 24.36 27.99 4.86 24.98 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 29.99 0.62 22.18 30.38 6.69 20.81 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 96 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 132 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 26.82 3.20 24.36 27.99 4.86 24.98 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 29.99 0.62 22.18 30.38 6.69 20.81 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 96 GLU D 44 GLU~? 13.05 C9 P6G D1130 A 132 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 26.82 3.20 24.36 27.99 4.86 24.98 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 29.99 0.62 22.18 30.38 6.69 20.81 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 96 GLU D 110 GLU~? 16.67 O1 P6G D1130 A 132 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo 31.23 12.29 16.44 30.82 11.56 18.39 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 26.82 3.20 24.36 27.99 4.86 24.98 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 29.99 0.62 22.18 30.38 6.69 20.81 10.74 10.01 -28.88 5.91 8.82 -26.43 1onr_c00 source 1onr TRANSALDOLASE B : 9 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 96 GLU A 44 GLU~? 13.07 O5 PG4 C1130 B 132 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.69 48.45 7.18 27.85 50.13 7.74 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 29.82 45.80 5.07 30.26 51.81 3.56 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 96 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 132 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.69 48.45 7.18 27.85 50.13 7.74 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 107 ASP.? 20.53 C4 PG4 C1130 B 96 GLU A 110 GLU~? 14.79 C2 PG4 C1130 B 132 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 26.69 48.45 7.18 27.85 50.13 7.74 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 29.82 45.80 5.07 30.26 51.81 3.56 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 96 GLU B 44 GLU~? 13.14 C6 P6G D1130 B 132 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.69 48.45 7.18 27.85 50.13 7.74 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 29.82 45.80 5.07 30.26 51.81 3.56 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 96 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 132 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.69 48.45 7.18 27.85 50.13 7.74 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 29.82 45.80 5.07 30.26 51.81 3.56 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 96 GLU C 44 GLU~? 12.88 O5 PG4 C1130 B 132 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 26.69 48.45 7.18 27.85 50.13 7.74 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 29.82 45.80 5.07 30.26 51.81 3.56 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 96 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 132 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 26.69 48.45 7.18 27.85 50.13 7.74 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 29.82 45.80 5.07 30.26 51.81 3.56 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 96 GLU D 44 GLU~? 13.05 C9 P6G D1130 B 132 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 26.69 48.45 7.18 27.85 50.13 7.74 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 29.82 45.80 5.07 30.26 51.81 3.56 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 96 GLU D 110 GLU~? 16.67 O1 P6G D1130 B 132 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo 31.16 57.31 -0.94 30.73 56.64 1.01 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 26.69 48.45 7.18 27.85 50.13 7.74 12.41 4.04 -29.37 12.28 4.39 -27.28 coo 29.82 45.80 5.07 30.26 51.81 3.56 10.74 10.01 -28.88 5.91 8.82 -26.43 1onr_c01 source 1onr TRANSALDOLASE B : 9 hits 1onr_c01 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 167 LYS A 124 LYS~? 16.08 O1 P6G D1130 A 201 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 26.53 8.31 20.37 28.45 8.41 19.40 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 24.92 6.08 13.38 27.75 4.33 18.83 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo 29.08 5.53 11.69 30.46 5.61 17.93 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 167 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 201 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 26.53 8.31 20.37 28.45 8.41 19.40 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 24.92 6.08 13.38 27.75 4.33 18.83 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 29.08 5.53 11.69 30.46 5.61 17.93 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 167 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 201 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 26.53 8.31 20.37 28.45 8.41 19.40 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 24.92 6.08 13.38 27.75 4.33 18.83 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 29.08 5.53 11.69 30.46 5.61 17.93 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 201 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 26.53 8.31 20.37 28.45 8.41 19.40 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 24.92 6.08 13.38 27.75 4.33 18.83 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 29.08 5.53 11.69 30.46 5.61 17.93 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 A 102 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 167 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 201 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 26.53 8.31 20.37 28.45 8.41 19.40 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 24.92 6.08 13.38 27.75 4.33 18.83 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 29.08 5.53 11.69 30.46 5.61 17.93 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 A 102 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 167 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 201 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 26.53 8.31 20.37 28.45 8.41 19.40 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 24.92 6.08 13.38 27.75 4.33 18.83 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 29.08 5.53 11.69 30.46 5.61 17.93 14.51 2.78 -43.17 17.25 -1.27 -44.64 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 6 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 129 ASP.? 5.22 O1 P6G D1130 B1167 LYS A 124 LYS~? 16.08 O1 P6G D1130 B1201 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 26.10 12.11 49.61 24.19 12.48 50.51 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.70 11.69 56.92 24.82 8.55 52.12 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo 23.50 11.64 58.67 22.19 10.19 52.59 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP A 129 ASP.? 5.22 O1 P6G D1130 B1167 LYS D 74 LYS~? -4.32 C2 P6G D1130s B1201 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 26.10 12.11 49.61 24.19 12.48 50.51 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 27.70 11.69 56.92 24.82 8.55 52.12 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 23.50 11.64 58.67 22.19 10.19 52.59 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B1167 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B1201 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 26.10 12.11 49.61 24.19 12.48 50.51 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 27.70 11.69 56.92 24.82 8.55 52.12 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 23.50 11.64 58.67 22.19 10.19 52.59 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B1167 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B1201 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 26.10 12.11 49.61 24.19 12.48 50.51 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 27.70 11.69 56.92 24.82 8.55 52.12 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 23.50 11.64 58.67 22.19 10.19 52.59 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 B1102 ASP D 85 ASP~? 10.24 C11 P6G D1130 B1167 LYS B 74 LYS~? 4.23 C14 P6G D1130 B1201 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 26.10 12.11 49.61 24.19 12.48 50.51 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 27.70 11.69 56.92 24.82 8.55 52.12 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 23.50 11.64 58.67 22.19 10.19 52.59 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 B1102 ASP D 107 ASP.? 14.84 O1 P6G D1130 B1167 LYS D 72 LYS~? 14.11 O7 P6G D1130 B1201 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 26.10 12.11 49.61 24.19 12.48 50.51 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 27.70 11.69 56.92 24.82 8.55 52.12 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 23.50 11.64 58.67 22.19 10.19 52.59 14.51 2.78 -43.17 17.25 -1.27 -44.64 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 6 hits 1p1x_c01 naa= 3 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 A 160 GLU C 109 GLU~? 22.49 C8 PG4 C1130 A 297 ASN C 108 ASN~? 16.59 C8 PG4 C1130 A 375 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 63.94 10.02 33.47 64.31 8.24 32.38 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 59.99 9.39 31.17 60.97 11.14 30.52 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 61.89 10.05 27.30 63.60 9.39 28.40 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 A 160 GLU C 110 GLU~? 19.54 O4 PG4 C1130 A 297 ASN C 108 ASN~? 16.59 C8 PG4 C1130 A 375 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 63.94 10.02 33.47 64.31 8.24 32.38 -28.66 1.59 -33.06 -27.87 1.89 -35.00 coo 59.99 9.39 31.17 60.97 11.14 30.52 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 61.89 10.05 27.30 63.60 9.39 28.40 -35.52 1.04 -31.85 -35.78 2.73 -33.13 1pbg_c00 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 2 hits 1pbg_c00 naa= 3 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 B 160 GLU C 109 GLU~? 22.49 C8 PG4 C1130 B 297 ASN C 108 ASN~? 16.59 C8 PG4 C1130 B 375 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 23.66 16.69 85.20 24.17 18.76 84.94 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 19.74 18.67 86.53 20.70 17.86 88.21 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 21.67 20.74 89.92 23.35 20.55 88.67 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 B 160 GLU C 110 GLU~? 19.54 O4 PG4 C1130 B 297 ASN C 108 ASN~? 16.59 C8 PG4 C1130 B 375 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 23.66 16.69 85.20 24.17 18.76 84.94 -28.66 1.59 -33.06 -27.87 1.89 -35.00 coo 19.74 18.67 86.53 20.70 17.86 88.21 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 21.67 20.74 89.92 23.35 20.55 88.67 -35.52 1.04 -31.85 -35.78 2.73 -33.13 1pbg_c01 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 2 hits 1pbg_c01 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 30 ALA~? 29.61 O5 PG4 C1130 A 126 LEU A 33 LEU~? 24.42 O5 PG4 C1130 A 158 GLU A 37 GLU~? 22.40 O5 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -15.40 4.53 10.49 -14.90 5.74 11.30 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -17.69 3.68 6.99 -19.58 4.76 6.65 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -18.08 5.74 1.85 -17.77 7.24 3.33 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 42 ALA~? 12.59 O5 PG4 C1130 A 126 LEU A 40 LEU~? 14.12 O5 PG4 C1130 A 158 GLU A 37 GLU~? 22.40 O5 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -14.02 2.58 -7.96 -13.02 1.59 -7.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -19.01 2.30 -3.28 -21.00 1.45 -3.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -18.08 5.74 1.85 -17.77 7.24 3.33 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 42 ALA~? 12.59 O5 PG4 C1130 A 126 LEU A 63 LEU.? 17.30 O5 PG4 C1130 A 158 GLU A 61 GLU~? 21.55 O5 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -14.02 2.58 -7.96 -13.02 1.59 -7.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -8.80 0.30 -4.09 -10.26 1.63 -3.22 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.37 6.43 -4.11 -7.95 7.95 -2.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 76 ALA~? 14.67 C6 PG4 C1130 A 126 LEU A 79 LEU~? 16.24 C6 PG4 C1130 A 158 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 90 ALA.? 19.83 O1 P6G D1130 A 126 LEU A 86 LEU~? 23.09 C6 PG4 C1130 A 158 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 95 ALA~? 21.68 O1 P6G D1130 A 126 LEU A 96 LEU~? 18.30 O1 P6G D1130 A 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA A 95 ALA~? 21.68 O1 P6G D1130 A 126 LEU A 96 LEU~? 18.30 O1 P6G D1130 A 158 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA A 102 ALA~? 18.16 C6 PG4 C1130 A 126 LEU A 79 LEU~? 16.24 C6 PG4 C1130 A 158 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 A 126 LEU A 103 LEU~? 23.56 C6 PG4 C1130 A 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 A 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 A 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 A 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 A 158 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA A 127 ALA.? 9.98 O1 P6G D1130 A 126 LEU D 70 LEU~? 9.48 O1 P6G D1130 A 158 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo -4.62 32.83 147.14 -5.50 32.85 149.12 11.83 -2.12 -46.05 12.13 -4.20 -45.51 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 30 ALA~? 30.31 C6 P6G D1130 A 126 LEU B 33 LEU~? 24.97 C6 P6G D1130 A 158 GLU B 37 GLU~? 22.87 C6 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.57 -3.13 -74.32 24.12 -4.20 -75.25 coo -4.62 32.83 147.14 -5.50 32.85 149.12 21.31 -2.38 -70.71 19.18 -2.95 -70.61 coo -0.83 29.57 149.77 -0.39 31.47 148.95 20.90 -4.08 -65.74 21.08 -5.77 -67.00 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA B 42 ALA~? 13.18 O4 P6G D1130 A 126 LEU B 40 LEU~? 14.67 C6 P6G D1130 A 158 GLU B 37 GLU~? 22.87 C6 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.08 -0.64 -55.99 26.08 0.25 -56.74 coo -4.62 32.83 147.14 -5.50 32.85 149.12 20.03 -0.73 -60.50 18.12 0.25 -60.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 20.90 -4.08 -65.74 21.08 -5.77 -67.00 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA B 42 ALA~? 13.18 O4 P6G D1130 A 126 LEU B 63 LEU.? 18.00 C8 P6G D1130 A 158 GLU B 61 GLU~? 21.58 O4 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 25.08 -0.64 -55.99 26.08 0.25 -56.74 coo -4.62 32.83 147.14 -5.50 32.85 149.12 30.19 1.62 -60.10 28.89 0.05 -60.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 30.88 -4.52 -59.91 31.08 -6.09 -61.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA B 76 ALA~? 14.74 C11 P6G D1130 A 126 LEU B 79 LEU~? 15.03 C3 P6G D1130 A 158 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 33.17 9.74 -42.93 33.99 10.72 -43.77 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.24 7.10 -39.73 34.51 5.30 -40.93 coo -0.83 29.57 149.77 -0.39 31.47 148.95 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA B 90 ALA.? 29.32 O1 P6G D1130 A 126 LEU B 86 LEU~? 21.10 C2 P6G D1130 A 158 GLU B 94 GLU~? 22.51 C2 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 39.13 5.51 -23.62 39.54 5.36 -22.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 36.40 4.60 -30.00 35.97 2.83 -31.17 coo -0.83 29.57 149.77 -0.39 31.47 148.95 38.57 0.93 -32.34 39.48 -0.67 -33.39 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA B 95 ALA~? 23.69 C3 P6G D1130 A 126 LEU B 96 LEU~? 27.30 C3 P6G D1130 A 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 39.47 6.03 -32.16 39.38 7.03 -31.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 44.10 6.64 -33.57 46.02 7.50 -33.98 coo -0.83 29.57 149.77 -0.39 31.47 148.95 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA B 102 ALA~? 17.96 C11 P6G D1130 A 126 LEU B 79 LEU~? 15.03 C3 P6G D1130 A 158 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 37.30 9.41 -41.92 36.70 9.99 -40.66 coo -4.62 32.83 147.14 -5.50 32.85 149.12 34.24 7.10 -39.73 34.51 5.30 -40.93 coo -0.83 29.57 149.77 -0.39 31.47 148.95 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA B 102 ALA~? 17.96 C11 P6G D1130 A 126 LEU B 103 LEU~? 23.43 C11 P6G D1130 A 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 37.30 9.41 -41.92 36.70 9.99 -40.66 coo -4.62 32.83 147.14 -5.50 32.85 149.12 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 A 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 A 126 LEU B 103 LEU~? 23.43 C11 P6G D1130 A 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -4.62 32.83 147.14 -5.50 32.85 149.12 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 A 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 A 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 A 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -4.62 32.83 147.14 -5.50 32.85 149.12 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -0.83 29.57 149.77 -0.39 31.47 148.95 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 A 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 A 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 A 158 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -4.62 32.83 147.14 -5.50 32.85 149.12 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -0.83 29.57 149.77 -0.39 31.47 148.95 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 A 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 A 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 A 158 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -4.62 32.83 147.14 -5.50 32.85 149.12 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -0.83 29.57 149.77 -0.39 31.47 148.95 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 A 70 ALA C 30 ALA~? 29.34 O5 PG4 C1130 A 126 LEU C 33 LEU~? 24.39 O5 PG4 C1130 A 158 GLU C 37 GLU~? 22.29 O5 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -23.96 1.34 11.06 -24.54 0.77 12.35 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -21.63 -0.11 7.58 -19.56 -0.63 7.98 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -21.28 -3.96 3.81 -21.51 -4.93 5.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 A 70 ALA C 42 ALA~? 11.94 O5 PG4 C1130 A 126 LEU C 40 LEU~? 13.85 O5 PG4 C1130 A 158 GLU C 37 GLU~? 22.29 O5 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.35 -3.23 -2.13 -18.56 -3.80 -3.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -21.28 -3.96 3.81 -21.51 -4.93 5.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 A 70 ALA C 42 ALA~? 11.94 O5 PG4 C1130 A 126 LEU C 63 LEU.? 16.71 O5 PG4 C1130 A 158 GLU C 61 GLU~? 21.06 O5 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.88 -1.64 -3.09 -28.87 -1.48 -2.33 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 A 70 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 126 LEU C 79 LEU~? -4.57 C5 PG4 C1130s A 158 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 A 70 ALA C 90 ALA.? 17.94 C1 PG4 C1130 A 126 LEU C 86 LEU~? 9.11 C1 PG4 C1130 A 158 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 A 70 ALA C 95 ALA~? 9.85 C1 PG4 C1130 A 126 LEU C 96 LEU~? 10.59 O1 PG4 C1130 A 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -22.38 -16.85 -29.95 -24.08 -18.13 -30.36 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 A 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 A 126 LEU C 79 LEU~? -4.57 C5 PG4 C1130s A 158 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 A 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 A 126 LEU C 103 LEU~? 13.07 C1 PG4 C1130 A 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 A 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 A 126 LEU C 103 LEU~? 13.07 C1 PG4 C1130 A 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 A 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 A 126 LEU C 119 LEU~? 12.55 C1 PG4 C1130 A 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 A 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 A 126 LEU C 119 LEU~? 12.55 C1 PG4 C1130 A 158 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 A 70 ALA D 30 ALA~? 29.97 C6 P6G D1130 A 126 LEU D 33 LEU~? 24.56 C6 P6G D1130 A 158 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.96 0.45 -75.16 14.44 1.05 -76.44 coo -4.62 32.83 147.14 -5.50 32.85 149.12 17.19 1.44 -71.70 18.51 3.04 -71.02 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 A 70 ALA D 42 ALA~? 12.47 C6 P6G D1130 A 126 LEU D 40 LEU~? 15.03 C8 P6G D1130 A 158 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.53 6.70 -57.84 12.64 5.49 -58.11 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.53 5.09 -62.01 20.58 4.43 -62.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 A 70 ALA D 42 ALA~? 12.47 C6 P6G D1130 A 126 LEU D 63 LEU.? 16.70 C6 P6G D1130 A 158 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.53 6.70 -57.84 12.64 5.49 -58.11 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.42 2.69 -60.22 9.99 3.13 -61.63 coo -0.83 29.57 149.77 -0.39 31.47 148.95 7.67 8.26 -62.85 7.30 9.08 -64.79 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 A 70 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 126 LEU D 79 LEU~? -4.46 C12 P6G D1130s A 158 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.35 7.56 -40.77 12.01 7.28 -40.05 coo -4.62 32.83 147.14 -5.50 32.85 149.12 15.99 10.92 -40.88 15.13 11.96 -42.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 A 70 ALA D 90 ALA.? 17.47 C18 P6G D1130 A 126 LEU D 86 LEU~? 8.72 C18 P6G D1130 A 158 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.43 19.70 -33.25 29.64 20.34 -32.58 coo -4.62 32.83 147.14 -5.50 32.85 149.12 24.52 16.51 -38.13 24.47 16.89 -40.23 coo -0.83 29.57 149.77 -0.39 31.47 148.95 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 A 70 ALA D 95 ALA~? 9.46 C18 P6G D1130 A 126 LEU D 96 LEU~? 10.22 O19 P6G D1130 A 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 20.99 18.21 -37.32 21.64 17.75 -36.04 coo -4.62 32.83 147.14 -5.50 32.85 149.12 17.51 21.39 -36.10 15.86 22.74 -35.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 A 70 ALA D 102 ALA~? 8.61 C12 P6G D1130 A 126 LEU D 79 LEU~? -4.46 C12 P6G D1130s A 158 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.48 11.81 -38.76 13.67 11.43 -37.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 15.99 10.92 -40.88 15.13 11.96 -42.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 A 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 A 126 LEU D 103 LEU~? 12.85 C18 P6G D1130 A 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.81 12.67 -32.57 12.84 12.61 -33.73 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.97 14.18 -35.42 8.61 14.71 -33.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 44 3 # 44 A 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 A 126 LEU D 119 LEU~? 12.39 C18 P6G D1130 A 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.81 12.67 -32.57 12.84 12.61 -33.73 coo -4.62 32.83 147.14 -5.50 32.85 149.12 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -0.83 29.57 149.77 -0.39 31.47 148.95 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 45 3 # 45 A 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 A 126 LEU D 119 LEU~? 12.39 C18 P6G D1130 A 158 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.81 12.67 -32.57 12.84 12.61 -33.73 coo -4.62 32.83 147.14 -5.50 32.85 149.12 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -0.83 29.57 149.77 -0.39 31.47 148.95 14.39 19.77 -25.34 13.72 21.78 -25.43 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 45 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 30 ALA~? 29.61 O5 PG4 C1130 B 126 LEU A 33 LEU~? 24.42 O5 PG4 C1130 B 158 GLU A 37 GLU~? 22.40 O5 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -15.40 4.53 10.49 -14.90 5.74 11.30 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -17.69 3.68 6.99 -19.58 4.76 6.65 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -18.08 5.74 1.85 -17.77 7.24 3.33 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 42 ALA~? 12.59 O5 PG4 C1130 B 126 LEU A 40 LEU~? 14.12 O5 PG4 C1130 B 158 GLU A 37 GLU~? 22.40 O5 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -14.02 2.58 -7.96 -13.02 1.59 -7.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -19.01 2.30 -3.28 -21.00 1.45 -3.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -18.08 5.74 1.85 -17.77 7.24 3.33 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 42 ALA~? 12.59 O5 PG4 C1130 B 126 LEU A 63 LEU.? 17.30 O5 PG4 C1130 B 158 GLU A 61 GLU~? 21.55 O5 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -14.02 2.58 -7.96 -13.02 1.59 -7.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -8.80 0.30 -4.09 -10.26 1.63 -3.22 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.37 6.43 -4.11 -7.95 7.95 -2.68 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 76 ALA~? 14.67 C6 PG4 C1130 B 126 LEU A 79 LEU~? 16.24 C6 PG4 C1130 B 158 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 90 ALA.? 19.83 O1 P6G D1130 B 126 LEU A 86 LEU~? 23.09 C6 PG4 C1130 B 158 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA A 95 ALA~? 21.68 O1 P6G D1130 B 126 LEU A 96 LEU~? 18.30 O1 P6G D1130 B 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA A 95 ALA~? 21.68 O1 P6G D1130 B 126 LEU A 96 LEU~? 18.30 O1 P6G D1130 B 158 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA A 102 ALA~? 18.16 C6 PG4 C1130 B 126 LEU A 79 LEU~? 16.24 C6 PG4 C1130 B 158 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 B 126 LEU A 103 LEU~? 23.56 C6 PG4 C1130 B 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 B 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 B 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 B 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 B 158 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA A 127 ALA.? 9.98 O1 P6G D1130 B 126 LEU D 70 LEU~? 9.48 O1 P6G D1130 B 158 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo -34.22 5.06 149.25 -33.65 4.24 151.15 11.83 -2.12 -46.05 12.13 -4.20 -45.51 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA B 30 ALA~? 30.31 C6 P6G D1130 B 126 LEU B 33 LEU~? 24.97 C6 P6G D1130 B 158 GLU B 37 GLU~? 22.87 C6 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.57 -3.13 -74.32 24.12 -4.20 -75.25 coo -34.22 5.06 149.25 -33.65 4.24 151.15 21.31 -2.38 -70.71 19.18 -2.95 -70.61 coo -33.03 9.93 151.71 -34.98 9.38 151.11 20.90 -4.08 -65.74 21.08 -5.77 -67.00 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA B 42 ALA~? 13.18 O4 P6G D1130 B 126 LEU B 40 LEU~? 14.67 C6 P6G D1130 B 158 GLU B 37 GLU~? 22.87 C6 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.08 -0.64 -55.99 26.08 0.25 -56.74 coo -34.22 5.06 149.25 -33.65 4.24 151.15 20.03 -0.73 -60.50 18.12 0.25 -60.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 20.90 -4.08 -65.74 21.08 -5.77 -67.00 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA B 42 ALA~? 13.18 O4 P6G D1130 B 126 LEU B 63 LEU.? 18.00 C8 P6G D1130 B 158 GLU B 61 GLU~? 21.58 O4 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 25.08 -0.64 -55.99 26.08 0.25 -56.74 coo -34.22 5.06 149.25 -33.65 4.24 151.15 30.19 1.62 -60.10 28.89 0.05 -60.91 coo -33.03 9.93 151.71 -34.98 9.38 151.11 30.88 -4.52 -59.91 31.08 -6.09 -61.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA B 76 ALA~? 14.74 C11 P6G D1130 B 126 LEU B 79 LEU~? 15.03 C3 P6G D1130 B 158 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 33.17 9.74 -42.93 33.99 10.72 -43.77 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.24 7.10 -39.73 34.51 5.30 -40.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA B 90 ALA.? 29.32 O1 P6G D1130 B 126 LEU B 86 LEU~? 21.10 C2 P6G D1130 B 158 GLU B 94 GLU~? 22.51 C2 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 39.13 5.51 -23.62 39.54 5.36 -22.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 36.40 4.60 -30.00 35.97 2.83 -31.17 coo -33.03 9.93 151.71 -34.98 9.38 151.11 38.57 0.93 -32.34 39.48 -0.67 -33.39 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA B 95 ALA~? 23.69 C3 P6G D1130 B 126 LEU B 96 LEU~? 27.30 C3 P6G D1130 B 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 39.47 6.03 -32.16 39.38 7.03 -31.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 44.10 6.64 -33.57 46.02 7.50 -33.98 coo -33.03 9.93 151.71 -34.98 9.38 151.11 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA B 102 ALA~? 17.96 C11 P6G D1130 B 126 LEU B 79 LEU~? 15.03 C3 P6G D1130 B 158 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 37.30 9.41 -41.92 36.70 9.99 -40.66 coo -34.22 5.06 149.25 -33.65 4.24 151.15 34.24 7.10 -39.73 34.51 5.30 -40.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA B 102 ALA~? 17.96 C11 P6G D1130 B 126 LEU B 103 LEU~? 23.43 C11 P6G D1130 B 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 37.30 9.41 -41.92 36.70 9.99 -40.66 coo -34.22 5.06 149.25 -33.65 4.24 151.15 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 B 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 B 126 LEU B 103 LEU~? 23.43 C11 P6G D1130 B 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -34.22 5.06 149.25 -33.65 4.24 151.15 41.52 11.84 -42.16 43.44 12.66 -42.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 B 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 B 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 B 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -34.22 5.06 149.25 -33.65 4.24 151.15 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -33.03 9.93 151.71 -34.98 9.38 151.11 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 B 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 B 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 B 158 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -34.22 5.06 149.25 -33.65 4.24 151.15 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -33.03 9.93 151.71 -34.98 9.38 151.11 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 B 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 B 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 B 158 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 39.06 14.29 -38.29 39.19 13.64 -39.65 coo -34.22 5.06 149.25 -33.65 4.24 151.15 43.87 12.60 -35.81 43.71 11.06 -37.32 coo -33.03 9.93 151.71 -34.98 9.38 151.11 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 B 70 ALA C 30 ALA~? 29.34 O5 PG4 C1130 B 126 LEU C 33 LEU~? 24.39 O5 PG4 C1130 B 158 GLU C 37 GLU~? 22.29 O5 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -23.96 1.34 11.06 -24.54 0.77 12.35 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -21.63 -0.11 7.58 -19.56 -0.63 7.98 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -21.28 -3.96 3.81 -21.51 -4.93 5.68 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 B 70 ALA C 42 ALA~? 11.94 O5 PG4 C1130 B 126 LEU C 40 LEU~? 13.85 O5 PG4 C1130 B 158 GLU C 37 GLU~? 22.29 O5 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.35 -3.23 -2.13 -18.56 -3.80 -3.25 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -21.28 -3.96 3.81 -21.51 -4.93 5.68 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 B 70 ALA C 42 ALA~? 11.94 O5 PG4 C1130 B 126 LEU C 63 LEU.? 16.71 O5 PG4 C1130 B 158 GLU C 61 GLU~? 21.06 O5 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.88 -1.64 -3.09 -28.87 -1.48 -2.33 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 B 70 ALA C 76 ALA~? 8.86 O4 PG4 C1130 B 126 LEU C 79 LEU~? -4.57 C5 PG4 C1130s B 158 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 B 70 ALA C 90 ALA.? 17.94 C1 PG4 C1130 B 126 LEU C 86 LEU~? 9.11 C1 PG4 C1130 B 158 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 B 70 ALA C 95 ALA~? 9.85 C1 PG4 C1130 B 126 LEU C 96 LEU~? 10.59 O1 PG4 C1130 B 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -22.38 -16.85 -29.95 -24.08 -18.13 -30.36 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 B 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 B 126 LEU C 79 LEU~? -4.57 C5 PG4 C1130s B 158 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 B 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 B 126 LEU C 103 LEU~? 13.07 C1 PG4 C1130 B 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 B 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 B 126 LEU C 103 LEU~? 13.07 C1 PG4 C1130 B 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 B 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 B 126 LEU C 119 LEU~? 12.55 C1 PG4 C1130 B 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 B 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 B 126 LEU C 119 LEU~? 12.55 C1 PG4 C1130 B 158 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 B 70 ALA D 30 ALA~? 29.97 C6 P6G D1130 B 126 LEU D 33 LEU~? 24.56 C6 P6G D1130 B 158 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.96 0.45 -75.16 14.44 1.05 -76.44 coo -34.22 5.06 149.25 -33.65 4.24 151.15 17.19 1.44 -71.70 18.51 3.04 -71.02 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 B 70 ALA D 42 ALA~? 12.47 C6 P6G D1130 B 126 LEU D 40 LEU~? 15.03 C8 P6G D1130 B 158 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.53 6.70 -57.84 12.64 5.49 -58.11 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.53 5.09 -62.01 20.58 4.43 -62.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 B 70 ALA D 42 ALA~? 12.47 C6 P6G D1130 B 126 LEU D 63 LEU.? 16.70 C6 P6G D1130 B 158 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.53 6.70 -57.84 12.64 5.49 -58.11 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.42 2.69 -60.22 9.99 3.13 -61.63 coo -33.03 9.93 151.71 -34.98 9.38 151.11 7.67 8.26 -62.85 7.30 9.08 -64.79 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 B 70 ALA D 76 ALA~? 8.45 O1 P6G D1130 B 126 LEU D 79 LEU~? -4.46 C12 P6G D1130s B 158 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.35 7.56 -40.77 12.01 7.28 -40.05 coo -34.22 5.06 149.25 -33.65 4.24 151.15 15.99 10.92 -40.88 15.13 11.96 -42.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 B 70 ALA D 90 ALA.? 17.47 C18 P6G D1130 B 126 LEU D 86 LEU~? 8.72 C18 P6G D1130 B 158 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.43 19.70 -33.25 29.64 20.34 -32.58 coo -34.22 5.06 149.25 -33.65 4.24 151.15 24.52 16.51 -38.13 24.47 16.89 -40.23 coo -33.03 9.93 151.71 -34.98 9.38 151.11 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 B 70 ALA D 95 ALA~? 9.46 C18 P6G D1130 B 126 LEU D 96 LEU~? 10.22 O19 P6G D1130 B 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 20.99 18.21 -37.32 21.64 17.75 -36.04 coo -34.22 5.06 149.25 -33.65 4.24 151.15 17.51 21.39 -36.10 15.86 22.74 -35.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 B 70 ALA D 102 ALA~? 8.61 C12 P6G D1130 B 126 LEU D 79 LEU~? -4.46 C12 P6G D1130s B 158 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.48 11.81 -38.76 13.67 11.43 -37.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 15.99 10.92 -40.88 15.13 11.96 -42.64 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 B 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 B 126 LEU D 103 LEU~? 12.85 C18 P6G D1130 B 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.81 12.67 -32.57 12.84 12.61 -33.73 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.97 14.18 -35.42 8.61 14.71 -33.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 44 3 # 44 B 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 B 126 LEU D 119 LEU~? 12.39 C18 P6G D1130 B 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.81 12.67 -32.57 12.84 12.61 -33.73 coo -34.22 5.06 149.25 -33.65 4.24 151.15 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -33.03 9.93 151.71 -34.98 9.38 151.11 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 45 3 # 45 B 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 B 126 LEU D 119 LEU~? 12.39 C18 P6G D1130 B 158 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.81 12.67 -32.57 12.84 12.61 -33.73 coo -34.22 5.06 149.25 -33.65 4.24 151.15 13.90 18.18 -31.81 13.32 18.29 -33.87 coo -33.03 9.93 151.71 -34.98 9.38 151.11 14.39 19.77 -25.34 13.72 21.78 -25.43 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 45 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 30 ALA~? 29.61 O5 PG4 C1130 C 126 LEU A 33 LEU~? 24.42 O5 PG4 C1130 C 158 GLU A 37 GLU~? 22.40 O5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -15.40 4.53 10.49 -14.90 5.74 11.30 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -17.69 3.68 6.99 -19.58 4.76 6.65 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -18.08 5.74 1.85 -17.77 7.24 3.33 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 42 ALA~? 12.59 O5 PG4 C1130 C 126 LEU A 40 LEU~? 14.12 O5 PG4 C1130 C 158 GLU A 37 GLU~? 22.40 O5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -14.02 2.58 -7.96 -13.02 1.59 -7.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -19.01 2.30 -3.28 -21.00 1.45 -3.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -18.08 5.74 1.85 -17.77 7.24 3.33 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 42 ALA~? 12.59 O5 PG4 C1130 C 126 LEU A 63 LEU.? 17.30 O5 PG4 C1130 C 158 GLU A 61 GLU~? 21.55 O5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -14.02 2.58 -7.96 -13.02 1.59 -7.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -8.80 0.30 -4.09 -10.26 1.63 -3.22 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -8.37 6.43 -4.11 -7.95 7.95 -2.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 76 ALA~? 14.67 C6 PG4 C1130 C 126 LEU A 79 LEU~? 16.24 C6 PG4 C1130 C 158 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 90 ALA.? 19.83 O1 P6G D1130 C 126 LEU A 86 LEU~? 23.09 C6 PG4 C1130 C 158 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -1.34 0.01 -40.98 -1.00 0.24 -42.46 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.85 0.15 -34.51 -4.48 1.96 -33.39 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 95 ALA~? 21.68 O1 P6G D1130 C 126 LEU A 96 LEU~? 18.30 O1 P6G D1130 C 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA A 95 ALA~? 21.68 O1 P6G D1130 C 126 LEU A 96 LEU~? 18.30 O1 P6G D1130 C 158 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.67 -0.88 -32.75 -0.76 -1.67 -34.05 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.08 -1.45 -31.59 6.05 -1.57 -30.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA A 102 ALA~? 18.16 C6 PG4 C1130 C 126 LEU A 79 LEU~? 16.24 C6 PG4 C1130 C 158 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 C 126 LEU A 103 LEU~? 23.56 C6 PG4 C1130 C 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.20 -7.99 -23.80 3.77 -9.56 -23.73 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 C 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 C 158 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 C 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 C 158 GLU A 120 GLU~? 20.88 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.82 -11.06 -31.67 7.44 -9.70 -30.14 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA A 115 ALA~? 21.26 C6 PG4 C1130 C 126 LEU A 119 LEU~? 21.73 O1 P6G D1130 C 158 GLU A 121 GLU~? 21.00 O1 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.35 -7.51 -29.89 4.64 -5.95 -28.37 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.80 -10.41 -36.92 3.82 -11.51 -38.44 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA A 127 ALA.? 9.98 O1 P6G D1130 C 126 LEU D 70 LEU~? 9.48 O1 P6G D1130 C 158 GLU D 69 GLU~? 15.99 C6 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 11.83 -2.12 -46.05 12.13 -4.20 -45.51 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.13 -2.81 -47.72 4.71 -3.46 -49.70 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA B 30 ALA~? 30.31 C6 P6G D1130 C 126 LEU B 33 LEU~? 24.97 C6 P6G D1130 C 158 GLU B 37 GLU~? 22.87 C6 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.57 -3.13 -74.32 24.12 -4.20 -75.25 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 21.31 -2.38 -70.71 19.18 -2.95 -70.61 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 20.90 -4.08 -65.74 21.08 -5.77 -67.00 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA B 42 ALA~? 13.18 O4 P6G D1130 C 126 LEU B 40 LEU~? 14.67 C6 P6G D1130 C 158 GLU B 37 GLU~? 22.87 C6 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.08 -0.64 -55.99 26.08 0.25 -56.74 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 20.03 -0.73 -60.50 18.12 0.25 -60.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 20.90 -4.08 -65.74 21.08 -5.77 -67.00 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA B 42 ALA~? 13.18 O4 P6G D1130 C 126 LEU B 63 LEU.? 18.00 C8 P6G D1130 C 158 GLU B 61 GLU~? 21.58 O4 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 25.08 -0.64 -55.99 26.08 0.25 -56.74 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 30.19 1.62 -60.10 28.89 0.05 -60.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 30.88 -4.52 -59.91 31.08 -6.09 -61.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA B 76 ALA~? 14.74 C11 P6G D1130 C 126 LEU B 79 LEU~? 15.03 C3 P6G D1130 C 158 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 33.17 9.74 -42.93 33.99 10.72 -43.77 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.24 7.10 -39.73 34.51 5.30 -40.93 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA B 90 ALA.? 29.32 O1 P6G D1130 C 126 LEU B 86 LEU~? 21.10 C2 P6G D1130 C 158 GLU B 94 GLU~? 22.51 C2 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 39.13 5.51 -23.62 39.54 5.36 -22.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 36.40 4.60 -30.00 35.97 2.83 -31.17 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 38.57 0.93 -32.34 39.48 -0.67 -33.39 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA B 95 ALA~? 23.69 C3 P6G D1130 C 126 LEU B 96 LEU~? 27.30 C3 P6G D1130 C 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 39.47 6.03 -32.16 39.38 7.03 -31.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 44.10 6.64 -33.57 46.02 7.50 -33.98 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA B 102 ALA~? 17.96 C11 P6G D1130 C 126 LEU B 79 LEU~? 15.03 C3 P6G D1130 C 158 GLU B 82 GLU~? 13.30 C2 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 37.30 9.41 -41.92 36.70 9.99 -40.66 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 34.24 7.10 -39.73 34.51 5.30 -40.93 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 30.92 4.89 -35.74 29.30 4.17 -34.66 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA B 102 ALA~? 17.96 C11 P6G D1130 C 126 LEU B 103 LEU~? 23.43 C11 P6G D1130 C 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 37.30 9.41 -41.92 36.70 9.99 -40.66 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 41.52 11.84 -42.16 43.44 12.66 -42.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 C 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 C 126 LEU B 103 LEU~? 23.43 C11 P6G D1130 C 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 39.06 14.29 -38.29 39.19 13.64 -39.65 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 41.52 11.84 -42.16 43.44 12.66 -42.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 23 3 # 23 C 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 C 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 C 158 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 39.06 14.29 -38.29 39.19 13.64 -39.65 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 43.87 12.60 -35.81 43.71 11.06 -37.32 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 24 3 # 24 C 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 C 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 C 158 GLU B 120 GLU~? 31.89 C11 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 39.06 14.29 -38.29 39.19 13.64 -39.65 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 43.87 12.60 -35.81 43.71 11.06 -37.32 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 46.57 16.64 -34.21 48.52 15.81 -33.97 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 25 3 # 25 C 70 ALA B 115 ALA~? 21.00 C11 P6G D1130 C 126 LEU B 119 LEU~? 26.05 C11 P6G D1130 C 158 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 39.06 14.29 -38.29 39.19 13.64 -39.65 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 43.87 12.60 -35.81 43.71 11.06 -37.32 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 26 3 # 26 C 70 ALA C 30 ALA~? 29.34 O5 PG4 C1130 C 126 LEU C 33 LEU~? 24.39 O5 PG4 C1130 C 158 GLU C 37 GLU~? 22.29 O5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -23.96 1.34 11.06 -24.54 0.77 12.35 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -21.63 -0.11 7.58 -19.56 -0.63 7.98 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -21.28 -3.96 3.81 -21.51 -4.93 5.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 27 3 # 27 C 70 ALA C 42 ALA~? 11.94 O5 PG4 C1130 C 126 LEU C 40 LEU~? 13.85 O5 PG4 C1130 C 158 GLU C 37 GLU~? 22.29 O5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.35 -3.23 -2.13 -18.56 -3.80 -3.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -21.28 -3.96 3.81 -21.51 -4.93 5.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 28 3 # 28 C 70 ALA C 42 ALA~? 11.94 O5 PG4 C1130 C 126 LEU C 63 LEU.? 16.71 O5 PG4 C1130 C 158 GLU C 61 GLU~? 21.06 O5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.88 -1.64 -3.09 -28.87 -1.48 -2.33 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -31.20 -6.64 -1.02 -31.34 -7.32 1.00 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 29 3 # 29 C 70 ALA C 76 ALA~? 8.86 O4 PG4 C1130 C 126 LEU C 79 LEU~? -4.57 C5 PG4 C1130s C 158 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 30 3 # 30 C 70 ALA C 90 ALA.? 17.94 C1 PG4 C1130 C 126 LEU C 86 LEU~? 9.11 C1 PG4 C1130 C 158 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 31 3 # 31 C 70 ALA C 90 ALA.? 17.94 C1 PG4 C1130 C 126 LEU C 86 LEU~? 9.11 C1 PG4 C1130 C 158 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 32 3 # 32 C 70 ALA C 95 ALA~? 9.85 C1 PG4 C1130 C 126 LEU C 86 LEU~? 9.11 C1 PG4 C1130 C 158 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 33 3 # 33 C 70 ALA C 95 ALA~? 9.85 C1 PG4 C1130 C 126 LEU C 96 LEU~? 10.59 O1 PG4 C1130 C 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -22.38 -16.85 -29.95 -24.08 -18.13 -30.36 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 34 3 # 34 C 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 C 126 LEU C 79 LEU~? -4.57 C5 PG4 C1130s C 158 GLU C 82 GLU~? -3.24 C6 PG4 C1130s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 35 3 # 35 C 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 C 126 LEU C 103 LEU~? 13.07 C1 PG4 C1130 C 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 36 3 # 36 C 70 ALA C 102 ALA~? 8.71 C5 PG4 C1130 C 126 LEU C 105 LEU~? 9.45 O3 PG4 C1130 C 158 GLU C 52 GLU~? 9.38 O2 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 37 3 # 37 C 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 C 126 LEU C 103 LEU~? 13.07 C1 PG4 C1130 C 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -29.89 -9.83 -29.16 -31.45 -10.15 -30.60 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 38 3 # 38 C 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 C 126 LEU C 119 LEU~? 12.55 C1 PG4 C1130 C 158 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 39 3 # 39 C 70 ALA C 115 ALA~? 12.20 C1 PG4 C1130 C 126 LEU C 119 LEU~? 12.55 C1 PG4 C1130 C 158 GLU C 120 GLU~? 18.24 C1 PG4 C1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.28 -7.35 -31.45 -27.18 -7.42 -30.20 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -26.14 -12.79 -32.78 -27.03 -14.39 -31.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.35 -14.00 -38.85 -28.54 -15.05 -37.43 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 40 3 # 40 C 70 ALA D 30 ALA~? 29.97 C6 P6G D1130 C 126 LEU D 33 LEU~? 24.56 C6 P6G D1130 C 158 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.96 0.45 -75.16 14.44 1.05 -76.44 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 17.19 1.44 -71.70 18.51 3.04 -71.02 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 41 3 # 41 C 70 ALA D 42 ALA~? 12.47 C6 P6G D1130 C 126 LEU D 40 LEU~? 15.03 C8 P6G D1130 C 158 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.53 6.70 -57.84 12.64 5.49 -58.11 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.53 5.09 -62.01 20.58 4.43 -62.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 42 3 # 42 C 70 ALA D 42 ALA~? 12.47 C6 P6G D1130 C 126 LEU D 63 LEU.? 16.70 C6 P6G D1130 C 158 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.53 6.70 -57.84 12.64 5.49 -58.11 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.42 2.69 -60.22 9.99 3.13 -61.63 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 7.67 8.26 -62.85 7.30 9.08 -64.79 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 43 3 # 43 C 70 ALA D 76 ALA~? 8.45 O1 P6G D1130 C 126 LEU D 79 LEU~? -4.46 C12 P6G D1130s C 158 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 15.99 10.92 -40.88 15.13 11.96 -42.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 44 3 # 44 C 70 ALA D 90 ALA.? 17.47 C18 P6G D1130 C 126 LEU D 86 LEU~? 8.72 C18 P6G D1130 C 158 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.43 19.70 -33.25 29.64 20.34 -32.58 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 24.52 16.51 -38.13 24.47 16.89 -40.23 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 45 3 # 45 C 70 ALA D 95 ALA~? 9.46 C18 P6G D1130 C 126 LEU D 96 LEU~? 10.22 O19 P6G D1130 C 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 20.99 18.21 -37.32 21.64 17.75 -36.04 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 17.51 21.39 -36.10 15.86 22.74 -35.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 46 3 # 46 C 70 ALA D 102 ALA~? 8.61 C12 P6G D1130 C 126 LEU D 79 LEU~? -4.46 C12 P6G D1130s C 158 GLU D 82 GLU~? -3.29 C11 P6G D1130s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 15.99 10.92 -40.88 15.13 11.96 -42.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.48 10.01 -42.20 22.42 10.27 -44.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 47 3 # 47 C 70 ALA D 102 ALA~? 8.61 C12 P6G D1130 C 126 LEU D 105 LEU~? 9.27 O13 P6G D1130 C 158 GLU D 52 GLU~? 9.77 O16 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.44 10.53 -41.97 9.61 9.55 -43.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 7.48 14.12 -48.51 7.76 13.12 -46.67 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 48 3 # 48 C 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 C 126 LEU D 103 LEU~? 12.85 C18 P6G D1130 C 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.81 12.67 -32.57 12.84 12.61 -33.73 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.97 14.18 -35.42 8.61 14.71 -33.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 49 3 # 49 C 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 C 126 LEU D 119 LEU~? 12.39 C18 P6G D1130 C 158 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.81 12.67 -32.57 12.84 12.61 -33.73 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 13.90 18.18 -31.81 13.32 18.29 -33.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 50 3 # 50 C 70 ALA D 115 ALA~? 12.07 C18 P6G D1130 C 126 LEU D 119 LEU~? 12.39 C18 P6G D1130 C 158 GLU D 120 GLU~? 20.19 C18 P6G D1130 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.81 12.67 -32.57 12.84 12.61 -33.73 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 13.90 18.18 -31.81 13.32 18.29 -33.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 14.39 19.77 -25.34 13.72 21.78 -25.43 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 50 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 270 LYS C 101 LYS~? -2.55 O1 PG4 C1130s A 382 MET C 68 MET~? 12.63 O5 PG4 C1130 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -27.44 -11.68 -24.14 -24.62 -14.57 -19.42 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -30.41 2.93 -12.23 -31.33 -0.17 -10.57 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 270 LYS A 124 LYS~? 16.08 O1 P6G D1130 B 382 MET D 68 MET~? 11.39 C6 P6G D1130 coo -11.82 154.51 43.38 -12.86 152.74 43.79 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo -5.09 158.39 43.41 -0.74 158.80 47.15 8.72 -6.45 -38.52 11.43 -11.38 -40.04 coo -2.79 145.52 50.38 -5.75 148.14 51.66 9.09 -0.77 -50.99 8.49 2.12 -52.39 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c03 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 106 SER~? 15.55 C4 PG4 C1130 B 69 ALA A 102 ALA~? 18.16 C6 PG4 C1130 B 241 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 13.24 41.94 33.13 13.08 39.54 33.17 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 coo 9.15 37.89 36.69 10.55 37.76 37.22 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 coo 10.91 43.03 38.47 11.81 41.82 36.93 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 106 SER~? 15.38 C14 P6G D1130 B 69 ALA B 102 ALA~? 17.96 C11 P6G D1130 B 241 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 13.24 41.94 33.13 13.08 39.54 33.17 36.13 12.10 -48.03 34.30 13.65 -47.56 coo 9.15 37.89 36.69 10.55 37.76 37.22 37.30 9.41 -41.92 36.70 9.99 -40.66 coo 10.91 43.03 38.47 11.81 41.82 36.93 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER C 106 SER~? 13.31 O4 PG4 C1130 B 69 ALA C 102 ALA~? 8.71 C5 PG4 C1130 B 241 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 13.24 41.94 33.13 13.08 39.54 33.17 -31.92 -4.19 -24.90 -31.13 -2.43 -26.36 coo 9.15 37.89 36.69 10.55 37.76 37.22 -27.42 -8.11 -25.47 -26.21 -7.45 -26.18 coo 10.91 43.03 38.47 11.81 41.82 36.93 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER D 106 SER~? 11.54 O1 P6G D1130 B 69 ALA D 102 ALA~? 8.61 C12 P6G D1130 B 241 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 13.24 41.94 33.13 13.08 39.54 33.17 8.27 7.70 -38.86 9.17 6.34 -37.11 coo 9.15 37.89 36.69 10.55 37.76 37.22 12.48 11.81 -38.76 13.67 11.43 -37.93 coo 10.91 43.03 38.47 11.81 41.82 36.93 7.42 15.00 -39.68 7.34 16.70 -38.37 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 4 hits 1pnl_c00 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 126 LEU~? 13.09 O1 P6G D1130 A 58 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 120 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 34.02 69.29 75.26 34.82 67.82 76.74 8.17 -0.63 -37.01 6.46 0.51 -36.38 coo 34.46 72.45 78.57 32.82 72.75 77.28 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 28.96 77.64 81.19 29.05 74.53 77.51 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 126 LEU~? 13.09 O1 P6G D1130 A 58 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 120 LYS D 112 LYS~? 16.61 O1 P6G D1130 coo 34.02 69.29 75.26 34.82 67.82 76.74 8.17 -0.63 -37.01 6.46 0.51 -36.38 coo 34.46 72.45 78.57 32.82 72.75 77.28 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 28.96 77.64 81.19 29.05 74.53 77.51 9.54 9.95 -32.52 4.98 7.78 -34.65 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU C 86 LEU~? 9.11 C1 PG4 C1130 A 58 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 120 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 34.02 69.29 75.26 34.82 67.82 76.74 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 34.46 72.45 78.57 32.82 72.75 77.28 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 28.96 77.64 81.19 29.05 74.53 77.51 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU C 86 LEU~? 9.11 C1 PG4 C1130 A 58 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 120 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 34.02 69.29 75.26 34.82 67.82 76.74 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 34.46 72.45 78.57 32.82 72.75 77.28 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 28.96 77.64 81.19 29.05 74.53 77.51 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU D 86 LEU~? 8.72 C18 P6G D1130 A 58 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 120 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 34.02 69.29 75.26 34.82 67.82 76.74 24.52 16.51 -38.13 24.47 16.89 -40.23 coo 34.46 72.45 78.57 32.82 72.75 77.28 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 28.96 77.64 81.19 29.05 74.53 77.51 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 A 48 LEU D 86 LEU~? 8.72 C18 P6G D1130 A 58 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 120 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 34.02 69.29 75.26 34.82 67.82 76.74 24.52 16.51 -38.13 24.47 16.89 -40.23 coo 34.46 72.45 78.57 32.82 72.75 77.28 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 28.96 77.64 81.19 29.05 74.53 77.51 30.12 7.76 -44.06 30.09 2.81 -42.01 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 6 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 126 LEU~? 13.09 O1 P6G D1130 B 58 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 120 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 54.50 104.32 58.69 55.83 105.69 59.81 8.17 -0.63 -37.01 6.46 0.51 -36.38 coo 57.63 101.19 59.83 56.60 100.89 57.99 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 61.58 95.88 55.22 58.18 99.30 54.71 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 126 LEU~? 13.09 O1 P6G D1130 B 58 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 120 LYS D 112 LYS~? 16.61 O1 P6G D1130 coo 54.50 104.32 58.69 55.83 105.69 59.81 8.17 -0.63 -37.01 6.46 0.51 -36.38 coo 57.63 101.19 59.83 56.60 100.89 57.99 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 61.58 95.88 55.22 58.18 99.30 54.71 9.54 9.95 -32.52 4.98 7.78 -34.65 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU C 86 LEU~? 9.11 C1 PG4 C1130 B 58 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 120 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 54.50 104.32 58.69 55.83 105.69 59.81 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 57.63 101.19 59.83 56.60 100.89 57.99 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 61.58 95.88 55.22 58.18 99.30 54.71 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU C 86 LEU~? 9.11 C1 PG4 C1130 B 58 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 120 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 54.50 104.32 58.69 55.83 105.69 59.81 -15.11 -12.44 -27.61 -15.01 -13.25 -25.57 coo 57.63 101.19 59.83 56.60 100.89 57.99 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 61.58 95.88 55.22 58.18 99.30 54.71 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU D 86 LEU~? 8.72 C18 P6G D1130 B 58 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 120 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 54.50 104.32 58.69 55.83 105.69 59.81 24.52 16.51 -38.13 24.47 16.89 -40.23 coo 57.63 101.19 59.83 56.60 100.89 57.99 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 61.58 95.88 55.22 58.18 99.30 54.71 30.12 7.76 -44.06 30.09 2.81 -42.01 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 68 ALA A 127 ALA.? 9.98 O1 P6G D1130 A 72 LEU D 70 LEU~? 9.48 O1 P6G D1130 coo 46.76 7.59 18.65 45.27 6.01 18.52 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 48.88 4.35 16.59 48.73 5.09 15.20 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo 53.89 6.25 15.09 52.88 7.92 14.14 11.83 -2.12 -46.05 12.13 -4.20 -45.51 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 68 ALA A 81 ALA~? 14.49 C6 PG4 C1130 A 72 LEU A 79 LEU~? 16.24 C6 PG4 C1130 coo 46.76 7.59 18.65 45.27 6.01 18.52 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 48.88 4.35 16.59 48.73 5.09 15.20 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 53.89 6.25 15.09 52.88 7.92 14.14 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP C 129 ASP.? 25.37 C1 PG4 C1130 A 68 ALA C 127 ALA~? 21.60 O1 PG4 C1130 A 72 LEU C 126 LEU~? 15.98 O1 PG4 C1130 coo 46.76 7.59 18.65 45.27 6.01 18.52 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 coo 48.88 4.35 16.59 48.73 5.09 15.20 -21.48 -22.98 -39.56 -22.74 -22.35 -40.13 coo 53.89 6.25 15.09 52.88 7.92 14.14 -20.99 -21.60 -35.33 -20.67 -21.36 -33.23 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 68 ALA B 81 ALA~? 14.45 C11 P6G D1130 A 72 LEU B 79 LEU~? 15.03 C3 P6G D1130 coo 46.76 7.59 18.65 45.27 6.01 18.52 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 48.88 4.35 16.59 48.73 5.09 15.20 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 53.89 6.25 15.09 52.88 7.92 14.14 34.24 7.10 -39.73 34.51 5.30 -40.93 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP D 129 ASP.? 22.88 C18 P6G D1130 A 68 ALA D 127 ALA~? 21.80 O19 P6G D1130 A 72 LEU D 126 LEU~? 15.96 O19 P6G D1130 coo 46.76 7.59 18.65 45.27 6.01 18.52 23.03 25.83 -22.84 23.72 24.15 -23.95 coo 48.88 4.35 16.59 48.73 5.09 15.20 19.87 29.05 -27.32 18.84 28.51 -26.37 coo 53.89 6.25 15.09 52.88 7.92 14.14 19.64 27.10 -31.39 19.65 26.64 -33.51 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 5 hits 1q6l_c05 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 55.48 26.51 40.65 55.39 23.99 39.43 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 47.58 17.35 41.83 51.40 20.85 40.83 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 A 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 55.48 26.51 40.65 55.39 23.99 39.43 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 47.58 17.35 41.83 51.40 20.85 40.83 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 55.48 26.51 40.65 55.39 23.99 39.43 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 48.87 29.19 44.63 49.10 27.34 43.63 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 47.58 17.35 41.83 51.40 20.85 40.83 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 47.58 17.35 41.83 51.40 20.85 40.83 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 55.48 26.51 40.65 55.39 23.99 39.43 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 48.87 29.19 44.63 49.10 27.34 43.63 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 47.58 17.35 41.83 51.40 20.85 40.83 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 B 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 B 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 B 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 B 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 C 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 39.51 34.34 13.63 37.63 32.61 14.79 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 37.54 22.37 12.10 37.83 27.55 13.24 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 C 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 39.51 34.34 13.63 37.63 32.61 14.79 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 37.54 22.37 12.10 37.83 27.55 13.24 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 C 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 39.51 34.34 13.63 37.63 32.61 14.79 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 37.54 22.37 12.10 37.83 27.55 13.24 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 C 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 39.51 34.34 13.63 37.63 32.61 14.79 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 37.54 22.37 12.10 37.83 27.55 13.24 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR B 51 TYR~? 10.58 C3 P6G D1130 C 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 39.51 34.34 13.63 37.63 32.61 14.79 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 45.78 31.11 9.51 44.25 30.06 10.53 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 37.54 22.37 12.10 37.83 27.55 13.24 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR C 51 TYR~? 9.35 C8 PG4 C1130 C 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 37.54 22.37 12.10 37.83 27.55 13.24 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR D 51 TYR~? 9.17 O7 P6G D1130 C 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 39.51 34.34 13.63 37.63 32.61 14.79 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 45.78 31.11 9.51 44.25 30.06 10.53 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 37.54 22.37 12.10 37.83 27.55 13.24 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 D 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 D 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 D 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 D 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 D 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR B 51 TYR~? 10.58 C3 P6G D1130 D 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR C 51 TYR~? 9.35 C8 PG4 C1130 D 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR D 51 TYR~? 9.17 O7 P6G D1130 D 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 D 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 E 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 E 261 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 E 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 E 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 E 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 E 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 E 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 E 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 E 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 E 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 51 TYR~? 10.58 C3 P6G D1130 E 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 E 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 35.19 -0.96 -55.86 35.42 3.27 -52.50 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 F 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 F 261 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 F 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 F 261 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 F 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 F 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 F 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 F 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 F 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 F 261 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 F 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 F 261 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 F 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 F 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR C 46 TYR~? -4.42 C8 PG4 C1130s F 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 F 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 46 TYR~? -4.28 C6 P6G D1130s F 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 F 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 G 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 G 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 G 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 G 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 G 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 G 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 G 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 G 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR B 51 TYR~? 10.58 C3 P6G D1130 G 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 G 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR C 51 TYR~? 9.35 C8 PG4 C1130 G 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 G 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR D 51 TYR~? 9.17 O7 P6G D1130 G 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 G 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 46 TYR~? 5.44 O5 PG4 C1130 H 236 ASP A 50 ASP~? 13.04 O5 PG4 C1130 H 261 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 H 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 H 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 H 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 H 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR B 46 TYR~? 5.77 O4 P6G D1130 H 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 H 261 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR B 51 TYR~? 10.58 C3 P6G D1130 H 236 ASP B 50 ASP~? 8.75 C2 P6G D1130 H 261 LYS B 59 LYS~? 17.23 O4 P6G D1130 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 35.19 -0.96 -55.86 35.42 3.27 -52.50 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR C 51 TYR~? 9.35 C8 PG4 C1130 H 236 ASP C 50 ASP~? 5.21 O2 PG4 C1130 H 261 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR D 51 TYR~? 9.17 O7 P6G D1130 H 236 ASP D 50 ASP~? 5.15 O16 P6G D1130 H 261 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 15.84 8.23 -60.47 13.98 13.25 -60.76 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 C 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 C 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 39.01 29.77 22.02 37.48 31.30 19.84 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 4.55 4.63 -38.29 4.19 5.10 -40.34 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 D 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 D 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 4.55 4.63 -38.29 4.19 5.10 -40.34 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 A 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 C 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 55.48 26.51 40.65 55.39 23.99 39.43 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 52.39 23.42 32.10 54.51 23.27 34.29 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 B 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 D 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 G 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 G 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 4.55 4.63 -38.29 4.19 5.10 -40.34 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 H 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 H 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 4.55 4.63 -38.29 4.19 5.10 -40.34 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 E 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 G 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 92 TYR~? 17.76 O1 P6G D1130 F 236 ASP D 107 ASP.? 14.84 O1 P6G D1130 H 110 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.30 -1.46 -39.04 1.18 -2.64 -41.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 9.14 -6.20 -31.52 9.40 -6.54 -28.47 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 147 THR A 89 THR.? 25.53 O1 P6G D1130 A 294 ASP D 107 ASP.? 14.84 O1 P6G D1130 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 4.55 4.63 -38.29 4.19 5.10 -40.34 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 256 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 30.54 71.65 32.58 31.73 72.26 30.92 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 256 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 256 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 30.54 71.65 32.58 31.73 72.26 30.92 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 256 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 30.54 71.65 32.58 31.73 72.26 30.92 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 256 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 30.54 71.65 32.58 31.73 72.26 30.92 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 37.87 70.12 31.80 36.61 69.74 30.15 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 256 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 37.87 70.12 31.80 36.61 69.74 30.15 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1qho_c04 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 256 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 30.54 71.65 32.58 31.73 72.26 30.92 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1qho_c04 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 256 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 30.54 71.65 32.58 31.73 72.26 30.92 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 31.47 6.05 -29.78 29.50 6.72 -30.15 1qho_c04 source 1qho ALPHA-AMYLASE : 8 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 261 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 34.02 79.89 42.60 34.73 78.01 41.86 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 261 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 329 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 34.02 79.89 42.60 34.73 78.01 41.86 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 261 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 34.02 79.89 42.60 34.73 78.01 41.86 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.47 11.48 -38.21 26.51 9.40 -38.05 1qho_c05 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 260 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 28.46 69.88 26.74 30.40 70.70 26.53 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 30.73 81.29 37.61 31.23 82.07 35.69 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.47 11.48 -38.21 26.51 9.40 -38.05 1qho_c07 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 39 THR~? 15.12 O5 PG4 C1130 A 182 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 186 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 73.61 90.42 31.12 71.36 89.66 29.64 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 73.54 84.00 28.64 69.01 86.68 29.71 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR A 39 THR~? 15.12 O5 PG4 C1130 A 182 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 186 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 coo 73.61 90.42 31.12 71.36 89.66 29.64 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 73.54 84.00 28.64 69.01 86.68 29.71 -16.40 4.87 -5.99 -15.06 9.32 -8.17 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR B 39 THR~? 16.03 C8 P6G D1130 A 182 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 186 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 73.61 90.42 31.12 71.36 89.66 29.64 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 73.54 84.00 28.64 69.01 86.68 29.71 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR B 39 THR~? 16.03 C8 P6G D1130 A 182 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 186 LYS B 41 LYS~? 19.06 O4 P6G D1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 24.60 1.04 -60.68 24.34 2.92 -61.79 coo 73.61 90.42 31.12 71.36 89.66 29.64 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 73.54 84.00 28.64 69.01 86.68 29.71 22.58 -3.09 -57.56 22.63 -7.38 -61.16 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 5 3 # 5 A 145 THR C 39 THR~? 14.51 O5 PG4 C1130 A 182 TYR A 43 TYR~? 9.79 O5 PG4 C1130 A 186 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 73.61 90.42 31.12 71.36 89.66 29.64 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 73.54 84.00 28.64 69.01 86.68 29.71 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 6 3 # 6 A 145 THR C 39 THR~? 14.51 O5 PG4 C1130 A 182 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 186 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 coo 73.61 90.42 31.12 71.36 89.66 29.64 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 73.54 84.00 28.64 69.01 86.68 29.71 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 7 3 # 7 A 145 THR C 89 THR~? 14.94 C2 PG4 C1130 A 182 TYR A 118 TYR~? 23.63 C5 PG4 C1130 A 186 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 73.61 90.42 31.12 71.36 89.66 29.64 -1.38 -9.05 -33.65 -3.37 -9.97 -35.41 coo 73.54 84.00 28.64 69.01 86.68 29.71 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 8 3 # 8 A 145 THR D 39 THR~? 15.06 C6 P6G D1130 A 182 TYR B 43 TYR~? 10.38 C8 P6G D1130 A 186 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 73.61 90.42 31.12 71.36 89.66 29.64 21.94 3.80 -56.34 23.03 6.24 -57.25 coo 73.54 84.00 28.64 69.01 86.68 29.71 15.84 8.23 -60.47 13.98 13.25 -60.76 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 9 3 # 9 A 145 THR D 39 THR~? 15.06 C6 P6G D1130 A 182 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 186 LYS D 41 LYS~? 14.07 C15 P6G D1130 coo 69.38 87.38 24.64 71.11 88.47 25.40 14.20 3.05 -61.19 14.08 0.91 -60.92 coo 73.61 90.42 31.12 71.36 89.66 29.64 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 73.54 84.00 28.64 69.01 86.68 29.71 15.84 8.23 -60.47 13.98 13.25 -60.76 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 9 hits 1qrr_c01 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 201 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 227 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 12.68 46.83 36.69 18.26 48.67 34.51 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 98 PHE~? 19.95 C6 PG4 C1130 A 201 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 227 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 25.52 45.12 37.98 23.98 46.65 37.85 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 12.68 46.83 36.69 18.26 48.67 34.51 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 201 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 227 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 25.52 45.12 37.98 23.98 46.65 37.85 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 12.68 46.83 36.69 18.26 48.67 34.51 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 201 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 227 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 25.52 45.12 37.98 23.98 46.65 37.85 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 201 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 227 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 25.52 45.12 37.98 23.98 46.65 37.85 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 98 PHE~? 17.75 C3 P6G D1130 A 201 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 227 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 36.48 4.26 -36.04 35.13 1.81 -35.88 coo 25.52 45.12 37.98 23.98 46.65 37.85 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 12.68 46.83 36.69 18.26 48.67 34.51 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE C 54 PHE~? 9.47 C8 PG4 C1130 A 201 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 227 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 23.39 49.81 32.16 21.33 51.68 32.26 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo 25.52 45.12 37.98 23.98 46.65 37.85 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.68 46.83 36.69 18.26 48.67 34.51 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 201 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 227 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 23.39 49.81 32.16 21.33 51.68 32.26 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 12.68 46.83 36.69 18.26 48.67 34.51 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE D 54 PHE~? 9.38 C6 P6G D1130 A 201 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 227 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 23.39 49.81 32.16 21.33 51.68 32.26 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 25.52 45.12 37.98 23.98 46.65 37.85 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 201 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 227 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 23.39 49.81 32.16 21.33 51.68 32.26 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 25.52 45.12 37.98 23.98 46.65 37.85 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 12.68 46.83 36.69 18.26 48.67 34.51 14.33 6.41 -44.26 15.86 10.02 -47.66 1qz9_c02 source 1qz9 KYNURENINASE : 10 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 186 ASN A 56 ASN~? 17.86 O5 PG4 C1130 A 260 ALA A 42 ALA~? 12.59 O5 PG4 C1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 11.43 26.53 7.41 13.01 27.56 8.43 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 21.53 26.33 6.96 20.26 25.69 7.52 -14.02 2.58 -7.96 -13.02 1.59 -7.38 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 186 ASN A 104 ASN~? 24.79 C6 PG4 C1130 A 260 ALA A 115 ALA~? 21.26 C6 PG4 C1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.96 -5.44 -19.69 4.71 -5.94 -20.83 coo 21.53 26.33 6.96 20.26 25.69 7.52 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 186 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 260 ALA A 102 ALA~? 18.16 C6 PG4 C1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 21.53 26.33 6.96 20.26 25.69 7.52 -2.07 -5.71 -23.42 -2.76 -6.16 -24.69 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 186 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 260 ALA A 115 ALA~? 21.26 C6 PG4 C1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 21.53 26.33 6.96 20.26 25.69 7.52 -0.34 -9.83 -28.12 -0.34 -9.28 -26.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 186 ASN B 56 ASN~? 16.63 C3 P6G D1130 A 260 ALA B 42 ALA~? 13.18 O4 P6G D1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 11.43 26.53 7.41 13.01 27.56 8.43 32.78 -4.61 -51.14 33.91 -4.71 -49.33 coo 21.53 26.33 6.96 20.26 25.69 7.52 25.08 -0.64 -55.99 26.08 0.25 -56.74 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 186 ASN C 56 ASN~? 14.82 O2 PG4 C1130 A 260 ALA C 42 ALA~? 11.94 O5 PG4 C1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 11.43 26.53 7.41 13.01 27.56 8.43 -33.22 -10.82 -9.01 -34.40 -11.65 -10.57 coo 21.53 26.33 6.96 20.26 25.69 7.52 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 186 ASN D 56 ASN~? 14.55 O16 P6G D1130 A 260 ALA D 42 ALA~? 12.47 C6 P6G D1130 coo 11.81 33.10 11.71 13.07 31.45 11.40 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 11.43 26.53 7.41 13.01 27.56 8.43 5.59 12.59 -55.26 4.79 13.42 -53.45 coo 21.53 26.33 6.96 20.26 25.69 7.52 13.53 6.70 -57.84 12.64 5.49 -58.11 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 7 hits 1r4f_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP B 85 ASP~? 16.97 O1 P6G D1130 595 GLU B 121 GLU~? 26.56 C11 P6G D1130 713 TYR B 92 TYR~? 29.58 C3 P6G D1130 coo 5.64 2.82 38.49 4.59 4.19 37.25 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 4.35 13.73 37.63 3.39 12.18 36.55 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 3.76 10.25 31.38 3.16 9.87 34.10 42.63 7.31 -26.13 41.44 8.28 -23.79 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP C 85 ASP~? 10.22 C6 PG4 C1130 595 GLU C 94 GLU~? 10.36 O1 PG4 C1130 713 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 5.64 2.82 38.49 4.59 4.19 37.25 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 4.35 13.73 37.63 3.39 12.18 36.55 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 3.76 10.25 31.38 3.16 9.87 34.10 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP C 107 ASP.? 16.10 C8 PG4 C1130 595 GLU C 55 GLU~? 14.48 C8 PG4 C1130 713 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 5.64 2.82 38.49 4.59 4.19 37.25 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 4.35 13.73 37.63 3.39 12.18 36.55 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 3.76 10.25 31.38 3.16 9.87 34.10 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP C 129 ASP.? 25.37 C1 PG4 C1130 595 GLU C 121 GLU~? 20.36 C1 PG4 C1130 713 TYR C 92 TYR~? 16.40 C1 PG4 C1130 coo 5.64 2.82 38.49 4.59 4.19 37.25 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 coo 4.35 13.73 37.63 3.39 12.18 36.55 -21.26 -10.90 -38.89 -21.15 -11.60 -40.90 coo 3.76 10.25 31.38 3.16 9.87 34.10 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP D 85 ASP~? 10.24 C11 P6G D1130 595 GLU D 94 GLU~? 9.44 O19 P6G D1130 713 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 5.64 2.82 38.49 4.59 4.19 37.25 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 3.76 10.25 31.38 3.16 9.87 34.10 24.24 21.35 -31.93 26.12 20.12 -30.25 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP D 129 ASP.? 22.88 C18 P6G D1130 595 GLU D 121 GLU~? 20.22 C18 P6G D1130 713 TYR D 92 TYR~? 16.07 C18 P6G D1130 coo 5.64 2.82 38.49 4.59 4.19 37.25 23.03 25.83 -22.84 23.72 24.15 -23.95 coo 4.35 13.73 37.63 3.39 12.18 36.55 19.28 17.06 -26.24 19.68 17.98 -24.36 coo 3.76 10.25 31.38 3.16 9.87 34.10 24.24 21.35 -31.93 26.12 20.12 -30.25 1sll_c00 source 1sll SIALIDASE L : 6 hits 1sll_c00 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 107 ASP.? 20.53 C4 PG4 C1130 E 168 LYS A 112 LYS~? 23.21 C4 PG4 C1130 E 171 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 5.36 16.20 22.10 3.88 17.00 23.31 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 5.06 22.32 18.11 1.02 22.08 22.74 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 6.68 21.78 22.39 5.28 20.74 23.60 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP C 107 ASP.? 16.10 C8 PG4 C1130 E 168 LYS C 112 LYS~? 18.47 C1 PG4 C1130 E 171 ASN C 108 ASN~? 16.59 C8 PG4 C1130 coo 5.36 16.20 22.10 3.88 17.00 23.31 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 5.06 22.32 18.11 1.02 22.08 22.74 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 6.68 21.78 22.39 5.28 20.74 23.60 -31.84 0.42 -27.78 -31.41 2.13 -28.96 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c03 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 81 ALA~? 14.49 C6 PG4 C1130 A 251 GLY A 83 GLY~? 20.43 C6 PG4 C1130 A 252 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 127 ALA.? 9.98 O1 P6G D1130 A 251 GLY A 128 GLY.? 6.90 O1 P6G D1130 A 252 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 12.96 -1.11 -42.18 13.03 -1.90 -41.92 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA B 81 ALA~? 14.45 C11 P6G D1130 A 251 GLY B 83 GLY~? 19.46 C3 P6G D1130 A 252 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 35.61 7.43 -33.25 34.89 7.70 -32.90 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA C 81 ALA~? 7.50 C6 PG4 C1130 A 251 GLY C 83 GLY~? 8.16 C1 PG4 C1130 A 252 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA C 127 ALA~? 21.60 O1 PG4 C1130 A 251 GLY C 128 GLY.? 23.20 O1 PG4 C1130 A 252 ASP C 129 ASP.? 25.37 C1 PG4 C1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -21.48 -22.98 -39.56 -22.74 -22.35 -40.13 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -18.12 -22.67 -41.34 -18.70 -22.15 -41.48 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA D 81 ALA~? 6.42 O1 P6G D1130 A 251 GLY D 83 GLY~? 7.98 C18 P6G D1130 A 252 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 21.39 8.12 -37.80 21.60 6.90 -38.67 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 21.02 13.56 -37.58 21.63 12.97 -37.48 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 7 3 # 7 A 250 ALA D 127 ALA~? 21.80 O19 P6G D1130 A 251 GLY D 128 GLY.? 23.24 O19 P6G D1130 A 252 ASP D 129 ASP.? 22.88 C18 P6G D1130 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 19.87 29.05 -27.32 18.84 28.51 -26.37 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 23.42 29.13 -25.94 22.84 28.44 -25.92 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 23.03 25.83 -22.84 23.72 24.15 -23.95 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 7 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 81 ALA~? 14.49 C6 PG4 C1130 B 251 GLY A 83 GLY~? 20.43 C6 PG4 C1130 B 252 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 127 ALA.? 9.98 O1 P6G D1130 B 251 GLY A 128 GLY.? 6.90 O1 P6G D1130 B 252 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 12.01 -2.63 -38.85 12.27 -4.10 -39.14 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 12.96 -1.11 -42.18 13.03 -1.90 -41.92 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA B 81 ALA~? 14.45 C11 P6G D1130 B 251 GLY B 83 GLY~? 19.46 C3 P6G D1130 B 252 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 35.61 7.43 -33.25 34.89 7.70 -32.90 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA C 81 ALA~? 7.50 C6 PG4 C1130 B 251 GLY C 83 GLY~? 8.16 C1 PG4 C1130 B 252 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA C 127 ALA~? 21.60 O1 PG4 C1130 B 251 GLY C 128 GLY.? 23.20 O1 PG4 C1130 B 252 ASP C 129 ASP.? 25.37 C1 PG4 C1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -21.48 -22.98 -39.56 -22.74 -22.35 -40.13 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -18.12 -22.67 -41.34 -18.70 -22.15 -41.48 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA D 81 ALA~? 6.42 O1 P6G D1130 B 251 GLY D 83 GLY~? 7.98 C18 P6G D1130 B 252 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 21.39 8.12 -37.80 21.60 6.90 -38.67 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 21.02 13.56 -37.58 21.63 12.97 -37.48 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 7 3 # 7 B 250 ALA D 127 ALA~? 21.80 O19 P6G D1130 B 251 GLY D 128 GLY.? 23.24 O19 P6G D1130 B 252 ASP D 129 ASP.? 22.88 C18 P6G D1130 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 19.87 29.05 -27.32 18.84 28.51 -26.37 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 23.42 29.13 -25.94 22.84 28.44 -25.92 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 23.03 25.83 -22.84 23.72 24.15 -23.95 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 7 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS B 32 LYS~? 26.29 C8 P6G D1130 138 ASN B 28 ASN~? 31.97 C8 P6G D1130 183 HIS B 26 HIS.? 35.25 C6 P6G D1130 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 26.85 0.91 -77.13 26.68 2.86 -77.97 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 20.40 -5.65 -79.75 19.20 -6.88 -80.97 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS D 32 LYS~? 27.03 C6 P6G D1130 138 ASN D 28 ASN~? 29.34 C6 P6G D1130 183 HIS B 26 HIS.? 35.25 C6 P6G D1130 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 14.22 -2.15 -70.37 13.65 -7.80 -70.43 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 12.87 -6.23 -74.94 11.61 -6.49 -73.22 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 20.40 -5.65 -79.75 19.20 -6.88 -80.97 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 2 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 44 GLU~? 13.07 O5 PG4 C1130 A 126 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 171 ALA A 42 ALA~? 12.59 O5 PG4 C1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -14.02 2.58 -7.96 -13.02 1.59 -7.38 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 126 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 171 ALA A 76 ALA~? 14.67 C6 PG4 C1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 82 GLU~? 16.13 C6 PG4 C1130 A 126 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 171 ALA A 81 ALA~? 14.49 C6 PG4 C1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 126 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 171 ALA B 42 ALA~? 13.18 O4 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 25.08 -0.64 -55.99 26.08 0.25 -56.74 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 126 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 171 ALA B 76 ALA~? 14.74 C11 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 33.17 9.74 -42.93 33.99 10.72 -43.77 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 126 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 171 ALA B 81 ALA~? 14.45 C11 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 30.85 9.91 -34.57 29.42 9.80 -35.00 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 A 46 GLU B 94 GLU~? 22.51 C2 P6G D1130 A 126 LYS B 84 LYS~? 19.45 C18 P6G D1130 A 171 ALA B 95 ALA~? 23.69 C3 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 39.47 6.03 -32.16 39.38 7.03 -31.00 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 A 46 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 126 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 171 ALA C 42 ALA~? 11.94 O5 PG4 C1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -25.46 -4.85 -6.38 -26.44 -3.69 -6.16 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 A 46 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 126 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 171 ALA C 76 ALA~? 8.86 O4 PG4 C1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 A 46 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 126 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 171 ALA C 81 ALA~? 7.50 C6 PG4 C1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 11 3 # 11 A 46 GLU D 44 GLU~? 13.05 C9 P6G D1130 A 126 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 171 ALA D 42 ALA~? 12.47 C6 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 13.53 6.70 -57.84 12.64 5.49 -58.11 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 12 3 # 12 A 46 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 126 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 171 ALA D 81 ALA~? 6.42 O1 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 21.39 8.12 -37.80 21.60 6.90 -38.67 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 13 3 # 13 A 46 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 126 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 171 ALA D 81 ALA~? 6.42 O1 P6G D1130 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 21.39 8.12 -37.80 21.60 6.90 -38.67 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 13 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 44 GLU~? 13.07 O5 PG4 C1130 B 126 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 171 ALA A 42 ALA~? 12.59 O5 PG4 C1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 24.73 94.37 14.59 21.08 89.84 11.98 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 24.38 86.32 12.71 22.88 86.54 12.71 -14.02 2.58 -7.96 -13.02 1.59 -7.38 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 126 LYS A 112 LYS~? 23.21 C4 PG4 C1130 B 171 ALA A 76 ALA~? 14.67 C6 PG4 C1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 24.73 94.37 14.59 21.08 89.84 11.98 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 24.38 86.32 12.71 22.88 86.54 12.71 -6.29 -6.45 -22.06 -5.54 -7.55 -21.34 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 82 GLU~? 16.13 C6 PG4 C1130 B 126 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 171 ALA A 81 ALA~? 14.49 C6 PG4 C1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 24.73 94.37 14.59 21.08 89.84 11.98 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 24.38 86.32 12.71 22.88 86.54 12.71 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU B 44 GLU~? 13.14 C6 P6G D1130 B 126 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 171 ALA B 42 ALA~? 13.18 O4 P6G D1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 24.73 94.37 14.59 21.08 89.84 11.98 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 24.38 86.32 12.71 22.88 86.54 12.71 25.08 -0.64 -55.99 26.08 0.25 -56.74 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU B 73 GLU~? 10.65 C14 P6G D1130 B 126 LYS B 112 LYS~? 22.45 C14 P6G D1130 B 171 ALA B 76 ALA~? 14.74 C11 P6G D1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 24.73 94.37 14.59 21.08 89.84 11.98 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 24.38 86.32 12.71 22.88 86.54 12.71 33.17 9.74 -42.93 33.99 10.72 -43.77 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU B 82 GLU~? 13.30 C2 P6G D1130 B 126 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 171 ALA B 81 ALA~? 14.45 C11 P6G D1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 24.73 94.37 14.59 21.08 89.84 11.98 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 30.85 9.91 -34.57 29.42 9.80 -35.00 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 B 46 GLU B 94 GLU~? 22.51 C2 P6G D1130 B 126 LYS B 84 LYS~? 19.45 C18 P6G D1130 B 171 ALA B 95 ALA~? 23.69 C3 P6G D1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo 24.73 94.37 14.59 21.08 89.84 11.98 34.20 9.92 -30.73 30.97 14.90 -30.33 coo 24.38 86.32 12.71 22.88 86.54 12.71 39.47 6.03 -32.16 39.38 7.03 -31.00 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 B 46 GLU C 73 GLU~? 12.72 C8 PG4 C1130 B 126 LYS C 112 LYS~? 18.47 C1 PG4 C1130 B 171 ALA C 76 ALA~? 8.86 O4 PG4 C1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 24.73 94.37 14.59 21.08 89.84 11.98 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 24.38 86.32 12.71 22.88 86.54 12.71 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 B 46 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 126 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 171 ALA C 81 ALA~? 7.50 C6 PG4 C1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 24.73 94.37 14.59 21.08 89.84 11.98 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 24.38 86.32 12.71 22.88 86.54 12.71 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 10 3 # 10 B 46 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 126 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 171 ALA D 81 ALA~? 6.42 O1 P6G D1130 coo 20.47 87.42 16.54 20.16 87.17 14.45 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 24.73 94.37 14.59 21.08 89.84 11.98 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 24.38 86.32 12.71 22.88 86.54 12.71 21.39 8.12 -37.80 21.60 6.90 -38.67 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 10 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 85 ASP~? 19.32 C6 PG4 C1130 255 GLU A 82 GLU~? 16.13 C6 PG4 C1130 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 52.57 37.12 10.17 53.37 35.95 11.75 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 85 ASP~? 19.32 C6 PG4 C1130 255 GLU C 88 GLU~? 16.97 C5 PG4 C1130 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 85 ASP~? 16.97 O1 P6G D1130 255 GLU B 82 GLU~? 13.30 C2 P6G D1130 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 52.57 37.12 10.17 53.37 35.95 11.75 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 85 ASP~? 16.97 O1 P6G D1130 255 GLU D 88 GLU~? 17.52 C12 P6G D1130 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 85 ASP~? 10.22 C6 PG4 C1130 255 GLU A 82 GLU~? 16.13 C6 PG4 C1130 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 52.57 37.12 10.17 53.37 35.95 11.75 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 85 ASP~? 10.22 C6 PG4 C1130 255 GLU C 88 GLU~? 16.97 C5 PG4 C1130 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP D 85 ASP~? 10.24 C11 P6G D1130 255 GLU B 82 GLU~? 13.30 C2 P6G D1130 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 52.57 37.12 10.17 53.37 35.95 11.75 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP D 85 ASP~? 10.24 C11 P6G D1130 255 GLU D 88 GLU~? 17.52 C12 P6G D1130 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 52.57 37.12 10.17 53.37 35.95 11.75 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.47 6.05 -29.78 29.50 6.72 -30.15 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 8 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 85 ASP~? 19.32 C6 PG4 C1130 218 GLU A 61 GLU~? 21.55 O5 PG4 C1130 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 70.09 11.71 8.46 70.56 12.89 6.77 -8.37 6.43 -4.11 -7.95 7.95 -2.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 85 ASP~? 19.32 C6 PG4 C1130 218 GLU C 69 GLU~? 15.05 O5 PG4 C1130 329 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 70.09 11.71 8.46 70.56 12.89 6.77 -32.98 6.49 -14.53 -31.30 7.57 -15.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 129 ASP.? 5.22 O1 P6G D1130 218 GLU B 109 GLU~? 22.36 C17 P6G D1130 329 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 70.09 11.71 8.46 70.56 12.89 6.77 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 129 ASP.? 5.22 O1 P6G D1130 218 GLU B 121 GLU~? 26.56 C11 P6G D1130 329 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 70.09 11.71 8.46 70.56 12.89 6.77 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 50 ASP~? 8.75 C2 P6G D1130 218 GLU D 120 GLU~? 20.19 C18 P6G D1130 329 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 14.39 19.77 -25.34 13.72 21.78 -25.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 85 ASP~? 16.97 O1 P6G D1130 218 GLU A 94 GLU~? 22.82 O1 P6G D1130 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 85 ASP~? 16.97 O1 P6G D1130 218 GLU B 61 GLU~? 21.58 O4 P6G D1130 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.88 -4.52 -59.91 31.08 -6.09 -61.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 85 ASP~? 16.97 O1 P6G D1130 218 GLU D 69 GLU~? 15.99 C6 P6G D1130 329 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP D 85 ASP~? 10.24 C11 P6G D1130 218 GLU A 120 GLU~? 20.88 O1 P6G D1130 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.47 6.05 -29.78 29.50 6.72 -30.15 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 9 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 129 ASP.? 5.22 O1 P6G D1130 242 GLU A 94 GLU~? 22.82 O1 P6G D1130 329 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 30.42 34.74 5.00 29.09 35.09 3.38 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 129 ASP.? 5.22 O1 P6G D1130 242 GLU A 100 GLU~? 21.70 O1 P6G D1130 329 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 30.42 34.74 5.00 29.09 35.09 3.38 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 50 ASP~? 8.75 C2 P6G D1130 242 GLU B 100 GLU~? 26.53 C3 P6G D1130 329 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 30.42 34.74 5.00 29.09 35.09 3.38 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 16.73 -3.96 -41.52 17.31 -2.00 -40.88 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 85 ASP~? 10.22 C6 PG4 C1130 242 GLU A 44 GLU~? 13.07 O5 PG4 C1130 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 85 ASP~? 10.22 C6 PG4 C1130 242 GLU C 44 GLU~? 12.88 O5 PG4 C1130 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 85 ASP~? 10.22 C6 PG4 C1130 242 GLU C 52 GLU~? 9.38 O2 PG4 C1130 329 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP D 85 ASP~? 10.24 C11 P6G D1130 242 GLU B 66 GLU.? 14.53 C15 P6G D1130 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 24.13 11.40 -59.41 22.89 12.15 -60.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP D 85 ASP~? 10.24 C11 P6G D1130 242 GLU D 44 GLU~? 13.05 C9 P6G D1130 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP D 85 ASP~? 10.24 C11 P6G D1130 242 GLU D 52 GLU~? 9.77 O16 P6G D1130 329 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 7.48 14.12 -48.51 7.76 13.12 -46.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 31.47 6.05 -29.78 29.50 6.72 -30.15 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 9 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 56 ASN~? 17.86 O5 PG4 C1130 457 GLY A 62 GLY~? 21.24 O5 PG4 C1130 459 GLU A 61 GLU~? 21.55 O5 PG4 C1130 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -4.33 1.80 -3.50 -5.15 1.89 -3.52 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -8.37 6.43 -4.11 -7.95 7.95 -2.68 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 91 ASN~? 22.38 O1 P6G D1130 457 GLY A 83 GLY~? 20.43 C6 PG4 C1130 459 GLU A 82 GLU~? 16.13 C6 PG4 C1130 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 56 ASN~? 16.63 C3 P6G D1130 457 GLY B 62 GLY~? 21.67 O4 P6G D1130 459 GLU B 61 GLU~? 21.58 O4 P6G D1130 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 32.78 -4.61 -51.14 33.91 -4.71 -49.33 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 34.71 0.16 -60.89 33.89 0.05 -60.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 30.88 -4.52 -59.91 31.08 -6.09 -61.35 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN C 91 ASN~? 14.02 C1 PG4 C1130 457 GLY C 83 GLY~? 8.16 C1 PG4 C1130 459 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN D 56 ASN~? 14.55 O16 P6G D1130 457 GLY D 62 GLY~? 20.43 C6 P6G D1130 459 GLU D 61 GLU~? 21.02 C9 P6G D1130 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 5.59 12.59 -55.26 4.79 13.42 -53.45 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 3.86 3.59 -61.51 4.65 3.76 -61.54 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 7.67 8.26 -62.85 7.30 9.08 -64.79 1vom_c00 source 1vom MYOSIN : 5 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 43 TYR~? 9.79 O5 PG4 C1130 A 317 GLU A 44 GLU~? 13.07 O5 PG4 C1130 A 365 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 3.06 2.85 52.79 4.83 3.89 53.24 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 3.82 17.09 49.56 4.09 14.32 50.84 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 43 TYR~? 9.79 O5 PG4 C1130 A 317 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 365 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 3.06 2.85 52.79 4.83 3.89 53.24 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 3.82 17.09 49.56 4.09 14.32 50.84 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 43 TYR~? 10.38 C8 P6G D1130 A 317 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 365 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 21.94 3.80 -56.34 23.03 6.24 -57.25 coo 3.06 2.85 52.79 4.83 3.89 53.24 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 3.82 17.09 49.56 4.09 14.32 50.84 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR B 43 TYR~? 10.38 C8 P6G D1130 A 317 GLU D 44 GLU~? 13.05 C9 P6G D1130 A 365 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 21.94 3.80 -56.34 23.03 6.24 -57.25 coo 3.06 2.85 52.79 4.83 3.89 53.24 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 3.82 17.09 49.56 4.09 14.32 50.84 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 317 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 365 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 3.06 2.85 52.79 4.83 3.89 53.24 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 3.82 17.09 49.56 4.09 14.32 50.84 28.29 14.60 -40.19 29.66 17.13 -41.31 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR C 43 TYR~? 9.68 O5 PG4 C1130 A 317 GLU C 44 GLU~? 12.88 O5 PG4 C1130 A 365 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 3.06 2.85 52.79 4.83 3.89 53.24 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 3.82 17.09 49.56 4.09 14.32 50.84 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1vzx_c02 2.04.01.0087 user 7 3 # 7 A 314 TYR D 43 TYR~? 10.27 C6 P6G D1130 A 317 GLU B 44 GLU~? 13.14 C6 P6G D1130 A 365 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 1.77 6.56 57.05 3.05 7.44 59.37 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 3.06 2.85 52.79 4.83 3.89 53.24 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 3.82 17.09 49.56 4.09 14.32 50.84 10.98 -2.55 -67.37 13.68 -3.80 -66.48 1vzx_c02 source 1vzx 2.04.01.0087 : 7 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 43 TYR~? 9.79 O5 PG4 C1130 B1317 GLU A 44 GLU~? 13.07 O5 PG4 C1130 B1365 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -20.52 4.31 -8.11 -20.92 5.63 -6.53 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 43 TYR~? 9.79 O5 PG4 C1130 B1317 GLU C 44 GLU~? 12.88 O5 PG4 C1130 B1365 ARG A 35 ARG~? 23.61 O5 PG4 C1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -17.15 -1.87 -7.90 -15.96 -4.30 -7.17 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -11.68 -1.74 4.09 -8.68 -2.48 3.95 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 43 TYR~? 10.38 C8 P6G D1130 B1317 GLU B 44 GLU~? 13.14 C6 P6G D1130 B1365 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 21.94 3.80 -56.34 23.03 6.24 -57.25 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR B 43 TYR~? 10.38 C8 P6G D1130 B1317 GLU D 44 GLU~? 13.05 C9 P6G D1130 B1365 ARG B 35 ARG~? 23.72 C8 P6G D1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 21.94 3.80 -56.34 23.03 6.24 -57.25 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 19.96 8.54 -58.15 20.29 9.21 -60.12 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 27.98 3.09 -66.94 26.77 4.37 -69.48 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR B 118 TYR~? 21.87 C11 P6G D1130 B1317 GLU B 121 GLU~? 26.56 C11 P6G D1130 B1365 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 28.29 14.60 -40.19 29.66 17.13 -41.31 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR C 43 TYR~? 9.68 O5 PG4 C1130 B1317 GLU C 44 GLU~? 12.88 O5 PG4 C1130 B1365 ARG C 35 ARG~? 22.08 O5 PG4 C1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -22.05 -0.91 -7.70 -22.95 1.73 -7.48 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -27.40 4.35 1.93 -30.39 4.99 1.63 ULMN 3 1vzx_c03 2.04.01.0087 user 7 3 # 7 B1314 TYR D 43 TYR~? 10.27 C6 P6G D1130 B1317 GLU B 44 GLU~? 13.14 C6 P6G D1130 B1365 ARG D 35 ARG~? 21.81 C6 P6G D1130 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 17.02 2.86 -56.49 16.12 0.22 -56.60 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 18.51 -2.46 -55.26 18.22 -3.73 -56.94 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 10.98 -2.55 -67.37 13.68 -3.80 -66.48 1vzx_c03 source 1vzx 2.04.01.0087 : 7 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 40 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 103 LEU A 45 LEU~? 11.97 O5 PG4 C1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 7.55 25.51 14.34 9.65 25.73 14.24 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 -14.74 5.11 -11.61 -14.05 7.02 -10.96 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 40 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 103 LEU B 45 LEU~? 11.29 O4 P6G D1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 7.55 25.51 14.34 9.65 25.73 14.24 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 11.83 18.73 16.99 10.99 19.71 15.26 24.70 -2.86 -52.16 25.38 -4.85 -52.81 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 40 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 103 LEU C 45 LEU~? 10.23 C3 PG4 C1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 7.55 25.51 14.34 9.65 25.73 14.24 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 11.83 18.73 16.99 10.99 19.71 15.26 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 40 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 103 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 7.55 25.51 14.34 9.65 25.73 14.24 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 11.83 18.73 16.99 10.99 19.71 15.26 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 40 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 103 LEU C 45 LEU~? 10.23 C3 PG4 C1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 7.55 25.51 14.34 9.65 25.73 14.24 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 11.83 18.73 16.99 10.99 19.71 15.26 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 40 ASP C 129 ASP.? 25.37 C1 PG4 C1130 A 103 LEU C 126 LEU~? 15.98 O1 PG4 C1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo 7.55 25.51 14.34 9.65 25.73 14.24 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 coo 11.83 18.73 16.99 10.99 19.71 15.26 -20.99 -21.60 -35.33 -20.67 -21.36 -33.23 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 40 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 103 LEU D 45 LEU~? 10.26 C15 P6G D1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 7.55 25.51 14.34 9.65 25.73 14.24 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 11.83 18.73 16.99 10.99 19.71 15.26 13.88 10.45 -55.46 13.15 11.98 -56.83 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 40 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 103 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 7.55 25.51 14.34 9.65 25.73 14.24 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 11.83 18.73 16.99 10.99 19.71 15.26 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 40 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 103 LEU D 45 LEU~? 10.26 C15 P6G D1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 7.55 25.51 14.34 9.65 25.73 14.24 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 11.83 18.73 16.99 10.99 19.71 15.26 13.88 10.45 -55.46 13.15 11.98 -56.83 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 40 ASP D 129 ASP.? 22.88 C18 P6G D1130 A 103 LEU D 126 LEU~? 15.96 O19 P6G D1130 coo 12.09 16.13 10.57 11.28 18.80 10.73 24.24 21.35 -31.93 26.12 20.12 -30.25 coo 7.55 25.51 14.34 9.65 25.73 14.24 23.03 25.83 -22.84 23.72 24.15 -23.95 coo 11.83 18.73 16.99 10.99 19.71 15.26 19.64 27.10 -31.39 19.65 26.64 -33.51 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 10 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 57 TYR~? 16.39 O5 PG4 C1130 B 40 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 103 LEU A 45 LEU~? 11.97 O5 PG4 C1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo 9.39 10.77 34.53 11.50 10.63 34.41 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 -14.74 5.11 -11.61 -14.05 7.02 -10.96 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 46 TYR~? 5.77 O4 P6G D1130 B 40 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 103 LEU B 45 LEU~? 11.29 O4 P6G D1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 9.39 10.77 34.53 11.50 10.63 34.41 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 12.89 17.60 31.13 12.34 16.51 32.90 24.70 -2.86 -52.16 25.38 -4.85 -52.81 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 57 TYR~? 16.24 O4 P6G D1130 B 40 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 103 LEU B 45 LEU~? 11.29 O4 P6G D1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo 9.39 10.77 34.53 11.50 10.63 34.41 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 12.89 17.60 31.13 12.34 16.51 32.90 24.70 -2.86 -52.16 25.38 -4.85 -52.81 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR C 46 TYR~? -4.42 C8 PG4 C1130s B 40 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 103 LEU C 45 LEU~? 10.23 C3 PG4 C1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 9.39 10.77 34.53 11.50 10.63 34.41 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.89 17.60 31.13 12.34 16.51 32.90 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 40 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B 103 LEU C 105 LEU~? 9.45 O3 PG4 C1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 9.39 10.77 34.53 11.50 10.63 34.41 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 12.89 17.60 31.13 12.34 16.51 32.90 -30.30 -7.36 -22.16 -29.90 -6.73 -20.13 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 57 TYR~? 15.97 O5 PG4 C1130 B 40 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 103 LEU C 45 LEU~? 10.23 C3 PG4 C1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo 9.39 10.77 34.53 11.50 10.63 34.41 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.89 17.60 31.13 12.34 16.51 32.90 -25.10 -8.53 -8.94 -25.63 -10.09 -7.50 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR C 92 TYR~? 16.40 C1 PG4 C1130 B 40 ASP C 129 ASP.? 25.37 C1 PG4 C1130 B 103 LEU C 126 LEU~? 15.98 O1 PG4 C1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo 9.39 10.77 34.53 11.50 10.63 34.41 -20.26 -19.29 -43.87 -21.24 -21.06 -44.56 coo 12.89 17.60 31.13 12.34 16.51 32.90 -20.99 -21.60 -35.33 -20.67 -21.36 -33.23 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR D 46 TYR~? -4.28 C6 P6G D1130s B 40 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 103 LEU D 45 LEU~? 10.26 C15 P6G D1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 9.39 10.77 34.53 11.50 10.63 34.41 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.89 17.60 31.13 12.34 16.51 32.90 13.88 10.45 -55.46 13.15 11.98 -56.83 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 40 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 103 LEU D 105 LEU~? 9.27 O13 P6G D1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 9.39 10.77 34.53 11.50 10.63 34.41 4.55 4.63 -38.29 4.19 5.10 -40.34 coo 12.89 17.60 31.13 12.34 16.51 32.90 9.44 10.53 -41.97 9.61 9.55 -43.87 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR D 57 TYR~? 15.84 C9 P6G D1130 B 40 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 103 LEU D 45 LEU~? 10.26 C15 P6G D1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 9.96 9.67 -59.45 11.06 8.95 -61.91 coo 9.39 10.77 34.53 11.50 10.63 34.41 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.89 17.60 31.13 12.34 16.51 32.90 13.88 10.45 -55.46 13.15 11.98 -56.83 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR D 92 TYR~? 16.07 C18 P6G D1130 B 40 ASP D 129 ASP.? 22.88 C18 P6G D1130 B 103 LEU D 126 LEU~? 15.96 O19 P6G D1130 coo 14.25 20.09 37.35 13.48 17.40 37.38 24.24 21.35 -31.93 26.12 20.12 -30.25 coo 9.39 10.77 34.53 11.50 10.63 34.41 23.03 25.83 -22.84 23.72 24.15 -23.95 coo 12.89 17.60 31.13 12.34 16.51 32.90 19.64 27.10 -31.39 19.65 26.64 -33.51 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 11 hits 1vzz_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 81 ALA~? 14.49 C6 PG4 C1130 B 126 ARG A 77 ARG~? 12.69 C2 PG4 C1130 B 138 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo 2.11 4.00 19.31 3.14 4.86 19.99 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 2.45 5.53 11.28 3.59 7.56 13.29 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 6.10 2.00 25.24 6.12 1.84 23.13 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 81 ALA~? 14.45 C11 P6G D1130 B 126 ARG B 77 ARG~? 12.24 C17 P6G D1130 B 138 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo 2.11 4.00 19.31 3.14 4.86 19.99 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 2.45 5.53 11.28 3.59 7.56 13.29 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 6.10 2.00 25.24 6.12 1.84 23.13 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA C 81 ALA~? 7.50 C6 PG4 C1130 B 126 ARG C 77 ARG~? 11.94 C8 PG4 C1130 B 138 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 2.11 4.00 19.31 3.14 4.86 19.99 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo 2.45 5.53 11.28 3.59 7.56 13.29 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 6.10 2.00 25.24 6.12 1.84 23.13 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA C 95 ALA~? 9.85 C1 PG4 C1130 B 126 ARG A 77 ARG~? 12.69 C2 PG4 C1130 B 138 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 2.11 4.00 19.31 3.14 4.86 19.99 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo 2.45 5.53 11.28 3.59 7.56 13.29 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 6.10 2.00 25.24 6.12 1.84 23.13 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA B 81 ALA~? 14.45 C11 P6G D1130 C 126 ARG B 77 ARG~? 12.24 C17 P6G D1130 C 138 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 30.85 9.91 -34.57 29.42 9.80 -35.00 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 28.29 14.60 -40.19 29.66 17.13 -41.31 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA C 81 ALA~? 7.50 C6 PG4 C1130 C 126 ARG C 77 ARG~? 11.94 C8 PG4 C1130 C 138 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 81 ALA~? 14.49 C6 PG4 C1130 D 126 ARG A 77 ARG~? 12.69 C2 PG4 C1130 D 138 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 6.23 0.50 57.10 5.93 0.72 59.19 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 81 ALA~? 14.45 C11 P6G D1130 D 126 ARG B 77 ARG~? 12.24 C17 P6G D1130 D 138 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 30.85 9.91 -34.57 29.42 9.80 -35.00 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 6.23 0.50 57.10 5.93 0.72 59.19 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA C 81 ALA~? 7.50 C6 PG4 C1130 D 126 ARG C 77 ARG~? 11.94 C8 PG4 C1130 D 138 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 6.23 0.50 57.10 5.93 0.72 59.19 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 81 ALA~? 14.49 C6 PG4 C1130 E 126 ARG A 77 ARG~? 12.69 C2 PG4 C1130 E 138 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -8.85 -5.53 -30.29 -10.21 -5.47 -29.65 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 81 ALA~? 14.45 C11 P6G D1130 E 126 ARG B 77 ARG~? 12.24 C17 P6G D1130 E 138 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo -4.56 10.03 62.36 -4.38 11.31 61.55 30.85 9.91 -34.57 29.42 9.80 -35.00 coo -3.02 12.00 70.07 -1.94 13.84 67.82 28.29 14.60 -40.19 29.66 17.13 -41.31 coo -8.67 12.22 56.54 -8.68 12.09 58.65 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA C 81 ALA~? 7.50 C6 PG4 C1130 E 126 ARG C 77 ARG~? 11.94 C8 PG4 C1130 E 138 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA B 81 ALA~? 14.45 C11 P6G D1130 F 126 ARG B 77 ARG~? 12.24 C17 P6G D1130 F 138 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 30.85 9.91 -34.57 29.42 9.80 -35.00 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 28.29 14.60 -40.19 29.66 17.13 -41.31 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA C 81 ALA~? 7.50 C6 PG4 C1130 F 126 ARG C 77 ARG~? 11.94 C8 PG4 C1130 F 138 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -18.49 -4.25 -26.46 -18.29 -3.13 -25.42 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c11 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 78 SER~? 11.56 C6 PG4 C1130 A 178 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 81.46 10.53 21.66 82.20 10.82 19.39 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 87.67 8.69 17.10 86.62 10.83 18.52 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 85.30 6.17 22.83 87.26 11.02 23.50 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER A 78 SER~? 11.56 C6 PG4 C1130 A 178 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 81.46 10.53 21.66 82.20 10.82 19.39 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 87.67 8.69 17.10 86.62 10.83 18.52 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 85.30 6.17 22.83 87.26 11.02 23.50 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 A 164 SER B 78 SER~? 10.35 C3 P6G D1130 A 178 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 81.46 10.53 21.66 82.20 10.82 19.39 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 87.67 8.69 17.10 86.62 10.83 18.52 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 85.30 6.17 22.83 87.26 11.02 23.50 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 A 164 SER B 78 SER~? 10.35 C3 P6G D1130 A 178 TYR B 51 TYR~? 10.58 C3 P6G D1130 A 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 81.46 10.53 21.66 82.20 10.82 19.39 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 87.67 8.69 17.10 86.62 10.83 18.52 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 85.30 6.17 22.83 87.26 11.02 23.50 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 A 164 SER C 78 SER~? -2.69 O4 PG4 C1130s A 178 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 182 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 81.46 10.53 21.66 82.20 10.82 19.39 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 87.67 8.69 17.10 86.62 10.83 18.52 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 85.30 6.17 22.83 87.26 11.02 23.50 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 A 164 SER C 78 SER~? -2.69 O4 PG4 C1130s A 178 TYR C 46 TYR~? -4.42 C8 PG4 C1130s A 182 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 81.46 10.53 21.66 82.20 10.82 19.39 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 87.67 8.69 17.10 86.62 10.83 18.52 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 85.30 6.17 22.83 87.26 11.02 23.50 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 6 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 78 SER~? 11.56 C6 PG4 C1130 B 178 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 61.22 3.61 34.51 60.46 1.86 35.98 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 57.40 2.23 30.19 55.43 5.44 33.87 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER A 78 SER~? 11.56 C6 PG4 C1130 B 178 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 61.22 3.61 34.51 60.46 1.86 35.98 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo 57.40 2.23 30.19 55.43 5.44 33.87 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 B 164 SER B 78 SER~? 10.35 C3 P6G D1130 B 178 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 61.22 3.61 34.51 60.46 1.86 35.98 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 54.99 -1.20 35.40 56.04 1.15 36.44 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 57.40 2.23 30.19 55.43 5.44 33.87 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 B 164 SER B 78 SER~? 10.35 C3 P6G D1130 B 178 TYR B 51 TYR~? 10.58 C3 P6G D1130 B 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 61.22 3.61 34.51 60.46 1.86 35.98 29.57 8.47 -39.24 28.68 6.25 -39.24 coo 54.99 -1.20 35.40 56.04 1.15 36.44 29.55 2.80 -46.55 31.14 4.40 -48.22 coo 57.40 2.23 30.19 55.43 5.44 33.87 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 B 164 SER C 78 SER~? -2.69 O4 PG4 C1130s B 178 TYR C 46 TYR~? -4.42 C8 PG4 C1130s B 182 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 61.22 3.61 34.51 60.46 1.86 35.98 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 57.40 2.23 30.19 55.43 5.44 33.87 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 B 164 SER C 78 SER~? -2.69 O4 PG4 C1130s B 178 TYR C 46 TYR~? -4.42 C8 PG4 C1130s B 182 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 61.22 3.61 34.51 60.46 1.86 35.98 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 57.40 2.23 30.19 55.43 5.44 33.87 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 6 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 22.22 16.06 48.76 23.94 15.33 49.78 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 14.16 13.09 37.03 20.00 12.44 37.49 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 A 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 14.16 13.09 37.03 20.00 12.44 37.49 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 22.22 16.06 48.76 23.94 15.33 49.78 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 22.22 16.06 48.76 23.94 15.33 49.78 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 22.22 16.06 48.76 23.94 15.33 49.78 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 22.22 16.06 48.76 23.94 15.33 49.78 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 14.16 13.09 37.03 20.00 12.44 37.49 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 14.16 13.09 37.03 20.00 12.44 37.49 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 A 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 A 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 14.16 13.09 37.03 20.00 12.44 37.49 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 22.22 16.06 48.76 23.94 15.33 49.78 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 22.22 16.06 48.76 23.94 15.33 49.78 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 22.22 16.06 48.76 23.94 15.33 49.78 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 A 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 22.22 16.06 48.76 23.94 15.33 49.78 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 A 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 A 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 14.16 13.09 37.03 20.00 12.44 37.49 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 A 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 14.16 13.09 37.03 20.00 12.44 37.49 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 22.22 16.06 48.76 23.94 15.33 49.78 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 A 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 14.16 13.09 37.03 20.00 12.44 37.49 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 22.22 16.06 48.76 23.94 15.33 49.78 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 A 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 22.22 16.06 48.76 23.94 15.33 49.78 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 38 3 # 38 A 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 A 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 22.22 16.06 48.76 23.94 15.33 49.78 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 39 3 # 39 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 22.22 16.06 48.76 23.94 15.33 49.78 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 40 3 # 40 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 22.22 16.06 48.76 23.94 15.33 49.78 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 41 3 # 41 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 22.22 16.06 48.76 23.94 15.33 49.78 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 42 3 # 42 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 22.22 16.06 48.76 23.94 15.33 49.78 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 43 3 # 43 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 44 3 # 44 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 45 3 # 45 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 46 3 # 46 A 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 14.16 13.09 37.03 20.00 12.44 37.49 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 47 3 # 47 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 14.16 13.09 37.03 20.00 12.44 37.49 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 48 3 # 48 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 14.16 13.09 37.03 20.00 12.44 37.49 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 49 3 # 49 A 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 14.16 13.09 37.03 20.00 12.44 37.49 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 50 3 # 50 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 51 3 # 51 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 52 3 # 52 A 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s A 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 22.22 16.06 48.76 23.94 15.33 49.78 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 53 3 # 53 A 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 22.22 16.06 48.76 23.94 15.33 49.78 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 54 3 # 54 A 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 14.16 13.09 37.03 20.00 12.44 37.49 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 55 3 # 55 A 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 22.22 16.06 48.76 23.94 15.33 49.78 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 56 3 # 56 A 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 A 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 57 3 # 57 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 22.22 16.06 48.76 23.94 15.33 49.78 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 58 3 # 58 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 59 3 # 59 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 60 3 # 60 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 22.22 16.06 48.76 23.94 15.33 49.78 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 61 3 # 61 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 22.22 16.06 48.76 23.94 15.33 49.78 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 62 3 # 62 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 22.22 16.06 48.76 23.94 15.33 49.78 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 63 3 # 63 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 64 3 # 64 A 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 14.16 13.09 37.03 20.00 12.44 37.49 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 22.22 16.06 48.76 23.94 15.33 49.78 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 65 3 # 65 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 66 3 # 66 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 67 3 # 67 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 68 3 # 68 A 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 69 3 # 69 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 70 3 # 70 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 71 3 # 71 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 72 3 # 72 A 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s A 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 18.28 7.83 36.39 22.82 8.75 39.52 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 22.22 16.06 48.76 23.94 15.33 49.78 12.41 4.04 -29.37 12.28 4.39 -27.28 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 72 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 74 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 21.39 11.56 68.52 20.24 13.13 67.73 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 165 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 41 LYS~? 15.70 O5 PG4 C1130 B 74 LYS A 38 LYS~? 22.91 O5 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 21.39 11.56 68.52 20.24 13.13 67.73 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 21.39 11.56 68.52 20.24 13.13 67.73 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 74 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 165 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 66 GLU.? 16.09 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 -13.67 -8.92 -3.69 -15.45 -9.11 -2.55 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS A 74 LYS~? 4.39 C4 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 100 GLU~? 21.70 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 4.82 -2.98 -24.68 6.51 -1.85 -25.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 74 LYS A 72 LYS~? 16.44 O5 PG4 C1130 B 165 GLU A 109 GLU~? 22.30 C2 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 21.39 11.56 68.52 20.24 13.13 67.73 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 74 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 21.39 11.56 68.52 20.24 13.13 67.73 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.89 -0.55 76.51 17.10 4.32 77.43 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.89 -0.55 76.51 17.10 4.32 77.43 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS B 41 LYS~? 19.06 O4 P6G D1130 B 74 LYS B 38 LYS~? 23.39 O4 P6G D1130 B 165 GLU D 37 GLU~? 22.00 C9 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 19.89 -0.55 76.51 17.10 4.32 77.43 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 16.41 7.14 -67.21 16.99 7.91 -69.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.39 11.56 68.52 20.24 13.13 67.73 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.39 11.56 68.52 20.24 13.13 67.73 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU B 110 GLU~? 14.17 C17 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.39 11.56 68.52 20.24 13.13 67.73 32.90 20.43 -41.22 30.91 19.85 -41.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 B 14 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 74 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 B 14 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 66 GLU.? 14.53 C15 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.13 11.40 -59.41 22.89 12.15 -60.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 100 GLU~? 26.53 C3 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 44.37 7.71 -38.80 45.94 6.33 -38.72 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 32 3 # 32 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU B 109 GLU~? 22.36 C17 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 38.03 21.53 -47.60 38.82 23.44 -47.86 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 33 3 # 33 B 14 LYS B 75 LYS~? 10.18 C3 P6G D1130 B 74 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 165 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 19.89 -0.55 76.51 17.10 4.32 77.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 34 3 # 34 B 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 21.39 11.56 68.52 20.24 13.13 67.73 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 35 3 # 35 B 14 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 74 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 21.39 11.56 68.52 20.24 13.13 67.73 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 36 3 # 36 B 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 165 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 21.39 11.56 68.52 20.24 13.13 67.73 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 37 3 # 37 B 14 LYS C 41 LYS~? 13.38 C3 PG4 C1130 B 74 LYS C 38 LYS~? 22.42 O5 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 21.39 11.56 68.52 20.24 13.13 67.73 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 38 3 # 38 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 21.39 11.56 68.52 20.24 13.13 67.73 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 39 3 # 39 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 21.39 11.56 68.52 20.24 13.13 67.73 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 40 3 # 40 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 41 3 # 41 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 21.39 11.56 68.52 20.24 13.13 67.73 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 42 3 # 42 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 43 3 # 43 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 44 GLU~? 12.88 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -19.11 -6.67 -6.22 -18.02 -7.94 -4.93 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 44 3 # 44 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 45 3 # 45 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 46 3 # 46 B 14 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 74 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 47 3 # 47 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 48 3 # 48 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 66 GLU.? 17.32 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -27.54 8.06 -6.82 -28.96 9.42 -7.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 49 3 # 49 B 14 LYS C 74 LYS~? 8.83 O5 PG4 C1130 B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 50 3 # 50 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 51 3 # 51 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 109 GLU~? 22.49 C8 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.52 1.04 -31.85 -35.78 2.73 -33.13 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 52 3 # 52 B 14 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 74 LYS C 72 LYS~? 14.53 C8 PG4 C1130 B 165 GLU C 110 GLU~? 19.54 O4 PG4 C1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 21.39 11.56 68.52 20.24 13.13 67.73 -28.66 1.59 -33.06 -27.87 1.89 -35.00 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 53 3 # 53 B 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 21.39 11.56 68.52 20.24 13.13 67.73 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 54 3 # 54 B 14 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 74 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 19.89 -0.55 76.51 17.10 4.32 77.43 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 55 3 # 55 B 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 165 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 21.39 11.56 68.52 20.24 13.13 67.73 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 56 3 # 56 B 14 LYS D 41 LYS~? 14.07 C15 P6G D1130 B 74 LYS D 38 LYS~? 22.21 C6 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 57 3 # 57 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.39 11.56 68.52 20.24 13.13 67.73 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 58 3 # 58 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 59 3 # 59 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.39 11.56 68.52 20.24 13.13 67.73 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 60 3 # 60 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 21.39 11.56 68.52 20.24 13.13 67.73 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 61 3 # 61 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.39 11.56 68.52 20.24 13.13 67.73 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 62 3 # 62 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 44 GLU~? 13.05 C9 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.39 11.56 68.52 20.24 13.13 67.73 19.96 8.54 -58.15 20.29 9.21 -60.12 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 63 3 # 63 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 64 3 # 64 B 14 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 74 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 19.89 -0.55 76.51 17.10 4.32 77.43 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 21.39 11.56 68.52 20.24 13.13 67.73 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 65 3 # 65 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 66 3 # 66 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 66 GLU.? 17.04 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.50 -6.01 -56.32 9.81 -7.18 -55.76 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 67 3 # 67 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 68 3 # 68 B 14 LYS D 74 LYS~? -4.32 C2 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 12.41 4.04 -29.37 12.28 4.39 -27.28 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 69 3 # 69 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 70 3 # 70 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 71 3 # 71 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 109 GLU~? 20.19 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 4.39 5.46 -30.92 3.12 7.08 -30.47 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 72 3 # 72 B 14 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 74 LYS D 72 LYS~? 14.11 O7 P6G D1130 B 165 GLU D 110 GLU~? 16.67 O1 P6G D1130 coo 13.51 0.92 76.10 12.98 6.13 74.68 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 19.89 -0.55 76.51 17.10 4.32 77.43 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 21.39 11.56 68.52 20.24 13.13 67.73 12.41 4.04 -29.37 12.28 4.39 -27.28 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 72 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 371 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 374 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 371 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 374 ASN C 108 ASN~? 16.59 C8 PG4 C1130 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -31.84 0.42 -27.78 -31.41 2.13 -28.96 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c03 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 85 ASP~? 19.32 C6 PG4 C1130 219 GLU A 82 GLU~? 16.13 C6 PG4 C1130 294 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 25.84 105.87 9.06 27.86 105.55 8.74 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 85 ASP~? 19.32 C6 PG4 C1130 219 GLU C 88 GLU~? 16.97 C5 PG4 C1130 294 ASP C 85 ASP~? 10.22 C6 PG4 C1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 85 ASP~? 16.97 O1 P6G D1130 219 GLU B 82 GLU~? 13.30 C2 P6G D1130 294 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 25.84 105.87 9.06 27.86 105.55 8.74 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 85 ASP~? 16.97 O1 P6G D1130 219 GLU D 88 GLU~? 17.52 C12 P6G D1130 294 ASP D 85 ASP~? 10.24 C11 P6G D1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 25.84 105.87 9.06 27.86 105.55 8.74 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 26.47 11.48 -38.21 26.51 9.40 -38.05 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP C 85 ASP~? 10.22 C6 PG4 C1130 219 GLU A 82 GLU~? 16.13 C6 PG4 C1130 294 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 25.84 105.87 9.06 27.86 105.55 8.74 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 85 ASP~? 10.22 C6 PG4 C1130 219 GLU C 88 GLU~? 16.97 C5 PG4 C1130 294 ASP A 85 ASP~? 19.32 C6 PG4 C1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP D 85 ASP~? 10.24 C11 P6G D1130 219 GLU B 82 GLU~? 13.30 C2 P6G D1130 294 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 25.84 105.87 9.06 27.86 105.55 8.74 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.47 6.05 -29.78 29.50 6.72 -30.15 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP D 85 ASP~? 10.24 C11 P6G D1130 219 GLU D 88 GLU~? 17.52 C12 P6G D1130 294 ASP B 85 ASP~? 16.97 O1 P6G D1130 coo 27.89 102.52 14.98 29.35 101.92 13.57 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 25.84 105.87 9.06 27.86 105.55 8.74 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 31.47 6.05 -29.78 29.50 6.72 -30.15 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 8 hits 2amg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG C 77 ARG~? 11.94 C8 PG4 C1130 A 161 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 174 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 161 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 174 TYR B 46 TYR~? 5.77 O4 P6G D1130 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 23.81 3.51 -50.06 24.23 5.64 -48.28 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG C 77 ARG~? 11.94 C8 PG4 C1130 B 161 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 174 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 161 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 174 TYR B 46 TYR~? 5.77 O4 P6G D1130 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -14.86 10.19 8.14 -14.82 12.31 8.42 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -21.46 12.70 8.53 -19.04 12.30 7.24 23.81 3.51 -50.06 24.23 5.64 -48.28 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 161 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 174 TYR D 51 TYR~? 9.17 O7 P6G D1130 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -14.86 10.19 8.14 -14.82 12.31 8.42 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -21.46 12.70 8.53 -19.04 12.30 7.24 9.62 8.34 -47.74 8.38 5.93 -48.44 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG C 77 ARG~? 11.94 C8 PG4 C1130 C 161 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 174 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo 2.84 19.43 40.34 1.59 20.35 37.65 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 5.94 13.28 27.17 3.53 13.05 28.58 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG D 77 ARG~? 8.78 O1 P6G D1130 C 161 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 174 TYR B 46 TYR~? 5.77 O4 P6G D1130 coo 2.84 19.43 40.34 1.59 20.35 37.65 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 5.94 13.28 27.17 3.53 13.05 28.58 23.81 3.51 -50.06 24.23 5.64 -48.28 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG D 77 ARG~? 8.78 O1 P6G D1130 C 161 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 174 TYR B 51 TYR~? 10.58 C3 P6G D1130 coo 2.84 19.43 40.34 1.59 20.35 37.65 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 5.94 13.28 27.17 3.53 13.05 28.58 29.55 2.80 -46.55 31.14 4.40 -48.22 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG C 77 ARG~? 11.94 C8 PG4 C1130 D 161 ASP C 50 ASP~? 5.21 O2 PG4 C1130 D 174 TYR C 51 TYR~? 9.35 C8 PG4 C1130 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG D 77 ARG~? 8.78 O1 P6G D1130 D 161 ASP B 50 ASP~? 8.75 C2 P6G D1130 D 174 TYR B 46 TYR~? 5.77 O4 P6G D1130 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 23.81 3.51 -50.06 24.23 5.64 -48.28 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 89 THR.? 25.53 O1 P6G D1130 242 CYH A 122 CYH~? 19.70 O1 P6G D1130 270 PHE A 87 PHE~? 21.78 O1 P6G D1130 coo 12.97 28.35 3.84 11.81 28.07 2.09 -5.16 0.04 -40.94 -6.61 0.89 -39.59 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 4.49 -4.79 -35.75 2.11 -4.18 -34.46 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 89 THR~? 23.45 O1 P6G D1130 242 CYH B 122 CYH~? 26.34 C3 P6G D1130 270 PHE B 87 PHE~? 27.15 C3 P6G D1130 coo 12.97 28.35 3.84 11.81 28.07 2.09 35.32 4.97 -23.65 34.17 3.75 -25.02 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 44.04 10.92 -29.63 42.03 9.66 -31.09 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 38.54 10.51 -27.65 40.38 12.27 -26.48 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 3 3 # 3 65 THR C 89 THR~? 14.94 C2 PG4 C1130 242 CYH C 122 CYH~? 12.47 C1 PG4 C1130 270 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo 12.97 28.35 3.84 11.81 28.07 2.09 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -20.89 -15.62 -35.11 -20.20 -14.08 -32.87 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 4 3 # 4 65 THR D 89 THR~? 14.44 C17 P6G D1130 242 CYH D 122 CYH~? 12.34 C18 P6G D1130 270 PHE D 87 PHE~? 15.25 C18 P6G D1130 coo 12.97 28.35 3.84 11.81 28.07 2.09 30.11 16.81 -35.09 30.09 15.90 -37.05 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 19.52 21.12 -30.74 19.88 19.17 -32.70 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 23.55 15.85 -31.50 22.92 16.84 -28.96 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 4 hits 2cnd_c01 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 233 GLU A 52 GLU~? 14.14 O5 PG4 C1130 A 300 ASN A 56 ASN~? 17.86 O5 PG4 C1130 coo 12.51 17.07 49.46 12.44 16.89 47.35 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 6.52 19.14 48.16 7.77 18.42 46.61 -7.58 5.14 -19.74 -8.46 3.38 -20.54 coo 9.30 22.40 41.76 10.10 20.96 40.36 -6.49 7.04 -12.83 -5.69 7.02 -14.83 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 233 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 300 ASN B 56 ASN~? 16.63 C3 P6G D1130 coo 12.51 17.07 49.46 12.44 16.89 47.35 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 6.52 19.14 48.16 7.77 18.42 46.61 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 9.30 22.40 41.76 10.10 20.96 40.36 32.78 -4.61 -51.14 33.91 -4.71 -49.33 2cpu_c01 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 37 GLU~? 22.40 O5 PG4 C1130 A 156 GLU C 37 GLU~? 22.29 O5 PG4 C1130 A 194 ASN C 28 ASN~? 31.96 O5 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 67.47 20.07 1.34 65.99 20.06 2.88 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 67.44 25.26 13.91 67.54 23.65 15.28 -25.75 8.02 11.14 -27.04 9.12 12.42 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 156 GLU A 109 GLU~? 22.30 C2 PG4 C1130 A 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 67.44 25.26 13.91 67.54 23.65 15.28 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 156 GLU A 109 GLU~? 22.30 C2 PG4 C1130 A 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 156 GLU A 110 GLU~? 14.79 C2 PG4 C1130 A 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 67.44 25.26 13.91 67.54 23.65 15.28 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 156 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 156 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 194 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 67.47 20.07 1.34 65.99 20.06 2.88 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 67.44 25.26 13.91 67.54 23.65 15.28 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU A 100 GLU~? 21.70 O1 P6G D1130 A 156 GLU A 120 GLU~? 20.88 O1 P6G D1130 A 194 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 67.44 25.26 13.91 67.54 23.65 15.28 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU A 109 GLU~? 22.30 C2 PG4 C1130 A 156 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 67.47 20.07 1.34 65.99 20.06 2.88 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU B 52 GLU~? 14.42 C2 P6G D1130 A 156 GLU B 82 GLU~? 13.30 C2 P6G D1130 A 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 67.47 20.07 1.34 65.99 20.06 2.88 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 67.44 25.26 13.91 67.54 23.65 15.28 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 67.44 25.26 13.91 67.54 23.65 15.28 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 67.47 20.07 1.34 65.99 20.06 2.88 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 67.44 25.26 13.91 67.54 23.65 15.28 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 194 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 67.47 20.07 1.34 65.99 20.06 2.88 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 67.44 25.26 13.91 67.54 23.65 15.28 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 156 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 194 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 67.47 20.07 1.34 65.99 20.06 2.88 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 67.44 25.26 13.91 67.54 23.65 15.28 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 156 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 194 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 67.47 20.07 1.34 65.99 20.06 2.88 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 67.44 25.26 13.91 67.54 23.65 15.28 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 2dbt_c00 CHITINASE C user 15 3 # 15 A 147 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 156 GLU B 69 GLU~? 16.29 C14 P6G D1130 A 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 67.47 20.07 1.34 65.99 20.06 2.88 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c00 CHITINASE C user 16 3 # 16 A 147 GLU B 109 GLU~? 22.36 C17 P6G D1130 A 156 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 67.47 20.07 1.34 65.99 20.06 2.88 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 67.44 25.26 13.91 67.54 23.65 15.28 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c00 CHITINASE C user 17 3 # 17 A 147 GLU B 121 GLU~? 26.56 C11 P6G D1130 A 156 GLU B 100 GLU~? 26.53 C3 P6G D1130 A 194 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 67.47 20.07 1.34 65.99 20.06 2.88 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 67.44 25.26 13.91 67.54 23.65 15.28 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 2dbt_c00 CHITINASE C user 18 3 # 18 A 147 GLU C 37 GLU~? 22.29 O5 PG4 C1130 A 156 GLU A 37 GLU~? 22.40 O5 PG4 C1130 A 194 ASN A 28 ASN~? 32.95 O5 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 67.47 20.07 1.34 65.99 20.06 2.88 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.06 -1.05 13.97 -11.31 -1.46 15.13 ULMN 3 2dbt_c00 CHITINASE C user 19 3 # 19 A 147 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 156 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 67.47 20.07 1.34 65.99 20.06 2.88 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c00 CHITINASE C user 20 3 # 20 A 147 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 156 GLU C 55 GLU~? 14.48 C8 PG4 C1130 A 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 67.47 20.07 1.34 65.99 20.06 2.88 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c00 CHITINASE C user 21 3 # 21 A 147 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 156 GLU C 109 GLU~? 22.49 C8 PG4 C1130 A 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 67.47 20.07 1.34 65.99 20.06 2.88 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c00 CHITINASE C user 22 3 # 22 A 147 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 156 GLU A 73 GLU~? 13.39 C4 PG4 C1130 A 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c00 CHITINASE C user 23 3 # 23 A 147 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 156 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 194 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2dbt_c00 CHITINASE C user 24 3 # 24 A 147 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 156 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 194 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 67.44 25.26 13.91 67.54 23.65 15.28 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2dbt_c00 CHITINASE C user 25 3 # 25 A 147 GLU C 109 GLU~? 22.49 C8 PG4 C1130 A 156 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 67.47 20.07 1.34 65.99 20.06 2.88 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 67.44 25.26 13.91 67.54 23.65 15.28 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c00 CHITINASE C user 26 3 # 26 A 147 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 156 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 67.47 20.07 1.34 65.99 20.06 2.88 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c00 CHITINASE C user 27 3 # 27 A 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 156 GLU D 55 GLU~? 14.43 O7 P6G D1130 A 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 67.44 25.26 13.91 67.54 23.65 15.28 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c00 CHITINASE C user 28 3 # 28 A 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 156 GLU D 69 GLU~? 15.99 C6 P6G D1130 A 194 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 67.44 25.26 13.91 67.54 23.65 15.28 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 2dbt_c00 CHITINASE C user 29 3 # 29 A 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 156 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 67.44 25.26 13.91 67.54 23.65 15.28 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c00 CHITINASE C user 30 3 # 30 A 147 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 156 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 194 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 67.47 20.07 1.34 65.99 20.06 2.88 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2dbt_c00 CHITINASE C user 31 3 # 31 A 147 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 156 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 194 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 67.47 20.07 1.34 65.99 20.06 2.88 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 67.44 25.26 13.91 67.54 23.65 15.28 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2dbt_c00 CHITINASE C user 32 3 # 32 A 147 GLU D 109 GLU~? 20.19 O1 P6G D1130 A 156 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 74.14 15.91 8.55 72.08 15.36 8.63 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 67.47 20.07 1.34 65.99 20.06 2.88 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 7.42 15.00 -39.68 7.34 16.70 -38.37 2dbt_c00 source 2dbt CHITINASE C : 32 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 37 GLU~? 22.40 O5 PG4 C1130 B 156 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 194 ASN A 28 ASN~? 32.95 O5 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.06 -1.05 13.97 -11.31 -1.46 15.13 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 37 GLU~? 22.40 O5 PG4 C1130 B 156 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 194 ASN C 28 ASN~? 31.96 O5 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 54.43 67.89 19.82 55.62 67.90 18.07 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 49.79 70.75 7.78 50.10 68.90 6.86 -25.75 8.02 11.14 -27.04 9.12 12.42 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 156 GLU A 109 GLU~? 22.30 C2 PG4 C1130 B 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 54.43 67.89 19.82 55.62 67.90 18.07 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 49.79 70.75 7.78 50.10 68.90 6.86 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 156 GLU A 109 GLU~? 22.30 C2 PG4 C1130 B 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 54.43 67.89 19.82 55.62 67.90 18.07 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 156 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 156 GLU A 100 GLU~? 21.70 O1 P6G D1130 B 194 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 54.43 67.89 19.82 55.62 67.90 18.07 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 49.79 70.75 7.78 50.10 68.90 6.86 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU A 109 GLU~? 22.30 C2 PG4 C1130 B 156 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 54.43 67.89 19.82 55.62 67.90 18.07 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 49.79 70.75 7.78 50.10 68.90 6.86 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 B 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 49.79 70.75 7.78 50.10 68.90 6.86 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 B 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 B 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 54.43 67.89 19.82 55.62 67.90 18.07 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 49.79 70.75 7.78 50.10 68.90 6.86 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 B 156 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 194 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 54.43 67.89 19.82 55.62 67.90 18.07 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.79 70.75 7.78 50.10 68.90 6.86 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU B 100 GLU~? 26.53 C3 P6G D1130 B 156 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 194 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 54.43 67.89 19.82 55.62 67.90 18.07 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 49.79 70.75 7.78 50.10 68.90 6.86 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU B 109 GLU~? 22.36 C17 P6G D1130 B 156 GLU B 69 GLU~? 16.29 C14 P6G D1130 B 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 54.43 67.89 19.82 55.62 67.90 18.07 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU B 109 GLU~? 22.36 C17 P6G D1130 B 156 GLU B 73 GLU~? 10.65 C14 P6G D1130 B 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 54.43 67.89 19.82 55.62 67.90 18.07 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 49.79 70.75 7.78 50.10 68.90 6.86 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c01 CHITINASE C user 14 3 # 14 B 147 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 156 GLU B 100 GLU~? 26.53 C3 P6G D1130 B 194 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 54.43 67.89 19.82 55.62 67.90 18.07 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 49.79 70.75 7.78 50.10 68.90 6.86 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 2dbt_c01 CHITINASE C user 15 3 # 15 B 147 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 156 GLU A 37 GLU~? 22.40 O5 PG4 C1130 B 194 ASN A 28 ASN~? 32.95 O5 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 54.43 67.89 19.82 55.62 67.90 18.07 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.06 -1.05 13.97 -11.31 -1.46 15.13 ULMN 3 2dbt_c01 CHITINASE C user 16 3 # 16 B 147 GLU C 37 GLU~? 22.29 O5 PG4 C1130 B 156 GLU A 37 GLU~? 22.40 O5 PG4 C1130 B 194 ASN C 28 ASN~? 31.96 O5 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 54.43 67.89 19.82 55.62 67.90 18.07 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 49.79 70.75 7.78 50.10 68.90 6.86 -25.75 8.02 11.14 -27.04 9.12 12.42 ULMN 3 2dbt_c01 CHITINASE C user 17 3 # 17 B 147 GLU C 55 GLU~? 14.48 C8 PG4 C1130 B 156 GLU C 73 GLU~? 12.72 C8 PG4 C1130 B 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 54.43 67.89 19.82 55.62 67.90 18.07 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c01 CHITINASE C user 18 3 # 18 B 147 GLU C 73 GLU~? 12.72 C8 PG4 C1130 B 156 GLU C 55 GLU~? 14.48 C8 PG4 C1130 B 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 54.43 67.89 19.82 55.62 67.90 18.07 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c01 CHITINASE C user 19 3 # 19 B 147 GLU C 73 GLU~? 12.72 C8 PG4 C1130 B 156 GLU C 109 GLU~? 22.49 C8 PG4 C1130 B 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 54.43 67.89 19.82 55.62 67.90 18.07 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c01 CHITINASE C user 20 3 # 20 B 147 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 156 GLU A 73 GLU~? 13.39 C4 PG4 C1130 B 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c01 CHITINASE C user 21 3 # 21 B 147 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 156 GLU C 94 GLU~? 10.36 O1 PG4 C1130 B 194 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2dbt_c01 CHITINASE C user 22 3 # 22 B 147 GLU C 94 GLU~? 10.36 O1 PG4 C1130 B 156 GLU C 82 GLU~? -3.24 C6 PG4 C1130s B 194 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 49.79 70.75 7.78 50.10 68.90 6.86 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2dbt_c01 CHITINASE C user 23 3 # 23 B 147 GLU C 109 GLU~? 22.49 C8 PG4 C1130 B 156 GLU C 73 GLU~? 12.72 C8 PG4 C1130 B 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 54.43 67.89 19.82 55.62 67.90 18.07 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 49.79 70.75 7.78 50.10 68.90 6.86 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c01 CHITINASE C user 24 3 # 24 B 147 GLU D 69 GLU~? 15.99 C6 P6G D1130 B 156 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 194 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 54.43 67.89 19.82 55.62 67.90 18.07 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 2dbt_c01 CHITINASE C user 25 3 # 25 B 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 156 GLU D 69 GLU~? 15.99 C6 P6G D1130 B 194 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 49.79 70.75 7.78 50.10 68.90 6.86 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 2dbt_c01 CHITINASE C user 26 3 # 26 B 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 156 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 49.79 70.75 7.78 50.10 68.90 6.86 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c01 CHITINASE C user 27 3 # 27 B 147 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 156 GLU D 94 GLU~? 9.44 O19 P6G D1130 B 194 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 54.43 67.89 19.82 55.62 67.90 18.07 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2dbt_c01 CHITINASE C user 28 3 # 28 B 147 GLU D 94 GLU~? 9.44 O19 P6G D1130 B 156 GLU D 82 GLU~? -3.29 C11 P6G D1130s B 194 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 54.43 67.89 19.82 55.62 67.90 18.07 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.79 70.75 7.78 50.10 68.90 6.86 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2dbt_c01 CHITINASE C user 29 3 # 29 B 147 GLU D 109 GLU~? 20.19 O1 P6G D1130 B 156 GLU D 73 GLU~? 10.67 O1 P6G D1130 B 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 45.64 63.11 17.20 47.48 62.43 16.45 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 54.43 67.89 19.82 55.62 67.90 18.07 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 7.42 15.00 -39.68 7.34 16.70 -38.37 2dbt_c01 source 2dbt CHITINASE C : 29 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 37 GLU~? 22.40 O5 PG4 C1130 C 156 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 194 ASN A 28 ASN~? 32.95 O5 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.06 -1.05 13.97 -11.31 -1.46 15.13 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 37 GLU~? 22.40 O5 PG4 C1130 C 156 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 194 ASN C 28 ASN~? 31.96 O5 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 44.75 23.09 5.51 46.77 22.91 6.12 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 49.75 21.00 18.12 50.45 23.02 18.26 -25.75 8.02 11.14 -27.04 9.12 12.42 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 C 156 GLU A 109 GLU~? 22.30 C2 PG4 C1130 C 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 49.75 21.00 18.12 50.45 23.02 18.26 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 C 156 GLU A 109 GLU~? 22.30 C2 PG4 C1130 C 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 C 156 GLU A 110 GLU~? 14.79 C2 PG4 C1130 C 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 coo 49.75 21.00 18.12 50.45 23.02 18.26 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 73 GLU~? 13.39 C4 PG4 C1130 C 156 GLU C 82 GLU~? -3.24 C6 PG4 C1130s C 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU A 82 GLU~? 16.13 C6 PG4 C1130 C 156 GLU C 88 GLU~? 16.97 C5 PG4 C1130 C 194 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -8.97 -0.62 -28.74 -8.81 1.15 -27.62 coo 44.75 23.09 5.51 46.77 22.91 6.12 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 49.75 21.00 18.12 50.45 23.02 18.26 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU A 94 GLU~? 22.82 O1 P6G D1130 C 156 GLU A 100 GLU~? 21.70 O1 P6G D1130 C 194 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 44.75 23.09 5.51 46.77 22.91 6.12 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 49.75 21.00 18.12 50.45 23.02 18.26 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU A 100 GLU~? 21.70 O1 P6G D1130 C 156 GLU A 120 GLU~? 20.88 O1 P6G D1130 C 194 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 4.82 -2.98 -24.68 6.51 -1.85 -25.22 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.82 -11.06 -31.67 7.44 -9.70 -30.14 coo 49.75 21.00 18.12 50.45 23.02 18.26 8.90 3.92 -35.18 9.80 2.60 -33.76 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU A 109 GLU~? 22.30 C2 PG4 C1130 C 156 GLU A 73 GLU~? 13.39 C4 PG4 C1130 C 194 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -1.10 -18.78 -20.33 -0.51 -20.78 -20.42 coo 44.75 23.09 5.51 46.77 22.91 6.12 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 49.75 21.00 18.12 50.45 23.02 18.26 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU B 37 GLU~? 22.87 C6 P6G D1130 C 156 GLU D 37 GLU~? 22.00 C9 P6G D1130 C 194 ASN B 28 ASN~? 31.97 C8 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 20.90 -4.08 -65.74 21.08 -5.77 -67.00 coo 44.75 23.09 5.51 46.77 22.91 6.12 16.41 7.14 -67.21 16.99 7.91 -69.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 26.85 0.91 -77.13 26.68 2.86 -77.97 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU B 52 GLU~? 14.42 C2 P6G D1130 C 156 GLU B 82 GLU~? 13.30 C2 P6G D1130 C 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 32.10 -2.10 -44.27 32.78 -3.62 -42.92 coo 44.75 23.09 5.51 46.77 22.91 6.12 30.92 4.89 -35.74 29.30 4.17 -34.66 coo 49.75 21.00 18.12 50.45 23.02 18.26 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU B 69 GLU~? 16.29 C14 P6G D1130 C 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 C 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 49.75 21.00 18.12 50.45 23.02 18.26 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 C 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 C 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 44.75 23.09 5.51 46.77 22.91 6.12 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 49.75 21.00 18.12 50.45 23.02 18.26 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c02 CHITINASE C user 15 3 # 15 C 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 C 156 GLU B 109 GLU~? 22.36 C17 P6G D1130 C 194 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 44.75 23.09 5.51 46.77 22.91 6.12 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 49.75 21.00 18.12 50.45 23.02 18.26 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 2dbt_c02 CHITINASE C user 16 3 # 16 C 147 GLU B 73 GLU~? 10.65 C14 P6G D1130 C 156 GLU D 82 GLU~? -3.29 C11 P6G D1130s C 194 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 44.75 23.09 5.51 46.77 22.91 6.12 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.75 21.00 18.12 50.45 23.02 18.26 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 3 2dbt_c02 CHITINASE C user 17 3 # 17 C 147 GLU B 100 GLU~? 26.53 C3 P6G D1130 C 156 GLU B 121 GLU~? 26.56 C11 P6G D1130 C 194 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 44.75 23.09 5.51 46.77 22.91 6.12 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 49.75 21.00 18.12 50.45 23.02 18.26 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 2dbt_c02 CHITINASE C user 18 3 # 18 C 147 GLU B 109 GLU~? 22.36 C17 P6G D1130 C 156 GLU B 69 GLU~? 16.29 C14 P6G D1130 C 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 44.75 23.09 5.51 46.77 22.91 6.12 32.72 14.03 -52.77 34.27 12.68 -52.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c02 CHITINASE C user 19 3 # 19 C 147 GLU B 109 GLU~? 22.36 C17 P6G D1130 C 156 GLU B 73 GLU~? 10.65 C14 P6G D1130 C 194 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 38.03 21.53 -47.60 38.82 23.44 -47.86 coo 44.75 23.09 5.51 46.77 22.91 6.12 30.54 14.87 -46.06 28.97 16.29 -46.38 coo 49.75 21.00 18.12 50.45 23.02 18.26 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 3 2dbt_c02 CHITINASE C user 20 3 # 20 C 147 GLU B 121 GLU~? 26.56 C11 P6G D1130 C 156 GLU B 100 GLU~? 26.53 C3 P6G D1130 C 194 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 44.75 23.09 5.51 46.77 22.91 6.12 44.37 7.71 -38.80 45.94 6.33 -38.72 coo 49.75 21.00 18.12 50.45 23.02 18.26 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 3 2dbt_c02 CHITINASE C user 21 3 # 21 C 147 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 156 GLU A 37 GLU~? 22.40 O5 PG4 C1130 C 194 ASN A 28 ASN~? 32.95 O5 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 44.75 23.09 5.51 46.77 22.91 6.12 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.06 -1.05 13.97 -11.31 -1.46 15.13 ULMN 3 2dbt_c02 CHITINASE C user 22 3 # 22 C 147 GLU C 37 GLU~? 22.29 O5 PG4 C1130 C 156 GLU A 37 GLU~? 22.40 O5 PG4 C1130 C 194 ASN C 28 ASN~? 31.96 O5 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -21.28 -3.96 3.81 -21.51 -4.93 5.68 coo 44.75 23.09 5.51 46.77 22.91 6.12 -18.08 5.74 1.85 -17.77 7.24 3.33 coo 49.75 21.00 18.12 50.45 23.02 18.26 -25.75 8.02 11.14 -27.04 9.12 12.42 ULMN 3 2dbt_c02 CHITINASE C user 23 3 # 23 C 147 GLU C 55 GLU~? 14.48 C8 PG4 C1130 C 156 GLU C 73 GLU~? 12.72 C8 PG4 C1130 C 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 44.75 23.09 5.51 46.77 22.91 6.12 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c02 CHITINASE C user 24 3 # 24 C 147 GLU C 73 GLU~? 12.72 C8 PG4 C1130 C 156 GLU C 55 GLU~? 14.48 C8 PG4 C1130 C 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 44.75 23.09 5.51 46.77 22.91 6.12 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c02 CHITINASE C user 25 3 # 25 C 147 GLU C 73 GLU~? 12.72 C8 PG4 C1130 C 156 GLU C 109 GLU~? 22.49 C8 PG4 C1130 C 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 44.75 23.09 5.51 46.77 22.91 6.12 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c02 CHITINASE C user 26 3 # 26 C 147 GLU C 82 GLU~? -3.24 C6 PG4 C1130s C 156 GLU A 73 GLU~? 13.39 C4 PG4 C1130 C 194 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 3 2dbt_c02 CHITINASE C user 27 3 # 27 C 147 GLU C 82 GLU~? -3.24 C6 PG4 C1130s C 156 GLU C 94 GLU~? 10.36 O1 PG4 C1130 C 194 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2dbt_c02 CHITINASE C user 28 3 # 28 C 147 GLU C 94 GLU~? 10.36 O1 PG4 C1130 C 156 GLU C 82 GLU~? -3.24 C6 PG4 C1130s C 194 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 49.75 21.00 18.12 50.45 23.02 18.26 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2dbt_c02 CHITINASE C user 29 3 # 29 C 147 GLU C 109 GLU~? 22.49 C8 PG4 C1130 C 156 GLU C 73 GLU~? 12.72 C8 PG4 C1130 C 194 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.52 1.04 -31.85 -35.78 2.73 -33.13 coo 44.75 23.09 5.51 46.77 22.91 6.12 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 49.75 21.00 18.12 50.45 23.02 18.26 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 3 2dbt_c02 CHITINASE C user 30 3 # 30 C 147 GLU D 55 GLU~? 14.43 O7 P6G D1130 C 156 GLU D 73 GLU~? 10.67 O1 P6G D1130 C 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 44.75 23.09 5.51 46.77 22.91 6.12 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c02 CHITINASE C user 31 3 # 31 C 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 C 156 GLU D 55 GLU~? 14.43 O7 P6G D1130 C 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 5.29 7.89 -51.10 4.11 8.75 -49.57 coo 49.75 21.00 18.12 50.45 23.02 18.26 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c02 CHITINASE C user 32 3 # 32 C 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 C 156 GLU D 69 GLU~? 15.99 C6 P6G D1130 C 194 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 5.13 -2.81 -47.72 4.71 -3.46 -49.70 coo 49.75 21.00 18.12 50.45 23.02 18.26 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 3 2dbt_c02 CHITINASE C user 33 3 # 33 C 147 GLU D 73 GLU~? 10.67 O1 P6G D1130 C 156 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 49.75 21.00 18.12 50.45 23.02 18.26 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 3 2dbt_c02 CHITINASE C user 34 3 # 34 C 147 GLU D 82 GLU~? -3.29 C11 P6G D1130s C 156 GLU D 94 GLU~? 9.44 O19 P6G D1130 C 194 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 44.75 23.09 5.51 46.77 22.91 6.12 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2dbt_c02 CHITINASE C user 35 3 # 35 C 147 GLU D 94 GLU~? 9.44 O19 P6G D1130 C 156 GLU D 82 GLU~? -3.29 C11 P6G D1130s C 194 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 44.75 23.09 5.51 46.77 22.91 6.12 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 49.75 21.00 18.12 50.45 23.02 18.26 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2dbt_c02 CHITINASE C user 36 3 # 36 C 147 GLU D 109 GLU~? 20.19 O1 P6G D1130 C 156 GLU D 73 GLU~? 10.67 O1 P6G D1130 C 194 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 41.23 29.31 13.28 43.03 29.85 12.29 4.39 5.46 -30.92 3.12 7.08 -30.47 coo 44.75 23.09 5.51 46.77 22.91 6.12 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 7.42 15.00 -39.68 7.34 16.70 -38.37 2dbt_c02 source 2dbt CHITINASE C : 36 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 2.77 37.17 4.99 6.33 34.76 8.06 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 A 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 2.77 37.17 4.99 6.33 34.76 8.06 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 A 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 A 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 2.77 37.17 4.99 6.33 34.76 8.06 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 2.77 37.17 4.99 6.33 34.76 8.06 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 A 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 2.77 37.17 4.99 6.33 34.76 8.06 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 0.07 40.30 18.65 -0.21 42.34 18.18 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 A 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 A 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 2.77 37.17 4.99 6.33 34.76 8.06 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 0.07 40.30 18.65 -0.21 42.34 18.18 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 A 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 2.77 37.17 4.99 6.33 34.76 8.06 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 5.98 42.76 7.73 10.19 38.62 9.02 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 2.77 37.17 4.99 6.33 34.76 8.06 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 0.07 40.30 18.65 -0.21 42.34 18.18 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 B 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 B 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 38.76 2.27 4.00 34.00 5.99 4.37 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 40.63 7.13 9.06 35.85 7.36 8.95 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 26.81 -2.80 -44.44 26.03 -3.69 -42.69 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 0.95 12.72 73.51 1.58 12.72 68.31 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 C 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 0.95 12.72 73.51 1.58 12.72 68.31 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 C 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 C 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 0.95 12.72 73.51 1.58 12.72 68.31 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 0.95 12.72 73.51 1.58 12.72 68.31 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 C 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 0.95 12.72 73.51 1.58 12.72 68.31 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -4.59 24.28 66.67 -6.26 24.34 67.99 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 C 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 C 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 0.95 12.72 73.51 1.58 12.72 68.31 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -4.59 24.28 66.67 -6.26 24.34 67.99 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 C 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 C 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 0.95 12.72 73.51 1.58 12.72 68.31 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 C 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s C 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo -5.66 12.40 71.13 -2.66 9.98 66.50 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 0.95 12.72 73.51 1.58 12.72 68.31 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -4.59 24.28 66.67 -6.26 24.34 67.99 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 D 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 D 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 D 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 D 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 D 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 D 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 D 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 D 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 D 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s D 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 E 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 E 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 E 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 E 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 E 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 E 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 E 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 E 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -23.22 55.98 120.74 -18.11 55.31 120.43 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 E 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 E 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 28.17 10.93 -44.80 23.06 12.97 -45.61 coo -23.22 55.98 120.74 -18.11 55.31 120.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -17.15 59.71 133.33 -17.96 61.54 134.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 E 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 E 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 30.12 7.76 -44.06 30.09 2.81 -42.01 coo -23.22 55.98 120.74 -18.11 55.31 120.43 31.42 9.18 -48.71 35.31 8.95 -53.15 coo -17.15 59.71 133.33 -17.96 61.54 134.01 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 E 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 E 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 E 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s E 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo -21.16 62.58 121.86 -16.35 60.33 119.23 9.63 4.64 -45.08 4.33 7.57 -43.39 coo -23.22 55.98 120.74 -18.11 55.31 120.43 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -17.15 59.71 133.33 -17.96 61.54 134.01 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 F 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 F 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 10.64 34.02 91.30 6.30 35.60 95.11 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 13.75 39.76 94.12 11.42 37.23 97.89 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 16.35 26.90 99.56 16.81 25.90 97.75 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 F 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 F 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 10.64 34.02 91.30 6.30 35.60 95.11 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 13.75 39.76 94.12 11.42 37.23 97.89 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 16.35 26.90 99.56 16.81 25.90 97.75 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 F 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 F 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 10.64 34.02 91.30 6.30 35.60 95.11 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 13.75 39.76 94.12 11.42 37.23 97.89 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 16.35 26.90 99.56 16.81 25.90 97.75 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 F 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 F 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 10.64 34.02 91.30 6.30 35.60 95.11 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 13.75 39.76 94.12 11.42 37.23 97.89 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 16.35 26.90 99.56 16.81 25.90 97.75 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 F 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 F 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 10.64 34.02 91.30 6.30 35.60 95.11 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 13.75 39.76 94.12 11.42 37.23 97.89 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 16.35 26.90 99.56 16.81 25.90 97.75 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 F 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s F 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 10.64 34.02 91.30 6.30 35.60 95.11 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 13.75 39.76 94.12 11.42 37.23 97.89 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 16.35 26.90 99.56 16.81 25.90 97.75 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 G 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 G 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 36.69 47.69 78.93 39.38 50.40 75.35 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 33.43 44.37 65.47 33.10 42.30 65.37 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 G 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 G 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 36.69 47.69 78.93 39.38 50.40 75.35 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 33.43 44.37 65.47 33.10 42.30 65.37 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 G 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 G 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 36.69 47.69 78.93 39.38 50.40 75.35 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 33.43 44.37 65.47 33.10 42.30 65.37 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 G 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 G 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 36.69 47.69 78.93 39.38 50.40 75.35 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 G 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 G 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 36.69 47.69 78.93 39.38 50.40 75.35 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 33.43 44.37 65.47 33.10 42.30 65.37 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 G 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 G 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 36.69 47.69 78.93 39.38 50.40 75.35 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 33.43 44.37 65.47 33.10 42.30 65.37 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 G 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 G 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 36.69 47.69 78.93 39.38 50.40 75.35 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 33.43 44.37 65.47 33.10 42.30 65.37 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 G 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s G 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 39.68 42.04 76.11 43.42 46.43 74.96 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 36.69 47.69 78.93 39.38 50.40 75.35 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 33.43 44.37 65.47 33.10 42.30 65.37 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 H 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 H 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 73.65 78.64 75.66 68.14 79.07 75.04 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 H 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 H 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 73.65 78.64 75.66 68.14 79.07 75.04 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 H 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 H 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 73.65 78.64 75.66 68.14 79.07 75.04 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 H 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 H 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 73.65 78.64 75.66 68.14 79.07 75.04 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 H 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 H 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 73.65 78.64 75.66 68.14 79.07 75.04 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 67.43 90.73 71.39 68.27 92.30 72.52 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 H 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 H 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 73.65 78.64 75.66 68.14 79.07 75.04 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 67.43 90.73 71.39 68.27 92.30 72.52 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 H 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 H 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 73.65 78.64 75.66 68.14 79.07 75.04 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 67.43 90.73 71.39 68.27 92.30 72.52 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 H 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s H 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 71.58 83.18 80.51 66.88 79.77 79.84 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 73.65 78.64 75.66 68.14 79.07 75.04 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 67.43 90.73 71.39 68.27 92.30 72.52 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 I 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 I 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 54.31 95.46 46.01 55.34 91.59 42.65 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 I 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 I 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 54.31 95.46 46.01 55.34 91.59 42.65 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 I 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 I 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 54.31 95.46 46.01 55.34 91.59 42.65 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 I 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 I 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 54.31 95.46 46.01 55.34 91.59 42.65 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 I 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 I 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 54.31 95.46 46.01 55.34 91.59 42.65 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 66.35 87.81 48.53 68.10 89.01 48.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 I 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 I 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 54.31 95.46 46.01 55.34 91.59 42.65 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 66.35 87.81 48.53 68.10 89.01 48.77 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 I 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 I 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 54.31 95.46 46.01 55.34 91.59 42.65 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 66.35 87.81 48.53 68.10 89.01 48.77 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 I 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s I 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 60.20 96.92 42.53 57.60 93.13 38.67 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 54.31 95.46 46.01 55.34 91.59 42.65 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 66.35 87.81 48.53 68.10 89.01 48.77 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 J 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 J 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 25.22 70.55 14.03 27.64 73.07 18.65 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 31.73 69.87 11.50 32.73 70.19 16.40 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 25.87 58.42 18.79 23.95 58.54 17.90 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 J 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 J 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 25.22 70.55 14.03 27.64 73.07 18.65 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 31.73 69.87 11.50 32.73 70.19 16.40 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 25.87 58.42 18.79 23.95 58.54 17.90 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 J 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 J 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 25.22 70.55 14.03 27.64 73.07 18.65 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 31.73 69.87 11.50 32.73 70.19 16.40 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 J 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 J 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 25.22 70.55 14.03 27.64 73.07 18.65 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 25.87 58.42 18.79 23.95 58.54 17.90 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 J 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 J 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 25.22 70.55 14.03 27.64 73.07 18.65 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 31.73 69.87 11.50 32.73 70.19 16.40 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 25.87 58.42 18.79 23.95 58.54 17.90 26.81 -2.80 -44.44 26.03 -3.69 -42.69 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 K 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 K 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 K 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 K 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 K 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 K 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 K 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 K 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 K 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 K 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 K 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 K 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 K 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 K 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 K 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s K 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS B 41 LYS~? 19.06 O4 P6G D1130 L 184 LYS B 38 LYS~? 23.39 O4 P6G D1130 L 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS D 41 LYS~? 14.07 C15 P6G D1130 L 184 LYS D 38 LYS~? 22.21 C6 P6G D1130 L 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 41 LYS~? 15.70 O5 PG4 C1130 M 184 LYS A 38 LYS~? 22.91 O5 PG4 C1130 M 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS B 41 LYS~? 19.06 O4 P6G D1130 M 184 LYS B 38 LYS~? 23.39 O4 P6G D1130 M 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS C 41 LYS~? 13.38 C3 PG4 C1130 M 184 LYS C 38 LYS~? 22.42 O5 PG4 C1130 M 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS D 41 LYS~? 14.07 C15 P6G D1130 M 184 LYS D 38 LYS~? 22.21 C6 P6G D1130 M 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 15.84 8.23 -60.47 13.98 13.25 -60.76 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 13.18 5.53 -63.93 7.70 4.95 -66.54 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 N 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 N 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 N 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 N 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 N 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 N 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 N 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 N 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 N 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 N 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 N 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 N 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 7 3 # 7 N 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 N 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 N 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 8 3 # 8 N 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 N 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s N 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 72 LYS~? 16.44 O5 PG4 C1130 O 184 LYS A 74 LYS~? 4.39 C4 PG4 C1130 O 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 74 LYS~? 4.39 C4 PG4 C1130 O 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 O 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 75 LYS~? 13.44 O5 PG4 C1130 O 184 LYS A 72 LYS~? 16.44 O5 PG4 C1130 O 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS B 72 LYS~? 17.42 C8 P6G D1130 O 184 LYS B 74 LYS~? 4.23 C14 P6G D1130 O 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 74 LYS~? 4.23 C14 P6G D1130 O 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 O 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 28.17 10.93 -44.80 23.06 12.97 -45.61 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS B 75 LYS~? 10.18 C3 P6G D1130 O 184 LYS B 72 LYS~? 17.42 C8 P6G D1130 O 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 30.12 7.76 -44.06 30.09 2.81 -42.01 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 31.42 9.18 -48.71 35.31 8.95 -53.15 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS C 72 LYS~? 14.53 C8 PG4 C1130 O 184 LYS C 74 LYS~? 8.83 O5 PG4 C1130 O 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -25.41 0.29 -20.42 -23.28 5.14 -19.07 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS D 72 LYS~? 14.11 O7 P6G D1130 O 184 LYS D 74 LYS~? -4.32 C2 P6G D1130s O 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 41 LYS~? 15.70 O5 PG4 C1130 P 184 LYS A 38 LYS~? 22.91 O5 PG4 C1130 P 345 ASP A 50 ASP~? 13.04 O5 PG4 C1130 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -16.40 4.87 -5.99 -15.06 9.32 -8.17 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -13.68 4.03 -1.81 -8.47 6.66 0.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -13.43 5.43 -19.54 -12.24 6.99 -18.79 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS B 41 LYS~? 19.06 O4 P6G D1130 P 184 LYS B 38 LYS~? 23.39 O4 P6G D1130 P 345 ASP B 50 ASP~? 8.75 C2 P6G D1130 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 22.58 -3.09 -57.56 22.63 -7.38 -61.16 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 25.30 -2.41 -62.07 30.29 -5.23 -64.65 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 26.81 -2.80 -44.44 26.03 -3.69 -42.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS C 41 LYS~? 13.38 C3 PG4 C1130 P 184 LYS C 38 LYS~? 22.42 O5 PG4 C1130 P 345 ASP C 50 ASP~? 5.21 O2 PG4 C1130 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -25.71 -3.86 -0.20 -30.77 -4.99 3.32 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS D 41 LYS~? 14.07 C15 P6G D1130 P 184 LYS D 38 LYS~? 22.21 C6 P6G D1130 P 345 ASP D 50 ASP~? 5.15 O16 P6G D1130 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 15.84 8.23 -60.47 13.98 13.25 -60.76 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 13.18 5.53 -63.93 7.70 4.95 -66.54 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 11.91 14.56 -48.67 12.89 16.26 -47.87 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 245 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 46 TYR~? 5.77 O4 P6G D1130 A 245 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 273 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 23.81 3.51 -50.06 24.23 5.64 -48.28 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 118 TYR~? 21.87 C11 P6G D1130 A 245 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 273 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 37.69 14.21 -33.01 35.23 15.36 -32.38 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 23.08 11.99 -34.73 21.14 6.51 -33.38 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 245 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 245 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 48 PHE~? 8.83 O5 PG4 C1130 A 245 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -22.33 5.37 -13.70 -24.67 4.22 -12.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 245 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 273 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE A 87 PHE~? 21.78 O1 P6G D1130 A 245 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 273 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE A 98 PHE~? 19.95 C6 PG4 C1130 A 245 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 273 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -3.45 0.03 -28.39 -4.86 2.42 -28.08 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE A 99 PHE~? 22.28 C6 PG4 C1130 A 245 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 273 LYS C 84 LYS~? 13.44 C6 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -16.84 -7.52 -29.99 -18.72 -1.90 -31.54 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 245 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 273 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE B 87 PHE~? 27.15 C3 P6G D1130 A 245 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 273 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 38.54 10.51 -27.65 40.38 12.27 -26.48 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE B 98 PHE~? 17.75 C3 P6G D1130 A 245 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 273 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 36.48 4.26 -36.04 35.13 1.81 -35.88 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 245 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 273 LYS D 84 LYS~? 10.25 O1 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 39.20 10.29 -35.14 37.62 10.52 -32.83 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 23.08 11.99 -34.73 21.14 6.51 -33.38 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 245 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 273 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 157 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 245 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 273 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 157 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 245 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 273 LYS A 72 LYS~? 16.44 O5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -7.82 -6.30 -16.17 -4.63 -3.65 -12.28 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 157 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 245 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 273 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 16 3 # 16 A 157 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 245 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 273 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 17 3 # 17 A 157 PHE D 48 PHE~? -7.47 C9 P6G D1130s A 245 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 273 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 18 3 # 18 A 157 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 245 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 273 LYS B 72 LYS~? 17.42 C8 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 31.42 9.18 -48.71 35.31 8.95 -53.15 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 19 3 # 19 A 157 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 245 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 273 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 20 3 # 20 A 157 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 245 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 273 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 17.40 15.07 -34.81 19.85 13.95 -34.07 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 34.20 9.92 -30.73 30.97 14.90 -30.33 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 20 hits 2gsa_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 263 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 292 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 63.95 45.30 16.71 59.11 49.15 16.05 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 292 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 63.95 45.30 16.71 59.11 49.15 16.05 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 A 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 A 292 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 63.95 45.30 16.71 59.11 49.15 16.05 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE C 48 PHE~? 7.58 C4 PG4 C1130 A 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 292 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 54.43 44.82 23.74 55.21 45.06 21.80 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE C 87 PHE~? 15.40 C1 PG4 C1130 A 263 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 292 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 63.95 45.30 16.71 59.11 49.15 16.05 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 292 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 54.43 44.82 23.74 55.21 45.06 21.80 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 292 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 54.43 44.82 23.74 55.21 45.06 21.80 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 63.95 45.30 16.71 59.11 49.15 16.05 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE D 48 PHE~? -7.47 C9 P6G D1130s A 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 51.51 50.32 16.39 52.13 49.68 13.75 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 54.43 44.82 23.74 55.21 45.06 21.80 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE D 87 PHE~? 15.25 C18 P6G D1130 A 263 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 292 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 54.43 44.82 23.74 55.21 45.06 21.80 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 292 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 51.51 50.32 16.39 52.13 49.68 13.75 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 54.43 44.82 23.74 55.21 45.06 21.80 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 51.51 50.32 16.39 52.13 49.68 13.75 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 54.43 44.82 23.74 55.21 45.06 21.80 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 63.95 45.30 16.71 59.11 49.15 16.05 14.51 2.78 -43.17 17.25 -1.27 -44.64 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 11 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 54 PHE~? 10.14 O5 PG4 C1130 B 263 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 292 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 292 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 292 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 B 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 B 292 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 49.99 26.05 6.28 51.46 26.87 8.49 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 14.33 6.41 -44.26 15.86 10.02 -47.66 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE C 48 PHE~? 7.58 C4 PG4 C1130 B 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 292 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE C 48 PHE~? 7.58 C4 PG4 C1130 B 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 292 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 49.99 26.05 6.28 51.46 26.87 8.49 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE C 87 PHE~? 15.40 C1 PG4 C1130 B 263 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 292 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 60.53 31.67 0.97 57.79 27.51 3.63 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE C 98 PHE~? -3.85 C1 PG4 C1130s B 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 292 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE C 98 PHE~? -3.85 C1 PG4 C1130s B 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 292 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 60.53 31.67 0.97 57.79 27.51 3.63 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE D 48 PHE~? -7.47 C9 P6G D1130s B 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 49.99 26.05 6.28 51.46 26.87 8.49 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE D 54 PHE~? 9.38 C6 P6G D1130 B 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 49.99 26.05 6.28 51.46 26.87 8.49 11.23 7.23 -52.90 10.96 4.47 -53.21 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE D 87 PHE~? 15.25 C18 P6G D1130 B 263 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 292 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 292 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 49.99 26.05 6.28 51.46 26.87 8.49 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 49.99 26.05 6.28 51.46 26.87 8.49 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 60.53 31.67 0.97 57.79 27.51 3.63 14.51 2.78 -43.17 17.25 -1.27 -44.64 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 14 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 54 PHE~? 10.14 O5 PG4 C1130 C 263 ASP A 50 ASP~? 13.04 O5 PG4 C1130 C 292 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo 12.82 3.49 4.98 17.80 5.59 1.90 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 C 292 LYS A 125 LYS~? 18.08 O1 P6G D1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 12.82 3.49 4.98 17.80 5.59 1.90 6.58 -3.76 -40.18 3.66 -7.32 -42.07 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 48 PHE~? 8.11 O4 P6G D1130 C 263 ASP A 129 ASP.? 5.22 O1 P6G D1130 C 292 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 17.31 -2.99 -49.76 14.99 -1.83 -50.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo 12.82 3.49 4.98 17.80 5.59 1.90 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 54 PHE~? 10.32 O4 P6G D1130 C 263 ASP B 50 ASP~? 8.75 C2 P6G D1130 C 292 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 27.47 1.32 -51.39 27.75 3.66 -52.87 coo 19.84 12.02 9.33 18.68 11.23 7.75 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE C 48 PHE~? 7.58 C4 PG4 C1130 C 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 292 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -17.87 -9.30 -11.62 -15.58 -7.75 -11.22 coo 19.84 12.02 9.33 18.68 11.23 7.75 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE C 87 PHE~? 15.40 C1 PG4 C1130 C 263 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 292 LYS A 84 LYS~? 19.93 C5 PG4 C1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 12.82 3.49 4.98 17.80 5.59 1.90 -5.67 -5.22 -34.18 -8.78 -8.99 -35.57 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE C 98 PHE~? -3.85 C1 PG4 C1130s C 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 292 LYS C 72 LYS~? 14.53 C8 PG4 C1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 19.84 12.02 9.33 18.68 11.23 7.75 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE C 98 PHE~? -3.85 C1 PG4 C1130s C 263 ASP C 50 ASP~? 5.21 O2 PG4 C1130 C 292 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo 19.84 12.02 9.33 18.68 11.23 7.75 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo 12.82 3.49 4.98 17.80 5.59 1.90 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE D 48 PHE~? -7.47 C9 P6G D1130s C 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 21.21 11.49 -53.11 23.48 9.91 -53.52 coo 19.84 12.02 9.33 18.68 11.23 7.75 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE D 87 PHE~? 15.25 C18 P6G D1130 C 263 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 292 LYS B 84 LYS~? 19.45 C18 P6G D1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 23.55 15.85 -31.50 22.92 16.84 -28.96 coo 19.84 12.02 9.33 18.68 11.23 7.75 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 34.20 9.92 -30.73 30.97 14.90 -30.33 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE D 98 PHE~? -3.66 C18 P6G D1130s C 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 292 LYS D 72 LYS~? 14.11 O7 P6G D1130 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 19.84 12.02 9.33 18.68 11.23 7.75 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 9.63 4.64 -45.08 4.33 7.57 -43.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE D 98 PHE~? -3.66 C18 P6G D1130s C 263 ASP D 50 ASP~? 5.15 O16 P6G D1130 C 292 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 19.42 15.07 -40.90 21.07 15.22 -43.15 coo 19.84 12.02 9.33 18.68 11.23 7.75 11.91 14.56 -48.67 12.89 16.26 -47.87 coo 12.82 3.49 4.98 17.80 5.59 1.90 14.51 2.78 -43.17 17.25 -1.27 -44.64 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 12 hits 2oat_c05 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 107 ASP.? 20.53 C4 PG4 C1130 A 151 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 154 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 41.42 17.90 44.98 43.39 18.36 45.61 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo 45.75 16.58 39.61 47.43 18.26 45.54 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 44.77 13.10 43.25 45.01 14.21 45.03 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 107 ASP.? 21.14 C14 P6G D1130 A 151 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 154 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 41.42 17.90 44.98 43.39 18.36 45.61 37.26 15.33 -51.32 39.19 15.47 -52.18 coo 45.75 16.58 39.61 47.43 18.26 45.54 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 44.77 13.10 43.25 45.01 14.21 45.03 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 151 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 154 ASN C 108 ASN~? 16.59 C8 PG4 C1130 coo 41.42 17.90 44.98 43.39 18.36 45.61 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo 45.75 16.58 39.61 47.43 18.26 45.54 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 44.77 13.10 43.25 45.01 14.21 45.03 -31.84 0.42 -27.78 -31.41 2.13 -28.96 2phk_c03 source 2phk MC-PEPTIDE : 3 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 50 ASP~? 13.04 O5 PG4 C1130 166 GLY A 83 GLY~? 20.43 C6 PG4 C1130 169 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 50 ASP~? 13.04 O5 PG4 C1130 166 GLY C 83 GLY~? 8.16 C1 PG4 C1130 169 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 50 ASP~? 13.04 O5 PG4 C1130 166 GLY C 83 GLY~? 8.16 C1 PG4 C1130 169 GLU C 100 GLU~? 11.21 O1 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.07 -15.72 -28.38 -28.84 -16.81 -28.81 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 107 ASP.? 20.53 C4 PG4 C1130 166 GLY A 83 GLY~? 20.43 C6 PG4 C1130 169 GLU A 88 GLU~? 23.13 C5 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.38 -13.22 -15.62 -0.19 -11.78 -14.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.25 -2.91 -31.49 -4.99 -3.15 -31.84 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -6.24 -5.88 -39.24 -8.02 -7.02 -38.94 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 129 ASP.? 5.22 O1 P6G D1130 166 GLY D 83 GLY~? 7.98 C18 P6G D1130 169 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.02 13.56 -37.58 21.63 12.97 -37.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 129 ASP.? 5.22 O1 P6G D1130 166 GLY D 83 GLY~? 7.98 C18 P6G D1130 169 GLU D 100 GLU~? 11.53 O19 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 16.73 -3.96 -41.52 17.31 -2.00 -40.88 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.02 13.56 -37.58 21.63 12.97 -37.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 11.11 19.18 -38.13 10.21 19.66 -36.27 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 50 ASP~? 8.75 C2 P6G D1130 166 GLY B 83 GLY~? 19.46 C3 P6G D1130 169 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.61 7.43 -33.25 34.89 7.70 -32.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 50 ASP~? 8.75 C2 P6G D1130 166 GLY B 83 GLY~? 19.46 C3 P6G D1130 169 GLU B 121 GLU~? 26.56 C11 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.61 7.43 -33.25 34.89 7.70 -32.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.84 14.63 -29.45 39.08 15.39 -28.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 50 ASP~? 8.75 C2 P6G D1130 166 GLY D 83 GLY~? 7.98 C18 P6G D1130 169 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.02 13.56 -37.58 21.63 12.97 -37.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.07 21.72 -40.89 25.61 20.78 -41.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 107 ASP.? 21.14 C14 P6G D1130 166 GLY B 83 GLY~? 19.46 C3 P6G D1130 169 GLU B 88 GLU~? 21.68 O1 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 37.26 15.33 -51.32 39.19 15.47 -52.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.61 7.43 -33.25 34.89 7.70 -32.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 33.13 10.31 -25.75 31.26 10.53 -26.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 107 ASP.? 16.10 C8 PG4 C1130 166 GLY C 67 GLY~? 12.71 O5 PG4 C1130 169 GLU A 44 GLU~? 13.07 O5 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.37 6.17 -12.18 -28.74 5.59 -11.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.52 4.31 -8.11 -20.92 5.63 -6.53 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 107 ASP.? 16.10 C8 PG4 C1130 166 GLY C 83 GLY~? 8.16 C1 PG4 C1130 169 GLU C 88 GLU~? 16.97 C5 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 107 ASP.? 16.10 C8 PG4 C1130 166 GLY C 83 GLY~? 8.16 C1 PG4 C1130 169 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.67 -9.66 -27.39 -18.12 -9.02 -27.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP D 107 ASP.? 14.84 O1 P6G D1130 166 GLY D 67 GLY~? 11.48 C5 P6G D1130 169 GLU B 44 GLU~? 13.14 C6 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 11.46 -3.78 -50.70 10.94 -3.36 -51.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 18.51 -2.46 -55.26 18.22 -3.73 -56.94 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP D 107 ASP.? 14.84 O1 P6G D1130 166 GLY D 83 GLY~? 7.98 C18 P6G D1130 169 GLU D 88 GLU~? 17.52 C12 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.02 13.56 -37.58 21.63 12.97 -37.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.48 12.16 -32.01 27.65 12.79 -30.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP D 107 ASP.? 14.84 O1 P6G D1130 166 GLY D 83 GLY~? 7.98 C18 P6G D1130 169 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 8.28 6.87 1.62 10.08 5.77 1.34 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.02 13.56 -37.58 21.63 12.97 -37.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.07 21.72 -40.89 25.61 20.78 -41.98 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 16 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 51 TYR~? 11.49 O5 PG4 C1130 A 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 256 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 214 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 256 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 214 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 256 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 214 ASP A 50 ASP~? 13.04 O5 PG4 C1130 A 256 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 214 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 256 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 214 ASP B 50 ASP~? 8.75 C2 P6G D1130 A 256 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 214 ASP C 107 ASP.? 16.10 C8 PG4 C1130 A 256 LYS C 113 LYS~? 22.50 C5 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 214 ASP C 50 ASP~? 5.21 O2 PG4 C1130 A 256 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 256 LYS A 112 LYS~? 23.21 C4 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 256 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 256 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 214 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 256 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 214 ASP D 50 ASP~? 5.15 O16 P6G D1130 A 256 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 14 3 # 14 A 122 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 214 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 256 LYS B 112 LYS~? 22.45 C14 P6G D1130 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 39.07 16.52 -42.78 41.38 14.10 -46.96 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 14 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 51 TYR~? 11.49 O5 PG4 C1130 B 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 256 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -9.96 0.03 -17.73 -8.42 -1.77 -16.26 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -16.04 12.06 11.09 -17.97 10.54 5.71 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 57 TYR~? 16.39 O5 PG4 C1130 B 214 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 256 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 57 TYR~? 16.39 O5 PG4 C1130 B 214 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 256 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 57 TYR~? 16.39 O5 PG4 C1130 B 214 ASP A 50 ASP~? 13.04 O5 PG4 C1130 B 256 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.43 5.43 -19.54 -12.24 6.99 -18.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR B 57 TYR~? 16.24 O4 P6G D1130 B 214 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 256 LYS B 74 LYS~? 4.23 C14 P6G D1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -26.88 17.61 16.89 -26.08 17.11 15.00 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 28.17 10.93 -44.80 23.06 12.97 -45.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR B 57 TYR~? 16.24 O4 P6G D1130 B 214 ASP B 50 ASP~? 8.75 C2 P6G D1130 B 256 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -32.67 22.74 10.17 -32.85 23.98 7.70 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -26.88 17.61 16.89 -26.08 17.11 15.00 26.81 -2.80 -44.44 26.03 -3.69 -42.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR C 51 TYR~? 9.35 C8 PG4 C1130 B 214 ASP C 107 ASP.? 16.10 C8 PG4 C1130 B 256 LYS C 113 LYS~? 22.50 C5 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -35.87 -1.56 -24.43 -36.34 -2.85 -22.80 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR C 57 TYR~? 15.97 O5 PG4 C1130 B 214 ASP C 50 ASP~? 5.21 O2 PG4 C1130 B 256 LYS C 74 LYS~? 8.83 O5 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -27.33 -12.17 -15.89 -26.49 -13.58 -17.20 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -25.41 0.29 -20.42 -23.28 5.14 -19.07 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR C 92 TYR~? 16.40 C1 PG4 C1130 B 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 256 LYS A 112 LYS~? 23.21 C4 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR C 92 TYR~? 16.40 C1 PG4 C1130 B 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 256 LYS A 113 LYS~? 24.04 C2 PG4 C1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -16.04 12.06 11.09 -17.97 10.54 5.71 0.05 -15.10 -26.92 0.90 -20.33 -24.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR C 92 TYR~? 16.40 C1 PG4 C1130 B 214 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 256 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo -32.67 22.74 10.17 -32.85 23.98 7.70 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR D 51 TYR~? 9.17 O7 P6G D1130 B 214 ASP D 107 ASP.? 14.84 O1 P6G D1130 B 256 LYS D 113 LYS~? 21.47 O1 P6G D1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.62 8.34 -47.74 8.38 5.93 -48.44 coo -26.88 17.61 16.89 -26.08 17.11 15.00 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -16.04 12.06 11.09 -17.97 10.54 5.71 10.74 10.01 -28.88 5.91 8.82 -26.43 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR D 57 TYR~? 15.84 C9 P6G D1130 B 214 ASP D 50 ASP~? 5.15 O16 P6G D1130 B 256 LYS D 74 LYS~? -4.32 C2 P6G D1130s coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 11.91 14.56 -48.67 12.89 16.26 -47.87 coo -16.04 12.06 11.09 -17.97 10.54 5.71 14.51 2.78 -43.17 17.25 -1.27 -44.64 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR D 92 TYR~? 16.07 C18 P6G D1130 B 214 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 256 LYS B 112 LYS~? 22.45 C14 P6G D1130 coo -32.67 22.74 10.17 -32.85 23.98 7.70 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -26.88 17.61 16.89 -26.08 17.11 15.00 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -16.04 12.06 11.09 -17.97 10.54 5.71 39.07 16.52 -42.78 41.38 14.10 -46.96 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 15 3 # 15 B 122 TYR D 92 TYR~? 16.07 C18 P6G D1130 B 214 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 256 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo -32.67 22.74 10.17 -32.85 23.98 7.70 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -26.88 17.61 16.89 -26.08 17.11 15.00 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -16.04 12.06 11.09 -17.97 10.54 5.71 14.33 6.41 -44.26 15.86 10.02 -47.66 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 15 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 130 SER C 78 SER~? -2.69 O4 PG4 C1130s A 159 LYS A 74 LYS~? 4.39 C4 PG4 C1130 coo 18.35 45.84 20.99 16.20 47.83 21.89 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 15.14 43.67 10.77 15.61 44.43 13.04 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 11.57 48.49 22.18 13.51 49.99 17.21 -11.19 -7.76 -20.17 -16.10 -10.21 -19.00 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 77 ARG~? 12.69 C2 PG4 C1130 A 130 SER C 78 SER~? -2.69 O4 PG4 C1130s A 159 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 18.35 45.84 20.99 16.20 47.83 21.89 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 15.14 43.67 10.77 15.61 44.43 13.04 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 11.57 48.49 22.18 13.51 49.99 17.21 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG B 77 ARG~? 12.24 C17 P6G D1130 A 130 SER D 78 SER~? -2.57 O10 P6G D1130s A 159 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 18.35 45.84 20.99 16.20 47.83 21.89 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 15.14 43.67 10.77 15.61 44.43 13.04 18.64 6.84 -41.57 17.91 7.53 -43.73 coo 11.57 48.49 22.18 13.51 49.99 17.21 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG C 77 ARG~? 11.94 C8 PG4 C1130 A 130 SER A 49 SER~? 11.15 O5 PG4 C1130 A 159 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 18.35 45.84 20.99 16.20 47.83 21.89 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 15.14 43.67 10.77 15.61 44.43 13.04 -17.04 6.36 -16.76 -15.36 6.96 -15.05 coo 11.57 48.49 22.18 13.51 49.99 17.21 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG C 123 ARG~? 15.20 O1 PG4 C1130 A 130 SER C 116 SER~? 17.33 C1 PG4 C1130 A 159 LYS C 124 LYS~? 22.44 C1 PG4 C1130 coo 18.35 45.84 20.99 16.20 47.83 21.89 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 15.14 43.67 10.77 15.61 44.43 13.04 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo 11.57 48.49 22.18 13.51 49.99 17.21 -21.90 -17.95 -39.79 -22.86 -12.89 -43.01 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG C 123 ARG~? 15.20 O1 PG4 C1130 A 130 SER C 116 SER~? 17.33 C1 PG4 C1130 A 159 LYS C 125 LYS~? 21.37 C1 PG4 C1130 coo 18.35 45.84 20.99 16.20 47.83 21.89 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 15.14 43.67 10.77 15.61 44.43 13.04 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo 11.57 48.49 22.18 13.51 49.99 17.21 -18.46 -18.75 -38.32 -16.55 -15.57 -41.09 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 6 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 77 ARG~? 12.69 C2 PG4 C1130 B 130 SER C 78 SER~? -2.69 O4 PG4 C1130s B 159 LYS A 75 LYS~? 13.44 O5 PG4 C1130 coo 58.72 31.58 20.45 60.80 29.39 20.94 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 coo 61.66 35.17 10.39 61.29 34.14 12.56 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo 65.38 28.77 21.17 63.49 28.03 16.12 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 77 ARG~? 12.24 C17 P6G D1130 B 130 SER D 78 SER~? -2.57 O10 P6G D1130s B 159 LYS B 75 LYS~? 10.18 C3 P6G D1130 coo 58.72 31.58 20.45 60.80 29.39 20.94 28.29 14.60 -40.19 29.66 17.13 -41.31 coo 61.66 35.17 10.39 61.29 34.14 12.56 18.64 6.84 -41.57 17.91 7.53 -43.73 coo 65.38 28.77 21.17 63.49 28.03 16.12 30.12 7.76 -44.06 30.09 2.81 -42.01 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG C 77 ARG~? 11.94 C8 PG4 C1130 B 130 SER A 49 SER~? 11.15 O5 PG4 C1130 B 159 LYS C 75 LYS~? -2.86 O3 PG4 C1130s coo 58.72 31.58 20.45 60.80 29.39 20.94 -24.62 1.84 -25.17 -22.44 3.18 -26.88 coo 61.66 35.17 10.39 61.29 34.14 12.56 -17.04 6.36 -16.76 -15.36 6.96 -15.05 coo 65.38 28.77 21.17 63.49 28.03 16.12 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG D 77 ARG~? 8.78 O1 P6G D1130 B 130 SER B 49 SER~? 9.77 C2 P6G D1130 B 159 LYS D 75 LYS~? -3.20 O13 P6G D1130s coo 58.72 31.58 20.45 60.80 29.39 20.94 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 61.66 35.17 10.39 61.29 34.14 12.56 22.79 -3.71 -47.01 24.67 -5.23 -47.38 coo 65.38 28.77 21.17 63.49 28.03 16.12 14.33 6.41 -44.26 15.86 10.02 -47.66 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP D 107 ASP.? 14.84 O1 P6G D1130 A 99 GLY A 93 GLY~? 17.18 O1 P6G D1130 A 125 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 4.55 4.63 -38.29 4.19 5.10 -40.34 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 3.56 2.15 -34.44 2.78 1.87 -34.42 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -2.12 2.70 -37.07 -3.24 4.07 -38.22 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 1 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 28 ASN~? 32.95 O5 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.06 -1.05 13.97 -11.31 -1.46 15.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 53 ASN~? 14.46 O5 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.99 7.33 -14.88 -12.11 8.95 -16.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 56 ASN~? 17.86 O5 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.49 7.04 -12.83 -5.69 7.02 -14.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 91 ASN~? 22.38 O1 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.12 2.70 -37.07 -3.24 4.07 -38.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 104 ASN~? 24.79 C6 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.96 -5.44 -19.69 4.71 -5.94 -20.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 108 ASN~? 14.80 C2 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 28 ASN~? 31.97 C8 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.85 0.91 -77.13 26.68 2.86 -77.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 53 ASN~? 12.45 C2 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.65 -4.82 -48.74 27.65 -6.49 -47.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 56 ASN~? 16.63 C3 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 32.78 -4.61 -51.14 33.91 -4.71 -49.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 91 ASN~? 25.69 C2 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 38.86 2.42 -27.25 38.09 1.11 -25.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 104 ASN~? 24.15 C3 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 41.89 8.42 -45.83 43.69 8.87 -44.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN C 28 ASN~? 31.96 O5 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -25.75 8.02 11.14 -27.04 9.12 12.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN C 53 ASN~? 9.07 C3 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.10 -11.89 -11.16 -28.12 -13.75 -12.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN C 56 ASN~? 14.82 O2 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -33.22 -10.82 -9.01 -34.40 -11.65 -10.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN C 91 ASN~? 14.02 C1 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN C 104 ASN~? 12.31 O1 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -32.39 -11.53 -24.93 -32.78 -13.02 -26.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN C 108 ASN~? 16.59 C8 PG4 C1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.84 0.42 -27.78 -31.41 2.13 -28.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN D 28 ASN~? 29.34 C6 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.87 -6.23 -74.94 11.61 -6.49 -73.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN D 53 ASN~? 9.14 O16 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 11.02 13.95 -53.31 10.93 15.95 -52.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN D 56 ASN~? 14.55 O16 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.59 12.59 -55.26 4.79 13.42 -53.45 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN D 91 ASN~? 13.51 O19 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.57 20.44 -37.63 28.54 20.81 -38.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN D 104 ASN~? 11.84 C18 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.42 15.00 -39.68 7.34 16.70 -38.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.90 3.92 -35.18 9.80 2.60 -33.76 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 24 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 57 TYR~? 16.39 O5 PG4 C1130 A 112 PHE A 54 PHE~? 10.14 O5 PG4 C1130 A 140 ASN A 53 ASN~? 14.46 O5 PG4 C1130 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -10.74 6.03 -7.67 -11.80 6.36 -5.11 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -11.84 1.01 -12.73 -11.60 -1.49 -11.50 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -11.99 7.33 -14.88 -12.11 8.95 -16.26 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 57 TYR~? 16.24 O4 P6G D1130 A 112 PHE B 54 PHE~? 10.32 O4 P6G D1130 A 140 ASN B 53 ASN~? 12.45 C2 P6G D1130 coo -6.29 44.15 17.65 -9.00 44.92 17.68 28.47 -3.97 -56.19 27.34 -4.39 -58.70 coo -7.38 52.77 16.75 -5.54 52.71 18.82 27.47 1.32 -51.39 27.75 3.66 -52.87 coo -4.46 50.64 12.29 -5.69 49.89 13.85 27.65 -4.82 -48.74 27.65 -6.49 -47.41 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR C 57 TYR~? 15.97 O5 PG4 C1130 A 112 PHE C 54 PHE~? 9.47 C8 PG4 C1130 A 140 ASN C 53 ASN~? 9.07 C3 PG4 C1130 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -28.98 -7.95 -4.69 -27.86 -7.25 -2.24 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -28.01 -5.09 -11.10 -28.47 -2.39 -10.65 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -28.10 -11.89 -11.16 -28.12 -13.75 -12.27 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR D 57 TYR~? 15.84 C9 P6G D1130 A 112 PHE D 54 PHE~? 9.38 C6 P6G D1130 A 140 ASN D 53 ASN~? 9.14 O16 P6G D1130 coo -6.29 44.15 17.65 -9.00 44.92 17.68 9.96 9.67 -59.45 11.06 8.95 -61.91 coo -7.38 52.77 16.75 -5.54 52.71 18.82 11.23 7.23 -52.90 10.96 4.47 -53.21 coo -4.46 50.64 12.29 -5.69 49.89 13.85 11.02 13.95 -53.31 10.93 15.95 -52.55 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 4 hits 1o8s_p00 naa= 3 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE B 111 ILE~? 15.99 C14 P6G D1130 A 52 ASN D 28 ASN~? 29.34 C6 P6G D1130 A 53 VAL D 31 VAL~? 27.66 C6 P6G D1130 A 78 ASN B 108 ASN~? 14.77 C17 P6G D1130 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 34.81 15.23 -43.34 33.94 14.43 -42.56 coo 81.20 29.47 37.49 79.47 28.44 38.24 12.87 -6.23 -74.94 11.61 -6.49 -73.22 coo 82.17 24.86 36.27 81.03 23.67 37.80 11.98 -0.35 -72.94 10.00 -1.25 -73.20 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 33.81 16.76 -46.84 32.68 18.25 -45.86 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE D 111 ILE~? 10.16 O1 P6G D1130 A 52 ASN D 28 ASN~? 29.34 C6 P6G D1130 A 53 VAL D 31 VAL~? 27.66 C6 P6G D1130 A 78 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 12.50 6.65 -34.56 13.01 5.56 -35.53 coo 81.20 29.47 37.49 79.47 28.44 38.24 12.87 -6.23 -74.94 11.61 -6.49 -73.22 coo 82.17 24.86 36.27 81.03 23.67 37.80 11.98 -0.35 -72.94 10.00 -1.25 -73.20 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 8.90 3.92 -35.18 9.80 2.60 -33.76 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 2 hits 1qfw_p00 naa= 4 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 108 ASN A 56 ASN~? 17.86 O5 PG4 C1130 A 135 ASN A 53 ASN~? 14.46 O5 PG4 C1130 coo 17.59 4.66 17.88 15.38 5.96 18.97 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 12.36 16.24 15.27 12.06 14.29 16.05 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 18.05 11.56 12.71 17.57 10.75 14.60 -11.99 7.33 -14.88 -12.11 8.95 -16.26 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 108 ASN D 56 ASN~? 14.55 O16 P6G D1130 A 135 ASN D 53 ASN~? 9.14 O16 P6G D1130 coo 17.59 4.66 17.88 15.38 5.96 18.97 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 12.36 16.24 15.27 12.06 14.29 16.05 5.59 12.59 -55.26 4.79 13.42 -53.45 coo 18.05 11.56 12.71 17.57 10.75 14.60 11.02 13.95 -53.31 10.93 15.95 -52.55 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 2 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 46 TYR~? 5.44 O5 PG4 C1130 A 108 ASN A 56 ASN~? 17.86 O5 PG4 C1130 A 135 ASN A 53 ASN~? 14.46 O5 PG4 C1130 coo 17.50 4.57 17.85 15.28 5.88 18.97 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 12.22 15.98 15.24 11.94 14.05 16.09 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 17.94 11.43 12.65 17.42 10.61 14.53 -11.99 7.33 -14.88 -12.11 8.95 -16.26 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR D 46 TYR~? -4.28 C6 P6G D1130s A 108 ASN D 56 ASN~? 14.55 O16 P6G D1130 A 135 ASN D 53 ASN~? 9.14 O16 P6G D1130 coo 17.50 4.57 17.85 15.28 5.88 18.97 14.78 5.72 -50.79 14.70 4.54 -48.27 coo 12.22 15.98 15.24 11.94 14.05 16.09 5.59 12.59 -55.26 4.79 13.42 -53.45 coo 17.94 11.43 12.65 17.42 10.61 14.53 11.02 13.95 -53.31 10.93 15.95 -52.55 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 2 hits 1uy4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 53 ASN~? 14.46 O5 PG4 C1130 A 384 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 385 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -11.99 7.33 -14.88 -12.11 8.95 -16.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 11.59 49.83 99.41 10.92 47.97 100.16 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 53 ASN~? 14.46 O5 PG4 C1130 A 384 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 385 GLU A 73 GLU~? 13.39 C4 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -11.99 7.33 -14.88 -12.11 8.95 -16.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 53 ASN~? 14.46 O5 PG4 C1130 A 384 ASN C 108 ASN~? 16.59 C8 PG4 C1130 A 385 GLU C 73 GLU~? 12.72 C8 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -11.99 7.33 -14.88 -12.11 8.95 -16.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 11.59 49.83 99.41 10.92 47.97 100.16 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 56 ASN~? 17.86 O5 PG4 C1130 A 384 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 385 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 7.06 50.07 96.17 8.50 48.54 96.31 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 11.59 49.83 99.41 10.92 47.97 100.16 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 384 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 385 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 7.06 50.07 96.17 8.50 48.54 96.31 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 384 ASN C 91 ASN~? 14.02 C1 PG4 C1130 A 385 GLU A 110 GLU~? 14.79 C2 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 7.06 50.07 96.17 8.50 48.54 96.31 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.36 -16.13 -26.16 -8.47 -16.04 -26.21 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 384 ASN D 53 ASN~? 9.14 O16 P6G D1130 A 385 GLU D 52 GLU~? 9.77 O16 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 7.06 50.07 96.17 8.50 48.54 96.31 11.02 13.95 -53.31 10.93 15.95 -52.55 coo 11.59 49.83 99.41 10.92 47.97 100.16 7.48 14.12 -48.51 7.76 13.12 -46.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 384 ASN A 53 ASN~? 14.46 O5 PG4 C1130 A 385 GLU A 52 GLU~? 14.14 O5 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 7.06 50.07 96.17 8.50 48.54 96.31 -11.99 7.33 -14.88 -12.11 8.95 -16.26 coo 11.59 49.83 99.41 10.92 47.97 100.16 -7.58 5.14 -19.74 -8.46 3.38 -20.54 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 384 ASN A 91 ASN~? 22.38 O1 P6G D1130 A 385 GLU A 94 GLU~? 22.82 O1 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 7.06 50.07 96.17 8.50 48.54 96.31 -2.12 2.70 -37.07 -3.24 4.07 -38.22 coo 11.59 49.83 99.41 10.92 47.97 100.16 -1.57 4.02 -31.47 -0.29 5.04 -30.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN B 53 ASN~? 12.45 C2 P6G D1130 A 384 ASN B 91 ASN~? 25.69 C2 P6G D1130 A 385 GLU B 94 GLU~? 22.51 C2 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 27.65 -4.82 -48.74 27.65 -6.49 -47.41 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 11.59 49.83 99.41 10.92 47.97 100.16 38.57 0.93 -32.34 39.48 -0.67 -33.39 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN B 53 ASN~? 12.45 C2 P6G D1130 A 384 ASN D 108 ASN~? 12.52 O1 P6G D1130 A 385 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 27.65 -4.82 -48.74 27.65 -6.49 -47.41 coo 7.06 50.07 96.17 8.50 48.54 96.31 8.90 3.92 -35.18 9.80 2.60 -33.76 coo 11.59 49.83 99.41 10.92 47.97 100.16 8.90 2.49 -40.53 8.63 4.21 -39.28 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN B 56 ASN~? 16.63 C3 P6G D1130 A 384 ASN B 91 ASN~? 25.69 C2 P6G D1130 A 385 GLU B 94 GLU~? 22.51 C2 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 32.78 -4.61 -51.14 33.91 -4.71 -49.33 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 11.59 49.83 99.41 10.92 47.97 100.16 38.57 0.93 -32.34 39.48 -0.67 -33.39 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN B 91 ASN~? 25.69 C2 P6G D1130 A 384 ASN B 53 ASN~? 12.45 C2 P6G D1130 A 385 GLU B 52 GLU~? 14.42 C2 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 7.06 50.07 96.17 8.50 48.54 96.31 27.65 -4.82 -48.74 27.65 -6.49 -47.41 coo 11.59 49.83 99.41 10.92 47.97 100.16 32.10 -2.10 -44.27 32.78 -3.62 -42.92 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN B 91 ASN~? 25.69 C2 P6G D1130 A 384 ASN B 56 ASN~? 16.63 C3 P6G D1130 A 385 GLU B 52 GLU~? 14.42 C2 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 7.06 50.07 96.17 8.50 48.54 96.31 32.78 -4.61 -51.14 33.91 -4.71 -49.33 coo 11.59 49.83 99.41 10.92 47.97 100.16 32.10 -2.10 -44.27 32.78 -3.62 -42.92 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN B 108 ASN~? 14.77 C17 P6G D1130 A 384 ASN B 91 ASN~? 25.69 C2 P6G D1130 A 385 GLU B 94 GLU~? 22.51 C2 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 7.06 50.07 96.17 8.50 48.54 96.31 38.86 2.42 -27.25 38.09 1.11 -25.75 coo 11.59 49.83 99.41 10.92 47.97 100.16 38.57 0.93 -32.34 39.48 -0.67 -33.39 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN C 53 ASN~? 9.07 C3 PG4 C1130 A 384 ASN A 108 ASN~? 14.80 C2 PG4 C1130 A 385 GLU A 73 GLU~? 13.39 C4 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -28.10 -11.89 -11.16 -28.12 -13.75 -12.27 coo 7.06 50.07 96.17 8.50 48.54 96.31 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -7.38 -11.37 -17.25 -7.52 -13.52 -17.17 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN C 53 ASN~? 9.07 C3 PG4 C1130 A 384 ASN C 91 ASN~? 14.02 C1 PG4 C1130 A 385 GLU C 94 GLU~? 10.36 O1 PG4 C1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 -28.10 -11.89 -11.16 -28.12 -13.75 -12.27 coo 7.06 50.07 96.17 8.50 48.54 96.31 -13.13 -16.06 -29.02 -11.08 -16.56 -28.64 coo 11.59 49.83 99.41 10.92 47.97 100.16 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN D 53 ASN~? 9.14 O16 P6G D1130 A 384 ASN B 108 ASN~? 14.77 C17 P6G D1130 A 385 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 11.02 13.95 -53.31 10.93 15.95 -52.55 coo 7.06 50.07 96.17 8.50 48.54 96.31 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 11.59 49.83 99.41 10.92 47.97 100.16 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 19 3 # 19 A 270 ASN D 53 ASN~? 9.14 O16 P6G D1130 A 384 ASN B 108 ASN~? 14.77 C17 P6G D1130 A 385 GLU B 73 GLU~? 10.65 C14 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 11.02 13.95 -53.31 10.93 15.95 -52.55 coo 7.06 50.07 96.17 8.50 48.54 96.31 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 11.59 49.83 99.41 10.92 47.97 100.16 30.54 14.87 -46.06 28.97 16.29 -46.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 20 3 # 20 A 270 ASN D 53 ASN~? 9.14 O16 P6G D1130 A 384 ASN D 91 ASN~? 13.51 O19 P6G D1130 A 385 GLU D 94 GLU~? 9.44 O19 P6G D1130 coo 22.28 63.17 110.61 22.47 65.06 111.53 11.02 13.95 -53.31 10.93 15.95 -52.55 coo 7.06 50.07 96.17 8.50 48.54 96.31 26.57 20.44 -37.63 28.54 20.81 -38.21 coo 11.59 49.83 99.41 10.92 47.97 100.16 24.07 21.72 -40.89 25.61 20.78 -41.98 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 20 hits 2v3r_p00 naa= 3 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR A 34 THR~? 24.96 O5 PG4 C1130 D 143 ARG C 35 ARG~? 22.08 O5 PG4 C1130 D 158 TYR C 46 TYR~? -4.42 C8 PG4 C1130s D 163 LYS C 41 LYS~? 13.38 C3 PG4 C1130 coo 59.11 133.43 75.29 57.02 133.64 74.76 -14.30 4.75 4.28 -13.10 5.81 5.73 coo 52.93 123.10 78.03 50.59 121.17 78.38 -27.40 4.35 1.93 -30.39 4.99 1.63 coo 39.29 134.52 82.26 37.39 135.28 80.34 -24.39 -3.37 -13.27 -24.57 -1.95 -15.66 coo 42.67 127.66 76.73 46.82 129.80 74.10 -23.20 -6.39 -3.72 -23.40 -11.16 -4.26 ULMN 4 1hbx_d00 GENE REGULATION user 2 4 # 2 D 140 THR C 34 THR~? 24.00 O5 PG4 C1130 D 143 ARG A 35 ARG~? 23.61 O5 PG4 C1130 D 158 TYR A 46 TYR~? 5.44 O5 PG4 C1130 D 163 LYS A 41 LYS~? 15.70 O5 PG4 C1130 coo 59.11 133.43 75.29 57.02 133.64 74.76 -25.16 -1.64 5.50 -26.64 -2.67 6.71 coo 52.93 123.10 78.03 50.59 121.17 78.38 -11.68 -1.74 4.09 -8.68 -2.48 3.95 coo 39.29 134.52 82.26 37.39 135.28 80.34 -15.48 -1.02 -14.15 -15.10 -2.94 -16.12 coo 42.67 127.66 76.73 46.82 129.80 74.10 -16.40 4.87 -5.99 -15.06 9.32 -8.17 1hbx_d00 source 1hbx GENE REGULATION : 2 hits 1hbx_d00 naa= 4 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG B 35 ARG~? 23.72 C8 P6G D1130 C 71 LYS B 32 LYS~? 26.29 C8 P6G D1130 C 72 VAL B 31 VAL~? 28.54 C8 P6G D1130 coo 23.89 33.54 29.21 26.59 34.86 28.68 27.98 3.09 -66.94 26.77 4.37 -69.48 coo 25.82 26.89 29.68 23.33 22.98 25.84 24.48 1.33 -71.20 20.78 5.38 -73.37 coo 28.86 29.08 30.37 28.04 31.02 29.93 26.59 -1.48 -72.75 28.54 -0.96 -73.63 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG C 35 ARG~? 22.08 O5 PG4 C1130 C 71 LYS C 32 LYS~? 27.65 O5 PG4 C1130 C 72 VAL C 31 VAL~? 26.91 O5 PG4 C1130 coo 23.89 33.54 29.21 26.59 34.86 28.68 -27.40 4.35 1.93 -30.39 4.99 1.63 coo 25.82 26.89 29.68 23.33 22.98 25.84 -24.29 3.76 6.29 -22.32 9.47 8.21 coo 28.86 29.08 30.37 28.04 31.02 29.93 -26.85 2.19 8.72 -28.84 3.14 8.90 1hwt_d00 source 1hwt GENE REGULATION/DNA : 2 hits 1hwt_d00 naa= 3 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 41 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 42 ILE A 114 ILE~? 19.56 C2 PG4 C1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 38.49 66.12 125.64 35.69 66.71 131.25 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 41.08 63.27 123.17 40.13 62.43 122.44 -3.58 -12.84 -29.25 -4.95 -12.96 -29.76 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 2 3 # 2 A 40 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 41 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 42 ILE A 111 ILE~? 16.13 C6 PG4 C1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 38.49 66.12 125.64 35.69 66.71 131.25 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 41.08 63.27 123.17 40.13 62.43 122.44 -4.69 -11.85 -23.32 -5.46 -10.81 -22.67 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 3 3 # 3 A 40 LYS A 113 LYS~? 24.04 C2 PG4 C1130 A 41 LYS A 112 LYS~? 23.21 C4 PG4 C1130 A 42 ILE A 114 ILE~? 19.56 C2 PG4 C1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 0.05 -15.10 -26.92 0.90 -20.33 -24.89 coo 38.49 66.12 125.64 35.69 66.71 131.25 -0.40 -12.75 -23.97 2.35 -14.52 -18.97 coo 41.08 63.27 123.17 40.13 62.43 122.44 -3.58 -12.84 -29.25 -4.95 -12.96 -29.76 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 4 3 # 4 A 40 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 41 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 42 ILE B 114 ILE~? 18.82 C17 P6G D1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 38.49 66.12 125.64 35.69 66.71 131.25 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 41.08 63.27 123.17 40.13 62.43 122.44 35.86 17.48 -37.63 34.50 17.64 -37.24 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 5 3 # 5 A 40 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 41 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 42 ILE B 111 ILE~? 15.99 C14 P6G D1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 38.49 66.12 125.64 35.69 66.71 131.25 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 41.08 63.27 123.17 40.13 62.43 122.44 34.81 15.23 -43.34 33.94 14.43 -42.56 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 6 3 # 6 A 40 LYS B 113 LYS~? 24.16 C17 P6G D1130 A 41 LYS B 112 LYS~? 22.45 C14 P6G D1130 A 42 ILE B 114 ILE~? 18.82 C17 P6G D1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 39.51 19.43 -40.28 40.84 23.44 -43.47 coo 38.49 66.12 125.64 35.69 66.71 131.25 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 41.08 63.27 123.17 40.13 62.43 122.44 35.86 17.48 -37.63 34.50 17.64 -37.24 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 7 3 # 7 A 40 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 41 LYS C 113 LYS~? 22.50 C5 PG4 C1130 A 42 ILE C 114 ILE~? 14.95 C5 PG4 C1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 38.49 66.12 125.64 35.69 66.71 131.25 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 coo 41.08 63.27 123.17 40.13 62.43 122.44 -25.37 -3.26 -32.97 -24.47 -2.17 -32.71 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 8 3 # 8 A 40 LYS C 113 LYS~? 22.50 C5 PG4 C1130 A 41 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 42 ILE C 111 ILE~? 13.17 O4 PG4 C1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 coo 38.49 66.12 125.64 35.69 66.71 131.25 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 41.08 63.27 123.17 40.13 62.43 122.44 -28.01 -1.33 -29.13 -27.95 -1.42 -28.18 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 9 3 # 9 A 40 LYS C 113 LYS~? 22.50 C5 PG4 C1130 A 41 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A 42 ILE C 114 ILE~? 14.95 C5 PG4 C1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 -29.79 -4.79 -34.65 -32.21 0.00 -37.08 coo 38.49 66.12 125.64 35.69 66.71 131.25 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 41.08 63.27 123.17 40.13 62.43 122.44 -25.37 -3.26 -32.97 -24.47 -2.17 -32.71 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 10 3 # 10 A 40 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 41 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 42 ILE D 114 ILE~? 13.31 O1 P6G D1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 38.49 66.12 125.64 35.69 66.71 131.25 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 41.08 63.27 123.17 40.13 62.43 122.44 15.12 8.83 -30.78 15.94 7.76 -31.02 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 11 3 # 11 A 40 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 41 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 42 ILE D 111 ILE~? 10.16 O1 P6G D1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 38.49 66.12 125.64 35.69 66.71 131.25 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 41.08 63.27 123.17 40.13 62.43 122.44 12.50 6.65 -34.56 13.01 5.56 -35.53 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 12 3 # 12 A 40 LYS D 113 LYS~? 21.47 O1 P6G D1130 A 41 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 42 ILE D 114 ILE~? 13.31 O1 P6G D1130 coo 36.07 63.73 124.22 32.72 60.75 122.39 10.74 10.01 -28.88 5.91 8.82 -26.43 coo 38.49 66.12 125.64 35.69 66.71 131.25 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 41.08 63.27 123.17 40.13 62.43 122.44 15.12 8.83 -30.78 15.94 7.76 -31.02 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 12 hits 1pyi_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 59 LYS~? 19.76 O5 PG4 C1130 A1294 ASN A 56 ASN~? 17.86 O5 PG4 C1130 A1297 GLU A 52 GLU~? 14.14 O5 PG4 C1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 -3.94 3.00 -8.37 -1.40 0.97 -13.12 coo 33.53 17.37-161.81 34.31 17.81-163.76 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 29.78 23.31-161.30 31.23 23.66-162.84 -7.58 5.14 -19.74 -8.46 3.38 -20.54 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 60 LYS~? 20.53 O5 PG4 C1130 A1294 ASN A 56 ASN~? 17.86 O5 PG4 C1130 A1297 GLU A 55 GLU~? 16.41 O5 PG4 C1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 -3.82 6.30 -6.49 -4.25 8.23 -10.56 coo 33.53 17.37-161.81 34.31 17.81-163.76 -6.49 7.04 -12.83 -5.69 7.02 -14.83 coo 29.78 23.31-161.30 31.23 23.66-162.84 -5.51 1.40 -14.13 -4.52 0.89 -15.91 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS B 59 LYS~? 17.23 O4 P6G D1130 A1294 ASN B 56 ASN~? 16.63 C3 P6G D1130 A1297 GLU B 52 GLU~? 14.42 C2 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 35.19 -0.96 -55.86 35.42 3.27 -52.50 coo 33.53 17.37-161.81 34.31 17.81-163.76 32.78 -4.61 -51.14 33.91 -4.71 -49.33 coo 29.78 23.31-161.30 31.23 23.66-162.84 32.10 -2.10 -44.27 32.78 -3.62 -42.92 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 60 LYS~? 18.39 O4 P6G D1130 A1294 ASN B 56 ASN~? 16.63 C3 P6G D1130 A1297 GLU B 55 GLU~? 15.05 C3 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 35.13 -4.39 -57.50 30.78 -7.61 -55.34 coo 33.53 17.37-161.81 34.31 17.81-163.76 32.78 -4.61 -51.14 33.91 -4.71 -49.33 coo 29.78 23.31-161.30 31.23 23.66-162.84 33.77 1.13 -50.00 34.67 1.54 -48.13 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 112 LYS~? 22.45 C14 P6G D1130 A1294 ASN B 108 ASN~? 14.77 C17 P6G D1130 A1297 GLU B 69 GLU~? 16.29 C14 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 39.07 16.52 -42.78 41.38 14.10 -46.96 coo 33.53 17.37-161.81 34.31 17.81-163.76 33.81 16.76 -46.84 32.68 18.25 -45.86 coo 29.78 23.31-161.30 31.23 23.66-162.84 32.72 14.03 -52.77 34.27 12.68 -52.28 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS C 59 LYS~? 18.46 C8 PG4 C1130 A1294 ASN C 56 ASN~? 14.82 O2 PG4 C1130 A1297 GLU C 52 GLU~? 9.38 O2 PG4 C1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 -35.73 -5.32 -6.23 -38.67 -6.39 -11.74 coo 33.53 17.37-161.81 34.31 17.81-163.76 -33.22 -10.82 -9.01 -34.40 -11.65 -10.57 coo 29.78 23.31-161.30 31.23 23.66-162.84 -31.51 -11.89 -15.93 -31.25 -10.85 -17.75 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 7 3 # 7 A1290 LYS C 60 LYS~? 23.71 C3 PG4 C1130 A1294 ASN C 56 ASN~? 14.82 O2 PG4 C1130 A1297 GLU C 55 GLU~? 14.48 C8 PG4 C1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 -35.53 -7.83 -3.33 -38.18 -11.20 -0.84 coo 33.53 17.37-161.81 34.31 17.81-163.76 -33.22 -10.82 -9.01 -34.40 -11.65 -10.57 coo 29.78 23.31-161.30 31.23 23.66-162.84 -33.95 -5.76 -12.70 -35.16 -6.44 -14.29 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 8 3 # 8 A1290 LYS C 112 LYS~? 18.47 C1 PG4 C1130 A1294 ASN C 108 ASN~? 16.59 C8 PG4 C1130 A1297 GLU C 73 GLU~? 12.72 C8 PG4 C1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 -30.77 -4.95 -30.93 -36.61 -5.10 -28.72 coo 33.53 17.37-161.81 34.31 17.81-163.76 -31.84 0.42 -27.78 -31.41 2.13 -28.96 coo 29.78 23.31-161.30 31.23 23.66-162.84 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 9 3 # 9 A1290 LYS D 59 LYS~? 18.77 O7 P6G D1130 A1294 ASN D 56 ASN~? 14.55 O16 P6G D1130 A1297 GLU D 52 GLU~? 9.77 O16 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 3.27 6.90 -57.68 0.31 8.60 -52.41 coo 33.53 17.37-161.81 34.31 17.81-163.76 5.59 12.59 -55.26 4.79 13.42 -53.45 coo 29.78 23.31-161.30 31.23 23.66-162.84 7.48 14.12 -48.51 7.76 13.12 -46.67 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 10 3 # 10 A1290 LYS D 60 LYS~? 24.27 C15 P6G D1130 A1294 ASN D 56 ASN~? 14.55 O16 P6G D1130 A1297 GLU D 55 GLU~? 14.43 O7 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 3.35 9.26 -60.71 0.52 11.83 -63.90 coo 33.53 17.37-161.81 34.31 17.81-163.76 5.59 12.59 -55.26 4.79 13.42 -53.45 coo 29.78 23.31-161.30 31.23 23.66-162.84 5.29 7.89 -51.10 4.11 8.75 -49.57 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 11 3 # 11 A1290 LYS D 101 LYS~? -3.05 O19 P6G D1130s A1294 ASN D 104 ASN~? 11.84 C18 P6G D1130 A1297 GLU D 52 GLU~? 9.77 O16 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 12.04 15.06 -40.68 14.50 17.55 -45.86 coo 33.53 17.37-161.81 34.31 17.81-163.76 7.42 15.00 -39.68 7.34 16.70 -38.37 coo 29.78 23.31-161.30 31.23 23.66-162.84 7.48 14.12 -48.51 7.76 13.12 -46.67 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 12 3 # 12 A1290 LYS D 112 LYS~? 16.61 O1 P6G D1130 A1294 ASN D 108 ASN~? 12.52 O1 P6G D1130 A1297 GLU D 73 GLU~? 10.67 O1 P6G D1130 coo 39.24 18.84-161.99 36.62 21.47-165.99 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 33.53 17.37-161.81 34.31 17.81-163.76 8.90 3.92 -35.18 9.80 2.60 -33.76 coo 29.78 23.31-161.30 31.23 23.66-162.84 8.90 2.49 -40.53 8.63 4.21 -39.28 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 12 hits 1xpx_d00 naa= 3 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA C 76 ALA~? 8.86 O4 PG4 C1130 A 87 GLU C 73 GLU~? 12.72 C8 PG4 C1130 A 123 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 182 ARG C 77 ARG~? 11.94 C8 PG4 C1130 coo 33.66 63.14 16.62 34.95 63.46 15.91 -26.43 -4.34 -23.18 -27.76 -3.97 -23.83 coo 28.97 64.99 12.92 27.92 64.06 11.28 -31.10 0.84 -22.65 -31.54 -0.70 -24.06 coo 38.40 63.73 13.00 38.79 62.53 10.47 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 29.35 67.59 19.60 30.93 68.47 17.09 -24.62 1.84 -25.17 -22.44 3.18 -26.88 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA C 90 ALA.? 17.94 C1 PG4 C1130 A 87 GLU C 88 GLU~? 16.97 C5 PG4 C1130 A 123 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 182 ARG A 77 ARG~? 12.69 C2 PG4 C1130 coo 33.66 63.14 16.62 34.95 63.46 15.91 -11.69 -14.70 -33.35 -10.59 -15.20 -34.29 coo 28.97 64.99 12.92 27.92 64.06 11.28 -13.02 -7.10 -32.81 -13.13 -6.14 -34.68 coo 38.40 63.73 13.00 38.79 62.53 10.47 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo 29.35 67.59 19.60 30.93 68.47 17.09 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 ULMN 4 2bgw_d00 HYDROLASE user 3 4 # 3 A 86 ALA C 95 ALA~? 9.85 C1 PG4 C1130 A 87 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 123 TYR C 92 TYR~? 16.40 C1 PG4 C1130 A 182 ARG A 77 ARG~? 12.69 C2 PG4 C1130 coo 33.66 63.14 16.62 34.95 63.46 15.91 -18.72 -14.02 -28.41 -18.14 -13.41 -29.67 coo 28.97 64.99 12.92 27.92 64.06 11.28 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 38.40 63.73 13.00 38.79 62.53 10.47 -16.16 -16.08 -34.53 -14.48 -14.63 -36.23 coo 29.35 67.59 19.60 30.93 68.47 17.09 -11.22 -10.86 -25.43 -9.74 -13.55 -25.06 ULMN 4 2bgw_d00 HYDROLASE user 4 4 # 4 A 86 ALA D 76 ALA~? 8.45 O1 P6G D1130 A 87 GLU D 73 GLU~? 10.67 O1 P6G D1130 A 123 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 182 ARG D 77 ARG~? 8.78 O1 P6G D1130 coo 33.66 63.14 16.62 34.95 63.46 15.91 13.35 7.56 -40.77 12.01 7.28 -40.05 coo 28.97 64.99 12.92 27.92 64.06 11.28 8.90 2.49 -40.53 8.63 4.21 -39.28 coo 38.40 63.73 13.00 38.79 62.53 10.47 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 29.35 67.59 19.60 30.93 68.47 17.09 14.97 1.88 -38.30 12.52 1.24 -36.50 ULMN 4 2bgw_d00 HYDROLASE user 5 4 # 5 A 86 ALA D 90 ALA.? 17.47 C18 P6G D1130 A 87 GLU D 88 GLU~? 17.52 C12 P6G D1130 A 123 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 182 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 33.66 63.14 16.62 34.95 63.46 15.91 28.43 19.70 -33.25 29.64 20.34 -32.58 coo 28.97 64.99 12.92 27.92 64.06 11.28 27.48 12.16 -32.01 27.65 12.79 -30.00 coo 38.40 63.73 13.00 38.79 62.53 10.47 24.24 21.35 -31.93 26.12 20.12 -30.25 coo 29.35 67.59 19.60 30.93 68.47 17.09 28.29 14.60 -40.19 29.66 17.13 -41.31 ULMN 4 2bgw_d00 HYDROLASE user 6 4 # 6 A 86 ALA D 95 ALA~? 9.46 C18 P6G D1130 A 87 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 123 TYR D 92 TYR~? 16.07 C18 P6G D1130 A 182 ARG B 77 ARG~? 12.24 C17 P6G D1130 coo 33.66 63.14 16.62 34.95 63.46 15.91 20.99 18.21 -37.32 21.64 17.75 -36.04 coo 28.97 64.99 12.92 27.92 64.06 11.28 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 38.40 63.73 13.00 38.79 62.53 10.47 24.24 21.35 -31.93 26.12 20.12 -30.25 coo 29.35 67.59 19.60 30.93 68.47 17.09 28.29 14.60 -40.19 29.66 17.13 -41.31 2bgw_d00 source 2bgw HYDROLASE : 6 hits 2bgw_d00 naa= 4 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 123 ARG~? 19.27 O1 P6G D1130 A 50 LYS D 112 LYS~? 16.61 O1 P6G D1130 A 51 ASN D 108 ASN~? 12.52 O1 P6G D1130 coo 28.68 23.77 42.74 27.76 26.72 42.93 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 14.40 30.33 40.28 14.25 28.31 45.36 9.54 9.95 -32.52 4.98 7.78 -34.65 coo 19.09 30.55 41.51 19.09 28.89 42.82 8.90 3.92 -35.18 9.80 2.60 -33.76 2hos_d00 source 2hos TRANSCRIPTION/DNA : 1 hits 2hos_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG D 77 ARG~? 8.78 O1 P6G D1130 A 32 LYS D 74 LYS~? -4.32 C2 P6G D1130s A 46 ARG A 123 ARG~? 19.27 O1 P6G D1130 coo -8.00 4.27 27.74 -7.09 2.66 30.09 14.97 1.88 -38.30 12.52 1.24 -36.50 coo -5.15 8.65 26.69 -4.26 5.48 32.02 14.51 2.78 -43.17 17.25 -1.27 -44.64 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 9.14 -6.20 -31.52 9.40 -6.54 -28.47 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 1 hits 2ky8_d00 naa= 3 ULMN 4 2p0j_d00 HYDROLASE/DNA user 1 4 # 1 A 46 GLU C 82 GLU~? -3.24 C6 PG4 C1130s A 133 LYS C 72 LYS~? 14.53 C8 PG4 C1130 A 134 TYR C 51 TYR~? 9.35 C8 PG4 C1130 A 172 SER C 78 SER~? -2.69 O4 PG4 C1130s coo 29.36 7.53 2.81 27.47 7.30 3.73 -17.10 -6.77 -22.35 -17.12 -7.39 -20.35 coo 20.43 15.67 9.20 23.49 12.62 10.53 -30.04 -1.92 -18.45 -35.52 -4.48 -19.87 coo 18.60 12.45 12.36 19.78 10.10 11.41 -29.80 -5.94 -16.24 -31.03 -3.64 -15.30 coo 23.78 7.59 5.40 26.01 7.14 6.26 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 ULMN 4 2p0j_d00 HYDROLASE/DNA user 2 4 # 2 A 46 GLU D 82 GLU~? -3.29 C11 P6G D1130s A 133 LYS D 72 LYS~? 14.11 O7 P6G D1130 A 134 TYR D 51 TYR~? 9.17 O7 P6G D1130 A 172 SER D 78 SER~? -2.57 O10 P6G D1130s coo 29.36 7.53 2.81 27.47 7.30 3.73 22.48 10.01 -42.20 22.42 10.27 -44.26 coo 20.43 15.67 9.20 23.49 12.62 10.53 9.63 4.64 -45.08 4.33 7.57 -43.39 coo 18.60 12.45 12.36 19.78 10.10 11.41 9.62 8.34 -47.74 8.38 5.93 -48.44 coo 23.78 7.59 5.40 26.01 7.14 6.26 18.64 6.84 -41.57 17.91 7.53 -43.73 2p0j_d00 source 2p0j HYDROLASE/DNA : 2 hits 2p0j_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 49 SER~? 11.15 O5 PG4 C1130 B 37 ASN A 53 ASN~? 14.46 O5 PG4 C1130 B 45 THR A 39 THR~? 15.12 O5 PG4 C1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -17.04 6.36 -16.76 -15.36 6.96 -15.05 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -11.99 7.33 -14.88 -12.11 8.95 -16.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -14.44 0.58 -3.19 -15.17 -1.32 -2.42 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 106 SER~? 15.55 C4 PG4 C1130 B 37 ASN A 108 ASN~? 14.80 C2 PG4 C1130 B 45 THR C 89 THR~? 14.94 C2 PG4 C1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -2.86 -9.54 -18.24 -4.86 -10.86 -18.80 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -5.42 -13.89 -19.95 -6.65 -15.12 -21.18 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 49 SER~? 9.77 C2 P6G D1130 B 37 ASN B 53 ASN~? 12.45 C2 P6G D1130 B 45 THR B 39 THR~? 16.03 C8 P6G D1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 22.79 -3.71 -47.01 24.67 -5.23 -47.38 coo -23.05 39.62 69.74 -22.86 39.59 67.61 27.65 -4.82 -48.74 27.65 -6.49 -47.41 coo -30.87 34.84 80.57 -28.94 34.51 81.49 24.60 1.04 -60.68 24.34 2.92 -61.79 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 106 SER~? 15.38 C14 P6G D1130 B 37 ASN B 108 ASN~? 14.77 C17 P6G D1130 B 45 THR D 89 THR~? 14.44 C17 P6G D1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 36.13 12.10 -48.03 34.30 13.65 -47.56 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.81 16.76 -46.84 32.68 18.25 -45.86 coo -30.87 34.84 80.57 -28.94 34.51 81.49 30.11 16.81 -35.09 30.09 15.90 -37.05 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER C 49 SER~? -6.70 C3 PG4 C1130s B 37 ASN C 53 ASN~? 9.07 C3 PG4 C1130 B 45 THR C 39 THR~? 14.51 O5 PG4 C1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -23.25 -11.39 -13.39 -25.00 -12.65 -12.19 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -28.10 -11.89 -11.16 -28.12 -13.75 -12.27 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.77 -1.30 -2.89 -24.97 0.82 -3.17 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER D 49 SER~? -6.76 C15 P6G D1130s B 37 ASN D 53 ASN~? 9.14 O16 P6G D1130 B 45 THR D 39 THR~? 15.06 C6 P6G D1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 15.84 13.68 -51.40 14.22 14.93 -52.69 coo -23.05 39.62 69.74 -22.86 39.59 67.61 11.02 13.95 -53.31 10.93 15.95 -52.55 coo -30.87 34.84 80.57 -28.94 34.51 81.49 14.20 3.05 -61.19 14.08 0.91 -60.92 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER D 106 SER~? 11.54 O1 P6G D1130 B 37 ASN D 108 ASN~? 12.52 O1 P6G D1130 B 45 THR A 89 THR.? 25.53 O1 P6G D1130 coo -19.49 41.97 71.08 -17.37 40.80 71.17 8.27 7.70 -38.86 9.17 6.34 -37.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 8.90 3.92 -35.18 9.80 2.60 -33.76 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -5.16 0.04 -40.94 -6.61 0.89 -39.59 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 7 hits 2z3x_d00 naa= 3 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 123 ARG~? 19.27 O1 P6G D1130 B 148 LYS A 75 LYS~? 13.44 O5 PG4 C1130 B 151 LEU A 79 LEU~? 16.24 C6 PG4 C1130 B 154 ILE A 80 ILE~? 17.21 C6 PG4 C1130 coo 13.00 32.05 60.31 16.02 31.73 59.80 9.14 -6.20 -31.52 9.40 -6.54 -28.47 coo 11.05 44.13 44.68 12.77 44.45 49.56 -9.26 -4.52 -20.69 -8.96 0.47 -22.55 coo 11.72 38.91 44.77 13.11 39.67 46.23 -5.34 -3.42 -24.95 -5.01 -1.75 -23.55 coo 7.03 36.97 46.99 7.83 37.90 47.52 -5.76 -7.89 -28.13 -5.24 -9.26 -28.11 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 B 122 ARG C 123 ARG~? 15.20 O1 PG4 C1130 B 148 LYS C 75 LYS~? -2.86 O3 PG4 C1130s B 151 LEU C 79 LEU~? -4.57 C5 PG4 C1130s B 154 ILE C 80 ILE~? 9.85 C5 PG4 C1130 coo 13.00 32.05 60.31 16.02 31.73 59.80 -26.79 -18.17 -34.77 -29.12 -16.66 -33.48 coo 11.05 44.13 44.68 12.77 44.45 49.56 -25.23 -3.43 -19.70 -23.01 -7.64 -16.61 coo 11.72 38.91 44.77 13.11 39.67 46.23 -23.61 -7.54 -23.45 -24.33 -8.75 -21.78 coo 7.03 36.97 46.99 7.83 37.90 47.52 -22.60 -4.86 -27.98 -23.50 -4.40 -28.98 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 3 4 # 3 B 122 ARG D 123 ARG~? 17.23 O19 P6G D1130 B 148 LYS D 75 LYS~? -3.20 O13 P6G D1130s B 151 LEU D 79 LEU~? -4.46 C12 P6G D1130s B 154 ILE D 80 ILE~? 9.47 O1 P6G D1130 coo 13.00 32.05 60.31 16.02 31.73 59.80 13.45 23.46 -30.88 10.46 22.96 -30.27 coo 11.05 44.13 44.68 12.77 44.45 49.56 14.33 6.41 -44.26 15.86 10.02 -47.66 coo 11.72 38.91 44.77 13.11 39.67 46.23 15.99 10.92 -40.88 15.13 11.96 -42.64 coo 7.03 36.97 46.99 7.83 37.90 47.52 17.31 8.62 -36.21 16.78 9.31 -35.04 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 3 hits 3odc_d00 naa= 4 ULMN 4 4ail_d00 TRANSFERASE user 1 4 # 1 C 495 TYR D 92 TYR~? 16.07 C18 P6G D1130 C 593 LYS D 112 LYS~? 16.61 O1 P6G D1130 C 613 ARG D 77 ARG~? 8.78 O1 P6G D1130 C 615 ASP A 129 ASP.? 5.22 O1 P6G D1130 coo 15.47 67.10 68.66 15.00 68.14 71.20 24.24 21.35 -31.93 26.12 20.12 -30.25 coo -0.58 65.96 78.57 4.36 67.40 76.38 9.54 9.95 -32.52 4.98 7.78 -34.65 coo -0.42 56.97 83.23 2.13 57.80 84.74 14.97 1.88 -38.30 12.52 1.24 -36.50 coo 1.55 52.45 87.75 1.51 54.41 86.94 16.73 -3.96 -41.52 17.31 -2.00 -40.88 4ail_d00 source 4ail TRANSFERASE : 1 hits 4ail_d00 naa= 4 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 78 SER~? 11.56 C6 PG4 C1130 A 166 PHE A 99 PHE~? 22.28 C6 PG4 C1130 A 182 PHE A 87 PHE~? 21.78 O1 P6G D1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 78 SER~? 11.56 C6 PG4 C1130 A 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 A 182 PHE C 98 PHE~? -3.85 C1 PG4 C1130s coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 78 SER~? 11.56 C6 PG4 C1130 A 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 A 182 PHE C 99 PHE~? 10.28 C1 PG4 C1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 78 SER~? 10.35 C3 P6G D1130 A 166 PHE B 99 PHE~? 22.15 C3 P6G D1130 A 182 PHE B 87 PHE~? 27.15 C3 P6G D1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -36.62 39.62 84.60 -38.76 41.24 85.25 39.20 10.29 -35.14 37.62 10.52 -32.83 coo -36.55 45.66 79.22 -38.34 43.94 80.53 38.54 10.51 -27.65 40.38 12.27 -26.48 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 78 SER~? 10.35 C3 P6G D1130 A 166 PHE D 87 PHE~? 15.25 C18 P6G D1130 A 182 PHE D 99 PHE~? 10.07 C18 P6G D1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -36.62 39.62 84.60 -38.76 41.24 85.25 23.55 15.85 -31.50 22.92 16.84 -28.96 coo -36.55 45.66 79.22 -38.34 43.94 80.53 17.40 15.07 -34.81 19.85 13.95 -34.07 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 78 SER~? 10.35 C3 P6G D1130 A 166 PHE D 98 PHE~? -3.66 C18 P6G D1130s A 182 PHE D 99 PHE~? 10.07 C18 P6G D1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -36.62 39.62 84.60 -38.76 41.24 85.25 19.42 15.07 -40.90 21.07 15.22 -43.15 coo -36.55 45.66 79.22 -38.34 43.94 80.53 17.40 15.07 -34.81 19.85 13.95 -34.07 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER C 78 SER~? -2.69 O4 PG4 C1130s A 166 PHE C 98 PHE~? -3.85 C1 PG4 C1130s A 182 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER C 78 SER~? -2.69 O4 PG4 C1130s A 166 PHE C 99 PHE~? 10.28 C1 PG4 C1130 A 182 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER C 116 SER~? 17.33 C1 PG4 C1130 A 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 A 182 PHE C 98 PHE~? -3.85 C1 PG4 C1130s coo -46.28 37.24 81.97 -44.96 39.32 82.40 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER D 78 SER~? -2.57 O10 P6G D1130s A 166 PHE D 99 PHE~? 10.07 C18 P6G D1130 A 182 PHE D 87 PHE~? 15.25 C18 P6G D1130 coo -46.28 37.24 81.97 -44.96 39.32 82.40 18.64 6.84 -41.57 17.91 7.53 -43.73 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.40 15.07 -34.81 19.85 13.95 -34.07 coo -36.55 45.66 79.22 -38.34 43.94 80.53 23.55 15.85 -31.50 22.92 16.84 -28.96 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 10 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 78 SER~? 11.56 C6 PG4 C1130 B 166 PHE A 99 PHE~? 22.28 C6 PG4 C1130 B 182 PHE A 87 PHE~? 21.78 O1 P6G D1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 78 SER~? 11.56 C6 PG4 C1130 B 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 B 182 PHE C 99 PHE~? 10.28 C1 PG4 C1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER B 78 SER~? 10.35 C3 P6G D1130 B 166 PHE B 99 PHE~? 22.15 C3 P6G D1130 B 182 PHE B 87 PHE~? 27.15 C3 P6G D1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -29.59 43.40 95.66 -28.22 45.54 94.50 39.20 10.29 -35.14 37.62 10.52 -32.83 coo -32.72 50.15 98.46 -30.32 48.85 97.77 38.54 10.51 -27.65 40.38 12.27 -26.48 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 78 SER~? 10.35 C3 P6G D1130 B 166 PHE D 87 PHE~? 15.25 C18 P6G D1130 B 182 PHE D 99 PHE~? 10.07 C18 P6G D1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -29.59 43.40 95.66 -28.22 45.54 94.50 23.55 15.85 -31.50 22.92 16.84 -28.96 coo -32.72 50.15 98.46 -30.32 48.85 97.77 17.40 15.07 -34.81 19.85 13.95 -34.07 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER B 78 SER~? 10.35 C3 P6G D1130 B 166 PHE D 98 PHE~? -3.66 C18 P6G D1130s B 182 PHE D 99 PHE~? 10.07 C18 P6G D1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -29.59 43.40 95.66 -28.22 45.54 94.50 19.42 15.07 -40.90 21.07 15.22 -43.15 coo -32.72 50.15 98.46 -30.32 48.85 97.77 17.40 15.07 -34.81 19.85 13.95 -34.07 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER C 78 SER~? -2.69 O4 PG4 C1130s B 166 PHE C 99 PHE~? 10.28 C1 PG4 C1130 B 182 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER D 78 SER~? -2.57 O10 P6G D1130s B 166 PHE D 99 PHE~? 10.07 C18 P6G D1130 B 182 PHE D 87 PHE~? 15.25 C18 P6G D1130 coo -19.94 46.29 97.83 -22.38 46.56 97.60 18.64 6.84 -41.57 17.91 7.53 -43.73 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.40 15.07 -34.81 19.85 13.95 -34.07 coo -32.72 50.15 98.46 -30.32 48.85 97.77 23.55 15.85 -31.50 22.92 16.84 -28.96 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 7 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 78 SER~? 11.56 C6 PG4 C1130 C 166 PHE A 99 PHE~? 22.28 C6 PG4 C1130 C 182 PHE A 87 PHE~? 21.78 O1 P6G D1130 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 78 SER~? 11.56 C6 PG4 C1130 C 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 C 182 PHE C 98 PHE~? -3.85 C1 PG4 C1130s coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 78 SER~? 11.56 C6 PG4 C1130 C 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 C 182 PHE C 99 PHE~? 10.28 C1 PG4 C1130 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 78 SER~? 10.35 C3 P6G D1130 C 166 PHE B 99 PHE~? 22.15 C3 P6G D1130 C 182 PHE B 87 PHE~? 27.15 C3 P6G D1130 coo -2.19 64.27 51.12 -3.34 62.10 50.60 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -11.14 61.91 46.89 -9.88 60.30 48.76 39.20 10.29 -35.14 37.62 10.52 -32.83 coo -7.71 55.92 42.70 -7.18 57.60 44.85 38.54 10.51 -27.65 40.38 12.27 -26.48 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER C 78 SER~? -2.69 O4 PG4 C1130s C 166 PHE C 98 PHE~? -3.85 C1 PG4 C1130s C 182 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER C 78 SER~? -2.69 O4 PG4 C1130s C 166 PHE C 99 PHE~? 10.28 C1 PG4 C1130 C 182 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER C 116 SER~? 17.33 C1 PG4 C1130 C 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 C 182 PHE C 98 PHE~? -3.85 C1 PG4 C1130s coo -2.19 64.27 51.12 -3.34 62.10 50.60 -28.23 -9.27 -34.09 -30.04 -9.74 -35.59 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER D 78 SER~? -2.57 O10 P6G D1130s C 166 PHE D 99 PHE~? 10.07 C18 P6G D1130 C 182 PHE D 87 PHE~? 15.25 C18 P6G D1130 coo -2.19 64.27 51.12 -3.34 62.10 50.60 18.64 6.84 -41.57 17.91 7.53 -43.73 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.40 15.07 -34.81 19.85 13.95 -34.07 coo -7.71 55.92 42.70 -7.18 57.60 44.85 23.55 15.85 -31.50 22.92 16.84 -28.96 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 78 SER~? 11.56 C6 PG4 C1130 D 166 PHE A 99 PHE~? 22.28 C6 PG4 C1130 D 182 PHE A 87 PHE~? 21.78 O1 P6G D1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -0.51 -5.66 -30.28 -2.37 -5.93 -32.36 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -1.55 -5.32 -37.44 0.08 -6.96 -39.02 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 78 SER~? 11.56 C6 PG4 C1130 D 166 PHE C 87 PHE~? 15.40 C1 PG4 C1130 D 182 PHE C 99 PHE~? 10.28 C1 PG4 C1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 78 SER~? 11.56 C6 PG4 C1130 D 166 PHE C 98 PHE~? -3.85 C1 PG4 C1130s D 182 PHE C 99 PHE~? 10.28 C1 PG4 C1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.99 -4.76 -25.54 -11.05 -2.62 -25.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -20.24 -11.57 -24.37 -18.49 -12.15 -22.27 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 78 SER~? 10.35 C3 P6G D1130 D 166 PHE B 99 PHE~? 22.15 C3 P6G D1130 D 182 PHE B 87 PHE~? 27.15 C3 P6G D1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -23.62 58.20 50.84 -23.76 56.14 48.96 39.20 10.29 -35.14 37.62 10.52 -32.83 coo -23.08 51.44 54.96 -24.43 52.71 52.88 38.54 10.51 -27.65 40.38 12.27 -26.48 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER B 78 SER~? 10.35 C3 P6G D1130 D 166 PHE D 87 PHE~? 15.25 C18 P6G D1130 D 182 PHE D 99 PHE~? 10.07 C18 P6G D1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -23.62 58.20 50.84 -23.76 56.14 48.96 23.55 15.85 -31.50 22.92 16.84 -28.96 coo -23.08 51.44 54.96 -24.43 52.71 52.88 17.40 15.07 -34.81 19.85 13.95 -34.07 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER B 78 SER~? 10.35 C3 P6G D1130 D 166 PHE D 98 PHE~? -3.66 C18 P6G D1130s D 182 PHE D 99 PHE~? 10.07 C18 P6G D1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 29.57 8.47 -39.24 28.68 6.25 -39.24 coo -23.62 58.20 50.84 -23.76 56.14 48.96 19.42 15.07 -40.90 21.07 15.22 -43.15 coo -23.08 51.44 54.96 -24.43 52.71 52.88 17.40 15.07 -34.81 19.85 13.95 -34.07 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER C 78 SER~? -2.69 O4 PG4 C1130s D 166 PHE C 99 PHE~? 10.28 C1 PG4 C1130 D 182 PHE C 87 PHE~? 15.40 C1 PG4 C1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -21.03 -3.47 -22.49 -21.84 -4.21 -20.38 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -22.61 -10.62 -30.21 -20.05 -9.49 -30.75 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -16.79 -10.60 -33.81 -17.70 -10.94 -36.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER D 78 SER~? -2.57 O10 P6G D1130s D 166 PHE D 99 PHE~? 10.07 C18 P6G D1130 D 182 PHE D 87 PHE~? 15.25 C18 P6G D1130 coo -32.42 55.27 46.18 -30.51 54.94 47.67 18.64 6.84 -41.57 17.91 7.53 -43.73 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.40 15.07 -34.81 19.85 13.95 -34.07 coo -23.08 51.44 54.96 -24.43 52.71 52.88 23.55 15.85 -31.50 22.92 16.84 -28.96 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 8 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 94 GLU~? 22.82 O1 P6G D1130 A 44 ASP A 85 ASP~? 19.32 C6 PG4 C1130 A 50 THR A 89 THR.? 25.53 O1 P6G D1130 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -5.16 0.04 -40.94 -6.61 0.89 -39.59 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 73 GLU~? 10.65 C14 P6G D1130 A 44 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 50 THR D 89 THR~? 14.44 C17 P6G D1130 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 30.54 14.87 -46.06 28.97 16.29 -46.38 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 30.11 16.81 -35.09 30.09 15.90 -37.05 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 94 GLU~? 22.51 C2 P6G D1130 A 44 ASP B 85 ASP~? 16.97 O1 P6G D1130 A 50 THR B 89 THR~? 23.45 O1 P6G D1130 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 38.57 0.93 -32.34 39.48 -0.67 -33.39 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 35.32 4.97 -23.65 34.17 3.75 -25.02 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU C 94 GLU~? 10.36 O1 PG4 C1130 A 44 ASP C 85 ASP~? 10.22 C6 PG4 C1130 A 50 THR C 89 THR~? 14.94 C2 PG4 C1130 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU D 94 GLU~? 9.44 O19 P6G D1130 A 44 ASP D 85 ASP~? 10.24 C11 P6G D1130 A 50 THR D 89 THR~? 14.44 C17 P6G D1130 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 24.07 21.72 -40.89 25.61 20.78 -41.98 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 30.11 16.81 -35.09 30.09 15.90 -37.05 3hde_o00 source 3HDE LYSOZYME : 5 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 94 GLU~? 22.82 O1 P6G D1130 B 44 ASP A 85 ASP~? 19.32 C6 PG4 C1130 B 50 THR A 89 THR.? 25.53 O1 P6G D1130 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -5.16 0.04 -40.94 -6.61 0.89 -39.59 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 121 GLU~? 26.56 C11 P6G D1130 B 44 ASP B 85 ASP~? 16.97 O1 P6G D1130 B 50 THR B 89 THR~? 23.45 O1 P6G D1130 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 40.84 14.63 -29.45 39.08 15.39 -28.50 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 31.47 6.05 -29.78 29.50 6.72 -30.15 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 35.32 4.97 -23.65 34.17 3.75 -25.02 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU C 94 GLU~? 10.36 O1 PG4 C1130 B 44 ASP C 85 ASP~? 10.22 C6 PG4 C1130 B 50 THR C 89 THR~? 14.94 C2 PG4 C1130 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU D 94 GLU~? 9.44 O19 P6G D1130 B 44 ASP D 85 ASP~? 10.24 C11 P6G D1130 B 50 THR D 89 THR~? 14.44 C17 P6G D1130 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 24.07 21.72 -40.89 25.61 20.78 -41.98 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 26.47 11.48 -38.21 26.51 9.40 -38.05 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 30.11 16.81 -35.09 30.09 15.90 -37.05 3hde_o01 source 3HDE LYSOZYME : 4 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 94 GLU~? 22.82 O1 P6G D1130 C 44 ASP A 85 ASP~? 19.32 C6 PG4 C1130 C 50 THR A 89 THR.? 25.53 O1 P6G D1130 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -1.57 4.02 -31.47 -0.29 5.04 -30.11 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -8.98 -1.84 -35.39 -10.62 -3.17 -35.56 coo 25.48 4.87 1.60 23.90 4.95 0.15 -5.16 0.04 -40.94 -6.61 0.89 -39.59 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 88 GLU~? 21.68 O1 P6G D1130 C 44 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 50 THR D 89 THR~? 14.44 C17 P6G D1130 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 33.13 10.31 -25.75 31.26 10.53 -26.75 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 25.48 4.87 1.60 23.90 4.95 0.15 30.11 16.81 -35.09 30.09 15.90 -37.05 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU B 121 GLU~? 26.56 C11 P6G D1130 C 44 ASP B 85 ASP~? 16.97 O1 P6G D1130 C 50 THR B 89 THR~? 23.45 O1 P6G D1130 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 40.84 14.63 -29.45 39.08 15.39 -28.50 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 31.47 6.05 -29.78 29.50 6.72 -30.15 coo 25.48 4.87 1.60 23.90 4.95 0.15 35.32 4.97 -23.65 34.17 3.75 -25.02 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU C 94 GLU~? 10.36 O1 PG4 C1130 C 44 ASP C 85 ASP~? 10.22 C6 PG4 C1130 C 50 THR C 89 THR~? 14.94 C2 PG4 C1130 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -15.29 -17.95 -25.87 -13.58 -17.15 -24.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -13.20 -7.46 -26.79 -13.21 -5.39 -26.57 coo 25.48 4.87 1.60 23.90 4.95 0.15 -9.88 -12.10 -31.19 -9.64 -11.56 -29.11 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU D 94 GLU~? 9.44 O19 P6G D1130 C 44 ASP D 85 ASP~? 10.24 C11 P6G D1130 C 50 THR D 89 THR~? 14.44 C17 P6G D1130 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 24.07 21.72 -40.89 25.61 20.78 -41.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 26.47 11.48 -38.21 26.51 9.40 -38.05 coo 25.48 4.87 1.60 23.90 4.95 0.15 30.11 16.81 -35.09 30.09 15.90 -37.05 3hde_o02 source 3HDE LYSOZYME : 5 hits 3hde_o02 naa= 3